Clinical and Molecular Hepatology

"Guidelines"

Review

Comparison of clinical practice guidelines for chronic hepatitis B: natural history classification and treatment initiation: Gi-Ae Kim, Won-Mook Choi, Gwang Hyeon Choi, In Hee Kim, Tatsuya Kanto, Ming-Lung Yu, Young-Suk Lim; Clin Mol Hepatol 2026;32(3):1186-1200.
Published online June 29, 2026; DOI: https://doi.org/10.3350/cmh.2026.0697

Abstract
PDF

International and regional clinical practice guidelines (CPGs) for chronic hepatitis B (CHB) have recently been updated to incorporate evolving clinical evidence. This review compares the latest major CPGs regarding natural history classification, treatment initiation, and selection of antiviral agents, specifically focusing on updates from the Korean Association for the Study of the Liver-East Asia Liver Alliance (KASL-EALA), the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the World Health Organization (WHO). While all guidelines recognize the heterogeneous and dynamic nature of CHB, managing patients in the “grey zone” or indeterminate phase remains a major challenge. The KASL–EALA 2026 guideline introduces a novel framework based primarily on hepatitis B virus (HBV) DNA levels—independent of alanine aminotransferase criteria—eliminating the indeterminate category to better align with hepatocellular carcinoma risks and simplify treatment decision-making. In contrast, AASLD 2025, EASL 2025, and WHO 2024 retain conventional immunological phase-based classifications for natural history. For treatment indications, all four guidelines advocate broader access to antiviral therapy despite their divergent structural approaches. AASLD suggests shared decision-making, EASL emphasizes individualized risk assessment, and WHO 2024 abandons the phase-based framework for treatment decisions entirely. Understanding these key similarities and differences will help clinicians optimize patient care and inform future efforts toward global harmonization in CHB management.

1,412 View
104 Download

Special Issues

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA): Won-Mook Choi, Ji Won Han, Tae Hyung Kim, Miyoung Choi, Moon Haeng Hur, Hyo Young Lee, Han Ah Lee, Byeong Geun Song, Heechul Nam, Jeong-Ju Yoo, Chang Hun Lee, Gi-Ae Kim, Hye Won Lee, Gwang Hyeon Choi, Young Eun Chon, Yun Bin Lee, Dong Hyun Sinn, Bo Hyun Kim, In Hee Kim, on behalf of the Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2026;32(3):1029-1116.
Published online June 12, 2026; DOI: https://doi.org/10.3350/cmh.2026.0579

Citations

Citations to this article as recorded by

Comparison of clinical practice guidelines for chronic hepatitis B: natural history classification and treatment initiation
Gi-Ae Kim, Won-Mook Choi, Gwang Hyeon Choi, In Hee Kim, Tatsuya Kanto, Ming-Lung Yu, Young-Suk Lim
Clinical and Molecular Hepatology.2026; 32(3): 1186. CrossRef

2,538 View
273 Download
Crossref

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications 2026: Do Seon Song, Jeong-Ju Yoo, Jeong Eun Song, Seong Hee Kang, Seung Kak Shin, Seul Ki Han, Sung Won Chung, Gi-Ae Kim, Moon Haeng Hur, Han Ah Lee, Yeonjung Ha, Young Chang, Jae Hyun Yoon, Jae Seung Lee, Sang Gyune Kim, Young Kul Jung, Moon Young Kim; Clin Mol Hepatol 2026;32(3):961-1028.
Published online April 28, 2026; DOI: https://doi.org/10.3350/cmh.2026.0281

2,536 View
190 Download

2025 KASL clinical practice guidelines for management of hepatitis C: Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung, on behalf of the Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2026;32(1):1-52.
Published online October 23, 2025; DOI: https://doi.org/10.3350/cmh.2025.0777

8,979 View
335 Download
1 Web of Science

Liver fibrosis, cirrhosis, and portal hypertension

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease: Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim, on behalf of The Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2024;30(Suppl):S5-S105.
Published online August 19, 2024; DOI: https://doi.org/10.3350/cmh.2024.0506

Citations

Citations to this article as recorded by

Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Haiyu Wang, Jinjun Chen
Clinical and Molecular Hepatology.2026; 32(1): e58. CrossRef
Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-Male-Albumin-Bilirubin-Platelet (aMAP) and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography
Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
Clinical Gastroenterology and Hepatology.2026; 24(7): 1897. CrossRef
Refining portal hypertension assessment: The clinical significance of spleen stiffness measurement in the Baveno VII Era: Editorial on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Do Seon Song
Clinical and Molecular Hepatology.2026; 32(1): 400. CrossRef
Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement
Joseph Rabbat, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel Tsochatzis, Salvatore Petta, Elisabetta Bugianesi, Masato Yoneda, Ming-Hua Zheng, Hannes Hagström, Jérôme Boursier, José Luis Calleja, George Boon-Bee Goh, Wah-Kheong Chan, Rocio Gallego-Durán,
Clinical and Molecular Hepatology.2026; 32(1): 289. CrossRef
Non-invasive Risk-based Surveillance Strategy for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease
Ji Won Han
The Korean Journal of Gastroenterology.2026; 86(1): 62. CrossRef
2025 KASL clinical practice guidelines for management of hepatitis C
Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung
Clinical and Molecular Hepatology.2026; 32(1): 1. CrossRef
Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease Subtypes
Gi-Ae Kim, Heejoon Jang, Moon Young Kim, Jeong Hwan Park, Jung Gil Park, Eun-Young Cho, Jae Yoon Jeong, Seogsong Jeong, Seul Ki Han, Heesu Kwon, Youngae Jung, Geum-Sook Hwang, Yu Rim Lee, Soo Young Park, Sang Gyune Kim, Won Kim
Gastroenterology.2026; 170(7): 1571. CrossRef
PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patients
Jaejun Lee, Dong Yeop Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Mi Young Byun, Seok Keun Cho, Seong Wook Yang, Si Hyun Bae, Pil Soo Sung
Journal of Liver Cancer.2026; 26(1): 147. CrossRef
Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
Annals of Hepatology.2026; 31(2): 102199. CrossRef
Diagnostic Value of MR Elastography and MRI‐Proton Density Fat Fraction in Cirrhosis Based on Explant Liver Histology
Eun‐Ki Min, Seung‐seob Kim, Byungsoo Ahn, Deok‐Gie Kim, Dong Jin Joo, Sang Hoon Ahn, Seung Up Kim, Jae Geun Lee
Journal of Gastroenterology and Hepatology.2026; 41(4): 1323. CrossRef
Systematic Review: Imaging‐Based Morphological Criteria for Liver Cirrhosis—A Call to Standardise
Mei Chin Lim, Ethan Joo Wei Quek, Talia Yi Hui Chan, Margaret Teng, Cheng Han Ng, Mirudhula Gnanavelou, Vincent L. Chen, Jonathan A. Fallowfield, Huimiao Zhang, Mazen Noureddin, Donghyun Ko, Benjamin Nah, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Jimm
Alimentary Pharmacology & Therapeutics.2026; 63(9): 1201. CrossRef
Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach
Beom Kyung Kim
The Kaohsiung Journal of Medical Sciences.2026;[Epub] CrossRef
The MASLD Journey in the General Population: Linkage‐to‐Care and Patient‐Reported Uptake of Fibrosis Risk Assessment
Joo Hyun Oh, Jun‐Hyuk Lee, Sang Bong Ahn, Eunjoo Kwon, Eileen L. Yoon, Hyo Young Lee, Seon Cho, Dae Won Jun
Liver International.2026;[Epub] CrossRef
Rethinking first-line screening in MASLD beyond the limitations of Fibrosis-4 index: Editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”
Han Ah Lee, Young Youn Cho, Hyung Joon Kim
Clinical and Molecular Hepatology.2026; 32(2): 921. CrossRef
AI Framework Integrated with InN Gas Sensing to Distinguish Sedentary Metabolic Fingerprints from Chronic Liver Disease
Tsung Ming Chao, Rakesh Kumar Patnaik, Yu Chen Lin, Ming-Chih Ho, J. Andrew Yeh
AI Sensors.2026; 2(2): 6. CrossRef
Risk Prediction of Early‐Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult Cohort
Seogsong Jeong, Gi‐Ae Kim, Heejoon Jang, Dong Hyeon Lee, Sae Kyung Joo, Keon Wook Kang, Hwamin Lee, Won Kim
Alimentary Pharmacology & Therapeutics.2026; 64(4): 507. CrossRef
Combined Associations of Lead and Arsenic Species with Liver Dysfunction and Hepatic Fibrosis Among Young Adults in Taiwan
Kai-Wei Liao, Chih-Wen Wang, Wei-Lun Hung, Ya-Ling Chen, Yee-How Say, Yang-Ching Chen, Wei-Shan Chin
Exposure and Health.2026;[Epub] CrossRef
Inflammatory activity stratification improves liver stiffness diagnosis of fibrosis in autoimmune hepatitis
Yan Huang, Delin Liu, Yunjiang Li, Xu Zhang, Yu Tang
Frontiers in Immunology.2026;[Epub] CrossRef
Non-Invasive Tests in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Diagnosis to Treatment Monitoring
Han Ah Lee, Young Youn Cho, Hyung Joon Kim
Clinical Ultrasound.2026; 11(1): 1. CrossRef
Alcohol consumption and dementia risk in steatotic liver disease: a nationwide cohort study
Ji Won Han, Seunghee Na, Kyungdo Han, Kyu Na Lee, Do Young Kim, Sang Hoon Ahn, Mi Na Kim
Hepatology International.2026;[Epub] CrossRef
Rule-Out Cutoff of Two-Dimensional Shear Wave Elastography for Significant Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease: Systematic Review, Meta-Analysis, and External Validation
Joo Hyun Oh, Jonghyun Lee, Miyoung Choi, Kento Imajo, Masato Yoneda, Hideki Fujii, Hyo Young Lee, Eileen L. Yoon, Mimi Kim, Dae Won Jun
Clinical Gastroenterology and Hepatology.2026;[Epub] CrossRef
Progression of Metabolic Dysfunction–Associated Steatohepatitis in US Adults Using Linked Records and Claims
Yestle Kim, Romina Fakhraei, John C. O’Donnell, Karissa Johnston, Melissa Bather, Reem Mustafa, Andrew R. Kennedy, Amreen Dinani
Gastro Hep Advances.2026; 5(9): 101031. CrossRef
Preventive strategies in hepatology: Role of multiparametric assessment of portal hypertension in chronic liver disease
Angela Peltec, Ioan Sporea
World Journal of Gastroenterology.2026;[Epub] CrossRef
Pharmabiotics, Phocaeicola dorei, ameliorates cholestatic liver fibrosis by alleviating macrophage efferocytosis of neutrophils
Jung A Eom, In Gyu Park, Ji Ye Hyun, Na Young Lee, Goo Hyun Kwon, Sang Jun Yoon, Sung-Min Won, Young Lim Ham, Kyeong Jin Lee, Sang Hak Han, Dong-Hoon Yang, Dong Joon Kim, Ki Tae Suk
Nature Communications.2026;[Epub] CrossRef
The risk of cardiovascular events in metabolic dysfunction–associated steatotic liver disease according to fibrosis stage and diabetes status: A cohort study
Jaehong Jeong, Jung Pyo Hong, Dong Yun Kim, Jae Seung Lee, Mi Na Kim, Jeong Eun Song, Hyun Chin Cho, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hye Won Lee, Seung Up Kim
Hepatology Communications.2026;[Epub] CrossRef
Threshold‐Defined Liver Stiffness Trajectories and Liver‐Related Event Risk in Chronic Liver Disease: A Cohort Study
Dong Yun Kim, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Liver International.2026;[Epub] CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA)
Won-Mook Choi, Ji Won Han, Tae Hyung Kim, Miyoung Choi, Moon Haeng Hur, Hyo Young Lee, Han Ah Lee, Byeong Geun Song, Heechul Nam, Jeong-Ju Yoo, Chang Hun Lee, Gi-Ae Kim, Hye Won Lee, Gwang Hyeon Choi, Young Eun Chon, Yun Bin Lee, Dong Hyun Sinn, Bo Hyun K
Clinical and Molecular Hepatology.2026; 32(3): 1029. CrossRef
Shear Wave Elastography Combined with ALBI Score Enhances Prediction of Hepatic Decompensation in Chronic Liver Disease
Jaejun Lee, Hyun Yang, Si Hyun Bae, Sun Hong Yoo, Soon Woo Nam, Jiwoon Yoon, Jung Hyun Kwon, Soon Kyu Lee
JHEP Reports.2026; : 101963. CrossRef
Emerging Indices Outperform Traditional Fibrosis Scores in Young Metabolic Dysfunction‐Associated Steatotic Liver Disease Across Divergent Screening Goals
Ahlim Lee, Chang In Han, Keungmo Yang, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Jaejun Lee
Journal of Gastroenterology and Hepatology.2026;[Epub] CrossRef
Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
Hee Yeon Kim, Miyoung Choi, Dae Won Jun
Clinical and Molecular Hepatology.2025; 31(1): e48. CrossRef
Non-Invasive Liver Fibrosis Test Using Shear Wave Elastography
Ji Won Han
The Korean Journal of Medicine.2025; 100(1): 26. CrossRef
Influence of Sex in the Development of Liver Diseases
Jie-Wen Zhang, Nan Zhang, Yi Lyu, Xu-Feng Zhang
Seminars in Liver Disease.2025; 45(01): 015. CrossRef
KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang
Clinical and Molecular Hepatology.2025; 31(Suppl): S1. CrossRef
Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study
G. Craig Wood, Anthony Hoovler, Rakesh Luthra, Christopher D. Still, Hamzah Shariff, Matthew Still, Jonathan Hayes, Peter Benotti, Chioma Uzoigwe
Expert Review of Gastroenterology & Hepatology.2025; 19(4): 427. CrossRef
Age serves as the silent architect of FIB-4’s precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on “Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liv
Ji Won Han, Dae Won Jun
Clinical and Molecular Hepatology.2025; 31(2): e152. CrossRef
The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study
Yanjun Guo, Wei Su, Lulong Tao, Guoxin Zhang, Kun Wang
BMC Gastroenterology.2025;[Epub] CrossRef
Future Perspectives of Liver Research in the Asia‐Pacific Region: Focus on Hepatitis B and C
Beom Kyung Kim
Journal of Gastroenterology and Hepatology.2025; 40(8): 1855. CrossRef
Novel Insights into Noninvasive Assessment of Liver Fibrosis in Chronic Hepatitis C Patients
Guanlan Liu, Li Liu, Xing Yang, Qihao Wang, Mingqin Qian
Journal of Clinical and Experimental Hepatology.2025; 15(6): 102610. CrossRef
A Case Report of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) with Improved Cardiometabolic Risk Factors Following Treatment with Saenggangunbi-tang
Eun Kyung Lee, Min Jeong Park, Youngchul Kim, Jang-Hoon Lee
The Journal of Internal Korean Medicine.2025; 46(2): 303. CrossRef
Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Clinical and Molecular Hepatology.2025; 31(3): 1018. CrossRef
Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population
Jean-Bonny Nsumbu, Jean-Robert Makulo, Trésor Mutombo Tshiswaka, Christian Kisoka Lusunsi, Charles Nlombi Mbendi
Hepatic Medicine: Evidence and Research.2025; Volume 17: 27. CrossRef
Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis
Toshikazu Kohira, Satoshi Oeda, Erina Eto, Yoshihito Kubotsu, Misa Norita, Kaori Inoue, Nagisa Hara, Shotaro Noge, Kenichi Tanaka, Shigenobu Yoshimura, Noriko Oza, Keizo Anzai, Yuichiro Eguchi, Cheng Han Ng, Daniel Q. Huang, Mark D. Muthiah, Atsushi Kawag
Scientific Reports.2025;[Epub] CrossRef
Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study
Jung Hee Kim, Jae Hyun Yoon, Sung-Eun Kim, Ji-Won Park, Yewan Park, Gi-Ae Kim, Seong Kyun Na, Young-Sun Lee, Jeong Han Kim
Medicina.2025; 61(9): 1601. CrossRef
Comment on ‘Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank’ by T. S. Lim et al.—Authors' Reply
Tae Seop Lim, Sujin Kwon, Sung A Bae, Hye Yeon Chon, Seol A. Jang, Ja Kyung Kim, Chul Sik Kim, Seok Won Park, Kyoung Min Kim
Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis
Mi Na Kim, Geun U. Park, Seng Chan You, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn
Journal of Gastroenterology and Hepatology.2025; 40(11): 2750. CrossRef
Prospects of late-stage development agents in the treatment of metabolic dysfunction-associated steatohepatitis
Brian Lee, Ussama Ghumman, Lisa D. Pedicone, Andres Gomez Aldana, Eric Lawitz
Clinical and Molecular Hepatology.2025; 31(4): 1167. CrossRef
Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis
Huiru Jin, Mengfan Jiao, Chengxiao Yu, Tingting Ren, Qingling Chen, Zixing Dai, Erfu Xie, Longfeng Jiang, Yuwen Li
European Journal of Medical Research.2025;[Epub] CrossRef
Mistakes in the utilization of vibration-controlled transient elastography in the evaluation of liver fibrosis: a narrative review
Madunil Anuk Niriella, Uditha Bandara Dassanayake, Charith Priyanga Madurapperuma, Indeewari Prathibha Wijesingha, Arjuna Priyadarshin De Silva, Hithnadura Janaka de Silva
Expert Review of Gastroenterology & Hepatology.2025; 19(12): 1299. CrossRef
A Novel Deep Learning Framework for Liver Fibrosis Staging and Etiology Diagnosis Using Integrated Liver–Spleen Elastography
Kai Yang, Fei Chen, Aiping Tian, Long Deng, Xiaorong Mao
Diagnostics.2025; 15(23): 2986. CrossRef
Shear-Wave Elastography: Principles, Techniques, and Clinical Considerations
Jae Seung Lee
Clinical Ultrasound.2025; 10(2): 53. CrossRef
Vibration-Controlled Transient Elastography in Chronic Liver Disease: Current Research Insights
Ho Soo Chun
Clinical Ultrasound.2025; 10(2): 69. CrossRef
Recent Trends in Noninvasive Tests for Assessing Hepatic Fibrosis in Patients with Chronic Liver Disease
Jung Hwan Yu
The Korean Journal of Medicine.2024; 99(5): 232. CrossRef
Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography
Mi Na Kim
The Korean Journal of Gastroenterology.2024; 84(5): 201. CrossRef
Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
Ye Ji Jun, Minjong Lee, Ho Soo Chun, Tae Hun Kim
The Korean Journal of Gastroenterology.2024; 84(5): 206. CrossRef
Serological Markers to Assess Liver Fibrosis and Their Roles
Beom Kyung Kim
The Korean Journal of Gastroenterology.2024; 84(5): 195. CrossRef
Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography
Han Ah Lee
Clinical Ultrasound.2024; 9(2): 70. CrossRef

24,397 View
397 Download
52 Web of Science
Crossref

Guideline

Autoimmune liver disease

KASL clinical practice guidelines for management of autoimmune hepatitis 2022: The Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2023;29(3):542-592.
Published online May 3, 2023; DOI: https://doi.org/10.3350/cmh.2023.0087

Citations

Citations to this article as recorded by

Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025
Atsushi Tanaka, Sombat Treeprasertsuk, Ming-Ling Chang, Soek-Siam Tan, Cumali Efe, Sook-Hyang Jeong, Xiong Ma, Martin Weltman, Hiroyuki Isayama, Jidong Jia
Hepatology International.2026; 20(1): 19. CrossRef
Clinical Outcomes of Children With Autoimmune Hepatitis in Korea: A Nationwide Multicenter Study
Jeong Eun Ahn, Jae Sung Ko, Jin Soo Moon, Shinjie Choi, Yeoun Joo Lee, Eun Joo Lee, Hong Koh, Ho Jung Choi, Seak Hee Oh, Kyung Mo Kim, Ki Soo Kang, Byung-Ho Choe, Seo-Hee Kim, Eun Sil Kim, Mi Jin Kim, Seon Young Kim, Kyung Jae Lee
Journal of Korean Medical Science.2026;[Epub] CrossRef
Relapse After Treatment Withdrawal in Autoimmune Hepatitis: Biopsy‐Guided Versus Clinically Guided Strategies—A Meta‐Analysis
Yongqi Dong, Dan Zhou, Leyu Zhou, Li Yang, Yi Shen
Liver International.2026;[Epub] CrossRef
Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study
Sung Won Chung, Ye-Jee Kim, Jihye Lim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sehee Kim, Won-Mook Choi
American Journal of Gastroenterology.2025; 120(10): 2302. CrossRef
Transient elastography for assessing liver fibrosis in autoimmune liver diseases: Excellent performance but limited details: Editorial on “Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver di
Kyung-Ah Kim
Clinical and Molecular Hepatology.2025; 31(1): 275. CrossRef
Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment
Atsumasa Komori, Yuki Kugiyama
Clinical and Molecular Hepatology.2025; 31(1): 90. CrossRef
Comment on “Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis”
Bilal Ahmad, Ayesha Arshad, Niqab Muhammad
Digestive Diseases and Sciences.2025; 70(11): 3977. CrossRef
Autoimmune hepatitis. Clinical case
Anna Usachova, Lyudmila Onyshchuk
The Ukrainian Scientific Medical Youth Journal.2025; 154(2): 35. CrossRef
Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis
Jihye Lim, Ye-Jee Kim, Sehee Kim, Ju Hyun Shim, Ashraf Elbahrawy
PLOS One.2025; 20(7): e0325066. CrossRef
Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia
Jiwon Yang, Sun Young Yim, Kunhee Kim, Hye Won Lee, Jonggi Choi
JHEP Reports.2025; 7(10): 101524. CrossRef
Difficult to treat and refractory autoimmune hepatitis: Recent advances in pharmacological management
Sayan Malakar, Umair Shamsul Hoda, Suprabhat Giri, Arghya Samanta, Akash Roy, Rajat Gupta, S Rakesh Kumar, Mayank Agarwal, Anubhav Pawar, Sumit Rungta, Uday C Ghoshal
World Journal of Hepatology.2025;[Epub] CrossRef
Mechanistic optimization of inavolisib combined with CDK4/6 inhibitors in the treatment of PIK3CA-mutated breast tumors
Rongyu Zhu, Haixin Zhang, Fuli Zhang
Frontiers in Immunology.2025;[Epub] CrossRef
Autoimmune hepatitis: current concepts in epidemiology, diagnosis, and management
Brian J. Wentworth, Kwang Il Seo
Kosin Medical Journal.2025; 40(4): 249. CrossRef
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
Atsumasa Komori
Clinical and Molecular Hepatology.2024; 30(2): 157. CrossRef
Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database
Jihye Lim, Hwa Jung Kim
Orphanet Journal of Rare Diseases.2024;[Epub] CrossRef
The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases
Soon Kyu Lee, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Seok Lee, Younghoon Kim, Ji Won Han, Hyun Yang, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Ke
Diagnostics.2024; 14(16): 1745. CrossRef
Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis
Jihyun An, Young Eun Chon, Gunho Kim, Mi Na Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Miyoung Choi, Dae Won Jun, Seung Up Kim, Ji Won Han, Young-Joo Jin
Clinical and Molecular Hepatology.2024; 30(Suppl): S134. CrossRef
Analysis of Azathioprine Metabolites in Autoimmune Hepatitis Patient Blood—Method Development and Validation
Andrea Guba, Patrícia Kováts, Zoltán A. Mezei, Mária Papp, Éva Csősz, Gergő Kalló
International Journal of Molecular Sciences.2024; 25(20): 11233. CrossRef
AUTOIMMUNE HEPATITIS AND THE COMPLEXITY OF ITS MANAGEMENT: A CLINICAL CASE
V. N. Zhdan, O. A. Kyrian, M. Yu. Babanina, I. V. Ivanytskyi, M. V. Tkachenko, V. G. Lebid
Bulletin of Problems Biology and Medicine.2023; 1(2): 179. CrossRef
Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity
Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim
Clinical and Molecular Hepatology.2023; 30(1): 37. CrossRef

21,188 View
466 Download
17 Web of Science
Crossref

Editorials

Hepatic neoplasm

Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma: Do Young Kim; Clin Mol Hepatol 2023;29(2):335-338.
Published online March 20, 2023; DOI: https://doi.org/10.3350/cmh.2023.0107

8,210 View
63 Download

Hepatic neoplasm

Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan: San-Chi Chen; Clin Mol Hepatol 2023;29(2):352-354.
Published online March 20, 2023; DOI: https://doi.org/10.3350/cmh.2023.0101

Citations

Citations to this article as recorded by

Factors Influencing Overall Survival Period of Stage IV Cancer Patients
Wen Pei Chang, Yen Kuang Lin, Shashank Kaushik
European Journal of Cancer Care.2025;[Epub] CrossRef

8,697 View
77 Download
1 Web of Science
Crossref

Guidelines

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma: Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea; Clin Mol Hepatol 2022;28(4):583-705.
Published online October 1, 2022; DOI: https://doi.org/10.3350/cmh.2022.0294

Abstract
PDF

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelines will provide useful and sensible advice for the clinical management of patients with HCC. A total of 49 experts in the fields of hepatology, oncology, surgery, radiology, and radiation oncology from the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2018 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions. These guidelines provide useful information and direction for all clinicians, trainees, and researchers in the diagnosis and treatment of HCC.

Citations

Citations to this article as recorded by

Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis
Youngsu Park, Yuri Cho, Seung Up Kim, Aryoung Kim, Hyunjae Shin, Hyo-Cheol Kim, In Joon Lee, Gyoung Min Kim, Dongho Hyun, Yunmi Ko, Jeayeon Park, Jae Woong Yoon, Gyung Sun Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan
Diagnostic and Interventional Imaging.2026; 107(1): 25. CrossRef
Risk-based selection of treatment strategies in hepatocellular carcinoma with macrovascular invasion
Nalee Kim, Hyunki Park, Jeong Il Yu, Hee Chul Park, Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Dong Hyun Sinn, Moon Seok Choi, Jung Yong Hong, Minsuk Kwon, Sung Wook Shin, Sung Ki Cho, Dongho Hyun
Radiotherapy and Oncology.2026; 214: 111260. CrossRef
Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-Male-Albumin-Bilirubin-Platelet (aMAP) and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography
Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
Clinical Gastroenterology and Hepatology.2026; 24(7): 1897. CrossRef
Deep learning approach for discrimination of liver lesions using nine time-phase images of contrast-enhanced ultrasound
Naohisa KAMIYAMA, Katsutoshi SUGIMOTO, Ryuichi NAKAHARA, Tatsuya KAKEGAWA, Takao ITOI
Choonpa Igaku.2026; 53(2): 73. CrossRef
Improving surgical treatments for hepatocellular carcinoma
Abdullah K. Malik, Daniel Geh, Thomas R. Jeffry Evans, Pierce K. H. Chow, Derek A. Mann, Steven A. White
Nature Reviews Gastroenterology & Hepatology.2026; 23(3): 208. CrossRef
External beam radiation for HCC: Ready for incorporation into guidelines?
Michael Buckstein, Laura A. Dawson
JHEP Reports.2026; 8(2): 101683. CrossRef
Non-contrast magnetic resonance imaging outperforms contrast-enhanced computed tomography in preoperative detection of hepatocellular carcinoma: A paired validation study
Laizhu Zhang, Weiwei Zong, Jialin Gao, Huan Li, Leizhou Xia, Xiaoli Mai, Jun Chen, Binghua Li, Decai Yu
Clinical and Molecular Hepatology.2026; 32(1): e34. CrossRef
Macrotrabecular-Massive Subtype Is Associated with a High Risk of the Recurrence of Hepatocellular Carcinoma
Sung Hwan Yoo, Ji Hae Nahm, Hye Young Chang, Jung Il Lee, Jin Hong Lim, Hyun Woong Lee
Journal of Clinical Medicine.2026; 15(2): 502. CrossRef
Preoperative contrast-enhanced CT prediction of distinct vascular patterns in solitary early-stage hepatocellular carcinoma and its prognostic value
Wanli Zhang, Wen Lv, Yi Long, Jiaxin Lin, Jiamin Li, Chuanxian Zhang, Yandong Zhao, Jie Zhan, Shengsheng Lai, Mingyong Gao, Xinqing Jiang, Ruimeng Yang
Insights into Imaging.2026;[Epub] CrossRef
Updates in Abbreviated MRI‐Based HCC Surveillance
Hyo Jung Park, So Yeon Kim, Young‐Suk Lim
Journal of Gastroenterology and Hepatology.2026; 41(3): 914. CrossRef
Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablation
Ching-Wei Chang, Ming-Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, Shih-Jer Hsu, Shen-Yung Wang, Chao-Hung Hung, Chih Horng Wu, San-Chi Chen, Yu-Ming Cheng, I-Cheng Lee, Yi-Chung Hsieh, Wei-Ting Chen, Chen-Chun Lin, Po-Chin Liang, Jen-I. Hwang, Shi-Ming Lin, Ka
Hepatology International.2026; 20(2): 240. CrossRef
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial
Hai-Dong Zhu, Wei-Jun Fan, Chang Zhao, Song Wang, Yu-Liang Li, Zhi-Cheng Jin, Zhe-Wei Zhang, Jin-He Guo, Hong-Tao Cheng, Qi Zhang, Jian Lu, Yong-Yi Zeng, Wei-Fu Lv, Hao Xu, Hai-Bo Shao, Wei-Guo Xu, Xu-Ya Zhao, Shan-Zhi Gu, Hai-Lan Lin, Wen-Heng Zheng, Lon
Journal of Clinical Oncology.2026; 44(11): 959. CrossRef
Bridging east and west: ancillary features and AFP to improve MRI diagnosis of ≤ 30 mm HCC
Jeong Hee Yoon, Jeong Min Lee
European Radiology.2026; 36(7): 5773. CrossRef
Hepatocellular carcinoma with macrovascular invasion: Navigating heterogeneous evidence
Manon Allaire, Irene Bargellini
Hepatology.2026;[Epub] CrossRef
The value of LI-RADS ancillary features and biomarker for hepatocellular carcinoma ≤ 30 mm in Western and Eastern guidelines on extracellular agent and gadoxetic acid-enhanced MRI
Jinhui Zhou, Siyu Ouyang, Haimei Chen, Dingyue Zhang, Yan Wang, Yuanqiang Xiao, Ying Zeng, Zebin Fang, Yufeng Wang, Lichun Chen, Jing Zhang, Tianhui Zhang, Xi Zhong, Qiqi Yang, XinXin Bu, Yang Yang, Jin Wang
European Radiology.2026; 36(7): 5755. CrossRef
Optimizing Screening of Hepatocellular Carcinoma with Computed Tomography and MR Imaging
Julie Y. An, Bari R. Dane, Robert M. Marks
Radiologic Clinics of North America.2026; 64(3): 475. CrossRef
Impact of Gadoxetic Acid Dilution on Arterial Phase Image Quality in Liver MRI: A Phase-by-Phase Analysis
Jordan Zheng Ting Sim, Xiaojia Ge, Hsien Min Low, Chau Hung Lee
Livers.2026; 6(2): 21. CrossRef
Value of des-gamma-carboxy prothrombin in comprehensive management of hepatocellular carcinoma
Zi-Han Liu, Wen-Jun Wang, Shuang-Suo Dang
World Chinese Journal of Digestology.2026; 34(2): 110. CrossRef
Focal lesions in the cirrhotic liver: an update on LI-RADS classification and clinical implications
Antonino Andrea Blandino, Federica Vernuccio, Roberto Cannella, Aoife Kilcoyne, Leo L. Tsai, Giuseppe Brancatelli
Digestive and Liver Disease.2026; 58(6): 713. CrossRef
Systematic Review: Imaging‐Based Morphological Criteria for Liver Cirrhosis—A Call to Standardise
Mei Chin Lim, Ethan Joo Wei Quek, Talia Yi Hui Chan, Margaret Teng, Cheng Han Ng, Mirudhula Gnanavelou, Vincent L. Chen, Jonathan A. Fallowfield, Huimiao Zhang, Mazen Noureddin, Donghyun Ko, Benjamin Nah, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Jimm
Alimentary Pharmacology & Therapeutics.2026; 63(9): 1201. CrossRef
Proposal for Modified Alpha Fetoprotein Use in Hepatocellular Carcinoma Surveillance: Analysis of the 2018–2020 National Cancer Screening Program
Shinae Yu, Sollip Kim, Hyeongsu Kim, Hye Ryun Lee, Jonggi Choi
Journal of Korean Medical Science.2026;[Epub] CrossRef
Severe Thrombocytopenia Is Associated With Bleeding in Hepatocellular Carcinoma Patients Receiving Antiangiogenic Therapy
Jun Tie, Zhengcai Liu, Xulong Yuan, Kai Li, Jing Niu, Jiao Xu, Li Xu, Yongquan Shi, Shuqiang Yue
Portal Hypertension & Cirrhosis.2026; 5(2): 140. CrossRef
Re-evaluating DAA therapy in active hepatocellular carcinoma: from controversy to clinical considerations
So Hyun Jeon, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
Journal of Liver Cancer.2026; 26(1): 93. CrossRef
Perioperative immunotherapy for resectable hepatocellular carcinoma – Authors’ reply
Fei Liang, Shaolai Zhou, Zheng Wang, Jia Fan, Jian Zhou
The Lancet.2026; 407(10536): 1334. CrossRef
Preoperative Gadoxetic-Acid-Enhanced MRI Features Associated with Rapid Recurrence (<6 Months) After Curative Resection for Hepatocellular Carcinoma
Jeong Woo Kim, Chang Hee Lee
Diagnostics.2026; 16(7): 1108. CrossRef
Liver resection versus radiofrequency ablation or transarterial chemoembolization for early multinodular BCLC-A hepatocellular carcinoma: a systematic review and meta-analysis
Maria F. F. Viana, Arthur A. Braga, Lucas B. Carvalho, Danilo C. M. S. Vasconcellos, Bianca C. M. R. Alexandrino, Felipe J. F. Coimbra
Journal of Liver Cancer.2026; 26(1): 157. CrossRef
Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patients
Boris Guiu, Clément Bailly, Eric Vibert, Ghoufrane Tlili, Denis Mariano-Goulart, Julien Edeline, Yann Touchefeu, Emmanuel Durand, Jean Frédéric Blanc, Julia Chalaye, Hélène Regnault, Antoine Bouvier, Geraldine Sergent, Christian Sengel, Stéphane Renaud, A
eClinicalMedicine.2026; 95: 103884. CrossRef
Proton beam therapy with or without transarterial chemoembolization for hepatocellular carcinoma: a propensity score matching analysis
Jen-Yu Cheng, Hee Chul Park, Jeong Il Yu, Nalee Kim, Jeong Ha Lee, Sung Koo Cho, Dongho Hyun, Yong-Han Paik
British Journal of Radiology.2026; 99(1182): 1221. CrossRef
Hepatocellular carcinoma surveillance: a health economic evaluation
Qi-Feng Chen, Xiong-Ying Jiang, Song Chen, Jiongliang Wang, Ming Zhao
Clinical and Molecular Hepatology.2026; 32(2): 536. CrossRef
HCC surveillance after curative treatment: A new frontier for abbreviated MRI: Editorial on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to
Hyungjin Rhee, Jin-Young Choi
Clinical and Molecular Hepatology.2026; 32(2): 939. CrossRef
Current and Emerging Immunotherapy Strategies in Hepatocellular Carcinoma: Standard Treatments and Biomarkers
Yoonseok Lee
Journal of Digestive Cancer Research.2026; 14(1): 53. CrossRef
Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
Hyo Jung Park, Dong Ho Lee, Won Chang, Hae Young Kim, Dong Hwan Kim, Won-Mook Choi, Sung Won Chung, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Han Chu Lee, Young-Suk Lim, Seon-Ok Kim, Amit G Singal, So Yeon Kim
BMJ Open.2026; 16(4): e116809. CrossRef
Correspondence to editorial on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography”
Dong Ho Lee
Clinical and Molecular Hepatology.2026; 32(2): e221. CrossRef
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort
Andrew M. Moon, Ted K. Yanagihara, Laura A. Dawson, Jeong Il Yu, Theodore S. Lawrence, Tae Hyun Kim, Michael Yan, Hiromitsu Iwata, Nima Nabavizadeh, Smith Apisarnthanarax, Emma M. Dunne, Michael I. Lock, Michael D. Chuong, Chi Leung Chiang, Marta Scorsett
Journal of Clinical Oncology.2026; 44(19): 1784. CrossRef
Hepatobiliary MRI contrast agents: Properties, clinical applications and future directions
Edouard Reizine, Riccardo Sartoris, Maxime Barat, Maxime Ronot, Sébastien Mulé, Laurent Milot, Anita Paisant
Diagnostic and Interventional Imaging.2026;[Epub] CrossRef
Radiofrequency ablation for large perivascular hepatocellular carcinoma: from biophysical limitations to holistic integrative strategies
Song Wang, Yu-han Shen, Bing Wang, Hao Wu, Zhong-yi Zhang, Kun Yan, Jing Wu, Wei Yang, Wei Wu
Holistic Integrative Oncology.2026;[Epub] CrossRef
Pain, analgesic use and misconceptions in patients with hepatocellular carcinoma: a cross-sectional survey
Jina Park, Jiwon Yang, Sung Won Chung, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
Journal of Liver Cancer.2026;[Epub] CrossRef
Case 25: A 37-Year-Old Woman with Fanconi Anemia and a Hepatic Mass
Min Gon Kang, Kwon Yong Tak, Kyoung Il Min, Ji Won Han
Journal of Korean Medical Science.2026;[Epub] CrossRef
Imaging-Based Liver Transplant Eligibility in Hepatocellular Carcinoma: Analysis of 1,094 Patients Using Liver Imaging Reporting and Data System and Asia-Pacific Guideline-Based Criteria
Yeongseok Hwang, Subin Heo, Jihyun An, Seong Kyun Na, Seon-Ok Kim, In-Hye Song, Jean-Charles Nault, Gi-won Song, Sang Hyun Choi, Ju Hyun Shim
Liver Cancer.2026; : 1. CrossRef
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses
Zhicheng Lai, Zefeng Du, Lichang Huang, Qijiong Li, Yexing Huang, Li Xu, Wei Wei, Yaojun Zhang, Minshan Chen, Ming Shi, Anna Kan, Minke He
Journal of the National Cancer Center.2026;[Epub] CrossRef
MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study
Hong Wei, Subin Heo, Yang Yang, Mengsi Li, Fangfang Fu, Tianyi Xia, Seung Soo Lee, Eun Sun Choi, Riccardo Sartoris, Jules Grégory, Christine Ying Kwok, Luna Wang, Junhan Pan, Yanyan Zhang, Roberto Cannella, Zhenru Wu, Yingyi Wu, Xinyuan Jia, Yuanan Wu, Ya
Journal of Hepatology.2026;[Epub] CrossRef
An Arterial‐Enhancing Liver Nodule With Washout in a Patient With Metabolic and Alcohol‐Associated Liver Disease
Soon Kyu Lee, Sun Young Jun, Young Chul Yoon
Journal of Gastroenterology and Hepatology.2026; 41(7): 1991. CrossRef
Expression of LHFPL2 in hepatocellular carcinoma and its association with prognosis after transarterial chemoembolization
Lei Sun, Kang Chen, Xiao-Li Zhu
World Journal of Gastrointestinal Surgery.2026;[Epub] CrossRef
Evaluation of Gd-EOB-DTPA MRI With Diffusion and Clinicopathologic Features for Predicting Microvascular Invasion in Hepatocellular Carcinoma
Ni Zhang, Hui Sun, Min Ge, Pengcheng Zhou
Journal of Computer Assisted Tomography.2026;[Epub] CrossRef
Antiviral Therapy and Post‐Resection Outcomes in Patients With Hepatitis B Virus‐Related Hepatocellular Carcinoma
Jaehong Jeong, Jung Pyo Hong, Dong Yun Kim, Jae Seung Lee, Mi Na Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hye Won Lee
Alimentary Pharmacology & Therapeutics.2026;[Epub] CrossRef
Survival outcomes of intensity-modulated radiotherapy combined with immunotherapy and targeted therapy for hepatocellular carcinoma with classification I–IV portal vein tumor thrombus: a propensity score matching study
Lijun Chen, Chunmi Wei, Zhehao Xiao, Qiaoyuan Wu, Liqing Li, Bangde Xiang, Shichun Guan, Peng Zhao, Shixiong Liang, Jianxu Li
Frontiers in Immunology.2026;[Epub] CrossRef
Hepatic Cysts in Korea: Prevalence, Incidence, and Risk Factors Based on a 5.8-Year Follow-up Health Screening Cohort
Kang Seo, Yujeong Kim, Sang Hyuk Park, Nam-Joon Yi, Jeong Hee Yoon, Goh Eun Chung, Jeong-Moo Lee, Seoung Yoon Rho, Min Su Park, Eun Kyung Choe, Aesun Shin
Journal of Korean Medical Science.2026;[Epub] CrossRef
Efficacy and safety of boosted transarterial radioembolization in patients with chemoembolization-refractory hepatocellular carcinoma
Gun Ha Kim, Eunbyeol Ko, Jeongyeon Kim, Minyoung Oh, Changhwan Sung, Jin Hyoung Kim, Dong Il Gwon
Acta Radiologica.2026;[Epub] CrossRef
Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study
Yuri Cho, Jeong-Hoon Lee, Baek-Yeol Ryoo, Ho Yeong Lim, Dong Eun Lee, Bo Hyun Kim, Joong-Won Park
Gut and Liver.2026; 20(4): 624. CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA)
Won-Mook Choi, Ji Won Han, Tae Hyung Kim, Miyoung Choi, Moon Haeng Hur, Hyo Young Lee, Han Ah Lee, Byeong Geun Song, Heechul Nam, Jeong-Ju Yoo, Chang Hun Lee, Gi-Ae Kim, Hye Won Lee, Gwang Hyeon Choi, Young Eun Chon, Yun Bin Lee, Dong Hyun Sinn, Bo Hyun K
Clinical and Molecular Hepatology.2026; 32(3): 1029. CrossRef
Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma
Ning Lyu, Jun-Zhe Yi, Xin-Tong Wu, Yi-Min Zhang, Tao Pan, Lu-Wen Mu, Song Chen, Jiong-Liang Wang, Jie Xu, Gen-Jun Tan, Yu-Nan Zhang, Zu-Qing Gao, Zi-Xi Ou-Yang, Wei-Jie Wu, Yu-Jia Song, Hai-Jing Deng, Meng He, Yi-Quan Jiang, Qi-Feng Chen, Ji-Bin Li, Ming
JAMA Oncology.2026;[Epub] CrossRef
Discrepancy Between Eligibility and Practice: A 14-Year Nationwide Study on Curative Resection in Elderly Hepatocellular Carcinoma Patients
Sun Woong Kim, Jun Sik Yoon, Young Lee, Heejoon Jang
Cancers.2026; 18(15): 2457. CrossRef
Safety and Efficacy of Adebrelimab plus Apatinib Combined with Hepatic Artery Infusion Chemotherapy for the Treatment of Unresectable Hepatocellular Carcinoma: A Retrospective Study
Bin Chen, Yilin Zeng, Karima Abdugheni, Linyuan Zeng, Haitao Dai, Keyu Tang, Guiyuan Zhang, Jianyong Yang, Yonghui Huang, Run Lin
ACS Pharmacology & Translational Science.2026;[Epub] CrossRef
Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study
Junzhe Yi, Jiongliang Wang, Yimin Zhang, Xiongying Jiang, Song Chen, Jie Xu, Xintong Wu, Suixing Zhong, Qifeng Chen, Yue Hu, Yujia Song, Genjun Tan, Yunan Zhang, Jibin Li, Ming Zhao, Ning Lyu
Nature Communications.2026;[Epub] CrossRef
A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
Journal of Hepatology.2025; 82(2): 235. CrossRef
Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma
Sung Won Chung, Hyun Jun Um, Won-Mook Choi, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee
Clinical Gastroenterology and Hepatology.2025; 23(2): 300. CrossRef
A classification model for resectability in hepatocellular carcinoma patients
Ikuo Nakamura, Tomoaki Yoh, Takashi Nishimura, Masayuki Okuno, Tomohiro Okamoto, Hideaki Sueoka, Kenjiro Iida, Masaharu Tada, Takamichi Ishii, Satoru Seo, Yasuhiro Fujimoto, Hiroko Iijima, Seiko Hirono, Etsuro Hatano
Hepatology Research.2025; 55(1): 94. CrossRef
The Critical Role of Regulatory T Cells in Immune Tolerance and Rejection Following Liver Transplantation: Interactions With the Gut Microbiome
Soon Kyu Lee, Jung Hyun Kwon, Jeong Won Jang, Si Hyun Bae, Seung Kew Yoon, Eun Sun Jung, Jong Young Choi
Transplantation.2025; 109(5): 784. CrossRef
Hepatic Resection for Hepatocellular Carcinoma
Parissa Tabrizian, Adriana Pero, Myron Schwartz
Clinics in Liver Disease.2025; 29(1): 59. CrossRef
Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCC
Jinyeong Lim, Myung Ji Goh, Byeong Geun Song, Dong Hyun Sinn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Dong Ik Cha, Kyowon Gu, Sang Yun Ha, Inwoo Hwang, Woong-Yang Park, Yong-Han Paik
JHEP Reports.2025; 7(4): 101304. CrossRef
The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors
Xiaoyu Huang, Gang Peng, Yaqing Kong, Xiaojing Cao, Xiang Zhou
Journal of Inflammation Research.2025; Volume 18: 203. CrossRef
The Cancer Clinical Library Database (CCLD) from the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) Project
Sangwon Lee, Yeon Ho Choi, Hak Min Kim, Min Ah Hong, Phillip Park, In Hae Kwak, Ye Ji Kang, Kui Son Choi, Hyun-Joo Kong, Hyosung Cha, Hyun-Jin Kim, Kwang Sun Ryu, Young Sang Jeon, Hwanhee Kim, Jip Min Jung, Jeong-Soo Im, Heejung Chae
Cancer Research and Treatment.2025; 57(1): 19. CrossRef
A Call for Quality Assurance in Alpha-Fetoprotein Testing within the National Cancer Screening Program to Improve Hepatocellular Carcinoma Surveillance in Korea
Hyorin Kim, Sollip Kim, Hyeongsu Kim, Hye Ryun Lee
Laboratory Medicine Online.2025; 15(1): 84. CrossRef
Correspondence to editorial on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”
Young-Joo Jin, Seung Up Kim
Clinical and Molecular Hepatology.2025; 31(1): e55. CrossRef
Hepatocellular carcinoma surveillance after sustained virological response in chronic hepatitis C: Editorial on “Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-ana
Ho Soo Chun, Minjong Lee
Clinical and Molecular Hepatology.2025; 31(1): 261. CrossRef
Canadian Association of Radiologists Cancer Diagnostic Imaging Referral Guideline
Candyce Hamel, Barb Avard, Howard Lim, Alex Mathieson, Alan Michaud, Kristoff Nelson, Devang Odedra, Jason Pantarotto, Anna Wilkinson, Karim Samji
Canadian Association of Radiologists Journal.2025; 76(3): 427. CrossRef
Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma
Kanghee Park, Hye Won Lee, Euichang Kim, Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Changhoon Yoo, Baek‐Yeol Ryoo, Seungbong Han, Jonggi Choi
Alimentary Pharmacology & Therapeutics.2025; 61(8): 1310. CrossRef
Temporal trends of liver cancer burden, comparative analysis of risk factors and trend forecasts to 2024 in China, USA, the Republic of Korea, and Mongolia: an analysis based on multiple data sources from Global Burden of Disease 2019, the Global Cancer O
Xing Yao, Xinchun Ling, Ziyi Zhu, Xiaolu Cao, Shaoliang Tang
Journal of Global Health.2025;[Epub] CrossRef
Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim
Cancers.2025; 17(4): 566. CrossRef
A Case of Splenic Oligometastasis without Intrehepatic Recurrence Identified Six Years Following Hepatectomy for Hepatocellular Carcinoma
Ji Won Han, Pil Soo Sung
The Korean Journal of Gastroenterology.2025; 85(1): 89. CrossRef
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
Journal of Hepatology.2025; 82(6): 1080. CrossRef
Prognostic Value of Changes in Combined Child–Pugh Class and ALBI Grade in Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Plus Targeted Therapy and PD-(L)1 Inhibitors
Xiaoyu Huang, Xiaojing Cao, Yaqing Kong, Fan Tang, Tianhao Cong, Xiang Zhou
Journal of Hepatocellular Carcinoma.2025; Volume 12: 481. CrossRef
Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: a multicenter, propensity score matching analysis
Zi-Hui Ma, Xiao-Lu Lin, Feng-Hua Liu, Jing-Lei Zhang, Mao-Lin Yan, Xing-Chao Song, Lei Guo, Jie Xue, Chong-De Lu, Jie Shi, Yan Meng, Shu-Qun Cheng, Wei-Xing Guo
BMC Cancer.2025;[Epub] CrossRef
Automated detection of small hepatocellular carcinoma in cirrhotic livers: applying deep learning to Gd-EOB-DTPA-enhanced MRI
JunQiang Lei, YongSheng Xu, YuanHui Zhu, ShanShan Jiang, Song Tian, Yi Zhu
Abdominal Radiology.2025; 50(9): 4087. CrossRef
Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?
Lorenzo Lani, Giacomo Zaccherini, Edoardo G. Giannini, Franco Trevisani
Hepatoma Research.2025;[Epub] CrossRef
Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma
Aryoung Kim, Byeong Geun Song, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Myung Ji Goh, Dong Hyun Sinn
Gut and Liver.2025; 19(2): 265. CrossRef
Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter study
Qizhen Huang, Xiaohong Zhong, Shaoxing Chen, Wenhui Liu, Jing Yang, Qingjing Chen, Tingting Yang, Fuqun Wei, Juhui Chen, Yufei Zhou, Lijuan Zhan, Xiuhui Liang, Jianji Pan, Kongying Lin, Jinsheng Hong, Yongyi Zeng
Hepatology International.2025; 19(4): 877. CrossRef
Effectiveness of noncontrast-abbreviated magnetic resonance imaging in a real-world hepatocellular carcinoma surveillance
Hyun Kyung Yang, Sunyoung Lee, Min Young Lee, Myeong-Jin Kim
European Radiology.2025; 35(9): 5792. CrossRef
A nationwide investigation on imaging follow-up after Locoregional therapy for hepatocellular carcinoma in China: Current practices and challenges
Shuwei Zhou, Chenxin Song, Pei Liu, Shenghong Ju, Yuan-Cheng Wang
European Journal of Radiology.2025; 186: 112057. CrossRef
Developing a novel predictive model for identifying risk factors associated with being lost to follow-up among high-risk patients for recurrence following radical resection of hepatocellular carcinoma: the first report
Zichen Yu, Wenli Cao, Chengfei Du, Jie Liu, Liping Peng, Fangqiang Wei
BMC Cancer.2025;[Epub] CrossRef
A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024
Hyunjae Shin, Su Jong Yu
Journal of Liver Cancer.2025; 25(1): 19. CrossRef
Microwave ablation vs. liver resection for patients with hepatocellular carcinomas
Hyundam Gu, Yeonjoo Seo, Dong Jin Chung, Kwang Yeol Paik, Seung Kew Yoon, Jihye Lim
Journal of Liver Cancer.2025; 25(1): 99. CrossRef
Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
Han Ah. Lee, Hyun Woong Lee, Yeon Seok Seo, Dong Hyun Sinn, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
Journal of Gastroenterology and Hepatology.2025; 40(7): 1675. CrossRef
Efficacy and safety of image-guided hypofractionated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective, multicenter study
Sang Min Lee, Jin Hwa Choi, Jung-Hwan Yoon, Yoon Jun Kim, Su Jong Yu, Jeong-Hoon Lee, Hyun-Cheol Kang, Eui Kyu Chie, Kyung Su Kim
BMC Cancer.2025;[Epub] CrossRef
A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B
Jiwon Yang, Mark D. Muthiah, Won-Mook Choi
Current Hepatology Reports.2025;[Epub] CrossRef
Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance
Dong Ho Lee
Journal of Liver Cancer.2025; 25(1): 31. CrossRef
Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry
Jihyun An, Young Chang, Gwang Hyeon Choi, Won Sohn, Jeong Eun Song, Hyunjae Shin, Jae Hyun Yoon, Jun Sik Yoon, Hye Young Jang, Eun Ju Cho, Ji Won Han, Suk Kyun Hong, Ju-Yeon Cho, Kyu-Won Jung, Eun Hye Park, Eunyang Kim, Bo Hyun Kim
Journal of Liver Cancer.2025; 25(1): 109. CrossRef
Letter: Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma—Authors' Reply
Jiwon Yang, Won‐Mook Choi
Alimentary Pharmacology & Therapeutics.2025; 61(12): 1975. CrossRef
Abbreviated MRI for Hepatocellular Carcinoma Screening: A Comprehensive Review
Ji Hye Min, Young Kon Kim, Woo Kyoung Jeong, Bachir Taouli
Current Hepatology Reports.2025;[Epub] CrossRef
Comparison of initial treatments for resectable hepatocellular carcinoma within Milan criteria: an observational study based on a nationwide survey
Sang Jin Kim, Woo Kyoung Jeong, Hyung-Joon Han, Gyu-Seong Choi, Kyun-Hwan Kim, Jongman Kim
Annals of Surgical Treatment and Research.2025; 108(5): 279. CrossRef
Differential Infiltration of T-Cell Populations in Tumor and Liver Tissues Predicts Recurrence-Free Survival in Surgically Resected Hepatocellular Carcinoma
Eun Ji Jang, Ho Joong Choi, Young Kyoung You, Deok Hwa Seo, Mi Hyun Kwon, Keungmo Yang, Jaejun Lee, Jeong Won Jang, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
Cancers.2025; 17(9): 1548. CrossRef
The effect of continuous infusion chemotherapy through femoral artery catheterization on GP73, AFP-L3, and safety efficacy in liver cancer patients
Qiong Yan, Xinguo Sun, Yubo Wang, Shijiao Duan, Bo Wang
Clinical and Experimental Medicine.2025;[Epub] CrossRef
Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma
Sung Won Chung, Jin Sun Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Kang Mo Kim
Clinical Cancer Research.2025; 31(10): 2046. CrossRef
Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics
Sunmin Park, Chai Hong Rim, Young Kul Jung, Hyung Joon Yim, Hwan Hoon Chung, Won Sup Yoon, Gregory Tiao
PLOS One.2025; 20(5): e0323450. CrossRef
Abbreviated MRI-Based Surveillance Strategies for Early Hepatocellular Carcinoma Detection
Hyo Jung Park, Dong Wook Kim, Won-Mook Choi, So Yeon Kim
Journal of the Korean Society of Radiology.2025; 86(3): 335. CrossRef
LI-RADS CT/MRI Treatment Response Assessment Update in 2024
Jaeseung Shin, Kyowon Gu, Ji Hye Min
Journal of the Korean Society of Radiology.2025; 86(3): 352. CrossRef
Hepatic Artery Infusion Chemotherapy for Hepatocellular Carcinoma: Clinical Advancements
Wei Xu, Qing Li, Bin Liang
Current Oncology.2025; 32(6): 313. CrossRef
Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation Study
Jia‐Yong Su, De‐Jia Huang, Shao‐Ping Liu, Xiao‐Ling Xu, Shu‐Chang Chen, Jun‐Jie Ou, Jian‐Rong Li, Tai‐Xin Yang, Wen‐Yang Li, Yuan Fan, Zhao‐Chan Wen, Le Chen, Zhen Qin, Bei‐Bei Long, Da‐Zhi Li, Jiang‐Hong Huang, Yi‐Jia Lu, Jun‐Chi Zhong, Hai‐Qiang Zhu, Li
Hepatology Research.2025; 55(9): 1263. CrossRef
The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection
Ning Peng, Lin-Feng Mao, Jia-Yong Su, Shao-Ping Liu, Jun-Jie Ou, Shu-Chang Chen, Ze Su, Wen-Feng Li, Fu-Quan Yang, Yong-Heng Zhou, Le Li, Jian-Hong Zhong
Frontiers in Immunology.2025;[Epub] CrossRef
Optimizing Yttrium-90 Radioembolization Dosimetry for Hepatocellular Carcinoma: A Korean Perspective
In Joon Lee, Hyo-Cheol Kim
Korean Journal of Radiology.2025; 26(7): 688. CrossRef
Significant Improvement in Long-Term Survival after Liver Resection for Hepatocellular Carcinoma: Evolving Outcomes over 20 Years
Na Reum Kim, Gi Hong Choi, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi
Yonsei Medical Journal.2025; 66(10): 637. CrossRef
Role of imaging-guided biopsy for hepatocellular carcinoma
Roberto Cannella, Zachary T. Berman, Nikhil V. Tirukkovalur, Samer T. Tohme, Marta I. Minervini, Alessandro Furlan
European Journal of Radiology.2025; 191: 112271. CrossRef
Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
Osteoporosis International.2025; 36(8): 1391. CrossRef
Outcome of hepatic resection for HCC in ideal and non-ideal candidates
Lorenzo Lani, Laura Bucci, Valentina Santi, Benedetta Stefanini, Bernardo Stefanini, Angelo Sangiovanni, Sara Grasselli, Giorgia Ghittoni, Carlo Saitta, Filomena Morisco, Giuseppe Cabibbo, Fabio Marra, Gianpaolo Vidili, Maurizia Rossana Brunetto, Francesc
Hepatology Communications.2025;[Epub] CrossRef
A technological convergence in hepatobiliary oncology: Evolving roles of smart surgical systems
Xuanci Bai, Runze Huang, Qinyu Liu, Xin Jin, Lu Wang, Wei Tang, Kenji Karako, Weiping Zhu
BioScience Trends.2025; 19(4): 410. CrossRef
Conversion therapy followed by surgery and adjuvant therapy improves survival in Barcelona C stage hepatocellular carcinoma ― A propensity score-matched analysis
Yinbiao Cao, Liru Pan, Zikun Ran, Wenwen Zhang, Junfeng Li, Xuerui Li, Tianyu Jiao, Zhe Liu, Tao Wan, Haowen Tang, Shichun Lu
BioScience Trends.2025; 19(4): 432. CrossRef
Enhancing TNM Stage Completeness Using the SEER Summary Stage: A Nationwide Study From Korea
Chang Kyun Choi, Mina Suh, Kyu-Won Jung, E Hwa Yun
Journal of Preventive Medicine and Public Health.2025; 58(4): 415. CrossRef
Pre- and postoperative predictors of extrahepatic recurrence after curative resection for hepatocellular carcinoma
Chang Hun Lee, Yun Chae Lee, Seung Young Seo, Ga Ram You, Hoon Gil Jo, Sung Bum Cho, Eun Young Cho, In Hee Kim, Sung Kyu Choi, Jae Hyun Yoon
BMC Cancer.2025;[Epub] CrossRef
Impact of an immediate short waiting period on ultrasound-based ablative margin assessment following radiofrequency ablation for hepatocellular carcinoma
Seungchul Han, Min Woo Lee, Kyowon Gu, Hyunchul Rhim
Ultrasonography.2025; 44(5): 354. CrossRef
Prognostic Role of Short-Chain Fatty Acid-Producing Gut Microbiota and Gut Microbial Dynamics in Patients with Hepatocellular Carcinoma Receiving Chemoembolization: A Prospective Study
Jiwon Yang, Jihye Lim, Eun Hye Kim, Jihyun An, Danbi Lee, Han Chu Lee, Jin-Yong Jeong, Ju Hyun Shim
Journal of Hepatocellular Carcinoma.2025; Volume 12: 1991. CrossRef
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma
Gwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, Alexander Kuo, Walid S. Ayoub, Hirsh Trivedi, Yun Wang, Aarshi Vipani, Pin-Jung Chen, Steven A. Miles, Emily A. Kaymen, Andrew Hendifar, Tsuyoshi Todo, Todd V. Brennan, Georgios Voidonikolas, Steven A. Wisel,
Liver Cancer.2025; 15(2): 193. CrossRef
Spectrum of therapeutic options in hepatocellular carcinoma
Hyun Phil Shin, Moonhyung Lee, Jung Won Jeon
Journal of Exercise Rehabilitation.2025; 21(4): 190. CrossRef
Precision Strategy for Hepatocellular Carcinoma Surveillance after Hepatitis C Cure: Debates across Guidelines
Masaaki Mino, Eiji Kakazu, Tatsuya Kanto
Gut and Liver.2025; 19(5): 651. CrossRef
Alternative Surveillance Improves Outcomes by Detecting Early-Stage Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Dong Ho Lee, Heejin Cho, Su Jong Yu, Min Kyung Park, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon
Gut and Liver.2025; 19(5): 770. CrossRef
15-Year Trends in Hepatocellular Carcinoma: Epidemiology, Treatment, and Outcomes from a Hospital-Based Registry
Songgyung Kim, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Ki-Hun Kim, Jonggi Choi
Gut and Liver.2025; 19(5): 746. CrossRef
Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
Annals of Surgical Treatment and Research.2025; 109(3): 123. CrossRef
Re-evaluating surgical strategies in Barcelona Clinic Liver Cancer-B hepatocellular carcinoma
Ioannis Liapis, Ioannis A Ziogas, Charalampos Theocharopoulos, Dimitrios P Moris, Trevor L Nydam, Ana L Gleisner, Richard D Schulick, Georgios Tsoulfas
World Journal of Hepatology.2025;[Epub] CrossRef
Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria
Hyun Yang, Soon Sun Kim, Seong Hee Kang, Jieun Kwon, Do Young Kim, Eunju Kim, Hyun Phil Shin, Jeong Il Yu, Jeong-Ju Yoo, Eileen L. Yoon, Sangheun Lee, Young Eun Chon, Janghan Jung, Jaekyung Cheon, Woosun Choi, Seul Ki Han, Ji Eun Han, Moon Haeng Hur, Hyun
Journal of Liver Cancer.2025; 25(2): 160. CrossRef
Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
Journal of Liver Cancer.2025; 25(2): 140. CrossRef
Predicting the outcome of transarterial chemoembolization combined with targeted immunotherapy for unresectable hepatocellular carcinoma based on MRI radiomics
Jiaxuan Liu, Na Zhao, Yuxin Hang, Qiwen You, Yulong Tian, Haibo Shao
Scientific Reports.2025;[Epub] CrossRef
Magnetic resonance imaging-guided radiotherapy for portal vein tumor thrombus in hepatocellular carcinoma: outcomes and prognostic factors
So Jung Lee, Myungsoo Kim
Radiation Oncology.2025;[Epub] CrossRef
Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab
Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Ji Hoon Kim, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Myeong Jun Song, Soon Woo
Clinical Cancer Research.2025; 31(20): 4323. CrossRef
Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography
Dong Wook Kim, Won Chang, So Yeon Kim, Young-Suk Lim, Jonggi Choi, Jungheum Cho, Jin-Wook Kim, Jai Young Cho, Sun Kyung Jeon, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Kyung-Suk Suh, Kwang-Woong Lee, Dong Ho Lee
Clinical and Molecular Hepatology.2025; 31(4): 1285. CrossRef
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
Zheng Wang, Jia Fan, Shaolai Zhou, Yunfan Sun, Fei Liang, Yuan Ji, Fangming Gu, Tao Li, Li Peng, Tao Peng, Xiaolun Huang, Zhenbin Ding, Dousheng Bai, Bangde Xiang, Guang Tan, Tianfu Wen, Yongyi Zeng, Feng Han, Yu Zhang, Shengdong Wu, Haitao Zhao, Yi Chen,
The Lancet.2025; 406(10515): 2089. CrossRef
Overview of the multidisciplinary team activity in patients with hepatocellular carcinoma and their survival outcomes
V. Guarini, C. Garzòn, D. Casado, M. Casanova, P. Villarejo, I. Azinovic, E. Crespo, I. Fernandez, M. Lopez, M.M. de Bourio, M. Moran, M. Jimenez, G. Medrano, V. Castellano, A. Lamarca
ESMO Gastrointestinal Oncology.2025; 10: 100263. CrossRef
Adverse Event Monitoring with Imaging: Prognostic Significance in Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma
Jeayeon Park, Dong Ho Lee, Yunmi Ko, Hyunjae Shin, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Su Jong Yu
Liver Cancer.2025; 15(3): 439. CrossRef
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study
Mira Kang, Won Chul Cha, Dong Hyun Sinn, Woo Kyoung Jeong, Do Young Kim, Min Ji Lee, Subin Lim, DongKyu Kim, Kyu-Pyo Kim, Baek-Yeol Ryoo, Won-Mook Choi, Kang Mo Kim, Ki-Hun Kim, Doik Lee, Eui Jun Choi, Choungwon Jung, Joohyun Kim, Jung Yong Hong
Journal of Hepatocellular Carcinoma.2025; Volume 12: 2611. CrossRef
Navigating the Therapeutic Pathway and Optimal First-Line Systemic Therapy for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
Hyun Phil Shin, Moonhyung Lee
Medicina.2025; 61(12): 2164. CrossRef
Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance
Jie Gao, Nan Bai, Mingyu Liu, Ninghua Yao, Zhangzhi Tang, Banglong Xu, Weiting Chen, Xuyang He, Jiayu Shao, Saiyan Bian, Hui Zhao, Wenjie Zheng
Oncogenesis.2025;[Epub] CrossRef
Abbreviated gadoxetic acid–enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol
Hyo Jung Park, Jonggi Choi, Dong Wook Kim, Sang Hyun Choi, Won-Mook Choi, Sung Won Chung, Danbi Lee, Ju Hyun Shim, Han Chu Lee, Young-Suk Lim, Min-Ju Kim, Amit G. Singal, Seong Ho Park, So Yeon Kim
Hepatology Communications.2025;[Epub] CrossRef
Hepatocellular carcinoma with macrovascular invasion: Review and survival meta-analysis of initial local therapy using minimal prognostic criteria
Marta Fortuny, Antonio De Rosa, Ignacio Roca, Dan Ouchi, Elisaul Suárez, Andrea Cadiz, Mario Matute-González, Andrew M. Moon, Jordi Rimola, Ferran Torres, Maria Reig
Hepatology.2025;[Epub] CrossRef
Updated Network Meta-Analysis of First-Line Systemic Treatments for Advanced HCC: Consistent Role of TACE
Ye Rim Kim, Euichang Kim, Ha Il Kim, Seungbong Han, Jihyun An, Ju Hyun Shim
Liver Cancer.2025; 15(1): 117. CrossRef
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines
Sun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, Eunji Kim, Jin-Kyu Kang, Won Il Jang, Ji Eun Moon, Isaure Roquette, Xavier Mirabel, Tomoki Kimura, Masayuki Ueno, Ting-Shi Su, Alison C. Tree, Matthias Guckenberger, Simon S. Lo, Marta Scorsetti, Ben J. Slotman
International Journal of Radiation Oncology*Biology*Physics.2024; 118(2): 337. CrossRef
Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection
Na Reum Kim, Heejin Bae, Hyeo Seong Hwang, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Mi-Suk Park, Gi Hong Choi
Liver Cancer.2024; 13(2): 181. CrossRef
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
Ming Zhao, Zhi Guo, Ying-Hua Zou, Xiao Li, Zhi-Ping Yan, Min-Shan Chen, Wei-Jun Fan, Hai-Liang Li, Ji-Jin Yang, Xiao-Ming Chen, Lin-Feng Xu, Yue-Wei Zhang, Kang-Shun Zhu, Jun-Hui Sun, Jia-Ping Li, Yong Jin, Hai-Peng Yu, Feng Duan, Bin Xiong, Guo-Wen Yin,
Hepatology International.2024; 18(1): 4. CrossRef
Comparative Performance of 2018 LI‐RADS versus Modified LIRADS (mLI‐RADS): An Individual Participant Data Meta‐Analysis
Stacy M. Goins, Hanyu Jiang, Christian B. van der Pol, Jean‐Paul Salameh, Eric Lam, Robert G. Adamo, Matthew D.F. McInnes, Andreu F. Costa, Christopher Clarke, Sang Hyun Choi, Tyler J. Fraum, Daniel R. Ludwig, Bin Song, Ijin Joo, Andrea S. Kierans, So Yeo
Journal of Magnetic Resonance Imaging.2024; 60(3): 1082. CrossRef
Deep learning approach for discrimination of liver lesions using nine time-phase images of contrast-enhanced ultrasound
Naohisa Kamiyama, Katsutoshi Sugimoto, Ryuichi Nakahara, Tatsuya Kakegawa, Takao Itoi
Journal of Medical Ultrasonics.2024; 51(1): 83. CrossRef
Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study
Bo Hyun Kim, Hee Chul Park, Tae Hyun Kim, Young-Hwan Koh, Jung Yong Hong, Yuri Cho, Dong Hyun Sinn, Boram Park, Joong-Won Park
JHEP Reports.2024; 6(4): 100991. CrossRef
The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma
Li-Yue Sun, Wen-Jian Cen, Xin-Xin Zeng, Yu-Yun Zhong, Ling Deng, Jiao-Jiao Yang, Ming Li, Fang Wang
The American Surgeon™.2024; 90(6): 1240. CrossRef
Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
Sojung Han, Do Young Kim, Ho Yeong Lim, Jung-Hwan Yoon, Baek-Yeol Ryoo, Yujeong Kim, Kookhee Kim, Bo Yeon Kim, So Young Yi, Dong-Sook Kim, Do-Yeon Cho, Jina Yu, Suhyun Kim, Joong-Won Park
Gut and Liver.2024; 18(1): 116. CrossRef
The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
Beom Kyung Kim
Gut and Liver.2024; 18(1): 3. CrossRef
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real‐world study
Jun‐Zhe Yi, Zhi‐Jian Zhu, Gong‐Wei Liu, Yi‐Min Zhang, Jie Xu, Xin‐Tong Wu, Ke Ding, Jian‐Chao Liu, Ke‐Fei Zhang, Xiong‐Ying Jiang, Qi‐Feng Chen, Yue Hu, Song Chen, Sui‐Xing Zhong, Jiong‐Liang Wang, Ning Lyu, Ming Zhao
Hepatology Research.2024; 54(6): 575. CrossRef
Clinical course of patients with hepatocellular carcinoma who experienced radiologic complete response after radioembolization
Sungmo Moon, Gyoung Min Kim, Jong Yun Won, Joon Ho Kwon, Juil Park, Kichang Han, Man-Deuk Kim, Hyung Cheol Kim, Dong Kyu Kim, Jin Young Choi
Frontiers in Oncology.2024;[Epub] CrossRef
A Prospective Analysis of the Effects of a Powder-Type Hemostatic Agent on the Short-Term Outcomes after Liver Resection
MeeYoung Kang, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, Yeshong Park, Jinju Kim
Medicina.2024; 60(2): 278. CrossRef
Image Quality and Diagnostic Performance of Low-Dose Liver CT with Deep Learning Reconstruction versus Standard-Dose CT
Dong Ho Lee, Jeong Min Lee, Chang Hee Lee, Saif Afat, Ahmed Othman
Radiology: Artificial Intelligence.2024;[Epub] CrossRef
Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinoma
Han Ah Lee, Minjong Lee, Jeong-Ju Yoo, Ho Soo Chun, Yewan Park, Hwi Young Kim, Tae Hun Kim, Yeon Seok Seo, Dong Hyun Sinn
International Journal of Surgery.2024; 110(2): 1008. CrossRef
Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Hidenori Toyoda, Toshifumi Tada, Kunihiko Tsuji, Toru Ishikawa, Takeshi Hatanaka, Ei Itobayashi, Koichi Takaguchi, Akemi Tsutsui, Atsushi Naganuma, Satoshi Yasuda, Satoru Kakizaki, Akiko Wakuta, Shohei Shi
Journal of Liver Cancer.2024; 24(1): 71. CrossRef
ESR Essentials: diagnosis of hepatocellular carcinoma—practice recommendations by ESGAR
Roberto Cannella, Marc Zins, Giuseppe Brancatelli
European Radiology.2024; 34(4): 2127. CrossRef
Association between Unplanned Conversion and Patient Survival after Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Propensity Score Matched Analysis
Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, MeeYoung Kang, Yeshong Park, Jinju Kim
Journal of Clinical Medicine.2024; 13(4): 1116. CrossRef
Achieving Textbook Outcomes after Laparoscopic Resection in Posterosuperior Segments of the Liver: The Impact of the Learning Curve
Mizelle D’Silva, Jai-Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae-Won Lee, Bo-Ram Lee, Mee-Young Kang, Ye-Shong Park, Jin-Ju Kim
Cancers.2024; 16(5): 930. CrossRef
Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
Diagnostics.2024; 14(5): 495. CrossRef
Comparison between laparoscopic liver resection and open liver resection in patients with hepatocellular carcinoma with portal vein tumor thrombosis
Kyeong Sik Kim, Gyu-Seong Choi, Jinsoo Rhu, Jongman Kim
Surgical Endoscopy.2024; 38(4): 2116. CrossRef
Usefulness of contrast-enhanced ultrasound-guided biopsy for suspected viable hepatocellular carcinoma after treatment: a single-arm prospective study
Jeongin Yoo, Dong Ho Lee
Ultrasonography.2024; 43(2): 88. CrossRef
Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis
Manuel Lim, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
Journal of Liver Cancer.2024; 24(1): 102. CrossRef
Radiofrequency for hepatocellular carcinoma larger than 3 cm: potential for applications in daily practice
Ji Hoon Kim, Pil Soo Sung
Journal of Liver Cancer.2024; 24(1): 1. CrossRef
A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
Hae Lim Lee, Seok Hwan Kim, Hee Yeon Kim, Sung Won Lee, Myeong Jun Song
Frontiers in Oncology.2024;[Epub] CrossRef
Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
Diyang Xie, Zhongchen Li, Jia Yuan, Xin Yin, Rongxin Chen, Lan Zhang, Zhenggang Ren
Journal of Hepatocellular Carcinoma.2024; Volume 11: 693. CrossRef
Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
Jungnam Lee, Young‐Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Jung Hwan Yu, Jin‐Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
Journal of Gastroenterology and Hepatology.2024; 39(9): 1924. CrossRef
A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients
Si-Ping Xiong, Chun-Hua Wang, Mei-fang Zhang, Xia Yang, Jing-Ping Yun, Li-Li Liu
Journal of Translational Medicine.2024;[Epub] CrossRef
Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
Yuri Cho, Bo Hyun Kim, Young-Suk Lim
Digestive Disease Interventions.2024; 08(03): 169. CrossRef
Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights
Tiago Biachi de Castria, Richard Kim
Pragmatic and Observational Research.2024; Volume 15: 79. CrossRef
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
Clinical and Molecular Hepatology.2024; 30(3): 360. CrossRef
A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
Ji W. Han, Soon K. Lee, Jung H. Kwon, Soon W. Nam, Hyun Yang, Si H. Bae, Ji H. Kim, Heechul Nam, Chang W. Kim, Hae L. Lee, Hee Y. Kim, Sung W. Lee, Ahlim Lee, U I. Chang, Do S. Song, Seok-Hwan Kim, Myeong J. Song, Pil S. Sung, Jong Y. Choi, Seung K. Yoon,
Clinical Cancer Research.2024; 30(13): 2812. CrossRef
Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung
Oncology Letters.2024;[Epub] CrossRef
Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim
Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235. CrossRef
Medios de contraste específicos para el estudio del hígado en resonancia magnética
A. Perez-Girbes, J.M. Lee, L. Martí-Bonmatí
Radiología.2024; 66: S75. CrossRef
Cost-effectiveness of immune checkpoint inhibitors as a first-line therapy for advanced hepatocellular carcinoma: a systematic review
Hongyu Gong, Siew Chin Ong, Fan Li, Yan Shen, Zhiying Weng, Keying Zhao, Zhengyou Jiang, Meng Wang
Health Economics Review.2024;[Epub] CrossRef
Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment
Rosmawati Mohamed, Wendy Wang, Tawesak Tanwandee, Irsan Hasan, Cam Phuong Pham, Young-Suk Lim, Sheng-Nan Lu, Murallitharan Munisamy, Thi Thanh Huong Tran, Evy Ratnawati, Wattana Sukeepaisarnjaroen, Mahir Karababa, Chee-Kiat Tan
Journal of Gastrointestinal Cancer.2024; 55(3): 1333. CrossRef
Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
Kyu-Pyo Kim, Kang Mo Kim, Baek-Yeol Ryoo, Won-Mook Choi, Won Chul Cha, Mira Kang, Dong Hyun Sinn, Myung Ji Goh, Do Young Kim, Min Ji Lee, Subin Lim, DongKyu Kim, Kyoungdae Baek, Joohyun Kim, Eui Jun Choi, Doik Lee, Jung-Ae Kim, Ki-Hun Kim
Liver Cancer.2024; : 1. CrossRef
Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Yong-Han Paik
Gut and Liver.2024; 18(4): 709. CrossRef
Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment
Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn
Cancers.2024; 16(15): 2652. CrossRef
Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma
Myung Ji Goh, Hee Chul Park, Nalee Kim, Bong Kyung Bae, Moon Seok Choi, Jinsoo Rhu, Min Woo Lee, Woo Kyoung Jeong, Minji Kim, Kyunga Kim, Jeong Il Yu
Journal of Korean Medical Science.2024;[Epub] CrossRef
Liver resection and transplantation in the era of checkpoint inhibitors
Parissa Tabrizian, Rebecca Marino, Pierce K.H. Chow
JHEP Reports.2024; 6(11): 101181. CrossRef
Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
Gut and Liver.2024; 18(5): 789. CrossRef
Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
Journal of Liver Cancer.2024; 24(2): 131. CrossRef
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
Jiwon Yang, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Deok-Bog Moon, Dong-Hwan Jung, Jonggi Choi
Journal of Liver Cancer.2024; 24(2): 178. CrossRef
The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases
Beom Kyung Kim
Journal of Liver Cancer.2024; 24(2): 129. CrossRef
Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
Korean Journal of Radiology.2024; 25(9): 773. CrossRef
Heavy smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment
Jaejun Lee, Jong Young Choi, Soon Kyu Lee
Journal of Liver Cancer.2024; 24(2): 253. CrossRef
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi
Journal of Liver Cancer.2024; 24(2): 243. CrossRef
Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging
Jae Seok Bae, Jeong Min Lee, Bo Yun Hur, Jeongin Yoo, Sae-Jin Park
Journal of Liver Cancer.2024; 24(2): 206. CrossRef
Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
Jae Hwan Lee, Kun Yung Kim, Chong-ho Lee, Minuk Kim, Chang Jin Yoon
Journal of Liver Cancer.2024; 24(2): 217. CrossRef
Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma
Ji Won Han, Min Woo Kang, Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Jae-Sung Yoo, Hee Sun Cho, Eun Ji Jang, Deok Hwa Seo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
Liver Cancer.2024; : 1. CrossRef
Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study
Ji Won Han, Won Sohn, Gwang Hyeon Choi, Jeong Won Jang, Gi Hyeon Seo, Bo Hyun Kim, Jong Young Choi
Journal of Liver Cancer.2024; 24(2): 274. CrossRef
Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis
Young-Joo Jin, Hee Yeon Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun, Miyoung Choi, Seung Up Kim
Clinical and Molecular Hepatology.2024; 30(Suppl): S159. CrossRef
Clinical and Radiologic Predictors of Response to Atezolizumab-Bevacizumab in Advanced Hepatocellular Carcinoma
Se Jin Choi, Sung Won Chung, Jonggi Choi, Kang Mo Kim, Hyung-Don Kim, Changhoon Yoo, Baek-Yeol Ryoo, Seung Soo Lee, Won-Mook Choi, Sang Hyun Choi
Cancer Research and Treatment.2024; 56(4): 1219. CrossRef
Hepatobiliary contrast agents for Liver Magnetic Resonance Imaging
A. Perez-Girbes, J.M. Lee, L. Martí-Bonmatí
Radiología (English Edition).2024; 66: S75. CrossRef
Clinical Significance of Biliary Invasion at Diagnosis in Barcelona Clinic Liver Cancer Stage B–C Hepatocellular Carcinoma: A Nationwide Cohort Analysis in South Korea
Chai Hong Rim, Won Sup Yoon, Sunmin Park
Oncology.2024; : 1. CrossRef
Diagnostic performance of Sonazoid-enhanced CEUS in identifying definitive hepatocellular carcinoma in cirrhotic patients according to KLCA-NCC 2022 and APASL 2017 guidelines
Zhe Huang, Rong-Hua Zhu, Shan-shan Li, Hong-Chang Luo, Kai-Yan Li
Insights into Imaging.2024;[Epub] CrossRef
Stage dependent microbial dynamics in hepatocellular carcinoma and adjacent normal liver tissues
Hee Eun Jo, Sophallika Khom, Sumi Lee, Su Hyeon Cho, Shin Young Park, Ga Ram You, Hyosin Kim, Nah Ihm Kim, Jae-Ho Jeong, Jae Hyun Yoon, Misun Yun
Scientific Reports.2024;[Epub] CrossRef
Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein throm
Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon
Clinical and Molecular Hepatology.2024; 30(4): 659. CrossRef
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma
Jiwon Yang, Won-Mook Choi, Hyung-Don Kim, Jonggi Choi, Changhoon Yoo, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee
Liver Cancer.2024; : 1. CrossRef
Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review
Jiahao Li, Yingnan Liu, Yuqi Qiu, Chao Qu, Jiarui Li
Frontiers in Immunology.2024;[Epub] CrossRef
New strategy of LI-RADS v2018 to improve the sensitivity for small hepatocellular carcinoma ≤ 3.0 cm on extracellular-contrast enhanced MRI
Jinhui Zhou, Yao Zhang, Jing Zhang, Jingbiao Chen, Hang Jiang, Linqi Zhang, Xi Zhong, Tianhui Zhang, Lichun Chen, Yufeng Wang, Yikai Xu, Jin Wang
European Journal of Radiology.2024; 181: 111830. CrossRef
A Case of Hepatic Epithelioid Hemangioendothelioma Treated with Radiofrequency Ablation
Yu Rim Lee, Jae Young Jang
Clinical Ultrasound.2024; 9(2): 96. CrossRef
Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography
Han Ah Lee
Clinical Ultrasound.2024; 9(2): 70. CrossRef
Albumin–Bilirubin Grade as a Valuable Predictor of Recurrence and Prognosis in Patients with Hepatocellular Carcinoma Following Radiofrequency Ablation
Chang Hun Lee, Ga Ram You, Hoon Gil Jo, Chung Hwan Jun, Eun Young Cho, In Hee Kim, Sung Kyu Choi, Jae Hyun Yoon
Cancers.2024; 16(24): 4167. CrossRef
Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
Ji Yeon Lee, Jaejun Lee, Suho Kim, Jae-sung Yoo, Ji Hoon Kim, Keungmo Yang, Ji Won Han, Jeong Won Jang, Jong Yong Choi, Seung Kew Yoon, Ho Jong Chun, Jung Suk Oh, Pil Soo Sung
Frontiers in Oncology.2024;[Epub] CrossRef
Noninvasive identification of proliferative hepatocellular carcinoma on multiphase dynamic CT: quantitative and LI-RADS lexicon-based evaluation
Wanli Zhang, Nan Li, Jiamin Li, Yue Zhao, Yi Long, Chutong He, Chuanxian Zhang, Bo Li, Yandong Zhao, Shengsheng Lai, Wenshuang Ding, Mingyong Gao, Lilian Tan, Xinhua Wei, Ruimeng Yang, Xinqing Jiang
European Radiology.2024; 35(6): 3460. CrossRef
Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
Yu-Tang Chen, Bo-Wen-Tao Chen, Jun-Ming Xu, Xiao-Cui You, Yi Tang, Shao-Jie Wu, Zhu-Ting Fang
Journal of Hepatocellular Carcinoma.2024; Volume 11: 2441. CrossRef
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
George Lau, Shuntaro Obi, Jian Zhou, Ryosuke Tateishi, Shukui Qin, Haitao Zhao, Motoyuki Otsuka, Sadahisa Ogasawara, Jacob George, Pierce K. H. Chow, Jianqiang Cai, Shuichiro Shiina, Naoya Kato, Osamu Yokosuka, Kyoko Oura, Thomas Yau, Stephen L. Chan, Min
Hepatology International.2024; 18(6): 1661. CrossRef
International perspectives on LI-RADS
Andrea S. Kierans, Diego A. Aguirre, Sonal Krishan, Jeong Min Lee, Maxime Ronot, Jin Wang, Elizabeth M. Hecht
Abdominal Radiology.2024; 50(7): 2917. CrossRef
Identification of macrotrabecular‐massive hepatocellular carcinoma through multiphasic CT‐based representation learning method
Zhenyang Zhang, Wanli Zhang, Chutong He, Jincheng Xie, Fangrong Liang, Yandong Zhao, Lilian Tan, Shengsheng Lai, Xinqing Jiang, Xinhua Wei, Xin Zhen, Ruimeng Yang
Medical Physics.2024; 51(12): 9017. CrossRef
The Pretreatment Neutrophil-to-Lymphocyte Ratio as a Near-Term Prognostic Indicator in Patients with Locally Advanced Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy: A Propensity Score Matching Cohort Study
Weifu Liu, Kongzhi Zhang, Shiguang Chen, Xiaolong Wang, Wenchang Yu
British Journal of Hospital Medicine.2024; 85(11): 1. CrossRef
Repeat laparoscopic hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: A multicenter, propensity score matching analysis
Zihui Ma, Xiaolu Lin, Jinglei Zhang, Xingchao Song, Maolin Yan, Lei Guo, Jie Xue, Chongde Lu, Jie Shi, Shuqun Cheng, Weixing Guo
BioScience Trends.2024; 18(6): 563. CrossRef
Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, Dong Yeup Lee, Keungmo Yang, Bohyun Kim, Joon-Il Choi, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
Frontiers in Immunology.2024;[Epub] CrossRef
Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study
Li-Fu Kuo, Wen-Chun Liu, Ming-Feng Li, Fu-Huan Huang, Chu-Kuang Chou, Tsung-Hsien Chen, Yi-Tseng Tsai, Ping-I. Hsu, Chao-Jen Li, I.-Ting Wu, Kun-Feng Tsai
Oncology.2024; 103(7): 549. CrossRef
A comprehensive study on the feasibility and diagnostic potential of fluctuation imaging in liver tumor assessment
Dong Ho Lee, Jae Young Lee
Scientific Reports.2024;[Epub] CrossRef
Emerging Prospects for Combining Immune Checkpoint Inhibitors with Loco-regional Therapy in Hepatocellular Carcinoma
Eun Young Cho, Chang Hun Lee, In Hee Kim
Journal of Digestive Cancer Research.2024; 12(3): 229. CrossRef
Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study
Jia-Yong Su, Shao-Ping Liu, Xiao-Ling Xu, Jun-Jie Ou, Po-Hua Ye, Bin-Tong Zhao, Jia-Song Chen, Qiu-Mei Luo, Jin-Rong Liu, Fei-Min Tang, Jian-Rong Li, Da-Long Yang, Zhu-Jian Deng, Li-Xin Pan, Yao-Jie Li, Le Li, Zhen-Ming Qin, Xiu-Mei Liang, Yi-Li Ma, Liang
Liver Cancer.2024; 14(4): 378. CrossRef
Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
European Journal of Clinical Investigation.2023;[Epub] CrossRef
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
Infectious Agents and Cancer.2023;[Epub] CrossRef
A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
Chih-Lang Lin, Kung-Hao Liang, Ching-Chih Hu, Cheng-Hung Chien, Li-Wei Chen, Rong-Nan Chien, Yang-Hsiang Lin, Chau-Ting Yeh
International Journal of Molecular Sciences.2023; 24(2): 1681. CrossRef
Barriers to palliative care in hepatocellular carcinoma: A review of the literature
Mostafa Abasseri, Shakira Hoque, BA Slavica Kochovska, Kim Caldwell, Linda Sheahan, Amany Zekry
Journal of Gastroenterology and Hepatology.2023; 38(7): 1047. CrossRef
Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis
Su Jong Yu, Jeong-Ju Yoo, Dong Ho Lee, Su Jin Kim, Eun Ju Cho, Se Hyung Kim, Jeong-Hoon Lee, Yoon Jun Kim, Jeong Min Lee, Jae Young Lee, Jung-Hwan Yoon
Biomedicines.2023; 11(2): 382. CrossRef
Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis
Yinbiao Cao, Haowen Tang, Bingyang Hu, Wenwen Zhang, Tao Wan, Jun Han, Tianyu Jiao, Junfeng Li, Xuerui Li, Zhanyu Yang, Zhe Liu, Minggen Hu, Weidong Duan, Chenggang Li, Zhiming Zhao, Shichun Lu
HPB.2023; 25(7): 775. CrossRef
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
Sung Won Chung, Heejin Cho, Hyunjae Shin, Jeayeon Park, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Myungsu Lee, Yoon Jun Kim, Jin Chul Paeng, Jung-Hwan Yoon, Jin Wook Chung, Jeong-Hoon Lee, Hyo-Cheol Kim
Frontiers in Oncology.2023;[Epub] CrossRef
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
Journal of Liver Cancer.2023; 23(1): 206. CrossRef
Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
Ja Kyung Yoon, Sunyoung Lee, Jeong Ah Hwang, Ji Eun Lee, Seung-seob Kim, Myeong-Jin Kim
Journal of Liver Cancer.2023; 23(1): 157. CrossRef
How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
Beom Kyung Kim
Journal of Liver Cancer.2023; 23(1): 121. CrossRef
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(2): 252. CrossRef
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Min Kyung Park, Yoon Jun Kim
Clinical and Molecular Hepatology.2023; 29(2): 332. CrossRef
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
Clinical and Molecular Hepatology.2023; 29(2): 206. CrossRef
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
Clinical and Molecular Hepatology.2023; 29(2): 197. CrossRef
The current trends in the health burden of primary liver cancer across the globe
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology.2023; 29(2): 358. CrossRef
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
Shen-Yung Wang
Clinical and Molecular Hepatology.2023; 29(2): 349. CrossRef
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
Do Young Kim
Clinical and Molecular Hepatology.2023; 29(2): 335. CrossRef
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
Clinical and Molecular Hepatology.2023; 29(2): 242. CrossRef
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
Clinical and Molecular Hepatology.2023; 29(2): 230. CrossRef
Higher Number of Tumor-Infiltrating PD-L1+ Cells Is Related to Better Response to Multikinase Inhibitors in Hepatocellular Carcinoma
Ji Won Han, Ji Hoon Kim, Dong Hyun Kim, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jaegyoon Ahn, Hyun Yang, Pil Soo Sung
Diagnostics.2023; 13(8): 1453. CrossRef
Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC
Wang Yao, Ran Wei, Jia Jia, Wang Li, Mengxuan Zuo, Shuqing Zhuo, Ge Shi, Peihong Wu, Chao An
Therapeutic Advances in Medical Oncology.2023;[Epub] CrossRef
Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
Diagnostics.2023; 13(9): 1537. CrossRef
Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation
Carlo Bosi, Margherita Rimini, andrea Casadei-Gardini, Giorgio Ercolani
Expert Review of Anticancer Therapy.2023; 23(5): 503. CrossRef
Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
Stergios A. Polyzos, Lampros Chrysavgis, Ilias D. Vachliotis, Evangelos Chartampilas, Evangelos Cholongitas
Seminars in Cancer Biology.2023; 93: 20. CrossRef
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
Hui Liu, Cheng-Long Han, Bao-Wen Tian, Zi-Niu Ding, Ya-Fei Yang, Yun-Long Ma, Chun-Cheng Yang, Guang-Xiao Meng, Jun-Shuai Xue, Dong-Xu Wang, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Expert Review of Gastroenterology & Hepatology.2023; 17(6): 623. CrossRef
Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection
Yue Xu, Xiaoqin Yao, Jinmei Li, Guoyuan Zhang, Guangcheng Luo, Qiang Wang
Cancer Medicine.2023; 12(12): 13329. CrossRef
Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes
Ji Hoon Kim, Jin Hyoung Kim, Hyun-Ki Yoon, Gi-Young Ko, Ji Hoon Shin, Dong Il Gwon, Heung-Kyu Ko, Hee Ho Chu, Seong Ho Kim, Gun Ha Kim, Yonghun Kim, Shakir Aljerdah
Frontiers in Oncology.2023;[Epub] CrossRef
Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score
Min Kyung Park, Dong Ho Lee, Bo Yun Hur, Hyung-Chul Lee, Yun Bin Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee
Radiology.2023;[Epub] CrossRef
Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology
Woo Kyoung Jeong, Hyo-Jin Kang, Sang Hyun Choi, Mi-Suk Park, Mi Hye Yu, Bohyun Kim, Myung-Won You, Sanghyeok Lim, Young Seo Cho, Min Woo Lee, Jeong Ah Hwang, Jae Young Lee, Jung Hoon Kim, Ijin Joo, Jae Seok Bae, So Yeon Kim, Yong Eun Chung, Dong Hwan Kim,
Korean Journal of Radiology.2023; 24(6): 482. CrossRef
Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
Korean Journal of Radiology.2023; 24(7): 606. CrossRef
Comparative Study of Long-Term Outcomes of Laparoscopic Liver Resection versus Radiofrequency Ablation for Single Small Hepatocellular Carcinoma Located in Left Lateral Segments of the Liver
MeeYoung Kang, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, Yeshong Park, Jinju Kim, Chang Jin Yoon
Medicina.2023; 59(6): 1063. CrossRef
Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Beom Kyung Kim, Sang Hoon Ahn
Journal of the Formosan Medical Association.2023; 122(12): 1238. CrossRef
Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
Bong Kyung Bae, Jeong Il Yu, Hee Chul Park, Myung Ji Goh, Yong-Han Paik
Radiation Oncology Journal.2023; 41(2): 98. CrossRef
Magnetic Resonance Imaging-Based Surveillance of Hepatocellular Carcinoma: Current Status and Future Perspectives
Hyo Jung Park, So Yeon Kim, Young-Suk Lim
Current Hepatology Reports.2023; 22(3): 83. CrossRef
Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria
Ja Kyung Yoon, Dai Hoon Han, Sunyoung Lee, Jin-Young Choi, Gi Hong Choi, Do Young Kim, Myeong-Jin Kim
Cancer Research and Treatment.2023; 55(3): 939. CrossRef
Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang
BMC Cancer.2023;[Epub] CrossRef
Comparison of Open versus Laparoscopic Approaches in Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation
Yeshong Park, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, MeeYoung Kang, Jinju Kim
Medicina.2023; 59(7): 1243. CrossRef
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study
Le Li, Pei-Sheng Wu, Xiu-Mei Liang, Kang Chen, Guan-Lan Zhang, Qi-Bin Su, Rong-Rui Huo, Rong-Wei Xie, Shan Huang, Liang Ma, Jian-Hong Zhong
Journal of Gastroenterology.2023; 58(10): 1043. CrossRef
Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim
Clinical and Molecular Hepatology.2023; 29(3): 763. CrossRef
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
Clinical and Molecular Hepatology.2023; 29(3): 521. CrossRef
Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging
Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, Bo Yun Hur, Dong Ho Lee, Haeryoung Kim
Clinical and Molecular Hepatology.2023; 29(3): 733. CrossRef
Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods
Seungchul Han, Se Woo Kim, Sungeun Park, Jeong Hee Yoon, Hyo-Jin Kang, Jeongin Yoo, Ijin Joo, Jae Seok Bae, Jeong Min Lee
Ultrasound in Medicine & Biology.2023; 49(10): 2256. CrossRef
Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
Jongman Kim, Dong-Jin Joo, Shin Hwang, Jeong-Moo Lee, Je-Ho Ryu, Yang-Won Nah, Dong-Sik Kim, Doo-Jin Kim, Young-Kyoung You, Hee-Chul Yu
World Journal of Gastrointestinal Surgery.2023; 15(7): 1340. CrossRef
Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
Journal of Liver Cancer.2023; 23(2): 241. CrossRef
A Case of Transverse Myelitis Following Treatment with Atezolizumab for Advanced Hepatocellular Carcinoma
Kyung Han Kim, Yang-Hyun Baek, Yeo Wool Kang, Byeol-A Yoon, Sang Yi Moon
The Korean Journal of Gastroenterology.2023; 82(1): 35. CrossRef
Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines from the Korean Society of Radiology and the Korean Society of Abdominal Radiology
Woo Kyoung Jeong, Hyo-Jin Kang, Sang Hyun Choi, Mi-Suk Park, Mi Hye Yu, Bohyun Kim, Myung-Won You, Sanghyeok Lim, Young Seo Cho, Min Woo Lee, Jeong Ah Hwang, Jae Young Lee, Jung Hoon Kim, Ijin Joo, Jae Seok Bae, So Yeon Kim, Yong Eun Chung, Dong Hwan Kim,
Korean Journal of Abdominal Radiology.2023; 7(1): 1. CrossRef
Suboptimal performance of LI-RADS v2018 on gadoxetic acid–enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates
Na Eun Oh, Sang Hyun Choi, Sehee Kim, Habeen Lee, Hyeon Ji Jang, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin
European Radiology.2023; 34(1): 465. CrossRef
External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion
Jeong Il Yu, Hee Chul Park, Hyunju Shin, Hyunki Park, Sung Wook Shin, Sung Ki Cho, Dongho Hyun, Jaeseung Shin, Myung Ji Goh, Moon Seok Choi, Boram Park, Sang Min Yoon, Jinhong Jung
Radiotherapy and Oncology.2023; 187: 109841. CrossRef
Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study
Jae-Hyun Yoon, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, Jeong-Han Kim
Medicina.2023; 59(8): 1436. CrossRef
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab
Kazuhiro Nouso, Shohei Shiota, Rio Fujita, Akiko Wakuta, Kazuya Kariyama, Atsushi Hiraoka, Masanori Atsukawa, Joji Tani, Toshifumi Tada, Shinichiro Nakamura, Kazuto Tajiri, Masaki Kaibori, Masashi Hirooka, Ei Itobayashi, Satoru Kakizaki, Atsushi Naganuma,
Cancer Medicine.2023; 12(17): 17849. CrossRef
Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
Hyo-Jin Kang, Jeong Min Lee, Se Woo Kim
Ultrasonography.2023; 42(4): 479. CrossRef
The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
Matthew Man Pok Lee, Landon Long Chan, Stephen Lam Chan
Journal of Liver Cancer.2023; 23(2): 262. CrossRef
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, Hae Lim Lee, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U Im Chang, Jin Mo Yang, Soon Woo Nam, Seok-Hwan Kim, Myeong Jun Song, Ji Hoon Kim, Ahlim Lee, Hyun Yang, Si Hyun Bae, Ji Won Han, Heechul Nam, Pil Soo Su
Cancers.2023; 15(17): 4423. CrossRef
Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma
Kazuhiro Nouso, Shohei Shiota, Rio Fujita, Akiko Wakuta, Kazuya Kariyama, Atsushi Hiraoka, Masanori Atsukawa, Joji Tani, Toshifumi Tada, Yu Matsuo, Shinichiro Nakamura, Kazuto Tajiri, Masaki Kaibori, Masashi Hirooka, Ei Itobayashi, Satoru Kakizaki, Atsush
Liver Cancer International.2023; 4(3-4): 101. CrossRef
Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea
Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han
Infectious Diseases and Therapy.2023; 12(10): 2387. CrossRef
A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
Yun Bin Lee, Joon Yeul Nam, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Hyo-Cheol Kim, Jin Chul Paeng, Jung-Hwan Yoon, Yoon Jun Kim
Clinical Cancer Research.2023; 29(18): 3650. CrossRef
Has the growing evidence of radiotherapy for hepatocellular carcinoma increased the use of radiotherapy in elderly patients?
Tae Hyun Kim
Radiation Oncology Journal.2023; 41(3): 141. CrossRef
Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation: A Retrospective Cohort Study with Propensity Score-Matched Analysis
Yeshong Park, Ho-Seong Han, Yoo-Seok Yoon, Chang Jin Yoon, Hae Won Lee, Boram Lee, MeeYoung Kang, Jinju Kim, Jai Young Cho
Cancers.2023; 15(19): 4745. CrossRef
Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis
Myung Ji Goh, Jihye Kim, Won Hyuk Chang, Dong Hyun Sinn, Geum-Yeon Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jong Man Kim, Wonseok Kang
Gut and Liver.2023; 17(5): 786. CrossRef
Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon
Clinical and Molecular Hepatology.2023; 29(4): 1029. CrossRef
Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes
Jae Hyun Yoon, Sung Kyu Choi
Journal of Liver Cancer.2023; 23(2): 300. CrossRef
Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis
Yingyi Wu, Chunchao Xia, Jie Chen, Qin Qin, Zheng Ye, Bin Song
Abdominal Radiology.2023; 49(1): 34. CrossRef
Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy
Sang Min Yoon
Clinical and Molecular Hepatology.2023; 29(4): 977. CrossRef
Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
Hyo-Cheol Kim
Clinical and Molecular Hepatology.2023; 29(4): 984. CrossRef
Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
Hyeon-Jong Kim, Seung Hyuk Lee, Hyun Jeong Shim, Hyun Jin Bang, Sang Hee Cho, Ik-Joo Chung, Eu Chang Hwang, Jun Eul Hwang, Woo Kyun Bae
Frontiers in Oncology.2023;[Epub] CrossRef
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
Sung Uk Lee, Tae Hyun Kim
Clinical and Molecular Hepatology.2023; 29(4): 958. CrossRef
Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice
Nalee Kim, Jeong Il Yu, Hee Chul Park, Jung Yong Hong, Ho Yeong Lim, Myung Ji Goh, Yong-Han Paik
Journal of Liver Cancer.2023; 23(2): 350. CrossRef
Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim
Clinical and Molecular Hepatology.2023; 29(4): 1013. CrossRef
The efficacy of treatment for hepatocellular carcinoma in elderly patients
Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
Journal of Liver Cancer.2023; 23(2): 362. CrossRef
Does threshold growth benefit imaging criteria when used as a major diagnostic imaging feature for hepatocellular carcinoma?
Ji Young Choi, Rohee Park, Sang Hyun Choi, Hyeon Ji Jang, Se Jin Choi, Subin Heo
European Journal of Radiology.2023; 169: 111188. CrossRef
Predicting the risk of early bleeding following endoscopic variceal ligation in cirrhotic patients with computed tomography
Hwaseong Ryu, Tae Un Kim, Ki Tae Yoon, Young Mi Hong
BMC Gastroenterology.2023;[Epub] CrossRef
Hepatocellular Carcinoma: Optimal Radiological Evaluation before Liver Transplantation
Marco Dioguardi Burgio, Lorenzo Garzelli, Roberto Cannella, Maxime Ronot, Valérie Vilgrain
Life.2023; 13(12): 2267. CrossRef
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study
Jonathan Abdelmalak, Simone I. Strasser, Natalie Ngu, Claude Dennis, Marie Sinclair, Avik Majumdar, Kate Collins, Katherine Bateman, Anouk Dev, Joshua H. Abasszade, Zina Valaydon, Daniel Saitta, Kathryn Gazelakis, Susan Byers, Jacinta Holmes, Alexander J.
Cancers.2023; 15(24): 5741. CrossRef
Survival Prediction Model for Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis Based on XGBoost Algorithm
Jihye Lim, Hyeon-Gi Jeon, Yeonjoo Seo, Moonjin Kim, Ja Un Moon, Se Hyun Cho
Journal of Hepatocellular Carcinoma.2023; Volume 10: 2251. CrossRef
Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis
Jieun Kwon, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
Annals of Liver Transplantation.2023; 3(2): 104. CrossRef
Thermal ablation of hepatocellular carcinoma
Laura Crocetti, Paola Scalise, Elena Bozzi, Gianvito Candita, Roberto Cioni
Journal of Medical Imaging and Radiation Oncology.2023; 67(8): 817. CrossRef
Development and Validation of a Difficulty Scoring System for Laparoscopic Liver Resection to Treat Hepatolithiasis
Yeongsoo Jo, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Eunhye Lee, Yeshong Park, MeeYoung Kang, Junghyun Lee
Medicina.2022; 58(12): 1847. CrossRef
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
Diagnostics.2022; 13(1): 3. CrossRef

39,012 View
1,022 Download
316 Web of Science
Crossref

Viral hepatitis

KASL clinical practice guidelines for management of chronic hepatitis B: The Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2022;28(2):276-331.
Published online April 1, 2022; DOI: https://doi.org/10.3350/cmh.2022.0084

Citations

Citations to this article as recorded by

Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-Male-Albumin-Bilirubin-Platelet (aMAP) and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography
Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
Clinical Gastroenterology and Hepatology.2026; 24(7): 1897. CrossRef
Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases
Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung
Journal of Korean Medical Science.2026;[Epub] CrossRef
Chronic comorbidities, concomitant medications, and treatment patterns of chronic hepatitis B patients receiving nucleos(t)ide analogue therapy: a hospital claims database study in Japan
Daisuke Nakamoto, Emi Ohata, Mayumi Yuda, Nobuyuki Fukui, Nao Makino, Rie Kanamori, Nozomi Aoki, Akio Kanazawa, Hirotake Mori, Yuji Nishizaki, Hirohide Yokokawa, Yuichiro Yano, Toshio Naito
BMC Infectious Diseases.2026;[Epub] CrossRef
2025 KASL clinical practice guidelines for management of hepatitis C
Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung
Clinical and Molecular Hepatology.2026; 32(1): 1. CrossRef
E-cigarette switching, smoking cessation, and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nationwide cohort study in South Korea
Byeong Geun Song, Myeongcheol Lee, Juhee Cho, Geum-Youn Gwak, Danbee Kang, Dong Hyun Sinn
Preventive Medicine.2026; 205: 108530. CrossRef
Atherosclerotic Cardiovascular Risk in Patients with Chronic Hepatitis B: Tenofovir Disoproxil Fumarate Vs. Tenofovir Alafenamide: A Korean Nationwide Study
Jiwon Yang, Jihye Lim, Ye‐jee Kim, Hwa Jung Kim, Jonggi Choi
Journal of Medical Virology.2026;[Epub] CrossRef
Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights
Maria Stella Franzè, Teresa Pollicino, Jean‐Michel Pawlotsky, Vincent Leroy, Giovanni Raimondo, Giuliana Amaddeo
Liver International.2026;[Epub] CrossRef
Comparative Renal Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A Korean Nationwide Study
Jihye Lim, Jiwon Yang, Ye-jee Kim, Hwa Jung Kim, Jonggi Choi
Journal of Korean Medical Science.2026;[Epub] CrossRef
Genetic Epidemiology of Hepatitis B Virus in Africa: A Review
Samson Laribik Dujing, Eugene Dogkotegne Kuugbee, Williams Walana
Gastro Hep Advances.2026; 5(6): 100968. CrossRef
Superior Efficacy of Besifovir in Reducing Hepatocellular Carcinoma Risk Compared to Tenofovir in Chronic Hepatitis B Patients: A Nationwide Cohort Study
Yoon E Shin, Jae Young Kim, Hyuk Kim, Jeong Ju Yoo, Sang Gyune Kim, Young Seok Kim
Journal of Korean Medical Science.2026;[Epub] CrossRef
Non‐Selective Beta‐Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation
Byeong Geun Song, Myeongcheol Lee, Danbee Kang, Wonseok Kang, Ju Hyun Shim, Dong Hyun Sinn, Geum‐Youn Gwak
Alimentary Pharmacology & Therapeutics.2026;[Epub] CrossRef
Insulin Resistance and Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients Under Antiviral Therapy
Dong Hyun Sinn, Kyung-Ah Kim, Jung Il Lee, Geum-Youn Gwak
Journal of Korean Medical Science.2026;[Epub] CrossRef
Hepatitis B core-related antigen as a multifaceted biomarker in chronic hepatitis B: implications for immune activity and hepatocellular carcinoma prediction
Kwon Yong Tak, Seok Hwan Kim, Myeong Jun Song
The Korean Journal of Internal Medicine.2026; 41(4): 636. CrossRef
A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
Journal of Hepatology.2025; 82(2): 235. CrossRef
Impact of Maternal Hepatitis B Virus Infection on Congenital Heart Disease Risk in Offspring: A National Cohort Study
Yewan Park, Jihye Heo, Danbee Kang, Geum‐Youn Gwak
Journal of Viral Hepatitis.2025;[Epub] CrossRef
A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis B
Yeonjung Ha, Seungseok Lee, Jihye Lim, Kwanjoo Lee, Young Eun Chon, Joo Ho Lee, Kwan Sik Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Dong Keon Yon, Jinseok Lee, Han Chu Lee
Liver International.2025;[Epub] CrossRef
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
Journal of Hepatology.2025; 82(6): 1080. CrossRef
Accelerating the momentum to achieve global elimination of hepatitis B infection: a scoping review of hepatitis B guidelines to reduce mother to child transmission
Ka Wang Cheung, Ying Rong Li, Ms Tiffany Sin-Tung Au, Mimi Tin Yan Seto
eClinicalMedicine.2025; 80: 103038. CrossRef
Effect of invasive tests during pregnancy on perinatal transmission of hepatitis B infection: a scoping review
Ka Wang Cheung, Tiffany Sin-Tung Au, Ying Rong Li, Zhenyan Han, Zhu Zhang, Mimi Tin Yan Seto
eClinicalMedicine.2025; 80: 103039. CrossRef
Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi
Clinical and Molecular Hepatology.2025; 31(1): 131. CrossRef
Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
Log Young Kim, Jae Young Kim, Jeong‐Ju Yoo, Sang Gyune Kim, Young‐Seok Kim
Journal of Medical Virology.2025;[Epub] CrossRef
Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
Jung Hee Kim, Sung-Eun Kim, Do Seon Song, Hee Yeon Kim, Eileen L. Yoon, Ji Won Park, Tae Hyung Kim, Young-Kul Jung, Ki Tae Suk, Hyung Joon Yim, Jung Hyun Kwon, Sung Won Lee, Seong Hee Kang, Moon Young Kim, Soung Won Jeong, Jae-Young Jang, Jeong Ju Yoo, Sa
Annals of Medicine.2025;[Epub] CrossRef
The sV184A Variant in HBsAg Specific to HBV Subgenotype C2 Leads to Enhanced Viral Replication and Apoptotic Cell Death Induced by PERK‐eIF2α‐CHOP‐Mediated ER Stress
Yu‐Min Choi, Dong Hyun Kim, Eun Ju Cho, Ziyun Kim, Junghwa Jang, Hyunsoo Kim, Su Jong Yu, Bum‐Joon Kim
Journal of Medical Virology.2025;[Epub] CrossRef
Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF
Hyuk Kim, Jae-Young Kim, Yoon E. Shin, Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
Scientific Reports.2025;[Epub] CrossRef
Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
Hae Lim Lee, Soon Kyu Lee, Ji Won Han, Hyun Yang, Heechul Nam, Pil Soo Sung, Hee Yeon Kim, Sung Won Lee, Do Seon Song, Jung Hyun Kwon, Chang Wook Kim, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
JHEP Reports.2025; 7(7): 101391. CrossRef
Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
Tyng‐Yuan Jang, Chia‐Yen Dai
Advances in Digestive Medicine.2025;[Epub] CrossRef
Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
Soon Kyu Lee, Jong Young Choi
Clinical and Molecular Hepatology.2025; 31(2): e161. CrossRef
Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
Chih-Wen Wang, Ming-Lung Yu
Clinical and Molecular Hepatology.2025; 31(2): 606. CrossRef
Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
Soon Kyu Lee, Jong Young Choi
Clinical and Molecular Hepatology.2025; 31(2): e212. CrossRef
Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
Jihye Lim, Hyundam Gu, Hyunji Sang, Su Jin Jeong, Ha Il Kim
Alzheimer's Research & Therapy.2025;[Epub] CrossRef
Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study
Napoleon Bellua Sam, Saeed Folorunsho Majeed, Adams Dramani
Health Science Reports.2025;[Epub] CrossRef
A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B
Jiwon Yang, Mark D. Muthiah, Won-Mook Choi
Current Hepatology Reports.2025;[Epub] CrossRef
A greater frequency of circulating CCR7loPD-1hi follicular helper T cells indicates a durable clinical cure after Peg IFN-α therapy in chronic hepatitis B patients
Shan Ren, Xiao Lin, Wenjing Wang, Wang Xiaoxiao, Lina Ma, Yanhong Zheng, Sujun Zheng, Xinyue Chen
Hepatology Communications.2025;[Epub] CrossRef
Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
Han Ah. Lee, Hyun Woong Lee, Yeon Seok Seo, Dong Hyun Sinn, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
Journal of Gastroenterology and Hepatology.2025; 40(7): 1675. CrossRef
Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis
Nobuharu Tamaki, Daniel Q. Huang, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Dong Hyun Sinn, Tae Seop Lim, Hiroyuki Marusawa, Seng Gee Lim, Hironori Ochi, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Masayuki Kurosaki, Beom Kyung K
Journal of Gastroenterology and Hepatology.2025; 40(6): 1595. CrossRef
Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients
Jihye Lim, Hyo Young Lee, Hyunji Sang, Su Jin Jeong, Ha Il Kim
Scientific Reports.2025;[Epub] CrossRef
Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis B
Tyng-Yuan Jang, Yu-ting Zeng, Po-Cheng Liang, Chih-Da Wu, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Yi-Shan Tsai, Ming-Yen Hsieh, Yi-Hung Lin, Meng-Hsuan Hsieh, Chih-Wen Wang, Jeng-Fu Yang, Ming-Lun Yeh, Chung-Feng Huang, Wan-Long Chuang, Jee-Fu Huang, Batbo
Journal of the Chinese Medical Association.2025; 88(5): 361. CrossRef
Concise Commentary: Gray Area—Underappreciated HCC Risk in Untreated “Gray Zone” and Immune-Tolerant CHB Patients
Won-Mook Choi
Digestive Diseases and Sciences.2025; 70(9): 2910. CrossRef
Immunizations in adult liver transplant candidates and recipients
Dongwook Kim, Pyoeng Gyun Choe
Annals of Liver Transplantation.2025; 5(1): 19. CrossRef
Emergency living donor liver transplantation
Jongman Kim
Annals of Liver Transplantation.2025; 5(1): 27. CrossRef
Association between maternal chronic hepatitis B virus infection and the neurodevelopment of children: A comprehensive Korean cohort study
Yewan Park, Jihye Heo, Danbee Kang, Geum-Youn Gwak
Preventive Medicine Reports.2025; 55: 103116. CrossRef
Letter on ‘Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma’. Authors' Reply
Jiwon Yang, Won‐Mook Choi
Alimentary Pharmacology & Therapeutics.2025; 62(2): 238. CrossRef
Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study
Young Joo Park, Ki Youn Yi, Hyun Young Woo, Jeong Heo, Geun Am Song, Riccardo Nevola
PLOS One.2025; 20(5): e0324019. CrossRef
Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
Liang Wang, Shipeng Ma, Lajpat Rai Malhi, Xiaoping Wu, Liping Liu, Xin Wan, Yuliang Zhang, Xiaopeng Li, Shanfei Ge
Annals of Hepatology.2025; 30(2): 101925. CrossRef
Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study
Young Eun Chon, Jonghyun Lee, Eileen L. Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
European Journal of Gastroenterology & Hepatology.2025;[Epub] CrossRef
Metabolic effects and cardiovascular disease risks of TDF or TAF in patients with chronic hepatitis B: a systematic review and meta-analysis
Yuan-Hai Zhou, Nan Cai, Yu-Xin Chen, Yong-Lu Su, Peng Hu
Frontiers in Pharmacology.2025;[Epub] CrossRef
A Case of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B Who was Not Under Surveillance Following the Loss of HBsAg
Myeong Jun Song
The Korean Journal of Gastroenterology.2025; 85(3): 425. CrossRef
Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
Osteoporosis International.2025; 36(8): 1391. CrossRef
Longitudinal changes in estimated glomerular filtration rates in chronic hepatitis B patients treated with Tenofovir Alafenamide vs Entecavir
Xuan Li, Qiang Wu, Fang Huang, Changxiang Lai, Fengjuan Chen, Juan Meng, Fang Wang, Hui Zeng, Lina Zhang
PeerJ.2025; 13: e19901. CrossRef
Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
Annals of Surgical Treatment and Research.2025; 109(3): 123. CrossRef
Chronic hepatitis B: Is it time for expanded antiviral treatment?
Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra
World Journal of Virology.2025;[Epub] CrossRef
Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate
Jiwon Yang, Jihye Lim, Ye‐Jee Kim, Hwa Jung Kim, Jonggi Choi
Liver International.2025;[Epub] CrossRef
Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis
Mi Na Kim, Geun U. Park, Seng Chan You, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn
Journal of Gastroenterology and Hepatology.2025; 40(11): 2750. CrossRef
Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
Journal of Liver Cancer.2025; 25(2): 140. CrossRef
Comparative Renal Safety of Besifovir Dipivoxil Maleate and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients: Insights From a Nationwide Cohort Study
Hyun Bin Choi, Jae Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
Journal of Korean Medical Science.2025;[Epub] CrossRef
Distinguishing True Immune Tolerant Hepatitis B Patients: Insights From Long‐Term Clinical Outcomes
Jung Hyun Kwon, Sung Won Lee, Hee‐Yeon Kim, Do Seon Song, Soon Kyu Lee, Heechul Nam, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
Journal of Viral Hepatitis.2025;[Epub] CrossRef
Disease burden of chronic hepatitis B and C patients in South Korea: a population-based 16-year cohort study
Oeuk Jeong, Changhee Chu, Jungyeon Kim, Jae Seung Lee, Jun Yong Park, Kyung Eun Lee, Jaehyun Seong, Min Jin Go
BMC Infectious Diseases.2025;[Epub] CrossRef
Factors associated with TDF-to-TAF switching in chronic hepatitis B: A nationwide cohort study in South Korea
Hyemin Ha, Kwang Il Seo, Nam Kyung Je
Journal of Infection and Chemotherapy.2025; 31(12): 102860. CrossRef
Predicting risk factors for waiting mortality in adult emergent living donor liver transplantation based on Korean national data
Sang Jin Kim, Jongman Kim, Kyunga Kim, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung
Annals of Liver Transplantation.2025; 5(2): 107. CrossRef
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Gwang Hyeon Choi, Yun Bin Lee, Dong Hyun Sinn, Young-Suk Lim
Gut.2024; 73(4): 649. CrossRef
Gray zone of hepatitis B virus infection
Young-Suk Lim
Saudi Journal of Gastroenterology.2024; 30(2): 76. CrossRef
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
Ho Soo Chun, George V. Papatheodoridis, Minjong Lee, Hye Ah Lee, Yeong Hwa Kim, Seo Hyun Kim, Yun-Seo Oh, Su Jin Park, Jihye Kim, Han Ah Lee, Hwi Young Kim, Tae Hun Kim, Eileen L. Yoon, Dae Won Jun, Sang Hoon Ahn, Vana Sypsa, Cihan Yurdaydin, Pietro Lampe
Journal of Hepatology.2024; 80(1): 20. CrossRef
Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment
Hyeyeon Hong, Minjoo Cho, Chaeyeon Lim, Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Jonggi Choi
Alimentary Pharmacology & Therapeutics.2024; 59(4): 515. CrossRef
Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy
Liandong Wu, Zhenggang Yang, Min Zheng
Journal of Viral Hepatitis.2024; 31(5): 255. CrossRef
Jaundice That Has Persisted for 5 Days
Young Chang
The Korean Journal of Medicine.2024; 99(3): 140. CrossRef
Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
Diagnostics.2024; 14(5): 495. CrossRef
Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
OncoTargets and Therapy.2024; Volume 17: 215. CrossRef
Linvencovir: Paving the way for functional cure in hepatitis B
Jiwon Yang, Jonggi Choi
Clinical and Molecular Hepatology.2024; 30(2): 164. CrossRef
Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
JHEP Reports.2024; 6(7): 101089. CrossRef
Clinical profile and parameters of patients monoinfected with HBV and infected with HDV in Western Amazon
Eugênia de Castro e Silva, Tárcio Peixoto Roca, Ana Maísa Passos-Silva, Lourdes Maria Pinheiro Borzacov, Adrhyan Araújo da Silva Oliveira, Jackson Alves da Silva Queiroz, Juan Miguel Villalobos Salcedo, Deusilene Vieira
Heliyon.2024; 10(10): e31065. CrossRef
Macrophage-2-Binding Protein Glycosylation Isomer (M2BPGi) and AGAP Score as Markers of Noninvasive Test for Liver Fibrosis versus FibroScan in Chronic Hepatitis B Patients: A Retrospective Observational Study
Laila Kurnia Pramono, Anna Tjandrawati, Dewi Kartika Turbawaty, Tiene Rostini, Muhammad Begawan Bestari, Haryono, Deny Budiman, Prapanca Nugraha, Dirk Uhlmann
International Journal of Hepatology.2024; 2024: 1. CrossRef
Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis
Jaejun Lee, Ahlim Lee, Pil Soo Sung, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hyun Yang
The Korean Journal of Internal Medicine.2024; 39(4): 577. CrossRef
Treatment decisions based on HBV DNA
Young‐Suk Lim
Journal of Viral Hepatitis.2024; 31(S2): 36. CrossRef
Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, Chia‐Yen Dai
Journal of Gastroenterology and Hepatology.2024; 39(11): 2327. CrossRef
Differential HBV replicative markers and covalently closed circular DNA transcription in immune‐active chronic hepatitis B with and without HBeAg
Hye Seon Kim, Jin Seoub Kim, Ji Min Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam, Pil Soo Sung, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
Liver International.2024; 44(10): 2753. CrossRef
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
Clinical and Molecular Hepatology.2024; 30(3): 500. CrossRef
Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review
Anadi Mahajan, Saifuddin Kharawala, Supriya Desai, Stuart Kendrick, Joyeta Das, Vera Gielen
Journal of Viral Hepatitis.2024; 31(11): 746. CrossRef
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Gwang Hyeon Choi, Won-Mook Choi, Jonggi Choi, Dong Hyun Sinn, Yong-Han Paik, Jeong-Hoon Lee, Yun Bin Lee, Ju-Yeon Cho, Nae-Yun Heo, Man-Fung Yuen, Vincent Wai-Sun Wong, Stephen L. Chan, Hwai-I Yang, Chien-Jen Chen
Annals of Internal Medicine.2024; 177(10): 1308. CrossRef
Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis
Jeong‐Ju Yoo, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Min Jae Kim
Journal of the International AIDS Society.2024;[Epub] CrossRef
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, D
Clinical and Molecular Hepatology.2024; 30(Suppl): S5. CrossRef
Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis
Young-Joo Jin, Hee Yeon Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun, Miyoung Choi, Seung Up Kim
Clinical and Molecular Hepatology.2024; 30(Suppl): S159. CrossRef
Recent Trends in Noninvasive Tests for Assessing Hepatic Fibrosis in Patients with Chronic Liver Disease
Jung Hwan Yu
The Korean Journal of Medicine.2024; 99(5): 232. CrossRef
Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
Yewan Park, Dong Hyun Sinn
Clinical and Molecular Hepatology.2024; 30(4): 718. CrossRef
Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography
Han Ah Lee
Clinical Ultrasound.2024; 9(2): 70. CrossRef
Effect of renin-angiotensin system inhibitor in incident cancer among chronic hepatitis B patients: An emulated target trial using a nationwide cohort
Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
Journal of the Renin-Angiotensin-Aldosterone System.2024;[Epub] CrossRef
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
Infectious Agents and Cancer.2023;[Epub] CrossRef
Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee
European Journal of Gastroenterology & Hepatology.2023; 35(4): 431. CrossRef
Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues
Tyng‐Yuan Jang
Alimentary Pharmacology & Therapeutics.2023; 57(5): 587. CrossRef
The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(5): 716. CrossRef
Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
Frontiers in Oncology.2023;[Epub] CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Journal of Liver Cancer.2023; 23(1): 1. CrossRef
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study
Moon Haeng Hur, Min Kyung Park, Terry Cheuk-Fung Yip, Chien-Hung Chen, Hyung-Chul Lee, Won-Mook Choi, Seung Up Kim, Young-Suk Lim, Soo Young Park, Grace Lai-Hung Wong, Dong Hyun Sinn, Young-Joo Jin, Sung Eun Kim, Cheng-Yuan Peng, Hyun Phil Shin, Chi-Yi Ch
American Journal of Gastroenterology.2023; 118(11): 1963. CrossRef
Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
Jeong-Ju Yoo, Sang Gyune Kim
Clinical and Molecular Hepatology.2023; 29(2): 513. CrossRef
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
Moon Haeng Hur, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2023; 29(2): 363. CrossRef
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clinical and Molecular Hepatology.2023; 29(2): 367. CrossRef
Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
Eui Gwon Hwang, Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
Hepatology International.2023; 17(4): 860. CrossRef
Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2023; 58(1): 99. CrossRef
Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
Diagnostics.2023; 13(9): 1537. CrossRef
CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B
Hye Yeon Chon, Han Ah Lee, Soo Young Park, Yeon Seok Seo, Sang Gyune Kim, Chang Hun Lee, Tae Hee Lee, Sang Hoon Ahn, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Lilian Yan Liang, In Hee Kim, Grace Lai‐Hung Wong, Seung Up Kim
Journal of Digestive Diseases.2023; 24(2): 113. CrossRef
Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study
Jihye Kim, Moon Haeng Hur, Seung Up Kim, Jin-Wook Kim, Dong Hyun Sinn, Hyun Woong Lee, Moon Young Kim, Jae Youn Cheong, Yong Jin Jung, Han Ah Lee, Young-Joo Jin, Jun Sik Yoon, Sung-Jae Park, Chang Hun Lee, In Hee Kim, June Sung Lee, Young Youn Cho, Hyung
Cancers.2023; 15(11): 2936. CrossRef
Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALT
宇行刘
Advances in Clinical Medicine.2023; 13(05): 8702. CrossRef
Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang
BMC Cancer.2023;[Epub] CrossRef
Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
BMC Gastroenterology.2023;[Epub] CrossRef
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
Liver International.2023; 43(8): 1813. CrossRef
Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non‐cirrhotic patients with chronic hepatitis B
Cheol‐Hyung Lee, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
Alimentary Pharmacology & Therapeutics.2023; 58(7): 704. CrossRef
The efficacy of treatment for hepatocellular carcinoma in elderly patients
Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
Journal of Liver Cancer.2023; 23(2): 362. CrossRef
Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia
Grace Chung‐Yan Lui, Grace Lai‐Hung Wong, Hung‐Chih Yang, Wang‐Huei Sheng, Sun Hee Lee
HIV Medicine.2023; 24(10): 1035. CrossRef
Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
BMC Gastroenterology.2023;[Epub] CrossRef
Adult-onset hypophosphatemic osteomalacia as a cause of widespread musculoskeletal pain: A retrospective case series of single center experience
Sungwon Kim, Sun Woong Kim, Byung Chan Lee, Du Hwan Kim, Duk Hyun Sung
World Journal of Clinical Cases.2023; 11(32): 7785. CrossRef
Hepatocellular carcinoma presenting as organized liver abscess: A case report
Sung Hyeok Ryou, Hyun Deok Shin, Suk Bae Kim
World Journal of Clinical Cases.2023; 11(33): 8078. CrossRef
The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
Jung Kim, Sung-Eun Kim, Do Song, Hee Kim, Eileen Yoon, Seong Kang, Young-Kul Jung, Jung Kwon, Sung Lee, Seul Han, Young Chang, Soung Jeong, Jeong Yoo, Young-Joo Jin, Gab Cheon, Byung Kim, Yeon Seo, Hyoungsu Kim, Ji Park, Tae Kim, Dong Sinn, Woo Chung, Hwi
Diagnostics.2023; 14(1): 14. CrossRef
Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
Clinical and Molecular Hepatology.2023; 30(1): 49. CrossRef
Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
Medicine.2023; 102(43): e34276. CrossRef
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scientific Reports.2022;[Epub] CrossRef
Reply to: “A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations”
Hyun Yang, Si Hyun Bae, Jeong Won Jang
Journal of Hepatology.2022; 77(6): 1724. CrossRef
Viral Hepatitis in Patients with Inflammatory Bowel Disease
Seung Hwan Shin, Sang Hyoung Park
The Korean Journal of Gastroenterology.2022; 80(2): 51. CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2022; 23(12): 1126. CrossRef
Updated Treatment Guidelines for Chronic Hepatitis B
Jihyun An
The Korean Journal of Medicine.2022; 97(6): 353. CrossRef

31,241 View
710 Download
111 Web of Science
Crossref

Reviews

Viral hepatitis

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop: Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee; Clin Mol Hepatol 2020;26(4):411-429.
Published online August 28, 2020; DOI: https://doi.org/10.3350/cmh.2020.0049

Abstract
PDF

Clinical practice guidelines are important for guiding the management of specific diseases by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as a reference for health policymakers in controlling diseases with a large public impact. With this in mind, practice guidelines for the management of chronic hepatitis B (CHB) have been developed in the United States, Europe, and Asian-Pacific regions to suggest the best-fit recommendations for each social and medical circumstance. Recently, the Korean Association for the Study of the Liver published a revised version of its clinical practice guidelines for the management of CHB. The guidelines included updated information based on newly available antiviral agents, the most recent opinion on the initiation and cessation of treatment, and updates for the management of drug resistance, partial virological response, and side effects. Additionally, CHB management in specific situations was comprehensively revised. This review compares the similarities and differences among the various practice guidelines to identify unmet needs and improve future recommendations.

Citations

Citations to this article as recorded by

Comparison of Hepatitis B e Antigen Clearance Rates between Tenofovir Alafenamide and Entecavir in Treatment-Naive Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients over 48–96 Weeks: A Retrospective Cohort Study
Yuliang Zhang, Xin Wan, Shipeng Ma, Liang Wang, Qian Liu, Yulun Tang, Lajpat Rai Malhi, Shanfei Ge
Digestive Diseases.2026; 44(2): 173. CrossRef
Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B
David Z Pan, Cameron M Soulette, Abhishek Aggarwal, Dong Han, Nicholas van Buuren, Peiwen Wu, Becket Feierbach, Jaw-Town Lin, Cheng-Hao Tseng, Chi-Yi Chen, Bryan Downie, Hongmei Mo, Lauri Diehl, Li Li, Simon P Fletcher, Scott Balsitis, Ricardo Ramirez, Vi
Gut.2025; 74(4): 628. CrossRef
Limited Value of HBV‐RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg‐negative Hepatitis B Patients
Valerie Ohlendorf, Maximilian Wübbolding, Christoph Höner zu Siederdissen, Birgit Bremer, Katja Deterding, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy
Journal of Viral Hepatitis.2025;[Epub] CrossRef
Overview of chronic hepatitis B management
Angela Jun, Sherona Bau, John S. Kim, Susanne J. Phillips
The Nurse Practitioner.2025; 50(1): 7. CrossRef
Effectiveness and safety of tenofovir amibufenamide and tenofovir alafenamide in treating elderly patients diagnosed with decompensated hepatitis B cirrhosis: a retrospective cohort study
Xinye Qiu, Yue Yin, Shibin Zhang, Wei Liu
Frontiers in Pharmacology.2025;[Epub] CrossRef
Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
Tyng‐Yuan Jang, Chia‐Yen Dai
Advances in Digestive Medicine.2025;[Epub] CrossRef
Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021
Pojsakorn Danpanichkul, Kwanjit Duangsonk, Vincent L. Chen, Preenapun Saokhieo, Disatorn Dejvajara, Banthoon Sukphutanan, Majd B. Aboona, Chawin Lopimpisuth, Yanfang Pang, Andrew F. Ibrahim, Michael B. Fallon, Daniel Q. Huang, Donghee Kim, Amit G. Singal,
Hepatology.2025; 82(5): 1274. CrossRef
Tenofovir alafenamide-related hyperlipidemia and cardiovascular risk
Ankur Jindal, Manoj Kumar
Hepatology International.2025; 19(4): 701. CrossRef
Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
Osteoporosis International.2025; 36(8): 1391. CrossRef
Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B
Jae Seung Lee, Sung Won Lee, Hae Lim Lee, Jeong-Ju Yoo, Yeon Seok Seo, Su Jong Yu, Hyung Joon Yim, Young Kul Jung, Jisu Moon, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Sang Gyune Kim, Seung Up Kim
Scientific Reports.2025;[Epub] CrossRef
Time for a globally unified chronic HBV terminology?
Su Wang, Catherine Freeland, Seng Gee Lim, Hailemichael Desalegn, Chari Cohen, Harry L.A. Janssen
JHEP Reports.2025; 7(12): 101570. CrossRef
Chronic hepatitis B: Is it time for expanded antiviral treatment?
Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra
World Journal of Virology.2025;[Epub] CrossRef
Modeling the Impact of Treatment on Hepatitis B Burden: Mathematical Analysis and Simulation
Jean Pierre II Kouenkam, Joseph Mbang, Gilbert Chendjou, Herieth Rwezaura, Jean Tchuenche
Operations Research Forum.2025;[Epub] CrossRef
Efficacy and safety of PEG-IFN α-2b and tenofovir amibufenamide in combination therapy for chronic hepatitis B
Wen Zhao, Longcan Li, Shihui Liu, Wenjie Zhang, Yufeng Gao, Zonghao Zhao, Xiaojun Liu, Yi Luo, Dongdong Li, Chuanmiao Liu
BMC Infectious Diseases.2025;[Epub] CrossRef
Precision Management of Patients with HBV Infection
Chih-Lin Lin, Jia-Horng Kao
Current Hepatology Reports.2024; 23(1): 22. CrossRef
Management of Hepatitis B in Pregnancy
Jeanette Rios, Lital Aliasi-Sinai, Natalia Schmidt, Tatyana Kushner
Current Hepatology Reports.2024; 23(2): 278. CrossRef
Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, Yeon Seok Seo, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
Gut and Liver.2024; 18(2): 305. CrossRef
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
Heechul Nam, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Myeong Jun Song, Jung Hyun Kwon, Jeong Won Jang, U‐Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Hee Yeon Kim
Journal of Gastroenterology and Hepatology.2024; 39(8): 1673. CrossRef
Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, Chia‐Yen Dai
Journal of Gastroenterology and Hepatology.2024; 39(11): 2327. CrossRef
Modern etiotropic therapy of chronic viral hepatitis B
E. B. Bun'kova, N. A. Bileva, A. E. Bilev, M. I. Sinel'nikov
Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2024; 14(4): 76. CrossRef
Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
Wei-Chun Lin, Ke Lin, Ming-Kai Li, Xiao Liu, Yi-Fei Huang, Xing Wang, Bin Wu
World Journal of Hepatology.2024; 16(11): 1321. CrossRef
Safety and efficacy of 48-week pegylated interferon-α-2b therapy in patients with hepatitis B virus-related compensated liver cirrhosis: a pilot observational study
Zehong Wang, Xuanxuan Wang, Li Zhou, Shaoyuan Shi, Yongli Hua, Yinong Feng
Frontiers in Medicine.2024;[Epub] CrossRef
Limited stability of Hepatitis B virus RNA in plasma and serum
Valerie Ohlendorf, Birgit Bremer, Lisa Sandmann, Carola Mix, Tammo Tergast, Markus Cornberg, Heiner Wedemeyer, Katja Deterding, Benjamin Maasoumy
Scientific Reports.2024;[Epub] CrossRef
Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
Shenglong Lin, Wanlong Huang, Ziyuan Liao, Huaxi Ma, Wenjun Wu, Minghua Lin, Defu Huang, Haibing Gao
Scientific Reports.2024;[Epub] CrossRef
Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
European Journal of Internal Medicine.2023; 107: 66. CrossRef
Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study
Byungyoon Yun, Juyeon Oh, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
American Journal of Gastroenterology.2023; 118(6): 1001. CrossRef
Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
Won Sohn, Yong-Han Paik
Clinical and Molecular Hepatology.2023; 29(1): 182. CrossRef
Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
Yoonseok Lee, Seryun Bae, Ji Hoon Kim, Minjung Kwak, So Yeon Jeon, Taehyung Kim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Journal of Clinical Medicine.2023; 12(2): 712. CrossRef
Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
Hepatology Communications.2023; 7(2): e0011. CrossRef
miR-548c-3p targets TRIM22 to attenuate the Peg–IFN–α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B
Ni Lin, Long Wang, Zhaopei Guo, Shaoying Guo, Can Liu, Jinpiao Lin, Songhang Wu, Siyi Xu, Hongyan Guo, Fenglin Fang, Ya Fu, Qishui Ou
Antiviral Research.2023; 213: 105584. CrossRef
Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Xingxin Zhang, Chenjian Gu, Qian Wei, Yirong Cao, Weimin She, Hong Shi, Youhua Xie, Jinsheng Guo
Journal of Hepatocellular Carcinoma.2023; Volume 10: 599. CrossRef
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
Clinical and Molecular Hepatology.2023; 29(2): 482. CrossRef
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi,
Hepatology.2023; 77(5): 1746. CrossRef
Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2023; 58(1): 99. CrossRef
The urgency to expand the antiviral indications of general chronic hepatitis B patients
Ping Fan, Lan-Qing Li, En-Qiang Chen
Frontiers in Medicine.2023;[Epub] CrossRef
Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
Lanqing Li, Jing Zhou, Yujing Li, Fada Wang, Dongmei Zhang, Menglan Wang, Yachao Tao, Enqiang Chen
Frontiers in Pharmacology.2023;[Epub] CrossRef
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
Heejoon Jang, Su Jong Yu, Hong Ghi Lee, Tae Min Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim
Journal of Korean Medical Science.2023;[Epub] CrossRef
Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
BMC Gastroenterology.2023;[Epub] CrossRef
Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Beom Kyung Kim, Sang Hoon Ahn
Journal of the Formosan Medical Association.2023; 122(12): 1238. CrossRef
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2023; 29(3): 794. CrossRef
Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
Soo Ryang Kim, Soo Ki Kim
Diagnostics.2023; 13(20): 3212. CrossRef
The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection
Marina Manea, Dimitri Apostol, Ileana Constantinescu
Microorganisms.2023; 11(11): 2731. CrossRef
Patient Preferences and Their Influence on Chronic Hepatitis B-A Review
Lin Zhang, Yunyue Liu, Jinping Tian
Patient Preference and Adherence.2023; Volume 17: 3119. CrossRef
Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR‐122
Yuh‐Jin Liang, Yu‐Wei Chiou, Abby Pei‐Ting Chiu, Ming‐Shi Shiao, Wei Teng, Chin‐Wei Lin, Mei‐Ling Cheng, Yen‐Hua Huang, Kung‐Hao Liang, Chien‐Wei Su, Chi‐Yu Lai, Chih‐Li Chen, Jaw‐Ching Wu
Journal of Medical Virology.2023;[Epub] CrossRef
Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
Medicine.2023; 102(43): e34276. CrossRef
Effectiveness and Safety of Tenofovir Alafenamide in Treatment-Naïve and Treatment-Experienced Patients with Chronic Hepatitis B: Results of a Real-World Study from China
Lan-Qing Li, Fa-Da Wang, Jing Zhou, Meng-Lan Wang, Yachao Tao, En-Qiang Chen
Hepatitis Monthly.2023;[Epub] CrossRef
Influence of Renal Function on the Single‐Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection
Jun Gi Hwang, Yu Kyong Kim, Young‐sim Choi, Soon Kil Kwon, Joung‐Ho Han, Min Kyu Park
The Journal of Clinical Pharmacology.2022; 62(1): 46. CrossRef
Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
Zhenyu Zhong, Weiting Liao, Lingyu Dai, Xiaojie Feng, Guannan Su, Yu Gao, Qiuying Wu, Peizeng Yang
Annals of the Rheumatic Diseases.2022; 81(4): 584. CrossRef
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(2): 288. CrossRef
Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
Anil Alpsoy, Haydar Adanir, Zeynep Bayramoglu, Gulsum Ozlem Elpek
World Journal of Hepatology.2022; 14(1): 260. CrossRef
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2022; 14(3): 711. CrossRef
Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries
Ben Kang, Dae Yong Yi, Byung-Ho Choe
Frontiers in Pediatrics.2022;[Epub] CrossRef
Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
Seunghwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Diagnostics.2022; 12(2): 441. CrossRef
Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study
Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2022; 29(4): 289. CrossRef
A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon, Yeon Seok Seo, Jeong Won Jang, Yong Kyun Cho, Byoung Kuk Jang, Byung Hoon Han, Changhyeong Lee, Joon Hyeok Lee, Jung-Hwan Yoon, Kang Mo Kim, Moon Young Kim, Do Young Kim, Neung Hwa Park, Eun Young Cho, June Sung
Journal of Korean Medical Science.2022;[Epub] CrossRef
Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim, Yeon Seok Seo
Journal of Clinical Medicine.2022; 11(6): 1729. CrossRef
Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
Hankil Lee, Sungin Jang, Sang Hoon Ahn, Beom Kyung Kim
Hepatology International.2022; 16(2): 294. CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology.2022; 28(2): 276. CrossRef
Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study
Byungyoon Yun, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(5): 758. CrossRef
Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk
David Sooik Kim, Beom Kyung Kim, Yeon Seok Seo, Byung Seok Kim, Byoung Kuk Jang, Sang Gyune Kim, Ki Tae Suk, Jin‐Woo Lee, Soung Won Jeong, Seung Up Kim
Liver International.2022; 42(8): 1902. CrossRef
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study
Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Journal of Viral Hepatitis.2022; 29(9): 756. CrossRef
Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study
Byungyoon Yun, Sang Hoon Ahn, Jin‐Ha Yoon, Beom Kyung Kim
Hepatology Communications.2022; 6(9): 2455. CrossRef
Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
European Journal of Internal Medicine.2022; 103: 122. CrossRef
[Retracted] Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment
Haixia Sun, Yinhui Liu, Yufeng Zhang, Yusheng Jie, Yuankai Wu, Zhanyi Li, Xuxia Wei, Xiangyong Li, Bing Niu
BioMed Research International.2022;[Epub] CrossRef
Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
Ran Cheng, Xiaoyuan Xu
Journal of Hepatocellular Carcinoma.2022; Volume 9: 987. CrossRef
Response to Liao et al.
Byungyoon Yun, Jin-Ha Yoon, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(10): 1718. CrossRef
Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
Hyung Joon Yim, Ji Hoon Kim, Yong Kyun Cho, Young Oh Kweon, Hyun Chin Cho, Jae Seok Hwang, Changhyeong Lee, Moon Soo Koh, Yang-Hyun Baek, Young-Min Park, Jeong-Hoon Lee, Seung Up Kim, Min-Kyu Kang, Neung Hwa Park, June Sung Lee, Young Eun Chon, Gab Jin Ch
Drug Design, Development and Therapy.2022; Volume 16: 3263. CrossRef
Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
Cancers.2022; 14(20): 5002. CrossRef
Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
Ji Hun Lee, Seung Kak Shin, Seong Hee Kang, Tae Hyung Kim, Hyung Joon Yim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Oh Sang Kwon, Soon Ho Um, Kwan Soo Byun
Journal of Clinical Medicine.2022; 11(22): 6613. CrossRef
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis
Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
Clinical and Molecular Hepatology.2022; 28(4): 876. CrossRef
Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
Jonggi Choi, Young‐Suk Lim
The Kaohsiung Journal of Medical Sciences.2021; 37(4): 262. CrossRef
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2021; 28(6): 951. CrossRef
Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Cancers.2021; 13(14): 3424. CrossRef
No Uniformity in the References of Clinical Practice Guidelines for Bariatric Surgery: a Review of 3 Similar Guidelines Published in 2020.
Mark J. R. Smeets, Ronald S. L. Liem
Obesity Surgery.2021; 31(12): 5427. CrossRef
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
Hepatology International.2021; 15(5): 1083. CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Hepatocellular Carcinoma.2021; Volume 8: 467. CrossRef
Critical Updates on Chronic Hepatitis B Virus Infection in 2021
Cyriac A Philips, Rizwan Ahamed, Jinsha K Abduljaleel, Sasidharan Rajesh, Philip Augustine
Cureus.2021;[Epub] CrossRef
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Korean Medical Science.2021;[Epub] CrossRef
Novel Therapies of Hepatitis B and D
Iman Waheed Khan, Mati Ullah Dad Ullah, Mina Choudhry, Mukarram Jamat Ali, Muhammad Ashar Ali, Sam L. K. Lam, Pir Ahmad Shah, Satinder Pal Kaur, Daryl T. Y. Lau
Microorganisms.2021; 9(12): 2607. CrossRef
Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
Yoon Seok Lee, Soo Min Bang, Young-Sun Lee
Journal of Clinical Medicine.2021; 10(11): 2320. CrossRef
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
Journal of Viral Hepatitis.2021; 28(11): 1570. CrossRef
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
Hepatology International.2021; 15(6): 1328. CrossRef
Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination
Fátima Higuera-de la Tijera, Alfredo Servín-Caamaño, Luis Servín-Abad
World Journal of Gastroenterology.2021; 27(26): 4004. CrossRef
Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2021; 13(23): 5892. CrossRef

22,821 View
1,496 Download
85 Web of Science
Crossref

Viral hepatitis

KASL clinical practice guidelines for management of chronic hepatitis B: Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2019;25(2):93-159.
Published online June 12, 2019; DOI: https://doi.org/10.3350/cmh.2019.1002

Citations

Citations to this article as recorded by

Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-Male-Albumin-Bilirubin-Platelet (aMAP) and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography
Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
Clinical Gastroenterology and Hepatology.2026; 24(7): 1897. CrossRef
A combined model of HBcrAg, anti-HBc, and anti-HBs predicts recurrence after functional cure of chronic hepatitis B
Xiao Lin, Shan Ren, Chunyang Huang, Pengfei Yu, Yanhong Zheng, Bin Xu, Sujun Zheng, Xinyue Chen
Hepatology International.2026; 20(2): 272. CrossRef
Redefining MTCT prevention strategies toward HBV elimination: Correspondence to editorial on “Factors associated with hepatitis B mother-to-child transmission in a national prevention program”
Moran Ki, Jong-Hyun Kim
Clinical and Molecular Hepatology.2026; 32(2): e224. CrossRef
Comparative effectiveness of antiviral therapy according to immune status among pregnant women with chronic hepatitis B virus infection: a retrospective cohort study
Lin Zhu, Jia Jia, Wenjing Yu, Guorong Han
The Journal of Maternal-Fetal & Neonatal Medicine.2026;[Epub] CrossRef
A Comparative Study of Entecavir and Tenofovir Alafenamide on Quantitative HBsAg Reduction in Patients With CHB
Jungnam Lee, Young‐Joo Jin
Journal of Medical Virology.2026;[Epub] CrossRef
Predictive value of serum S100A8/A9 for liver dysfunction in pregnant women with chronic hepatitis B
Weiwei Geng, Hong Yu, Yuan Li, Li Liu, Yanfang Xiao
Virology Journal.2026;[Epub] CrossRef
Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
Tyng‐Yuan Jang, Yu‐Ting Zeng, Po‐Cheng Liang, Chih‐Da Wu, Yu‐Ju Wei, Pei‐Chien Tsai, Ming‐Yen Hsieh, Yi‐Hung Lin, Meng‐Hsuan Hsieh, Chih‐Wen Wang, Jeng‐Fu Yang, Ming‐Lun Yeh, Chung‐Feng Huang, Wan‐Long Chuang, Jee‐Fu Huang, Ya‐Yun Cheng, Chia‐Yen Dai, Pau
Alimentary Pharmacology & Therapeutics.2025; 61(9): 1458. CrossRef
Evaluating the predictive value of clinical models for HBV-related hepatocellular carcinoma: A meta-analysis
Long Huang, Luhuai Feng, Yang Lu, Bobin Hu, Hongqian Liang, Aoli Ren, Hang Wang, Wenming He, Caifang Deng, Minghua Su, Jianning Jiang
Frontiers in Medicine.2025;[Epub] CrossRef
Delayed Hepatitis B Virus Reactivation at 33 Months after the Completion of Rituximab-based Chemotherapy
Banri Ogawa, Toshiro Kamoshida, Asaji Yamamoto, Yuji Yamaguchi, Yukako Hamano, Haruka Okawara, Atsushi Okawara, Nobushige Kakinoki, Shinji Hirai
Internal Medicine.2025; 64(20): 2966. CrossRef
Air pollution as a potential risk factor for pancreatic cancer and cholangiocarcinoma in Taiwanese patients
Tyng‐Yuan Jang, Chi‐Chang Ho, Chih‐Da Wu, Chia‐Yen Dai, Pau‐chung Chen
Advances in Digestive Medicine.2025;[Epub] CrossRef
MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response
Haimei Chen, Jie Zhu, Jinhui Zhou, Ziying Yin, Jun Chen, Sudhakar K. Venkatesh, Meng Yin, Richard L. Ehman, Jin Wang
European Radiology.2025; 35(12): 8032. CrossRef
Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial
Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Wo
Clinical and Molecular Hepatology.2025; 31(3): 810. CrossRef
Long-Term Safety and Efficacy of Tenofovir Alafenamide in Chronic Hepatitis B: Raising the Need for Studies on Functional Cure—Editorial on “Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B”
Soon Kyu Lee
The Korean Journal of Gastroenterology.2025; 85(3): 245. CrossRef
Single-nucleotide polymorphisms in CYP27B1 and VDR genes associated with treatment outcomes in hepatitis B and C: A minireview
Alessandra Ramalho Correia, Victor Cavicchioli, Lara Cândida de Sousa Machado, Rahisa Scussel, Ricardo Andrez Machado-de-Ávila, Iane de Oliveira Pires Porto, Iara Barreto Neves Oliveira
Pharmacological Research - Reports.2025; 4: 100061. CrossRef
Interferon-based optimal antiviral strategies in underage patients with chronic hepatitis B: A propensity score-weighted cohort study
Limin Wang, Meina Li, Yi Dong, Xiaofang Yu, Jing Chen, Yaojie Kang, Weiwei Liu, Pan Zhao
International Journal of Antimicrobial Agents.2025; 66(6): 107618. CrossRef
Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B
Jae Seung Lee, Sung Won Lee, Hae Lim Lee, Jeong-Ju Yoo, Yeon Seok Seo, Su Jong Yu, Hyung Joon Yim, Young Kul Jung, Jisu Moon, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Sang Gyune Kim, Seung Up Kim
Scientific Reports.2025;[Epub] CrossRef
Factors associated with hepatitis B mother-to-child transmission in a national prevention program
Moran Ki, Byung-Woo Kim, Dahye Baik, Jong-Hyun Kim
Clinical and Molecular Hepatology.2025; 31(4): 1298. CrossRef
Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B
Jie Li, Meng Li, Hui Sun, Yan-Ting Yu, Yu-Hang Zhou, Fei Fu, Lei Yan
World Journal of Gastrointestinal Surgery.2025;[Epub] CrossRef
Development and Validation of an Extra Spindle Pole Bodies–like 1–Based Diagnostic and Prognostic Model for Hepatitis B Virus–Related Hepatocellular Carcinoma: Retrospective Cohort Study
Lu-Huai Feng, Hengkai Liang, Bobin Hu, Lu Wei, Qingmei Li, Tumei Su, Qianbing Yin, Yanfei Feng, Long Huang, Hongqian Liang, Minghua Su, Jianning Jiang
JMIR Medical Informatics.2025; 13: e78354. CrossRef
Pretreatment gamma‐glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
Tyng‐Yuan Jang, Po‐Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih‐Wen Wang, Man‐Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, Eileen L. Yoon, Jihyun An, Masaru Enomoto, Ritsuzo Kozuka, Makoto Chuma, Akito Nozaki, Toru Ishikawa,
The Kaohsiung Journal of Medical Sciences.2024; 40(2): 188. CrossRef
Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma
Won Tae Cho, Tae Yoo, Jung Min Lee, Jung Woo Lee, Hanbaro Kim, Ji Soo Lee, Sang Hyup Han
Journal of Surgical Research.2024; 295: 231. CrossRef
The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis
Log Young Kim, Jeong-Ju Yoo, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Dong Hyeon Lee, Jae Young Jang
Journal of Korean Medical Science.2024;[Epub] CrossRef
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines
Malgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, Michele Bartoletti, Anna Maria Frustaci, Andrea Visentin, Candida Vitale, Francesca R. Mauro
Blood Reviews.2024; 65: 101180. CrossRef
Air pollution as a potential risk factor for hepatocellular carcinoma in Taiwanese patients after adjusting for chronic viral hepatitis
Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
Journal of the Chinese Medical Association.2024; 87(3): 287. CrossRef
Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Sang Hoon Ahn, Won Kim, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Sun Young Yim, Jin Kyung Park, Soon
Cancers.2024; 16(5): 887. CrossRef
Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
Diagnostics.2024; 14(5): 495. CrossRef
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study
Tyng‐Yuan Jang, Po‐Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih‐Wen Wang, Man‐Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, Eileen L Yoon, Jihyun An, Masaru Enomoto, Ritsuzo Kozuka, Makoto Chuma, Akito Nozaki, Toru Ishikawa,
Journal of Gastroenterology and Hepatology.2024; 39(6): 1190. CrossRef
Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, Yeon Seok Seo, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
Gut and Liver.2024; 18(2): 305. CrossRef
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
Heechul Nam, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Myeong Jun Song, Jung Hyun Kwon, Jeong Won Jang, U‐Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Hee Yeon Kim
Journal of Gastroenterology and Hepatology.2024; 39(8): 1673. CrossRef
How Does Chronic Hepatitis B Infection Impact on Severity of COVID-19 Infection?
Behnaz Khodabakhshi, Mahdi Mazandarani, Narges Lashkarbolouk, Mehrnaz Razzazan, Khadije Amjadi
International Journal of Infection.2024;[Epub] CrossRef
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
PLOS ONE.2024; 19(8): e0307712. CrossRef
Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study
Nicoleta Mihai, Mihaela Cristina Olariu, Oana-Alexandra Ganea, Aida-Isabela Adamescu, Violeta Molagic, Ștefan Sorin Aramă, Cătălin Tilișcan, Victoria Aramă
Journal of Clinical Medicine.2024; 13(20): 6032. CrossRef
Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis
Mi Na Kim, Jihyun An, Eun Hwa Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Young-Joo Jin, Young Eun Chon, Seung Up Kim, Dae Won Jun, Ji Won Han, Miyoung Choi
Clinical and Molecular Hepatology.2024; 30(Suppl): S106. CrossRef
Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
Wei-Chun Lin, Ke Lin, Ming-Kai Li, Xiao Liu, Yi-Fei Huang, Xing Wang, Bin Wu
World Journal of Hepatology.2024; 16(11): 1321. CrossRef
Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals
Soo Young Hwang, Sung Hwan Yoo, Hye Young Chang, Sora Kim, Jung Il Lee, Kwan Sik Lee, Young Youn Cho, Kim Hyung Joon, Hyun Woong Lee
Journal of Viral Hepatitis.2023; 30(1): 39. CrossRef
Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
Hepatology Communications.2023; 7(2): e0011. CrossRef
The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(5): 716. CrossRef
Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis
Jiwon Yang, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
American Journal of Gastroenterology.2023; 118(6): 1010. CrossRef
Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea–Japan collaborative study with 9200 patients
Woo‐Hyoung Kang, Shin Hwang, Masaki Kaibori, Jong Man Kim, Kyung Sik Kim, Tsuyoshi Kobayashi, Hiroto Kayashima, Yang Seok Koh, Keiichi Kubota, Akira Mori, Yutaka Takeda, Sung Su Yun, Kousuke Matsui, Kan Toriguchi, Hiroaki Nagano, Myung Hee Yoon, Yuji Soej
Journal of Hepato-Biliary-Pancreatic Sciences.2023; 30(8): 993. CrossRef
Long-term outcomes of liver transplantation using grafts from donors with active hepatitis B virus replication: a multicenter cohort study
Sujin Gang, YoungRok Choi, Boram Lee, Kyung Chul Yoon, Su young Hong, Sanggyun Suh, Eui Soo Han, Suk Kyun Hong, Hae Won Lee, Jai Young Cho, Nam-joon Yi, Kwang-Woong Lee, Kyung-Suk Suh
Annals of Surgical Treatment and Research.2023; 104(4): 183. CrossRef
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clinical and Molecular Hepatology.2023; 29(2): 367. CrossRef
Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2023; 58(1): 99. CrossRef
Research Progress on the Need for Antiviral Therapy in Chronic HBV Infected Patients with Normal ALT
益帆胡
Advances in Clinical Medicine.2023; 13(04): 5360. CrossRef
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos Pyrsopoulos, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(8): 1372. CrossRef
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
Joo Hyun Oh, Yewan Park, Myung Ji Goh, Dong Hyun Sinn, Sang Bong Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
Scientific Reports.2023;[Epub] CrossRef
Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Beom Kyung Kim, Sang Hoon Ahn
Journal of the Formosan Medical Association.2023; 122(12): 1238. CrossRef
Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?
Jonggi Choi, Won-Mook Choi, Young-Suk Lim
Clinics in Liver Disease.2023; 27(4): 809. CrossRef
Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
World Journal of Gastroenterology.2023; 29(24): 3843. CrossRef
KASL clinical practice guidelines for management of autoimmune hepatitis 2022

Clinical and Molecular Hepatology.2023; 29(3): 542. CrossRef
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
Liver International.2023; 43(8): 1813. CrossRef
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2023; 29(3): 794. CrossRef
Five‐year on‐treatment variables‐based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir‐treated patients
Yeonjung Ha, Jihye Lim, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Seong Gyu Hwang, Seungbong Han, Han Chu Lee
International Journal of Cancer.2023; 153(12): 2045. CrossRef
The Effect of Entecavir and Tenofovir Disoproxil on Bone Mineral Density in Chronic Hepatitis B Treatment
Yasemin EMÜR GÜNAY, Arif Mansur COŞAR
Journal of Contemporary Medicine.2023; 13(5): 1013. CrossRef
Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea
Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han
Infectious Diseases and Therapy.2023; 12(10): 2387. CrossRef
Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
Soo Ryang Kim, Soo Ki Kim
Diagnostics.2023; 13(20): 3212. CrossRef
Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis
Cesar Henriquez-Camacho, Ana Isabel Hijas-Gomez, Carlos Risco Risco, Maria Angeles Ruiz Lapuente, Rosa Escudero-Sanchez, Victor Moreno Cuerda
Viruses.2023; 15(11): 2241. CrossRef
A MicroRNA-Based Method for High-Viremia Detection—A New Approach on a Romanian Lot of Chronically Infected Patients with Hepatitis B Virus
Marina Manea, Dimitri Apostol, Ileana Constantinescu
Diagnostics.2023; 13(22): 3425. CrossRef
Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance
Saein Kim, Sunghwan Yoo, Jung Il Lee, Sora Kim, Hye Young Chang, Dokyun Kim, Seok Hoon Jeong, Kwan Sik Lee, Hyun Woong Lee
Digestive Diseases and Sciences.2022; 67(1): 321. CrossRef
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(2): 288. CrossRef
Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B
Chan-Young Jung, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Clinical Gastroenterology and Hepatology.2022; 20(4): 956. CrossRef
Long‐term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B
Young Eun Chon, Seung Up Kim, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, Yun Ho Roh, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Soo Young Park, Beom Kyung Kim
Journal of Gastroenterology and Hepatology.2022; 37(1): 200. CrossRef
Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B
Myung Ji Goh, Wonseok Kang, Kwang Min Kim, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2022; 57(1): 70. CrossRef
Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
Zhenyu Zhong, Weiting Liao, Lingyu Dai, Xiaojie Feng, Guannan Su, Yu Gao, Qiuying Wu, Peizeng Yang
Annals of the Rheumatic Diseases.2022; 81(4): 584. CrossRef
Clinical Outcomes of Hepatitis B Virus–Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels
Jong-In Chang, Dong Hyun Sinn, Hyun Cho, Seonwoo Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2022; 67(9): 4565. CrossRef
Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas
Jihyun An, Deokhoon Kim, Bora Oh, Yoo‐Jin Oh, Jihyun Song, Naomi Park, Ha Il Kim, Hyo Jeong Kang, Ji‐Hye Oh, Wonkyung Kim, Eunjung Lee, Chang Ohk Sung, Gi‐Won Song, Dae‐Ghon Kim, Eunsil Yu, Eric Letouzé, Jessica Zucman‐Rossi, Han Chu Lee, Ju Hyun Shim
Hepatology.2022; 75(4): 997. CrossRef
Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients
Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jae Young Jang, Dong Joon Kim, Eun‐Sook Park, So‐Young Jin, Kyun‐Hwan Kim
Journal of Gastroenterology and Hepatology.2022; 37(2): 378. CrossRef
On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
Chung‐Feng Huang, Tyng‐Yuan Jang, Dae Won Jun, Sang Bong Ahn, Jihyun An, Masaru Enomoto, Hirokazu Takahashi, Eiichi Ogawa, Eileen Yoon, Soung Won Jeong, Jae‐Jun Shim, Jae Yoon Jeong, Sung Eun Kim, Hyunwoo Oh, Hyoung Su Kim, Yong Kyun Cho, Ritsuzo Kozuka,
Liver International.2022; 42(1): 59. CrossRef
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B
Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Digestive Diseases and Sciences.2022; 67(7): 3412. CrossRef
Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
BMC Medicine.2022;[Epub] CrossRef
Identification and Characterization of Besifovir-Resistant Hepatitis B Virus Isolated from a Chronic Hepatitis B Patient
Jong Chul Kim, Hye Young Lee, Ah Ram Lee, Mehrangiz Dezhbord, Da Rae Lee, Seong Ho Kim, Juhee Won, Soree Park, Na Yeon Kim, Jae Jin Shin, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo, Kyun-Hwan Kim
Biomedicines.2022; 10(2): 282. CrossRef
Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries
Ben Kang, Dae Yong Yi, Byung-Ho Choe
Frontiers in Pediatrics.2022;[Epub] CrossRef
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
Young‐Suk Lim, Wai‐Kay Seto, Masayuki Kurosaki, Scott Fung, Jia‐Horng Kao, Jinlin Hou, Stuart C. Gordon, John F. Flaherty, Leland J. Yee, Yang Zhao, Kosh Agarwal, Pietro Lampertico
Alimentary Pharmacology & Therapeutics.2022; 55(8): 921. CrossRef
Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study
Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2022; 29(4): 289. CrossRef
Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B
Chan‐Young Jung, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Liver International.2022; 42(5): 1017. CrossRef
Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis
Heejoon Jang, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Joon Yeul Nam, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
Hepatology.2022; 76(2): 492. CrossRef
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis
Na Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jihye Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
BMC Gastroenterology.2022;[Epub] CrossRef
A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study
Yong Zhao, Ling Xiang Kong, Feng Shi Feng, Jiayin Yang, Guo Wei
BMC Cancer.2022;[Epub] CrossRef
A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
Hyun Yang, Si Hyun Bae, Heechul Nam, Hae Lim Lee, Sung Won Lee, Sun Hong Yoo, Myeong Jun Song, Jung Hyun Kwon, Soon Woo Nam, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
Journal of Hepatology.2022; 77(3): 632. CrossRef
Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B
Young Mi Hong, Ki Tae Yoon
The Korean Journal of Gastroenterology.2022; 79(4): 156. CrossRef
Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis
Young‐Suk Lim, Sang Hoon Ahn, Jae‐Jun Shim, Homie Razavi, Devin Razavi‐Shearer, Dong Hyun Sinn
Alimentary Pharmacology & Therapeutics.2022; 56(3): 519. CrossRef
Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Seungbong Han, Young-Suk Lim
Journal of Clinical Investigation.2022;[Epub] CrossRef
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study
Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Journal of Viral Hepatitis.2022; 29(9): 756. CrossRef
Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir
Juhee Won, Ah Ram Lee, Mehrangiz Dezhbord, Da Rae Lee, Seong Ho Kim, Jong Chul Kim, Soree Park, Nayeon Kim, Byengjune Jae, Kyun-Hwan Kim
Biomedicines.2022; 10(7): 1637. CrossRef
Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
European Journal of Internal Medicine.2022; 103: 122. CrossRef
Study on the Retreatment, Outcome, and Potential Predictors of Recurrence in Patients With Recurrence of Hepatitis B After Functional Cure
Xiao Lin, Aixin Song, Junfeng Lu, Sujun Zheng, Zhongjie Hu, Lina Ma, Zhenhuan Cao, Hong Li, Yanhong Zheng, Shan Ren, Xinyue Chen
Frontiers in Immunology.2022;[Epub] CrossRef
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
Clinical and Molecular Hepatology.2022; 28(3): 425. CrossRef
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee
Clinical and Molecular Hepatology.2022; 28(3): 351. CrossRef
Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
Abdominal Radiology.2022; 47(11): 3733. CrossRef
Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment
Soo Min Ahn, Jonggi Choi, Byong Duk Ye, Suk-Kyun Yang, Ji Seon Oh, Yong‑Gil Kim, Chang-Keun Lee, Bin Yoo, Sang Hyoung Park, Seokchan Hong
Gut and Liver.2022; 16(4): 567. CrossRef
Correlation between hepatic venous pressure gradient and portal venous pressure gradient in hepatitis B cirrhosis with different hepatic veins anatomy
Yifan Lv, Qingkun Song, Zhendong Yue, Hongwei Zhao, Lei Wang, Zhenhua Fan, Yifan Wu, Mingming Meng, Ke Zhang, Li Jiang, Huiguo Ding, Yuening Zhang, Fuquan Liu
European Journal of Radiology.2022; 155: 110463. CrossRef
Viral Hepatitis in Patients with Inflammatory Bowel Disease
Seung Hwan Shin, Sang Hyoung Park
The Korean Journal of Gastroenterology.2022; 80(2): 51. CrossRef
Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
Ji Hun Lee, Seung Kak Shin, Seong Hee Kang, Tae Hyung Kim, Hyung Joon Yim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Oh Sang Kwon, Soon Ho Um, Kwan Soo Byun
Journal of Clinical Medicine.2022; 11(22): 6613. CrossRef
Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
Xiao Lin, Yanhong Zheng, Hong Li, Junfeng Lu, Shan Ren, Yisi Liu, Xiaoxiao Wang, Sujun Zheng, Lina Ma, Zhenhuan Cao, Xinyue Chen
Frontiers in Immunology.2022;[Epub] CrossRef
Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
Hyung Joon Yim, Ji Hoon Kim, Yong Kyun Cho, Young Oh Kweon, Hyun Chin Cho, Jae Seok Hwang, Changhyeong Lee, Moon Soo Koh, Yang-Hyun Baek, Young-Min Park, Jeong-Hoon Lee, Seung Up Kim, Min-Kyu Kang, Neung Hwa Park, June Sung Lee, Young Eun Chon, Gab Jin Ch
Drug Design, Development and Therapy.2022; Volume 16: 3263. CrossRef
Chronic Hepatitis B Viral Activity Enough to Take Antiviral Drug Could Predict the Survival Rate in Malignant Lymphoma
Kwang-Il Seo, Jae-Cheol Jo, Da-Jung Kim, Jee-Yeong Jeong, Sangjin Lee, Ho-Sup Lee
Viruses.2022; 14(9): 1943. CrossRef
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B
Chan‐Young Jung, Hyung Woo Kim, Jung Il Lee, Hyun Woong Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Liver International.2022; 42(11): 2408. CrossRef
Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
Joo Hyun Oh, Dong Ah Park, Min Jung Ko, Jeong-Ju Yoo, Sun Young Yim, Ji-Hyun Ahn, Dae Won Jun, Sang Bong Ahn
Journal of Personalized Medicine.2022; 12(12): 1957. CrossRef
Updated Treatment Guidelines for Chronic Hepatitis B
Jihyun An
The Korean Journal of Medicine.2022; 97(6): 353. CrossRef
A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab
Xiangjuan Guo, Tongtong Ji, Shengliang Xin, Jinghang Xu, Yanyan Yu
Frontiers in Immunology.2022;[Epub] CrossRef
Report on the External Quality Assessment Scheme for Molecular Microbiology, Hepatitis Virus 1, 2 (2016–2021)
Hee-Won Moon, Tae Hwan Lee, Jong Do Seo
Journal of Laboratory Medicine and Quality Assurance.2022; 44(4): 191. CrossRef
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Digestive Diseases and Sciences.2021; 66(8): 2816. CrossRef
Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Surgical Resection
Jonggi Choi, Chanyoung Jo, Young‐Suk Lim
Hepatology.2021; 73(2): 661. CrossRef
Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B
Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, Jeong Won Jang, Heechul Nam, Kyoung Won Baik, Sun Hong Yoo, Soon Woo Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Liver International.2021; 41(2): 288. CrossRef
Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B
Hye-Lin Kim, Gi-Ae Kim, Jae-A Park, Hye-Rim Kang, Eui-Kyung Lee, Young-Suk Lim
Gut.2021; 70(11): 2172. CrossRef
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B
Hye Won Lee, Young Eun Chon, Beom Kyung Kim, Terry Cheuk-Fung Yip, Yee-Kit Tse, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Sang Hoon Ahn
European Journal of Internal Medicine.2021; 84: 68. CrossRef
Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
Jonggi Choi, Young‐Suk Lim
The Kaohsiung Journal of Medical Sciences.2021; 37(4): 262. CrossRef
Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B
Young Eun Ahn, Sang Jun Suh, Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
The Korean Journal of Gastroenterology.2021; 77(1): 22. CrossRef
Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
Yewan Park, Jeong-Hoon Lee, Dong Hyun Sinn, Jun Yong Park, Minseok Albert Kim, Yoon Jun Kim, Jung-Hwan Yoon, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clinical and Translational Gastroenterology.2021; 12(1): e00290. CrossRef
Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B
Sung Hwan Yoo, Tae Seop Lim, Hyun Woong Lee, Ja Kyung Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jung Il Lee, Kwan Sik Lee, Seung Up Kim
Journal of Viral Hepatitis.2021; 28(10): 1362. CrossRef
Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
Xinhe Zhang, Lin Guan, Haoyu Tian, Zilu Zeng, Jiayu Chen, Die Huang, Ji Sun, Jiaqi Guo, Huipeng Cui, Yiling Li
Frontiers in Oncology.2021;[Epub] CrossRef
The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
Minah Kim, Yeonju Lee, Jun Sik Yoon, Minjong Lee, So Shin Kye, Sun Woong Kim, Yuri Cho
Cancers.2021; 13(10): 2301. CrossRef
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Hepatocellular Carcinoma.2021; Volume 8: 467. CrossRef
Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B
Jeong Eun Song, Jun Yong Park
Expert Opinion on Pharmacotherapy.2021; 22(18): 2427. CrossRef
Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
Yoon Seok Lee, Soo Min Bang, Young-Sun Lee
Journal of Clinical Medicine.2021; 10(11): 2320. CrossRef
Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea
Young Cheol Ju, Dae Won Jun, Eileen L. Yoon, Sang Bong Ahn, Yun Jin Kim, Mindie H. Nguyen
Journal of Clinical Medicine.2021; 10(20): 4633. CrossRef
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2021; 28(6): 951. CrossRef
Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir
Xiaomo Wang, Yu Chen, Manman Xu, Kailiang Cheng, Xiaoman Duan, Wei Liao, Yanhong Wang, Ying Lu, Zhongping Duan, Li Wang
Expert Review of Gastroenterology & Hepatology.2021; 15(11): 1337. CrossRef
Twelve‐month post‐treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B
Sang Bong Ahn, Jun Choi, Dae Won Jun, Hyunwoo Oh, Eileen L. Yoon, Hyoung Su Kim, Soung Won Jeong, Sung Eun Kim, Jae‐Jun Shim, Yong Kyun Cho, Hyo Young Lee, Sung Won Han, Mindie H. Nguyen
Liver International.2021; 41(7): 1652. CrossRef
Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
Hankil Lee, Beom Kyung Kim, Sungin Jang, Sang Hoon Ahn
Clinical and Translational Gastroenterology.2021; 12(2): e00299. CrossRef
Association between HBs Ag quantification and the risk of hepatocellular carcinoma in patients treated with tenofovir disoproxil fumarate or entecavir
Jung Hyun Lim, Jung Hwan Yu, Young Ju Suh, Jin-Woo Lee, Young-Joo Jin
Medicine.2021; 100(39): e27417. CrossRef
Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
Soon Kyu Lee, Pil Soo Sung, Sung-Soo Park, Chang-Ki Min, Heechul Nam, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
Clinical Infectious Diseases.2021; 73(6): e1372. CrossRef
Development and Pilot Testing of a Smartphone-Based Self-Care Program for Patients with Chronic Hepatitis B
Yeonsoo Jang, Sang Hoon Ahn, Kyunghwa Lee, Oh Young Kwon, Jeong Hyun Kim
International Journal of Environmental Research and Public Health.2021; 18(21): 11139. CrossRef
Overexpressed Proteins in HCC Cell-Derived Exosomes, CCT8, and Cofilin-1 Are Potential Biomarkers for Patients with HCC
Hyo Jung Cho, Geum Ok Baek, Moon Gyeong Yoon, Hye Ri Ahn, Ju A Son, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
Diagnostics.2021; 11(7): 1221. CrossRef
Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
Yu-Fen Tsai, Chin-Mu Hsu, Hui-Hua Hsiao
Journal of Personalized Medicine.2021; 11(4): 267. CrossRef
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Hepatology International.2021; 15(4): 892. CrossRef
Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway
Sung Won Lee, Sung Min Kim, Wonhee Hur, Byung-Yoon Kang, Hae Lim Lee, Heechul Nam, Sun Hong Yoo, Pil Soo Sung, Jung Hyun Kwon, Jeong Won Jang, Seong-Jun Kim, Seung Kew Yoon, Partha Mukhopadhyay
PLOS ONE.2021; 16(12): e0261067. CrossRef
Reply to “Emergent liver transplantation for patients with acute-on-chronic liver failure”
Ji Eun Kim, Dong Hyun Sinn, Gyu-Seong Choi
Digestive and Liver Disease.2021; 53(10): 1361. CrossRef
Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Cancers.2021; 13(14): 3424. CrossRef
Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
Young-Hwan Ahn, Heirim Lee, Do Young Kim, Hye Won Lee, Su Jong Yu, Young Youn Cho, Jeong Won Jang, Byoung Kuk Jang, Chang Wook Kim, Hee Yeon Kim, Hana Park, Hyo Jung Cho, Bumhee Park, Soon Sun Kim, Jae Youn Cheong
Gut and Liver.2021; 15(3): 410. CrossRef
Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
Jihye Lim, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Han Chu Lee, Yeonjung Ha
Cancers.2021; 13(22): 5609. CrossRef
Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response
Ji Eun Na, Dong Hyun Sinn, Jeong‐Hoon Lee, Hee Joon Jang, Seon Yeong Baek, Kyung A Kim, Won Seok Kang, Geum‐Youn Gwak, Young‐Han Paik, Yoon Jun Kim, Moon Seok Choi, Jung‐Hwan Yoon, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Viral Hepatitis.2021; 28(10): 1392. CrossRef
Differential Effectiveness of Tenofovir and Entecavir for Prophylaxis of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Depending on Coexisting Cirrhosis and Prior Exposure to Antiviral Therapy
Seogsong Jeong, Yuri Cho, Sang Min Park, Won Kim
Journal of Clinical Gastroenterology.2021; 55(9): e77. CrossRef
Improving the Prediction of Relapse After Nucleos(t)ide Analogue Discontinuation in Patients With Chronic Hepatitis B
Do Seon Song, Jeong Won Jang, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clinical Infectious Diseases.2021; 73(4): e892. CrossRef
Association of Metabolic Risk Factors With Risks of Cancer and All‐Cause Mortality in Patients With Chronic Hepatitis B
Yun Bin Lee, Hyemi Moon, Jeong‐Hoon Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Fabien Zoulim, Juneyoung Lee, Jung‐Hwan Yoon
Hepatology.2021; 73(6): 2266. CrossRef
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma
Ji Hyun Lee, Beom Kyung Kim, Soo Young Park, Won Young Tak, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Dong Hyun Sinn, Seung Up Kim
European Journal of Internal Medicine.2021; 89: 48. CrossRef
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
Hepatology International.2021; 15(5): 1083. CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef
Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infection
Dmitry V. Garbuzenko
Medical Journal of the Russian Federation.2021; 27(4): 373. CrossRef
Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Hwa Kim, Ha Yan Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo
Clinical Gastroenterology and Hepatology.2020; 18(3): 693. CrossRef
Reply to: “Comment on – A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea”
Beom Kyung Kim
Journal of Hepatology.2020; 72(1): 198. CrossRef
Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy
Chung Gyo Seo, Sun Young Yim, Soon Ho Um, Yoo Ra Lee, Yoo Jin Lee, Tae Hyung Kim, Hyun Gil Goh, Young Sun Lee, Sang Jun Suh, Na Yeon Han, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Hyung Joon Yim, Ji Hoon Kim, Dong Sik Kim, Yoon Tae Jeen, Hoon
Clinics and Research in Hepatology and Gastroenterology.2020; 44(4): 532. CrossRef
Kidney disease in patients with chronic liver disease
Jae Hyun Chang
Journal of the Korean Medical Association.2020; 63(1): 14. CrossRef
Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
Hyo Cho, Jung Eun, Geum Baek, Chul Seo, Hye Ahn, Soon Kim, Sung Cho, Jae Cheong
Journal of Clinical Medicine.2020; 9(1): 281. CrossRef
Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen‐negative, core antibody‐positive recipients
Jihye Kim, Se Jin Chung, Dong Hyun Sinn, Kyo Won Lee, Jae Berm Park, Wooseong Huh, Jung Eun Lee, Hye Ryoun Jang, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Viral Hepatitis.2020; 27(7): 739. CrossRef
Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
Yeon Woo Jung, Moonhyun Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Journal of Korean Medical Science.2020;[Epub] CrossRef
Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B
Emilia Hadziyannis, Stephanos Hadziyannis
Expert Review of Gastroenterology & Hepatology.2020; 14(4): 243. CrossRef
Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinoma
Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim
Journal of Gastroenterology and Hepatology.2020; 35(11): 1960. CrossRef
Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients
Gi‐Ae Kim, Seungbong Han, Gwang Hyeon Choi, Jonggi Choi, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2020; 51(11): 1169. CrossRef
Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
Hyun Woong Lee, Jung Il Lee, Saein Kim, Sora Kim, Hye Young Chang, Kwan Sik Lee
BMC Gastroenterology.2020;[Epub] CrossRef
An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well‐controlled viremia
Hye W. Lee, Soo Y. Park, Myeongjee Lee, Eun J. Lee, Jinae Lee, Seung U. Kim, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Beom K. Kim
Liver International.2020; 40(7): 1736. CrossRef
Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg‐positive versus HBeAg‐negative patients. Authors' reply
Gi‐Ae Kim, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2020; 51(12): 1440. CrossRef
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase
Han Ah Lee, Hyun Woong Lee, In Hee Kim, Soo Young Park, Dong Hyun Sinn, Jung Hwan Yu, Yeon Seok Seo, Soon Ho Um, Jung Il Lee, Kwan Sik Lee, Chang Hun Lee, Won Young Tak, Young Oh Kweon, Wonseok Kang, Yong‐Han Paik, Jin‐Woo Lee, Sang Jun Suh, Young Kul Jun
Alimentary Pharmacology & Therapeutics.2020; 52(1): 196. CrossRef
Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir
Tae Seop Lim, Hyun Woong Lee, Jung Il Lee, In Hee Kim, Chang Hun Lee, Byoung Kuk Jang, Woo Jin Chung, Hyung Joon Yim, Sang Jun Suh, Yeon Seok Seo, Han Ah Lee, Jung Hwan Yu, Jin‐Woo Lee, Sang Gyune Kim, Young Seok Kim, Soo Young Park, Won Young Tak, Soon S
Journal of Viral Hepatitis.2020; 27(10): 1052. CrossRef
Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma
Mi Young Jeon, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Seung Up Kim
Journal of Viral Hepatitis.2020; 27(9): 932. CrossRef
High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis
Young Eun Chon, Kyu Sik Jung, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Jun Yong Park
Journal of Viral Hepatitis.2020; 27(11): 1119. CrossRef
Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
Byoung Kuk Jang
Clinical and Molecular Hepatology.2020; 26(3): 312. CrossRef
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial
Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Byung Seok Lee, Ju Hyun Kim, Hong Soo Ki
American Journal of Gastroenterology.2020; 115(8): 1217. CrossRef
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B
Kyung Hyun Kim, Dong Jin Joo, Yong-ho Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Digestive and Liver Disease.2020; 52(11): 1338. CrossRef
Serum ERK1/2 proteins fluctuating with HBV infection report frequency of viral-specific CD8+ T cells and predict IFNα therapeutic effect in chronic hepatitis B patients
Zhong Fang, Xiaoyu Yu, Shuangmei Tong, Chuan Lu, Yuxian Huang, Liang Chen, Zhenghong Yuan, Yi Zhang
Clinical Immunology.2020; 219: 108570. CrossRef
Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang
Scientific Reports.2020;[Epub] CrossRef
Editorial: comorbidities in patients with chronic hepatitis B—authors' reply
Eileen L. Yoon, Hyunwoo Oh, Dae Won Jun, Mindie H. Nguyen
Alimentary Pharmacology & Therapeutics.2020; 52(5): 893. CrossRef
A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
Seung Up Kim, Yong Eun Chon, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, In Kyung Min, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Beom Kyung Kim, Soo Young Park
Journal of Viral Hepatitis.2020; 27(12): 1352. CrossRef
THERAPEUTIC PLASMAPHERESIS IN A COMPLEX TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS
Vladislav V. Lyubchak, Viktoriia M. Plaksa, Ihor M. Pelo, Michael P. Kovalishyn, Viktor P. Lyubchak, Vladimir V. Horokh, Tetyana Iu. Lisovenko, Viktoriia V. Ilyina, Liliya M. Khomenko
Wiadomości Lekarskie.2020; 73(7): 1454. CrossRef
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

Sojung Han, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Dai Hoon Han, Beom Kyung Kim
Journal of Hepatocellular Carcinoma.2020; Volume 7: 403. CrossRef
Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective
Tung‐Hung Su, Jia‐Horng Kao
Clinical Liver Disease.2020; 16(6): 244. CrossRef
Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients
Daniel E Dulek, Robert C Fuhlbrigge, Alison C Tribble, James A Connelly, Michele M Loi, Hassan El Chebib, Shanmuganathan Chandrakasan, William R Otto, Caroline Diorio, Garrett Keim, Kelly Walkovich, Preeti Jaggi, Jennifer E Girotto, April Yarbrough, Edwar
Journal of the Pediatric Infectious Diseases Society.2020; 9(6): 716. CrossRef
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
Hye Won Lee, Eun Hwa Kim, Jinae Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Clinical and Translational Gastroenterology.2020; 11(3): e00140. CrossRef
Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Ju Lee, Hye Jung Shin, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Young Park
Cancer Epidemiology, Biomarkers & Prevention.2020; 29(4): 832. CrossRef
Reply to: “Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction”
Beom Kyung Kim
Journal of Hepatology.2019; 71(4): 847. CrossRef
New Potential Therapies for Chronic Hepatitis B
Sun Hong Yoo, Jung Hyun Kwon
The Korean Journal of Gastroenterology.2019; 74(5): 267. CrossRef
Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma
Hyun Woong Lee
The Korean Journal of Gastroenterology.2019; 74(5): 251. CrossRef
Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients
Eileen L. Yoon
The Korean Journal of Gastroenterology.2019; 74(5): 258. CrossRef
Natural History and Treatment Indications of Chronic Hepatitis B
Dong Hyun Sinn
The Korean Journal of Gastroenterology.2019; 74(5): 245. CrossRef

39,850 View
688 Download
185 Web of Science
Crossref

Viral hepatitis

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C: The Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2018;24(3):169-229.
Published online August 10, 2018; DOI: https://doi.org/10.3350/cmh.2018.1004

Citations

Citations to this article as recorded by

Implementation of an alert system for the care cascade of Hepatitis C infection in patients undergoing elective surgery
Jae Seung Lee, Ho Soo Chun, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Infection and Public Health.2026; 19(2): 103076. CrossRef
Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection
Jeayeon Park, Jae Yoon Jeong, Soon Sun Kim, Jae Hyun Yoon, Hyuk Soo Eun, Jonggi Choi, Ki Tae Yoon, Young Kul Jung, Soo Young Park, Geum-Youn Gwak, Do Young Kim, Ji Hoon Kim, Jin-Woo Lee, Tae Yeob Kim, Jeong Won Jang, Su Jong Yu
World Journal of Gastroenterology.2026;[Epub] CrossRef
2025 KASL clinical practice guidelines for management of hepatitis C
Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung
Clinical and Molecular Hepatology.2026; 32(1): 1. CrossRef
Re-evaluating DAA therapy in active hepatocellular carcinoma: from controversy to clinical considerations
So Hyun Jeon, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
Journal of Liver Cancer.2026; 26(1): 93. CrossRef
Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
Jung Hee Kim, Sung-Eun Kim, Do Seon Song, Hee Yeon Kim, Eileen L. Yoon, Ji Won Park, Tae Hyung Kim, Young-Kul Jung, Ki Tae Suk, Hyung Joon Yim, Jung Hyun Kwon, Sung Won Lee, Seong Hee Kang, Moon Young Kim, Soung Won Jeong, Jae-Young Jang, Jeong Ju Yoo, Sa
Annals of Medicine.2025;[Epub] CrossRef
Prevalence, Clinical Characteristics, and Treatment Status of Hepatitis C Virus Infection among People Who Use Drugs in South Korea: A Prospective Multicenter Study
Gwang Hyeon Choi, Young-Hoon Chon, Do Hoon Kwon, Sung Nam Jo, Og-Jin Jang, Kyung-Ah Kim, Dahye Baik, Eun Sun Jang, Sook-Hyang Jeong
Gut and Liver.2025; 19(5): 725. CrossRef
Temporal Dynamics and Treatment Outcomes of Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Multicenter Retrospective Study from South Korea
Jae Yoon Jeong, Su Jong Yu, Jeayeon Park, Na Ryung Choi, Soon Sun Kim, Jae Hyun Yoon, Hyuk Soo Eun, Jonggi Choi, Ki Tae Yoon, Young Kul Jung, Soo Young Park, Geum-Youn Gwak, Tae Yeob Kim, Dong Yun Kim, Do Young Kim, Ji Hoon Kim, Jin-Woo Lee, Jeong Won Jan
Gut and Liver.2025; 19(6): 868. CrossRef
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
Graham S Cooke, Barnaby Flower, Evan Cunningham, Alison D Marshall, Jeffrey V Lazarus, Adam Palayew, Jidong Jia, Rakesh Aggarwal, Mamum Al-Mahtab, Yashuito Tanaka, Sook-Hyang Jeong, Kittiyod Poovorawan, Imam Waked, Lindsey Hiebert, Pham M Khue, Jason Greb
The Lancet Gastroenterology & Hepatology.2024; 9(4): 346. CrossRef
Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center
Jae Seung Lee, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2024; 39(6): 1155. CrossRef
Toward hepatitis C virus elimination using artificial intelligence
Moon Haeng Hur, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2024; 30(2): 147. CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Journal of Liver Cancer.2023; 23(1): 1. CrossRef
Occurrence of Liver Cancer in People without Traditional Risk Factors
Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
Korean Journal of Clinical Geriatrics.2023; 24(1): 41. CrossRef
Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
BMC Medicine.2022;[Epub] CrossRef
Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
Gwang Hyeon Choi, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, In Hee Kim, Sung Bum Cho, Han Chu Lee, Jeong Won Jang, Moran Ki, Hwa Young Choi, Dahye Baik, Sook-Hyang Jeong
World Journal of Gastroenterology.2022; 28(30): 4182. CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2022; 23(12): 1126. CrossRef
Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital
Mi Seon Park, Young-Mo Yang, Ki Hyun Park, Hyonok Yoon, Ju Sin Kim, Eun Joo Choi
Korean Journal of Clinical Pharmacy.2022; 32(3): 191. CrossRef
Viral Hepatitis in Patients with Inflammatory Bowel Disease
Seung Hwan Shin, Sang Hyoung Park
The Korean Journal of Gastroenterology.2022; 80(2): 51. CrossRef
Report on the External Quality Assessment Scheme for Molecular Microbiology, Hepatitis Virus 1, 2 (2016–2021)
Hee-Won Moon, Tae Hwan Lee, Jong Do Seo
Journal of Laboratory Medicine and Quality Assurance.2022; 44(4): 191. CrossRef
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Digestive Diseases and Sciences.2021; 66(8): 2816. CrossRef
Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea
Dae Hyun Lim, Jae Yoon Jeong, Seongwoo Nam, Jongkyoung Choi, Hyeok Choon Kwon, Yong Bum Yoon, Yeonjae Kim, BumSik Chin
Journal of Korean Medical Science.2021;[Epub] CrossRef
Retreatment of Chronic Hepatitis C Failed to Daclatasvir Plus Asunaprevir by Other Direct-acting Antivirals
Dong Hoon Lee, Soo Hyung Ryu, Hee jun Myung, Yun Jae Shin, Si Hyeong Lee, Tae Young Park, Jeong Seop Moon
The Korean Journal of Gastroenterology.2021; 77(2): 88. CrossRef
Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study
Dong Hyun Sinn, Danbee Kang, Yun Soo Hong, Kwang Cheol Koh, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak, Luca Rinaldi
PLOS ONE.2021; 16(8): e0255624. CrossRef
Real-Life Effectiveness and Safety of Glecaprevir/Pibrentasvir for Korean Patients with Chronic Hepatitis C at a Single Institution
Young Joo Park, Hyun Young Woo, Jeong Heo, Sang Gyu Park, Young Mi Hong, Ki Tae Yoon, Dong Uk Kim, Gwang Ha Kim, Hyung Hoi Kim, Geun Am Song, Mong Cho
Gut and Liver.2021; 15(3): 440. CrossRef
Survival in untreated hepatocellular carcinoma: A national cohort study
Young Ae Kim, Danbee Kang, Hyeyoung Moon, Donghyun Sinn, Minwoong Kang, Sang Myung Woo, Yoon Jung Chang, Boram Park, Sun-Young Kong, Eliseo Guallar, Soo-Yong Shin, Geunyeon Gwak, Joung Hwan Back, Eun Sook Lee, Juhee Cho, Gianfranco D. Alpini
PLOS ONE.2021; 16(2): e0246143. CrossRef
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival
Min Woo Lee, Danbee Kang, Hyo Keun Lim, Juhee Cho, Dong Hyun Sinn, Tae Wook Kang, Kyoung Doo Song, Hyunchul Rhim, Dong Ik Cha, David S. K. Lu
European Radiology.2020; 30(4): 2391. CrossRef
Kidney disease in patients with chronic liver disease
Jae Hyun Chang
Journal of the Korean Medical Association.2020; 63(1): 14. CrossRef
Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection
Naoki Morishita, Ryotaro Sakamori, Tomomi Yamada, Yugo Kai, Yuki Tahata, Ayako Urabe, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Yoshinori Doi, Shinji Tamura, Hideki Hagiwara, Yasuharu Imai, Sadaharu Iio, Tomohide Tatsumi, Tetsuo Takehara, Jason Blacka
PLOS ONE.2020; 15(6): e0234811. CrossRef
Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score
Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
International Journal of Epidemiology.2020; 49(5): 1562. CrossRef
Development and Evaluation of an Antiviral Agent Medication Adherence Education Program for Patients with Chronic Hepatitis C
Hoo Jeung Cho, Euna Park
International Journal of Environmental Research and Public Health.2020; 17(18): 6518. CrossRef
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2020; 12(11): 3414. CrossRef
Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
Gut and Liver.2020; 14(6): 775. CrossRef
A case report of glecaprevir/pibrentasvir-induced severe hyperbilirubinemia in a patient with compensated liver cirrhosis
Jae Hyun Yoon, Sun Min Kim, Gaeun Kang, Hee Joon Kim, Chung Hwan Jun, Sung Kyu Choi
Medicine.2019; 98(39): e17343. CrossRef
The Efficacy and Safety of Direct-acting Antiviral Treatment for Chronic Hepatitis C Patients: A Single Center Study
Seong Jun Park, Ah Ran Kim, Won Hyeok Choe, Jeong Han Kim, Byung Chul Yoo, So Young Kwon
The Korean Journal of Gastroenterology.2018; 72(4): 197. CrossRef

23,065 View
243 Download
27 Web of Science
Crossref

Viral hepatitis

Prevention of Hepatitis B reactivation in the setting of immunosuppression: Venessa Pattullo; Clin Mol Hepatol 2016;22(2):219-237.
Published online June 13, 2016; DOI: https://doi.org/10.3350/cmh.2016.0024

Abstract
PDF

Advances in the treatment of malignant and inflammatory diseases have developed over time, with increasing use of chemotherapeutic and immunosuppressive agents of a range of drug classes with varying mechanism and potency in their effects on the immune system. These advances have been met with the challenge of increased risk of hepatitis B virus (HBV) reactivation in susceptible individuals. The magnitude of risk of HBV reactivation is associated with the individual’s HBV serological status and the potency and duration of immunosuppression. Individuals with chronic hepatitis B (CHB) and previously infected but serologically cleared HBV infection are both susceptible to HBV reactivation. HBV reactivation in the setting of immunosuppression is a potentially life threatening condition leading to liver failure and death in extreme cases. It is important to recognize that HBV reactivation in the setting of immunosuppression is potentially preventable. Therefore, identification of patients at risk of HBV reactivation and institution of prophylactic antiviral therapy prior to initiation of immunosuppression is essential.

Citations

Citations to this article as recorded by

SOX6 is a novel host factor that promotes hepatitis B virus replication by enhancing the transcriptional activity of enhancer I
Yarong Song, Yitong Zeng, Han Zheng, Shu Shi, Zhongqing Li, Mingchen Liu, Sijin Shao, Ziheng Luo, Yurong Li, Jie Li, Kuanhui Xiang, Jie Wang
Antiviral Research.2026; 247: 106359. CrossRef
Experience With Rituximab in Patients With Pemphigus Vulgaris and Hepatitis B
R. Collado Gomez, O.L. Forero, M.E. Candiz, S. Paz, S. Lloveras, J. Carranza
Actas Dermo-Sifiliográficas.2026; 117(7): 104634. CrossRef
HBV Serologic Testing Practices and Reactivation Outcomes Before Rituximab Initiation: A Retrospective Observational Study at an Academic Tertiary Care Centre
Ahmed S. Barefah, Omar M. Raslan, Hatem M. Alahwal, Eman M. Mansory, Osman O. Radhwi, Esraa Almutairi, Lujain Alsayegh, Lujain Alrabghi, Basmah S. Almutairi, Mohammed A. Alsaadi, Salem M. Bahashwan
Journal of Clinical Medicine.2026; 15(15): 5762. CrossRef
Cordycepin Ameliorates Psoriasis-Like Skin Lesion by Regulating p53/MDM2 Feedback Loop
Ya Chen, Congcong Zhu, Zongguang Tai, Tianyan Lian, Quangang Zhu, Zhongjian Chen
Molecular Biotechnology.2025; 67(6): 2481. CrossRef
Impact of Hepatitis B Infection on Patient and Graft Survival After Kidney Transplantation
Anissa Paschereit, Vivien Greese, Kayo Sakurayama, Michael Duerr, Fabian Halleck, Lutz Liefeldt, Mira Choi, Klemens Budde, Marcel G. Naik
Journal of Clinical Medicine.2025; 14(6): 2124. CrossRef
Synchronous triple-negative breast cancer, rectal adenocarcinoma, and chemotherapy-induced hepatitis B virus reactivation: a case report and review of the literature
Ahmad Al-Bitar, Israa Tellawi, Hazem Kamil, Dana Al-Masalma, Karam Jeji, Souheb Al-mahasna
Journal of Medical Case Reports.2025;[Epub] CrossRef
Antineoplastic agents-associated hepatitis B virus reactivation: Research progress and molecular mechanisms
Huajie Xie, Meijun Lv, Qin Jia, Yanyan Wang, Wanlin Na, Yuan Liu, Kai Chang
Virus Research.2025; 361: 199655. CrossRef
Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors
Zhenyun Yang, Renguo Guan, Yizhen Fu, Dandan Hu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang
Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
Terapia corticosteroidea nella pratica reumatologica
G. Nocturne
EMC - AKOS - Trattato di Medicina.2024; 26(1): 1. CrossRef
Hepatitis B virus reactivation in hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy combined with and without immunotherapy
Lijie Zhang, Yiming Liu, Songlin Song, Joyman Makamure, Heshui Shi, Chuansheng Zheng, Bin Liang
Infectious Agents and Cancer.2024;[Epub] CrossRef
Real-world effectiveness, safety and immunogenicity of ocrelizumab in turkish multiple sclerosis patients: a single-center experience for 4-year follow-up
Tugba Erdogan, Cagri Cansu, Belgin Kocer, Sedanur Akkaya, Helin Kokmen
Acta Neurologica Belgica.2024; 124(4): 1385. CrossRef
Hepatitis B Reactivation and Vaccination Effectiveness after Solid Organ Transplantation: A Matched Case-Control Study
Yongseop Lee, Jaeeun Seong, Sangmin Ahn, Min Han, Jung Ah Lee, Jung Ho Kim, Jin Young Ahn, Nam Su Ku, Jun Yong Choi, Joon-Sup Yeom, Beom Kyung Kim, Su Jin Jeong
Vaccines.2024; 12(7): 804. CrossRef
Evaluation of Hepatitis Serology Screening Frequency and Viral Reactivation in Patients Followed with Biological Therapy or Cytotoxic Chemotherapy
Arif Kılçar, Atalay Doğru
SDÜ Tıp Fakültesi Dergisi.2024;[Epub] CrossRef
Hepatitis B virus reactivation risk associated with immune checkpoint inhibitors in tumor treatment: a retrospective study
Yue Yin, Bao Jiang Liu, Yan Hua Zhang, Xin Ye Qiu
Japanese Journal of Clinical Oncology.2024; 54(12): 1288. CrossRef
Risk factors of HBV reactivation in leukemia patients with resolved HBV infection after allogeneic hematopoietic stem cell transplantation
Danping Xiong, Wen Cai, Weifeng Zhao
Clinics and Research in Hepatology and Gastroenterology.2024; 48(8): 102447. CrossRef
Serological Profiles of Hepatitis B Virus in Patients With Crohn’s Disease Undergoing Anti-Tumor Necrosis Factor Alpha (TNFα) Therapy at Ibn Sina University Hospital, Rabat
Imane Louhab, Hajar Daoudi, Mina Elcadi, Ghizlane El Amin, Amal Zouaki, Jalila Zirar, Myriam Seffar, Mouna Salihoun, Hakima Kabbaj
Cureus.2024;[Epub] CrossRef
Hepatitis and Hepatitis B Virus Reactivation in Everolimus-Treated Solid Tumor Patients: A Focus on HBV-Endemic Areas
Chien-Hao Su, Chung-Yu Chen, Chien-Ting Liu, Yi-Hsin Yang, Pao-Chu Wu
Cancers.2024; 16(23): 3997. CrossRef
A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma
Kentaro Sato, Hidemichi Imamura, Yu Watahiki, Hiromasa Hazama, Takeaki Hashimoto, Shinji Mukae, Hiromasa Ohhira
Internal Medicine.2023; 62(11): 1611. CrossRef
The interplay of long noncoding RNAs and hepatitis B virus
Nima Sarfaraz, Srinivas Somarowthu, Michael J. Bouchard
Journal of Medical Virology.2023;[Epub] CrossRef
Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines
Samuel Etienne, Jürg Vosbeck, Christine Bernsmeier, Michael Osthoff
Journal of General Internal Medicine.2023; 38(2): 490. CrossRef
Hepatobiliary disease after bone marrow transplant
Maria Gabriela Fernandes Dezan, Lourianne Nascimento Cavalcante, Helma Pinchemel Cotrim, Andre Castro Lyra
Expert Review of Gastroenterology & Hepatology.2023; 17(2): 129. CrossRef
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapy
Shan Fu, Qiqi Zhang, Ruirui Jing, Cheng Zu, Fang Ni, Yuqi Lv, Jiazhen Cui, Haiqiong Zheng, Yanlei Zhang, Mingming Zhang, Guoqing Wei, Zenan Cen, Alex H. Chang, Yongxian Hu, He Huang
Bone Marrow Transplantation.2023; 58(6): 701. CrossRef
Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease
Jessica A. Ulrich, Nawras W. Habash, Yasmine A. Ismail, William J. Tremaine, Amy L. Weaver, Joseph A. Murray, Edward V. Loftus, Imad Absah
Clinical Gastroenterology and Hepatology.2023; 21(11): 2901. CrossRef
Corticoterapia en la práctica reumatológica
G. Nocturne
EMC - Tratado de Medicina.2023; 27(2): 1. CrossRef
Test All for Hepatitis B Virus
Katerina Roma, Zahra Dossaji, Lubaba Haque, Tooba Laeeq, Robert G. Gish, Carol Brosgart
Clinics in Liver Disease.2023; 27(4): 997. CrossRef
Hepatitis B virus infection in patients presenting for immunosuppressive cancer therapy with and without underlying HIV infection
Malowane H. Ngoato, Edina Amponsah-Dacosta, Ntombifuthi Blose, Selokela G. Selabe, Thembeni L. Msibi, Mojakgomo H. Motswaledi, Andrew M. Musyoki
Frontiers in Virology.2023;[Epub] CrossRef
Living-donor lobar lung transplantation from a hepatitis B surface antigen-positive donor to a negative recipient
Takafumi Yamaya, Masaaki Sato, Chihiro Konoeda, Jun Nakajima
BMJ Case Reports.2023; 16(10): e255663. CrossRef
Evaluation of HBV Reactivation and Antiviral Prophylaxis in Patients Receiving Immunosuppressive Therapy
Ahmet ŞAHİN, Selda ASLAN
Journal of Contemporary Medicine.2023; 13(5): 809. CrossRef
The importance of triple panel testing for hepatitis B and the burden of isolated anti-hepatitis B core antibodies within a community sample
Catherine Freeland, Vivek Sreepathi, Richard W. Hass, Jonathan M. Fenkel, Jessie Torgersen, Kenneth Rothstein, Chari Cohen, Robert G. Gish
Journal of Virus Eradication.2023; 9(4): 100358. CrossRef
Corticothérapie en pratique rhumatologique
G. Nocturne
EMC - Traité de médecine AKOS.2023; 26(1): 1. CrossRef
Recommendations for prevention of infection in systemic autoimmune rheumatic diseases
Íñigo Rúa-Figueroa Fernández de Larrinoa, Patricia E. Carreira, Noé Brito García, Petra Díaz del Campo Fontecha, José María Pego Reigosa, José A. Gómez Puerta, Rafaela Ortega-Castro, Beatriz Tejera Segura, José María Aguado García, Julián Torre-Cisneros,
Reumatología Clínica (English Edition).2022; 18(6): 317. CrossRef
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area
Yibo Wu, Yi Chen, Panpan Zhu, Baodong Ye, Ying Lu, Jimin Shi, Yamin Tan, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Jianping Lan, Ting Si, Lihong Ni, He Huang, Yi Luo
Annals of Hematology.2022; 101(3): 631. CrossRef
Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas
Íñigo Rúa-Figueroa Fernández de Larrinoa, Patricia E. Carreira, Noé Brito García, Petra Díaz del Campo Fontecha, José María Pego Reigosa, José A. Gómez Puerta, Rafaela Ortega-Castro, Beatriz Tejera Segura, José María Aguado García, Julián Torre-Cisneros,
Reumatología Clínica.2022; 18(6): 317. CrossRef
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment
Sun Yoo, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Changhoon Yoo, Baek-Yeol Ryoo, Jonggi Choi
Clinical Gastroenterology and Hepatology.2022; 20(4): 898. CrossRef
Antivirale Medikamente
Jakob J. Malin, Till Bunse, Christoph D. Spinner, Ulrike Protzer
Der Internist.2022; 63(1): 118. CrossRef
Late Hepatitis B reactivation after treatment with rituximab
Sara Lacerda Pereira, Raquel Duro, António Sarmento
IDCases.2022; 27: e01393. CrossRef
Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma
Qiao Zhou, Qi Zhang, Kaiwen Wang, Ting Huang, Shaoping Deng, Yi Wang, Chunming Cheng
Pharmacological Research.2022; 178: 106181. CrossRef
The altered HLA‐DQ expression in peripheral blood T cells of chronic hepatitis B patients characterizes the function of T cells
Xingyue Zeng, Ayibaota Bahabayi, Bulidierxin Tuerhanbayi, Mohan Zheng, Tianci Liu, Lijuan Xu, Yan Long, Changsheng Xia, Songsong Lu, Ying Song, Chen Liu
Journal of Viral Hepatitis.2022; 29(5): 340. CrossRef
İmmünsüpresif ilaçlar ve HBV reaktivasyonu
Betül ERSÖZ ACAR
Bolu Abant Izzet Baysal Universitesi Tip Fakultesi Abant Tip Dergisi.2022;[Epub] CrossRef
Prevalence of Occult Hepatitis B Infection in Liver Biopsy Sample of Patients with Nonviral Liver Disease
Bulent Cakal, Alp Atasoy, Bilger Cavus, Mehves Poda, Mesut Bulakci, Mine Gulluoglu, Mehmet Demirci, Filiz Akyuz
Future Virology.2022; 17(10): 733. CrossRef
Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies
João Marcello de Araujo-Neto, Gabriela Sousa Guimarães, Flavia Ferreira Fernandes, Marcelo A. Soares
Viruses.2022; 14(8): 1780. CrossRef
Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
Mohamed A. Elsebaey, Tamer A. Elbedewy, Heba Elashry, Waleed Elrefaey, Samah A. Elshweikh, Ahmed A. Elhadidy, Neveen A. Shalaby, Assem Mohamed Elsokkary, Hossam Eldin A. Elashtokhy, Yousry Esam-Eldin Abo-Amer, Ashraf Rafat Abo-Elfetoh, Sharaf Elsayed Ali
Medicine.2022; 101(47): e31962. CrossRef
The Impact of b/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis
Der-Yuan Chen, Hsin-Hua Chen, Shih-Hsin Chang, Yi-Ming Chen, Po-Hao Huang, Chia-Wei Hsieh, Joung-Liang Lan, Kuo-Tung Tang
Journal of Clinical Medicine.2022; 12(1): 86. CrossRef
Chronic viral hepatitis B and rheumatic diseases: Modern view on problem
G. I. Gridneva, B. S. Belov, E. S. Aronova
Medical alphabet.2022; (29): 20. CrossRef
Monitoring by viral load and quantitative hepatitis B surface antigen in patients with hepatitis B virus infection receiving immunosuppressive therapy
Hsien-Chung Yu, Jui-Cheng Tseng, Ling-Ying Lu, Jwi-Chieh Hu, Yan-Hua Chen, Chiao-Lin Hsu, Pin-Chieh Wu, Guang-Yuan Mar, Kung-Hung Lin
European Journal of Gastroenterology & Hepatology.2021; 33(1): 107. CrossRef
Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation
Yibo Wu, He Huang, Yi Luo
Frontiers in Immunology.2021;[Epub] CrossRef
HBV Reactivation in Patients with HBsAg(-)/HBcAb(+) Induced by Rituximab Combined with Chemotherapy: A Case Report and Literature Review
碧碧宣
Advances in Clinical Medicine.2021; 11(11): 5224. CrossRef
HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu, Hongda Lu
Frontiers in Oncology.2021;[Epub] CrossRef
Management of immunosuppressants in the era of coronavirus disease-2019
Michael Manansala, Robert Baughman, Richard Novak, Marc Judson, Nadera Sweiss
Current Opinion in Pulmonary Medicine.2021; 27(3): 176. CrossRef
Management of Hepatitis‐B Virus Infection in Immunocompromised Children
Pier Luigi Calvo, Michele Pinon, Dominic Dell'Olio, Andrea Carpino, Eleonora Biasin, Antonio Pizzol, Silvia Catalano, Licia Peruzzi, Caterina Rigazio, Fabio Cisarò, Anna Opramolla, Sebastian Dorin Asaftei, Paola Quarello, Franca Fagioli
Journal of Pediatric Gastroenterology and Nutrition.2021; 72(4): 597. CrossRef
The compliance of our practice of hepatitis B virus screening with the current guidelines in patients undergoing chemotherapy for hematological malignancies
Funda PEPEDİL TANRİKULU, Didar YANARDAĞ AÇIK, Bilal AYGUN, Mehmet BANKİR, Mikail ÖZDEMİR
Journal of Surgery and Medicine.2021; 5(11): 1095. CrossRef
Use of Hepatitis B Virus–Positive Organs in Organ Transplantation
Saro Khemichian, Jeffrey Kahn, Norah A. Terrault
Clinics in Liver Disease.2021; 25(4): 841. CrossRef
Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma
Branko Borojevic, Ayushi Chauhan, Scott Patterson
BMJ Case Reports.2021; 14(7): e243526. CrossRef
Effect of Low-Dose Corticosteroid Use on HBV Reactivation in HBsAg-positive Rheumatoid Arthritis Patients
Wooseong Jeong, Jung-Yoon Choe, Byung-Cheol Song, Chang-Keun Lee, Hoon-Suk Cha, Byeongzu Ghang, Jinseok Kim
The Open Rheumatology Journal.2021; 15(1): 39. CrossRef
Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis
Ping Li, Lili Zhou, Shiguang Ye, Wenjun Zhang, Junbang Wang, Xiaochen Tang, Jie Liu, Yangyang Xu, Wenbin Qian, Aibin Liang
Frontiers in Immunology.2021;[Epub] CrossRef
The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion-transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia
Hiroshi Okano, Tatsunori Nakano, Ryugo Ito, Ami Tanaka, Yuji Hoshi, Keiji Matsubayashi, Hiroki Asakawa, Kenji Nose, Satomi Tsuruga, Tomomasa Tochio, Hiroaki Kumazawa, Yoshiaki Isono, Hiroki Tanaka, Shimpei Matsusaki, Tomohiro Sase, Tomonori Saito, Katsumi
Clinical Journal of Gastroenterology.2020; 13(2): 252. CrossRef
Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Aibin Zhang, Yibo Wu, Yamin Tan, Jimin Shi, Yanmin Zhao, Yongxian Hu, Jian Yu, Weiyan Zheng, Xiaoyu Lai, Mingming Zhang, Yuanyuan Zhu, Yishan Ye, Yaping Huang, Shan Fu, He Huang, Yi Luo
Biology of Blood and Marrow Transplantation.2020; 26(5): 956. CrossRef
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen
Intestinal Research.2020; 18(1): 18. CrossRef
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B
Giordano Madeddu, Vito Fiore, Michela Melis, Silvia Ortu, Franca Mannu, Alberto Augusto Muredda, Giovanni Garrucciu, Franco Bandiera, Salvatore Zaru, Paola Bagella, Diego Francesco Calvisi, Sergio Babudieri
Scientific Reports.2020;[Epub] CrossRef
Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen‐negative, core antibody‐positive recipients
Jihye Kim, Se Jin Chung, Dong Hyun Sinn, Kyo Won Lee, Jae Berm Park, Wooseong Huh, Jung Eun Lee, Hye Ryoun Jang, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Viral Hepatitis.2020; 27(7): 739. CrossRef
Alteración de las pruebas de función hepática en el paciente inmunodeprimido
N. Marcos Carrasco, A. Martínez Ortega, D. Burgos Santamaría, L. Téllez Villajos
Medicine - Programa de Formación Médica Continuada Acreditado.2020; 13(5): 282. CrossRef
Management of hepatitis B in the era of checkpoint inhibition
Janice Dutcher
Journal for ImmunoTherapy of Cancer.2020; 8(1): e000276. CrossRef
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad, Albert J. Czaja
Hepatology.2020; 72(2): 671. CrossRef
Adherence to guidelines across different specialties to prevent infections in patients undergoing immunosuppressive therapies
David R. Chadwick, Laila Sayeed, Matthew Rose, Emily Budd, Mo Mohammed, Sarah Harrison, Jaskiran Azad, Jamie Maddox
BMC Infectious Diseases.2020;[Epub] CrossRef
Safety considerations with biologics and new inflammatory bowel disease therapies
Natália S.F. Queiroz, Miguel Regueiro
Current Opinion in Gastroenterology.2020; 36(4): 257. CrossRef
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye, Michael Boyle
Clinical Microbiology Reviews.2020;[Epub] CrossRef
Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 Update
Michele S. Barnhill, Joshua M. Steinberg, Joseph J. Jennings, James H. Lewis
Current Gastroenterology Reports.2020;[Epub] CrossRef
Biological Features of Hepatitis B Virus Strains Associated With Fulminant Hepatitis
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic
Future Virology.2020; 15(7): 455. CrossRef
Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016
Graça M. Dores, Rochelle E. Curtis, Nicole H. Dalal, Martha S. Linet, Lindsay M. Morton
Journal of Clinical Oncology.2020; 38(35): 4149. CrossRef
Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
Dimitrios C Ziogas, Frosso Kostantinou, Evangelos Cholongitas, Amalia Anastasopoulou, Panagiotis Diamantopoulos, John Haanen, Helen Gogas
Journal for ImmunoTherapy of Cancer.2020; 8(2): e000943. CrossRef
Hepatitis B virus reactivation following imatinib therapy: A comparative review of 9 cases
Faisal Inayat, Fei Song, Nouman Safdar Ali, Muhammad Haseeb Aslam, Aishatu Aloma, Hilal Hachem, Muhammad Wasif Saif
Journal of Oncology Pharmacy Practice.2019; 25(6): 1500. CrossRef
Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case report
Arturo Ciccullo, F. R. Ponziani, E. Maiolo, F. Pallavicini, M. Pompili
Infection.2019; 47(2): 313. CrossRef
HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?
Linda Drößler, Clara Lehmann, Karin Töpelt, Dirk Nierhoff, Jörg J. Vehreschild, Jan Rybniker, Michael Hallek, Julia Fischer, Verena Stormberg, Gerd Fätkenheuer, Ulrike Wieland, Norma Jung
Infection.2019; 47(2): 293. CrossRef
Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease
Uday N. Shivaji, Caroline L. Sharratt, Tom Thomas, Samuel C. L. Smith, Marietta Iacucci, Gordon W. Moran, Subrata Ghosh, Neeraj Bhala
Alimentary Pharmacology & Therapeutics.2019; 49(6): 664. CrossRef
Infection par le virus de l’hépatite B : histoire naturelle, manifestations cliniques et principes thérapeutiques
O. Paccoud, L. Surgers, K. Lacombe
La Revue de Médecine Interne.2019; 40(9): 590. CrossRef
Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B
Hae Lim Lee, Jeong Won Jang, Ji Won Han, Sung Won Lee, Si Hyun Bae, Jong Young Choi, Nam Ik Han, Seung Kew Yoon, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Chang-Ki Min, Dong-Wook Kim, Jong Wook Lee
Digestive Diseases and Sciences.2019; 64(10): 2992. CrossRef
A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection
Romina Salpini, Arianna Battisti, Luna Colagrossi, Domenico Di Carlo, Lavinia Fabeni, Lorenzo Piermatteo, Carlotta Cerva, Miriam Lichtner, Claudio Mastroianni, Massimo Marignani, Sarah Maylin, Constance Delaugerre, Filomena Morisco, Nicola Coppola, Aldo M
Journal of Viral Hepatitis.2019; 26(7): 846. CrossRef
Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola
World Journal of Gastroenterology.2019; 25(26): 3299. CrossRef
Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic
Viruses.2019; 11(9): 778. CrossRef
The epidemiology of hepatitis B virus infection in Korea
Sun Young Yim, Ji Hoon Kim
The Korean Journal of Internal Medicine.2019; 34(5): 945. CrossRef
Rheumatologists’ awareness of hepatitis B reactivation before immunosuppressive therapy
Bilal Toka, Ahmet Tarik Eminler, Emel Gönüllü, Mukaddes Tozlu, Mustafa Ihsan Uslan, Erkan Parlak, Oğuz Karabay, Aydin Seref Koksal
Rheumatology International.2019; 39(12): 2077. CrossRef
Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management
Alessandra Zannella, Massimo Marignani, Paola Begini
Viruses.2019; 11(9): 858. CrossRef
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies
Danielle J. Smalls, Reagan E. Kiger, LeAnn B. Norris, Charles L. Bennett, Bryan L. Love
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2019; 39(12): 1190. CrossRef
Profilaktyka reaktywacji zakażeń HBV – rekomendacje grupy roboczej profilaktyki reaktywacji HBV
Małgorzata Pawłowska, Robert Flisiak, Lidia Gil, Andrzej Horban, Iwona Hus, Jerzy Jaroszewicz, Ewa Lech-Marańda, Jan Styczyński
Acta Haematologica Polonica.2019; 50(4): 192. CrossRef
Anti-TNF alfa kullanan hastalarda hepatit B reaktivasyonunun değerlendirilmesi
İlkay BOZKURT, Ahmet BEKTAŞ
Dicle Tıp Dergisi.2019; 46(3): 553. CrossRef
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Anil Arora, Shivaram P. Singh, Ashish Kumar, Vivek A. Saraswat, Rakesh Aggarwal, Manisha Bangar, Pradip Bhaumik, Harshad Devarbhavi, Radha K. Dhiman, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Dharmesh Kapoor, Kaushal Madan, Jimmy Narayan, Sandeep Nij
Journal of Clinical and Experimental Hepatology.2018; 8(1): 58. CrossRef
Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysis
Charat Thongprayoon, Wisit Kaewput, Konika Sharma, Karn Wijarnpreecha, Napat Leeaphorn, Patompong Ungprasert, Ankit Sakhuja, Franco H Cabeza Rivera, Wisit Cheungpasitporn
World Journal of Hepatology.2018; 10(2): 337. CrossRef
Viral Hepatitis and Acute Liver Failure
Daniel Sedhom, Melroy D’Souza, Elizabeth John, Vinod Rustgi
Clinics in Liver Disease.2018; 22(2): 289. CrossRef
Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma
Matthew Kelling, Lubomir Sokol, Samir Dalia
Cancer Control.2018;[Epub] CrossRef
Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis
Jiang Su, Li Long, Kun Zou
Clinical Rheumatology.2018; 37(12): 3201. CrossRef
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids
Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nag
Journal of Clinical and Experimental Hepatology.2018; 8(4): 403. CrossRef
Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements
Vincenzo Malagnino, Djeneba Bocar Fofana, Karine Lacombe, Joel Gozlan
Open Forum Infectious Diseases.2018;[Epub] CrossRef
Disparities in Hepatitis B Virus Infection and Immunity Among New York City Asian American Patients, 1997 to 2017
Amy S. Tang, Janice Lyu, Su Wang, Qingqing He, Perry Pong, Aaron M. Harris
American Journal of Public Health.2018; 108(S4): S327. CrossRef
The Positivity Ratios of HBsAg, Anti-HBs and Isolated Anti-HBc in Patients with Breast and Gynecologic Cancers Prior to Chemotherapy
Ayşe İnci, Özgür Açıkgöz, Mustafa Uygar Kalaycı, Volkan Ülker
Journal of Clinical and Experimental Investigations.2018;[Epub] CrossRef
Minimal Risk of HBV Reactivation in Resolved HBV-Infected Patients During Immunosuppressive Therapy
Yüksel Gümürdülü, Salih Tokmak, Ümit Karaoğullarından, Didem Arslan Taş, İ. Oğuz Kara, Ahmet Barış Güzel, Ghanim Khatib
SSRN Electronic Journal .2018;[Epub] CrossRef
Hepatocellular Carcinoma: Known and Emerging Risk Factors
Daniela Sciancalepore, Maria Teresa Zingaro, Chiara Valentina Luglio, Carlo Sabbà, Nicola Napoli
Journal of Cancer Therapy.2018; 09(05): 417. CrossRef
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke
Journal of Hepatology.2017; 67(2): 370. CrossRef
Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea
Kyeong Hun Lee, Kyu Seok Shim, In Seok Lim, Soo Ahn Chae, Sin Weon Yun, Na Mi Lee, Young Bae Choi, Dae Yong Yi
BMC Pediatrics.2017;[Epub] CrossRef
Hepatitis B in renal transplant patients
Smaragdi Marinaki, Kyriaki Kolovou, Stratigoula Sakellariou, John N Boletis, Ioanna K Delladetsima
World Journal of Hepatology.2017; 9(25): 1054. CrossRef
Hepatitis B in patients with hematological diseases: An update
Chiara Coluccio, Paola Begini, Alfredo Marzano, Adriano Pellicelli, Barbara Imperatrice, Giulia Anania, Gianfranco Delle Fave, Massimo Marignani
World Journal of Hepatology.2017; 9(25): 1043. CrossRef

23,515 View
695 Download
96 Web of Science
Crossref

Viral hepatitis

KASL clinical practice guidelines: management of hepatitis C: The Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2016;22(1):76-139.
Published online March 28, 2016; DOI: https://doi.org/10.3350/cmh.2016.22.1.76

Citations

Citations to this article as recorded by

2025 KASL clinical practice guidelines for management of hepatitis C
Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung
Clinical and Molecular Hepatology.2026; 32(1): 1. CrossRef
Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
Jihye Lim, Hyundam Gu, Hyunji Sang, Su Jin Jeong, Ha Il Kim
Alzheimer's Research & Therapy.2025;[Epub] CrossRef
Precision Strategy for Hepatocellular Carcinoma Surveillance after Hepatitis C Cure: Debates across Guidelines
Masaaki Mino, Eiji Kakazu, Tatsuya Kanto
Gut and Liver.2025; 19(5): 651. CrossRef
Temporal Dynamics and Treatment Outcomes of Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Multicenter Retrospective Study from South Korea
Jae Yoon Jeong, Su Jong Yu, Jeayeon Park, Na Ryung Choi, Soon Sun Kim, Jae Hyun Yoon, Hyuk Soo Eun, Jonggi Choi, Ki Tae Yoon, Young Kul Jung, Soo Young Park, Geum-Youn Gwak, Tae Yeob Kim, Dong Yun Kim, Do Young Kim, Ji Hoon Kim, Jin-Woo Lee, Jeong Won Jan
Gut and Liver.2025; 19(6): 868. CrossRef
Epidemiology and Management of Hepatitis C in Korea
Jaeyoun Cheong
Korean Journal of Healthcare-Associated Infection Control and Prevention.2025; 30(2): 118. CrossRef
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, D
Clinical and Molecular Hepatology.2024; 30(Suppl): S5. CrossRef
Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
Clinical and Molecular Hepatology.2023; 29(2): 496. CrossRef
Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
Jeong Heo, Yoon Jun Kim, Sung Wook Lee, Youn-Jae Lee, Ki Tae Yoon, Kwan Soo Byun, Yong Jin Jung, Won Young Tak, Sook-Hyang Jeong, Kyung Min Kwon, Vithika Suri, Peiwen Wu, Byoung Kuk Jang, Byung Seok Lee, Ju-Yeon Cho, Jeong Won Jang, Soo Hyun Yang, Seung W
The Korean Journal of Internal Medicine.2023; 38(4): 504. CrossRef
Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
BMC Gastroenterology.2023;[Epub] CrossRef
The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
Jung Kim, Sung-Eun Kim, Do Song, Hee Kim, Eileen Yoon, Seong Kang, Young-Kul Jung, Jung Kwon, Sung Lee, Seul Han, Young Chang, Soung Jeong, Jeong Yoo, Young-Joo Jin, Gab Cheon, Byung Kim, Yeon Seo, Hyoungsu Kim, Ji Park, Tae Kim, Dong Sinn, Woo Chung, Hwi
Diagnostics.2023; 14(1): 14. CrossRef
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease
Ji Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, Jung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, Hee Chul Nam, Hee Yeon Kim, Chang Wook Kim, Hyun Yang, Si Hyun Bae, Do Seon Song, U Im Chang, Jin Mo Yang, Sung Won Lee, Hae Lim Lee, Soon Kyu Lee, Pil Soo Sung, Jeong
The Korean Journal of Internal Medicine.2022; 37(5): 958. CrossRef
Viral Hepatitis in Patients with Inflammatory Bowel Disease
Seung Hwan Shin, Sang Hyoung Park
The Korean Journal of Gastroenterology.2022; 80(2): 51. CrossRef
Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital
Mi Seon Park, Young-Mo Yang, Ki Hyun Park, Hyonok Yoon, Ju Sin Kim, Eun Joo Choi
Korean Journal of Clinical Pharmacy.2022; 32(3): 191. CrossRef
Sofosbuvir–velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan
Tetsuo Takehara, Namiki Izumi, Satoshi Mochida, Takuya Genda, Shigetoshi Fujiyama, Kazuo Notsumata, Akihiro Tamori, Fumitaka Suzuki, Vithika Suri, Renee‐Claude Mercier, Takuma Matsuda, Kana Matsuda, Naoya Kato, Kazuaki Chayama, Hiromitsu Kumada
Hepatology Research.2022; 52(10): 833. CrossRef
Combination treatment with sofosbuvir and ribavirin for patients diagnosed with hepatitis C genotype 2: A real-world, single-center study
Ik Sung Choi, Kwang Min Kim, Sang Goon Shim
Arab Journal of Gastroenterology.2021; 22(1): 23. CrossRef
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials
Jeong Heo, Yoon Jun Kim, Jin-Woo Lee, Ji Hoon Kim, Young-Suk Lim, Kwang-Hyub Han, Sook-Hyang Jeong, Mong Cho, Ki Tae Yoon, Si Hyun Bae, Eric D. Crown, Linda M. Fredrick, Negar Niki Alami, Armen Asatryan, Do Hyun Kim, Seung Woon Paik, Youn-Jae Lee
Gut and Liver.2021; 15(6): 895. CrossRef
Prevalence of hepatitis B and C viral markers among apparently healthy residents of the Socialist Republic of Vietnam (Southern Vietnam)
Yu. V. Ostankova, A. V. Semenov, E. B. Zueva, E. N. Serikova, A. N. Schemelev, D. E. Valutite, H. K.T. Huinh, S. A. Egorova, A. A. Totolian
Russian Journal of Infection and Immunity.2021; 11(6): 1131. CrossRef
Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study
Dong Hyun Sinn, Danbee Kang, Yun Soo Hong, Kwang Cheol Koh, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak, Luca Rinaldi
PLOS ONE.2021; 16(8): e0255624. CrossRef
Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea
Dae Hyun Lim, Jae Yoon Jeong, Seongwoo Nam, Jongkyoung Choi, Hyeok Choon Kwon, Yong Bum Yoon, Yeonjae Kim, BumSik Chin
Journal of Korean Medical Science.2021;[Epub] CrossRef
Factors Associated with Hepatitis C Antibody Positivity in Korean Adults: A Cross-Sectional Study Based on 2013–2018 Korea National Health and Nutrition Examination Survey
Taehui Kim, Jiyoung Kim
Healthcare.2021; 9(10): 1366. CrossRef
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Sook Young Woo, Hyun Cho, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Hepatology.2020; 71(6): 2023. CrossRef
Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study
Joon Yeul Nam, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, In Hee Kim, Sung Bum Cho, Han Chu Lee, Si Hyun Bae, Moran Ki, Hwa Young Choi, Eun Young Lee, Sook-Hyang Jeong
Gut and Liver.2020; 14(2): 207. CrossRef
Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea
Do Young Kim, Gabriel Wong, Janet Lee, Myung Hwa Kim, Nathaniel Smith, Rob Blissett, Hyung Joon Kim
Current Medical Research and Opinion.2020; 36(6): 993. CrossRef
Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C
Sang Hoon Ahn, Won Hyeok Choe, Yoon Jun Kim, Jeong Heo, Dorota Latarska-Smuga, Jiho Kang, Seung Woon Paik
Gut and Liver.2020; 14(3): 368. CrossRef
Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
Gut and Liver.2020; 14(6): 775. CrossRef
A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea
Gwang Hyeon Choi, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong
Gut and Liver.2020; 14(6): 808. CrossRef
Editorial: comorbidities, concomitant medications, and potential drug‐drug interactions with interferon‐free direct‐acting anti‐viral agents in chronic hepatitis C
Naoto Kawabe, Senju Hashimoto, Kentaro Yoshioka
Alimentary Pharmacology & Therapeutics.2019; 49(1): 116. CrossRef
Cost‐effectiveness of sofosbuvir plus ribavirin therapy for hepatitis C virus genotype 2 infection in South Korea
Wankyo Chung, Kyung‐Ah Kim, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook‐Hyang Jeong
Journal of Gastroenterology and Hepatology.2019; 34(4): 776. CrossRef
Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea
Jung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, Hee Yeon Kim, Chang Wook Kim, Chan Ran You, Sang Wook Choi, Se Hyun Cho, Joon‐Yeol Han, Do Seon Song, U Im Chang, Jin Mo Yang, Sung Won Lee, Hae Lim Lee, Nam Ik Han, Seok‐Hwan Kim, Myeong Jun Song, Pil Soo Sung,
Journal of Medical Virology.2019; 91(6): 1104. CrossRef
Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan
Yu-Kang Chang, Yuan-Tsung Tseng, Kou-Huang Chen, Kow-Tong Chen
BMC Endocrine Disorders.2019;[Epub] CrossRef
Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on Hemodialysis
Byung Seok Lee, Myeong Jun Song, Jung Hyun Kwon, Tae Hee Lee, Ji Woong Jang, Seok Hyun Kim, Sae Hwan Lee, Hong Soo Kim, Ji Hoon Kim, Seok Bae Kim, Soon Young Ko, Do Seon Song
Gut and Liver.2019; 13(2): 191. CrossRef
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
KLCA Korean Liver Cancer Association, NCC National Cancer Center
Gut and Liver.2019; 13(3): 227. CrossRef
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2019; 20(7): 1042. CrossRef
Dynamic Changes in Ex Vivo T-Cell Function After Viral Clearance in Chronic HCV Infection
Ji Won Han, Pil Soo Sung, Kyung Hwan Kim, Seon-Hui Hong, Eui-Cheol Shin, Myeong Jun Song, Su-Hyung Park
The Journal of Infectious Diseases.2019; 220(8): 1290. CrossRef
Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test
Eun Sun Jang, Kyung‐Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook‐Hyang Jeong
Journal of Medical Virology.2019; 91(12): 2158. CrossRef
Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea
Young-Hwan Ahn, Hyungcheol Park, Myeon Jae Lee, Dong Hyun Kim, Sung Bum Cho, Eunae Cho, Chung Hwan Jun, Sung Kyu Choi
Gut and Liver.2019; 13(5): 549. CrossRef
Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study
Seung Kak Shin, Jin-Woo Lee, Hannah Ra, Oh Sang Kwon, Jong-Beom Shin, Young-Joo Jin, Sangheun Lee, Ki Jun Han, Young Nam Kim, Tae Hun Kim, Yun Soo Kim, Ju Hyun Kim
Journal of Korean Medical Science.2019;[Epub] CrossRef
Correlation between Hepatitis B Virus Infection and Colorectal Neoplasia
Yoon Suk Jung, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn
Journal of Clinical Medicine.2019; 8(12): 2085. CrossRef
Alcohol attenuates anti‐HCV function of IFN‐λ1 through up‐regulation of PLASy expression in human hepatic cells
Meihua Ran, Jiegang Huang, Hao Liang, Junjun Jiang, Bingyu Liang, Chuanyi Ning, Ning Zang, Weibo Liao, Huifang Liu, Fengxiang Qin, Quanlue Yang, Wenzhe Ho, Li Ye, Hui Chen
Journal of Medical Virology.2018; 90(6): 1112. CrossRef
Cycling of Dexmedetomidine May Prevent Delirium After Liver Transplantation
K.S. Hong, N.R. Kim, S.H. Song, G. Hong
Transplantation Proceedings.2018; 50(4): 1080. CrossRef
Early development of de novo hepatocellular carcinoma after direct‐acting agent therapy: Comparison with pegylated interferon‐based therapy in chronic hepatitis C patients
S. H. Yoo, J. H. Kwon, S. W. Nam, H. Y. Kim, C. W. Kim, C. R. You, S. W. Choi, S. H. Cho, J.‐Y. Han, D. S. Song, U. I. Chang, J. M. Yang, H. L. Lee, S. W. Lee, N. I. Han, S.‐H. Kim, M. J. Song, S. Hwang, P. S. Sung, J. W. Jang, S. H. Bae, J. Y. Choi, S. K
Journal of Viral Hepatitis.2018; 25(10): 1189. CrossRef
Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment
Jung-Hwan Yu, Ja Kyung Kim, Kwan Sik Lee, Jung Il Lee
Journal of Clinical Gastroenterology.2018; 52(6): 557. CrossRef
Evolution and persistence of resistance‐associated substitutions of hepatitis C virus after direct‐acting antiviral treatment failures
Y. Jeong, B. Jin, H. W. Lee, H. J. Park, J. Y. Park, D. Y. Kim, K.‐H. Han, S. H. Ahn, S. Kim
Journal of Viral Hepatitis.2018; 25(11): 1251. CrossRef
2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis C: What's New?
Kyung-Ah Kim
The Korean Journal of Gastroenterology.2018; 71(6): 315. CrossRef
Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
Jong Man Kim, Kwang-Woong Lee, Dong-Hyun Sinn, Gyu-Seong Choi, Nam-Joon Yi, Choon Hyuck David Kwon, Kyung-Suk Suh, Jae-Won Joh
Annals of Surgical Treatment and Research.2018; 95(3): 147. CrossRef
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
Yun Bin Lee, Joon Yeul Nam, Jeong-Hoon Lee, Young Chang, Hyeki Cho, Young Youn Cho, Eun Ju Cho, Su Jong Yu, Hwi Young Kim, Dong Ho Lee, Jeong Min Lee, Seong Gyu Hwang, Yoon Jun Kim, Jung-Hwan Yoon
Scientific Reports.2018;[Epub] CrossRef
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan
Chen‐Hua Liu, Ming‐Lung Yu, Cheng‐Yuan Peng, Tsai‐Yuan Hsieh, Yi‐Hsiang Huang, Wei‐Wen Su, Pin‐Nan Cheng, Chih‐Lin Lin, Ching‐Chu Lo, Chi‐Yi Chen, Jyh‐Jou Chen, Qian Ma, Craig Brooks‐Rooney, Jia‐Horng Kao
Alimentary Pharmacology & Therapeutics.2018; 48(11-12): 1290. CrossRef
Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs
Seung Ho Lee, Young-Joo Jin, Jun Young Shin, Jin-Woo Lee
Medicine.2017; 96(1): e5321. CrossRef
Suppression of autophagy by mycophenolic acid contributes to inhibition of HCV replication in human hepatoma cells
Shoucai Fang, Jinming Su, Bingyu Liang, Xu Li, Yu Li, Junjun Jiang, Jiegang Huang, Bo Zhou, Chuanyi Ning, Jieliang Li, Wenzhe Ho, Yiping Li, Hui Chen, Hao Liang, Li Ye
Scientific Reports.2017;[Epub] CrossRef
Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study
Su Rin Shin, Young Seok Kim, Young-Seok Lim, June Sung Lee, Jin Woo Lee, Sun Myung Kim, Sook-Hyang Jeong, Joo Hyun Sohn, Myung Seok Lee, Sang Hoon Park
Gut and Liver.2017; 11(2): 270. CrossRef
Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era
Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong
Gut and Liver.2017; 11(4): 543. CrossRef
Hepatitis B and C virus infection and diabetes mellitus: A cohort study
Yun Soo Hong, Yoosoo Chang, Seungho Ryu, Miguel Cainzos-Achirica, Min-Jung Kwon, Yiyi Zhang, Yuni Choi, Jiin Ahn, Sanjay Rampal, Di Zhao, Roberto Pastor-Barriuso, Mariana Lazo, Hocheol Shin, Juhee Cho, Eliseo Guallar
Scientific Reports.2017;[Epub] CrossRef
IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection
Pil Soo Sung, Seon-Hui Hong, Jae-Hee Chung, Sojeong Kim, Su-Hyung Park, Ho Min Kim, Seung Kew Yoon, Eui-Cheol Shin
Scientific Reports.2017;[Epub] CrossRef
Treatment of Chronic Hepatitis C Patients Who Do Not Respond to Direct Acting Antivirals
Jeong Han Kim
The Korean Journal of Gastroenterology.2017; 70(2): 111. CrossRef
Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C
Jung Hwan Yu, Jung Il Lee, Kwan Sik Lee, Ja Kyung Kim
Virology Journal.2017;[Epub] CrossRef
Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced
Hyun Woong Lee, Ki Young Yoo, Joung Won Won, Hyung Joon Kim
Gut and Liver.2017; 11(5): 721. CrossRef
Occupational blood exposures in health care workers: incidence, characteristics, and transmission of bloodborne pathogens in South Korea
Ju Hyun Lee, Junhyeon Cho, Yung Jung Kim, Sang Hyuk Im, Eun Sun Jang, Jin-Wook Kim, Hong Bin Kim, Sook-Hyang Jeong
BMC Public Health.2017;[Epub] CrossRef
Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study
Sajjad Iqbal, Muhammad Haroon Yousuf, Muhammad Iftikhar Yousaf
World Journal of Gastroenterology.2017; 23(44): 7899. CrossRef
The clinical outcomes of chronic hepatitis C in South Korea
Kyeong Sam Ok, Sook-Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, In Hee Kim, Sung Bum Cho, Si Hyun Bae, Han Chu Lee
Medicine.2016; 95(35): e4594. CrossRef
Strategy for Hepatitis C Treatment in Liver Transplant Settings
Jun Yong Park
Korean Journal of Transplantation.2016; 30(4): 149. CrossRef

38,459 View
222 Download
69 Web of Science
Crossref

Viral hepatitis

KASL clinical practice guidelines: management of chronic hepatitis B: The Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2016;22(1):18-75.
Published online March 28, 2016; DOI: https://doi.org/10.3350/cmh.2016.22.1.18

Citations

Citations to this article as recorded by

Prognostic validation of ADV and MoRAL scores for hepatocellular carcinoma recurrence following living donor liver transplantation: a long-term follow-up study
Young-In Yoon, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Woo-Hyoung Kang, Sung-Gyu Lee
Clinical Transplantation and Research.2026; 40(2): 243. CrossRef
Factors associated with hepatitis B mother-to-child transmission in a national prevention program
Moran Ki, Byung-Woo Kim, Dahye Baik, Jong-Hyun Kim
Clinical and Molecular Hepatology.2025; 31(4): 1298. CrossRef
Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
The Journal of Infectious Diseases.2024; 229(1): 108. CrossRef
Comparison of Glecaprevir/Pibrentasvir and Sofosbuvir/Ledipasvir in Patients with Hepatitis C Virus Genotype 1 and 2 in South Korea
Hyun Deok Shin, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Hyuk Soo Eun, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Seok Hwan Kim, Myung Joon Song, Soon Yeong Ko, Suk Bae Kim
The Korean Journal of Gastroenterology.2024; 83(3): 111. CrossRef
Non-Invasive Monitoring of the Impact of Low-Level Viremia on Liver Fibrosis in Treated Chronic Hepatitis B Patients
Jinxian Xu, Yang Zhang, Lujian Zhu, Shiyue Tang, Hanglu Xu, Dehe Zhang, Haijun Chen, Jing Zhou
Infection and Drug Resistance.2024; Volume 17: 2751. CrossRef
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
PLOS ONE.2024; 19(8): e0307712. CrossRef
Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis
Su Jong Yu, Jeong-Ju Yoo, Dong Ho Lee, Su Jin Kim, Eun Ju Cho, Se Hyung Kim, Jeong-Hoon Lee, Yoon Jun Kim, Jeong Min Lee, Jae Young Lee, Jung-Hwan Yoon
Biomedicines.2023; 11(2): 382. CrossRef
Occurrence of Liver Cancer in People without Traditional Risk Factors
Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
Korean Journal of Clinical Geriatrics.2023; 24(1): 41. CrossRef
Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score
Min Kyung Park, Dong Ho Lee, Bo Yun Hur, Hyung-Chul Lee, Yun Bin Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee
Radiology.2023;[Epub] CrossRef
Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
BMC Gastroenterology.2023;[Epub] CrossRef
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase
Gyeol Seong, Dong Hyun Sinn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
European Journal of Gastroenterology & Hepatology.2022; 34(1): 69. CrossRef
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2022; 14(3): 711. CrossRef
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
Sun Yoo, Ji Yoon Kim, Young-Suk Lim, Seungbong Han, Jonggi Choi
Journal of Hepatology.2022; 77(4): 939. CrossRef
Expression Patterns of Tumor Markers in Liver Transplant Recipients Showing Complete Pathological Response of Hepatocellular Carcinoma
Min-Jae Kim, Woo-Hyoung Kang, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park
Journal of Clinical Medicine.2022; 11(19): 5897. CrossRef
Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers
Jung Hun Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung-chul Yoo, Eileen L. Yoon, Seong Hee Kang
Antimicrobial Agents and Chemotherapy.2022;[Epub] CrossRef
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon Kim
Journal of Liver Cancer.2022; 22(2): 103. CrossRef
Risk stratification of primary liver cancer
You-Wen Tan
World Journal of Clinical Cases.2022; 10(26): 9545. CrossRef
Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis
Xiangbo Meng, Zhengqi Pan, Jiawei Zhao, Quansheng Feng
Medicine.2022; 101(46): e31664. CrossRef
Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study
Jeong-Hoon Lee, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Clinical Infectious Diseases.2021; 73(9): e3308. CrossRef
Absence of association between pretransplant serum soluble programmed death protein-1 level and prognosis following living donor liver transplantation in patients with hepatocellular carcinoma
Byeong-Gon Na, Yun Kyu Kim, Shin Hwang, Kyung Jin Lee, Gil-Chun Park, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Hunji Yang, Young-In Yoon, Eunyoung Tak, Yo-Han Park, Sung-Gyu Lee
Medicine.2021; 100(17): e25640. CrossRef
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Hepatology International.2021; 15(4): 892. CrossRef
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
Hepatology International.2021; 15(6): 1328. CrossRef
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, Claus Niederau, Frank Tacke, Thomas Berg, Dieter Glebe, Wolfgang Jilg, Heiner Wedemeyer, Stefan Wirth, Christoph Höner zu Siederdissen, Petra Lynen-Jansen, Pia van Leeuwen, Jörg Petersen
Zeitschrift für Gastroenterologie.2021; 59(07): 691. CrossRef
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
Han Ah Lee, Young-Sun Lee, Beom Kyung Kim, Young Kul Jung, Seung Up Kim, Jun Yong Park, Ji Hoon Kim, Hyunggin An, Do Young Kim, Hyung Joon Yim, Sang Hoon Ahn, Jong Eun Yeon, Kwan Soo Byun, Kwang-Hyub Han, Soon Ho Um, Yeon Seok Seo
Gut and Liver.2021; 15(3): 420. CrossRef
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
Hye Yeon Chon, Jae Seung Lee, Hye Won Lee, Ho Soo Chun, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Hepatology Research.2021; 51(4): 406. CrossRef
Prevalence of hepatitis B and C viral markers among apparently healthy residents of the Socialist Republic of Vietnam (Southern Vietnam)
Yu. V. Ostankova, A. V. Semenov, E. B. Zueva, E. N. Serikova, A. N. Schemelev, D. E. Valutite, H. K.T. Huinh, S. A. Egorova, A. A. Totolian
Russian Journal of Infection and Immunity.2021; 11(6): 1131. CrossRef
Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
Hankil Lee, Beom Kyung Kim, Sungin Jang, Sang Hoon Ahn
Clinical and Translational Gastroenterology.2021; 12(2): e00299. CrossRef
Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation
Shin Hwang, Gi-Won Song, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Young-In Yoon, Sung-Gyu Lee
Journal of Gastrointestinal Surgery.2021; 25(10): 2503. CrossRef
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B
Hye Yeon Chon, Yeon Seok Seo, Jung il Lee, Byung Seok Kim, Byoung Kuk Jang, Sang Gyune Kim, Ki Tae Suk, In Hee Kim, Jin-Woo Lee, Young Eun Chon, Moon Young Kim, Soung Won Jeong, Han Ah Lee, Sun Young Yim, Soon Ho Um, Hyun Woong Lee, Kwan Sik Lee, Jeong Eu
European Journal of Gastroenterology & Hepatology.2021; 33(6): 885. CrossRef
Reporting and Performance of Hepatocellular Carcinoma Risk Prediction Models: Based on TRIPOD Statement and Meta‐Analysis
Liuqing Yang, Qiang Wang, Tingting Cui, Jinxin Huang, Hui Jin, Stefano Gitto
Canadian Journal of Gastroenterology and Hepatology.2021;[Epub] CrossRef
Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2021; 13(23): 5892. CrossRef
Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study
Jayoun Lee, Gi‐Ae Kim, Hyo Jeong Kim, Songhee Cho, Min Jung Ko, Young‐Suk Lim
Journal of Viral Hepatitis.2021; 28(8): 1150. CrossRef
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival
Min Woo Lee, Danbee Kang, Hyo Keun Lim, Juhee Cho, Dong Hyun Sinn, Tae Wook Kang, Kyoung Doo Song, Hyunchul Rhim, Dong Ik Cha, David S. K. Lu
European Radiology.2020; 30(4): 2391. CrossRef
The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
Journal of Rheumatic Diseases.2020; 27(1): 4. CrossRef
Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
Gil-Chun Park, Shin Hwang, Myoung-Soo Kim, Dong-Hwan Jung, Gi-Won Song, Kwang-Woong Lee, Jong Man Kim, Jae Geun Lee, Je Ho Ryu, Dong Lak Choi, Hee-Jung Wang, Bong-Wan Kim, Dong-Sik Kim, Yang Won Nah, Young Kyoung You, Koo Jeong Kang, Hee Chul Yu, Yo-Han P
Journal of Korean Medical Science.2020;[Epub] CrossRef
Treatment and outcomes of extrahepatic malignancy incidentally diagnosed during pretransplant evaluation for living donor liver transplantation
Gil‐Chun Park, Shin Hwang, Gi‐Won Song, Dong‐Hwan Jung, Deok‐Bog Moon, Chul‐Soo Ahn, Ki‐Hun Kim, Tae‐Yong Ha, Young‐In Yoon, Sung‐Gyu Lee
Journal of Hepato-Biliary-Pancreatic Sciences.2020; 27(4): 200. CrossRef
Is renal replacement therapy necessary in deceased donor liver transplantation candidates with hepatorenal syndrome?: a 2-year experience at a high-volume center
Gil-Chun Park, Shin Hwang, Dong-Hwan Jung, Gi-Won Song, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Young-In Yoon, Hui-Dong Cho, Jae-Hyun Kwon, Yong-Kyu Chung, Sang-Hyun Kang, I-Ji Jung, Jin Uk Choi, Sung-Gyu Lee
Annals of Surgical Treatment and Research.2020; 98(2): 102. CrossRef
Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation
Gil-Chun Park, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Young-In Yoon, Hui-Dong Cho, Jae-Hyun Kwon, Yong-Kyu Chung, Sang-Hyun Kang, Jin-Uk Choi, I-Ji Jung, Sung-Gyu Lee
Journal of Korean Medical Science.2020;[Epub] CrossRef
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Sook Young Woo, Hyun Cho, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Hepatology.2020; 71(6): 2023. CrossRef
Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment
Ya‐Chao Tao, Meng‐Lan Wang, Dong‐Mei Zhang, Dong‐Bo Wu, Yong‐Hong Wang, Juan Liao, Hong Tang, En‐Qiang Chen
Journal of Viral Hepatitis.2020; 27(7): 731. CrossRef
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
Hye Won Lee, Eun Hwa Kim, Jinae Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Clinical and Translational Gastroenterology.2020; 11(3): e00140. CrossRef
Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinoma
Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim
Journal of Gastroenterology and Hepatology.2020; 35(11): 1960. CrossRef
Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
Young Youn Cho, Young Chang, Joon Yeul Nam, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Gut and Liver.2020; 14(2): 225. CrossRef
An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well‐controlled viremia
Hye W. Lee, Soo Y. Park, Myeongjee Lee, Eun J. Lee, Jinae Lee, Seung U. Kim, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Beom K. Kim
Liver International.2020; 40(7): 1736. CrossRef
Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database
Gil-Chun Park, Shin Hwang, Yo-Han Park, Jin-Uk Choi
Annals of Surgical Treatment and Research.2020; 98(5): 235. CrossRef
Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score
Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
International Journal of Epidemiology.2020; 49(5): 1562. CrossRef
Child-Pugh, MELD, MELD-Na, and ALBI scores: which liver function models best predicts prognosis for HCC patient with ascites?
Kwang Min Kim, Sang Goon Shim, Dong Hyun Sinn, Jeong Eun Song, Byung Seok Kim, Ho Gak Kim
Scandinavian Journal of Gastroenterology.2020; 55(8): 951. CrossRef
Tenofovir‐based combination therapy or monotherapy for multidrug‐resistant chronic hepatitis B: Long‐term data from a multicenter cohort study
Hyung Joon Yim, Sang Jun Suh, Young Kul Jung, Seong Gyu Hwang, Yeon Seok Seo, Soon Ho Um, Sae Hwan Lee, Young Seok Kim, Jae Young Jang, In Hee Kim, Hyoung Su Kim, Ji Hoon Kim, Young Sun Lee, Eileen L. Yoon, Myeong Jun Song, Jun Yong Park
Journal of Viral Hepatitis.2020; 27(12): 1306. CrossRef
A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
Seung Up Kim, Yong Eun Chon, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, In Kyung Min, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Beom Kyung Kim, Soo Young Park
Journal of Viral Hepatitis.2020; 27(12): 1352. CrossRef
Reduced liver cancer mortality with regular clinic follow‐up among patients with chronic hepatitis B: A nationwide cohort study
Jae‐Jun Shim, Gi‐Ae Kim, Chi Hyuk Oh, Jung Wook Kim, Jisun Myung, Byung‐Ho Kim, In‐Hwan Oh
Cancer Medicine.2020; 9(20): 7781. CrossRef
A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean population
Jung Yeon Seo, Joong-Gon Shin, Byeong Ju Youn, Suhg Namgoong, Hyun Sub Cheong, Lyoung Hyo Kim, Ji On Kim, Hyoung Doo Shin, Yoon Jun Kim
BMC Medical Genetics.2020;[Epub] CrossRef
Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease
Dong Won Park, Yoon Jin Lee, Won Chang, Ji Hoon Park, Kyoung Ho Lee, Young Hoon Kim, Nam Kyu Kang, Jung Wha Chung, Hee Yoon Jang, Soomin Ahn, Haeryoung Kim, Sook-Hyang Jeong, Jin-Wook Kim, Eun Sun Jang, Silvia C. Sookoian
PLOS ONE.2019; 14(3): e0212771. CrossRef
Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
Joonhong Park, Hanwool Cho, Seung Jun Choi, Gun Dong Lee, Sang Hyun Sin, Ji Hyeong Ryu, Hye-Sun Park, Hyeyoung Lee, Yonggoo Kim, Eun-Jee Oh
Annals of Laboratory Medicine.2019; 39(1): 86. CrossRef
Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers
Hye Soo Kim, Oidov Baatarkhuu, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang‐Hyub Han, Beom Kyung Kim, Seung Up Kim
Liver International.2019; 39(1): 81. CrossRef
Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology
Dong-Hwan Jung, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Won Song, Chul-Soo Ahn, Deok-Bog Moon, Sung-Gyu Lee
Annals of Surgery.2019; 269(3): 511. CrossRef
Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea
Jung Hyun Kwon, Myeong Jun Song, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U. Im Chang, Jin Mo Yang, Chan Ran You, Sang Wook Choi, Hae Lim Lee, Sung Won Lee, Nam Ik Han, Soon Woo Nam, Sang Gy
Digestive Diseases and Sciences.2019; 64(7): 2039. CrossRef
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
Hye Won Lee, Seung Up Kim, Oidov Baatarkhuu, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Scientific Reports.2019;[Epub] CrossRef
Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study
Dong Hyun Sinn, Danbee Kang, Minwoong Kang, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
BMC Cancer.2019;[Epub] CrossRef
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Young Park
Journal of Hepatology.2019; 71(3): 456. CrossRef
Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate
In Suk Min, Chang Hun Lee, Ik Sang Shin, Na Eun Lee, Hong Seon Son, Seung Bum Kim, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim
Gut and Liver.2019; 13(1): 93. CrossRef
Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
Mi Na Kim, Seong Gyu Hwang, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Seung Up Kim, Sang Hoon Ahn
Gut and Liver.2019; 13(2): 197. CrossRef
Hepatitis B virus S gene therapy with 10-23 DNAzyme delivered by chitosan-g-stearic acid micelles
Yun Hong, Dongsen Mao, Rui Wu, Zhe Gao, Tingting Meng, Rongrong Wang, Lin Liu, Jing Miao
RSC Advances.2019; 9(27): 15196. CrossRef
High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, Seungbong Han, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2019; 50(2): 215. CrossRef
Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
Jung Hwan Yu, Young Ju Suh, Young-Joo Jin, Nae-Yun Heo, Ji Woong Jang, Chan Ran You, Hyun Young An, Jin-Woo Lee
European Journal of Gastroenterology & Hepatology.2019; 31(7): 865. CrossRef
Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective Study
Yeonjung Ha, Sohyun Hwang, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang
Journal of Clinical Medicine.2019; 8(5): 656. CrossRef
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
KLCA Korean Liver Cancer Association, NCC National Cancer Center
Gut and Liver.2019; 13(3): 227. CrossRef
External validation of the modified PAGE‐B score in Asian chronic hepatitis B patients receiving antiviral therapy
Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Beom Kyung Kim
Liver International.2019; 39(9): 1624. CrossRef
Assessment of patient safety and the efficiency of facility utilization following simplified ultra-rapid intravenous infusion of hepatitis B immunoglobulin in a high-volume liver transplantation center
I-Ji Jeong, Shin Hwang, Dong-Hwan Jung, Gi-Won Song, Gil-Chun Park, Chul-Soo Ahn, Deok-Bog Moon, Ki-Hun Kim, Tae-Yong Ha, Hea-Seon Ha, Jung-Ja Hong, In-Ok Kim, Sung-Gyu Lee
Annals of Hepato-Biliary-Pancreatic Surgery.2019; 23(2): 128. CrossRef
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2019; 20(7): 1042. CrossRef
Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
Hye Won Lee, Seung Up Kim, Jun Yong Park, Oidov Baatarkhuu, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Clinical and Translational Gastroenterology.2019; 10(6): e00036. CrossRef
Hepatitis B virus DNA levels and overall survival in hepatitis B‐related hepatocellular carcinoma patients with low‐level viremia
Tae‐Se Kim, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Gastroenterology and Hepatology.2019; 34(11): 2028. CrossRef
The risk of hepatocellular carcinoma among chronic hepatitis B virus‐infected patients outside current treatment criteria
Dong Hyun Sinn, Sung Eun Kim, Beom Kyung Kim, Ji Hoon Kim, Moon Seok Choi
Journal of Viral Hepatitis.2019; 26(12): 1465. CrossRef
Stimulated phospholipid synthesis is key for hepatitis B virus replications
Qingxia Huang, Hehua Lei, Laifeng Ding, Yulan Wang
Scientific Reports.2019;[Epub] CrossRef
Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis
Shin Hwang, Gi-Won Song, Young-Kyu Chung, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Young-In Yoon, Hwui-Dong Cho, Jae-Hyun Kwon, Sang-Hyun Kang, I-Ji Jeong, Jin-Uk Choi, Sung-Gyu Lee
Journal of Korean Medical Science.2019;[Epub] CrossRef
Result Patterns and Characteristics of HBeAg and HBV DNA in Patients with Chronic Hepatitis B
Eun Jin Choi, Jae Han Kim, Mi-Soon Han
Laboratory Medicine Online.2019; 9(4): 210. CrossRef
Association between Aspartate Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study
Chuanmeng Zhang, Jiayuan Wu, Juan Xu, Jie Xu, Jianchun Xian, Shanshan Xue, Jun Ye
Disease Markers.2019; 2019: 1. CrossRef
Natural History and Treatment Indications of Chronic Hepatitis B
Dong Hyun Sinn
The Korean Journal of Gastroenterology.2019; 74(5): 245. CrossRef
Antiviral drug Utilization and Annual Expenditures for Patients with Chronic HBV Infection in Guangzhou, China, in 2008–2015
Feng Zhou, Weidong Jia, Shuo Yang, Ge Chen, Guanhai Li, Yueping Li, Yingfang Liang, Yi Yang, Yanhui Gao, Yue Chen
Antiviral Therapy.2019; 24(6): 405. CrossRef
Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma
Chul‐Soo Ahn, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Sung‐Gyu Lee
ANZ Journal of Surgery.2018; 88(3): 212. CrossRef
Clinico‐pathological correlation of hepatic angiomyolipoma: a series of 23 resection cases
Dong Hwan Jung, Shin Hwang, Seung Mo Hong, Ki Hun Kim, Chul Soo Ahn, Deok Bog Moon, Abdulwahab A Alshahrani, Sung Gyu Lee
ANZ Journal of Surgery.2018;[Epub] CrossRef
Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
Namyoung Paik, Dong H. Sinn, Ji H. Lee, In S. Oh, Jung H. Kim, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
Liver International.2018; 38(1): 68. CrossRef
Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
Mi Young Jeon, Hye Won Lee, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn
Liver International.2018; 38(4): 676. CrossRef
Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B
Jung Gil Park, Yu Rim Lee, Soo Young Park, Heon Ju Lee, Won Young Tak, Young Oh Kweon, Se Young Jang, Jae Min Chun, Young Seok Han, Keun Hur, Hye Won Lee, Min Kyu Kang
Digestive and Liver Disease.2018; 50(2): 163. CrossRef
Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance
Dong Yun Kim, Hye Won Lee, Jeong Eun Song, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Jun Yong Park
Journal of Medical Virology.2018; 90(3): 497. CrossRef
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Anil Arora, Shivaram P. Singh, Ashish Kumar, Vivek A. Saraswat, Rakesh Aggarwal, Manisha Bangar, Pradip Bhaumik, Harshad Devarbhavi, Radha K. Dhiman, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Dharmesh Kapoor, Kaushal Madan, Jimmy Narayan, Sandeep Nij
Journal of Clinical and Experimental Hepatology.2018; 8(1): 58. CrossRef
Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study
Shin Hwang, Jae‐Won Joh, Hee Jung Wang, Dong Goo Kim, Kyung Sik Kim, Kyung‐Suk Suh, Seong Hoon Kim, Hee Chul Yu, Chol Kyoon Cho, Young‐Joo Lee, Ki‐Hun Kim, Jong Man Kim, Bong‐Wan Kim, Sung‐Gyu Lee
World Journal of Surgery.2018; 42(8): 2579. CrossRef
A direct role for hepatitis B virus X protein in inducing mitochondrial membrane permeabilization
H‐R. Lee, Y. Y. Cho, G. Y. Lee, D‐g. You, Y. D. Yoo, Y. J. Kim
Journal of Viral Hepatitis.2018; 25(4): 412. CrossRef
Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients
Heon Ju Lee, Sang Jin Kim, Young Oh Kweon, Soo Young Park, Jeong Heo, Hyun Young Woo, Jae Seok Hwang, Woo Jin Chung, Chang Hyeong Lee, Byung Seok Kim, Jeong Ill Suh, Won Young Tak, Byoung Kuk Jang, Jose Ignacio Herrero
PLOS ONE.2018; 13(1): e0190581. CrossRef
Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population
Suhg Namgoong, Joong‐Gon Shin, Hyun Sub Cheong, Lyoung Hyo Kim, Ji On Kim, Jung Yeon Seo, Hyoung Doo Shin, Yoon Jun Kim
Liver International.2018; 38(9): 1576. CrossRef
Effect of tenofovir on renal function in patients with chronic hepatitis B
Woo Jin Jung, Jae Young Jang, Won Young Park, Soung Won Jeong, Hee Jeong Lee, Sang Joon Park, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Baigal Baymbajav
Medicine.2018; 97(7): e9756. CrossRef
Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyon-Suk Kim, Young Nyun Park, Kwang-Hyub Han, Kijun Song, Seung Up Kim
Gut and Liver.2018; 12(2): 190. CrossRef
Three types of preS1 start codon deletion variants in the natural course of chronic hepatitis B infection
Won Hyeok Choe, Hong Kim, So‐Young Lee, Yu‐Min Choi, So Young Kwon, Hee Won Moon, Mina Hur, Bum‐Joon Kim
Journal of Gastroenterology and Hepatology.2018; 33(7): 1370. CrossRef
Validation of prognostic scores to predict short‐term mortality in patients with acute‐on‐chronic liver failure
Do Seon Song, Tae Yeob Kim, Dong Joon Kim, Hee Yeon Kim, Dong Hyun Sinn, Eileen L Yoon, Chang Wook Kim, Young Kul Jung, Ki Tae Suk, Sang Soo Lee, Chang Hyeong Lee, Tae Hun Kim, Won Hyeok Choe, Hyung Joon Yim, Sung Eun Kim, Soon Koo Baik, Jae Young Jang, H
Journal of Gastroenterology and Hepatology.2018; 33(4): 900. CrossRef
Serum alanine aminotransferase level and liver‐related mortality in patients with chronic hepatitis B: A large national cohort study
Jae‐Jun Shim, Jung Wook Kim, Chi Hyuk Oh, Ye‐Rin Lee, Ji Sung Lee, So‐Youn Park, Byung‐Ho Kim, In‐Hwan Oh
Liver International.2018; 38(10): 1751. CrossRef
Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma
Sang‐Hyun Kang, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Sung‐Gyu Lee
Journal of Hepato-Biliary-Pancreatic Sciences.2018; 25(4): 240. CrossRef
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee
Gut.2018; 67(5): 945. CrossRef
Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patients
Y. Y. Cho, J.‐H. Lee, Y. Chang, J. Y. Nam, H. Cho, D. H. Lee, E. J. Cho, D. H. Lee, S. J. Yu, J. M. Lee, Y. J. Kim, J.‐H. Yoon
Journal of Viral Hepatitis.2018; 25(10): 1161. CrossRef
Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial
H. J. Yim, I. H. Kim, S. J. Suh, Y. K. Jung, J. H. Kim, Y. S. Seo, J. E. Yeon, C. W. Kim, S. Y. Kwon, S. H. Park, M. S. Lee, S. H. Um, K. S. Byun
Journal of Viral Hepatitis.2018; 25(11): 1321. CrossRef
Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
Jung Hwan Yu, Young‐Joo Jin, Jin‐Woo Lee, Don‐Haeng Lee
Hepatology Research.2018; 48(11): 862. CrossRef
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids
Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nag
Journal of Clinical and Experimental Hepatology.2018; 8(4): 403. CrossRef
Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence
Dong‐Hwan Jung, Eunyoung Tak, Shin Hwang, Gi‐Won Song, Chul‐Soo Ahn, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gil‐Chun Park, Baek‐Yeol Ryoo, Kyung Jin Lee, Nayoung Kim, Jae‐Hyeon Kwon, Eun‐Kyoung Jwa, Sung‐Gyu Lee
Liver Transplantation.2018; 24(7): 932. CrossRef
Step-down Strategy in Antiviral Resistant Chronic Hepatitis B Patients Who Achieved Viral Suppression With Rescue Combination Therapy
Dong Yun Kim, Jun Yong Park
Future Virology.2018; 13(10): 711. CrossRef
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Byeong G. Song, Dong H. Sinn, Sangah Chi, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
European Journal of Gastroenterology & Hepatology.2018; 30(12): 1447. CrossRef
Hepatitis B virus infection and development of chronic kidney disease: a cohort study
Yun Soo Hong, Seungho Ryu, Yoosoo Chang, Miguel Caínzos-Achirica, Min-Jung Kwon, Di Zhao, Tariq Shafi, Mariana Lazo, Roberto Pastor-Barriuso, Hocheol Shin, Juhee Cho, Eliseo Guallar
BMC Nephrology.2018;[Epub] CrossRef
Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?
Sung Won Chung, Young Chang, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Gastroenterology Research and Practice.2018; 2018: 1. CrossRef
Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas
Su-Min Ha, Shin Hwang, Jin Young Park, Young-Joo Lee, Ki-Hun Kim, Gi-Won Song, Dong-Hwan Jung, Yun-Suk Yu, Jinpyo Kim, Kyoung-Jin Lee, Eunyoung Tak, Yo-Han Park, Sung-Gyu Lee
Annals of Surgical Treatment and Research.2018; 95(6): 303. CrossRef
Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation
Yong-Kyu Chung, Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Baek-Yeol Ryoo, Sung-Gyu Lee
Annals of Hepato-Biliary-Pancreatic Surgery.2018; 22(4): 297. CrossRef
Tenofovir Disoproxil Fumarate Monotherapy is Superior to Entecavir-Adefovir Combination Therapy in Patients with Suboptimal Response to Lamivudine-Adefovir Therapy for Nucleoside-Resistant HBV: A 96-Week Prospective Multicentre Trial
Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim, Baek Gyu Jun, Young Don Kim, Dae Won Jun, Joo Hyun Sohn, Tae Yeob Kim, Byung Seok Lee
Antiviral Therapy.2018; 23(3): 219. CrossRef
Durability of the virological response after lamivudine discontinuation in lamivudine‐resistant patients with a complete virological response after lamivudine and adefovir combination therapy
Mi Na Kim, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang‐Hyub Han
Journal of Medical Virology.2017; 89(1): 85. CrossRef
Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
S. Lee, S. H. Ahn, K. S. Jung, D. Y. Kim, B. K. Kim, S. U. Kim, O. Baatarkhuu, H. J. Ku, K. Han, J. Y. Park
Journal of Viral Hepatitis.2017; 24(2): 141. CrossRef
Clinicopathological Features and Post‐resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Dong‐Hwan Jung, Shin Hwang, Ki‐Hun Kim, Seung‐Mo Hong, Young‐Joo Lee, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Gil‐Chun Park, Eun Sil Yu, Sung‐Gyu Lee
World Journal of Surgery.2017; 41(3): 825. CrossRef
Post‐resection Prognosis of Combined Hepatocellular Carcinoma‐Cholangiocarcinoma According to the 2010 WHO Classification
Dong‐Hwan Jung, Shin Hwang, Seung‐Mo Hong, Yong‐Kyu Chung, Gi‐Won Song, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gil‐Chun Park, Han Chu Lee, Young‐Suk Lim, Eun Sil Yu, Sung‐Gyu Lee
World Journal of Surgery.2017; 41(5): 1347. CrossRef
Low‐level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
Jung Hee Kim, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Hepatology.2017; 66(2): 335. CrossRef
Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta‐analysis of prophylaxis management
Z. Liu, L. Jiang, G. Liang, E. Song, W. Jiang, Y. Zheng, C. Gong
Journal of Viral Hepatitis.2017; 24(7): 561. CrossRef
Reversal of liver cirrhosis: current evidence and expectations
Young Kul Jung, Hyung Joon Yim
The Korean Journal of Internal Medicine.2017; 32(2): 213. CrossRef
Longterm prognosis of combined hepatocellular carcinoma‐cholangiocarcinoma following liver transplantation and resection
Dong‐Hwan Jung, Shin Hwang, Gi‐Won Song, Chul‐Soo Ahn, Deok‐Bog Moon, Ki‐Hun Kim, Tae‐Yong Ha, Gil‐Chun Park, Seung‐Mo Hong, Wan‐Jun Kim, Woo‐Hyoung Kang, Seok‐Hwan Kim, Eun Sil Yu, Sung‐Gyu Lee
Liver Transplantation.2017; 23(3): 330. CrossRef
Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
Young Eun Chon, Jun Yong Park, Sung-Min Myoung, Kyu Sik Jung, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han
American Journal of Gastroenterology.2017; 112(6): 882. CrossRef
Rituximab and hepatitis B reactivation in HBsAg-negative/ anti-HBc-positive kidney transplant recipients
Juhan Lee, Jun Yong Park, Kyu Ha Huh, Beom Seok Kim, Myoung Soo Kim, Soon Il Kim, Sang Hoon Ahn, Yu Seun Kim
Nephrology Dialysis Transplantation.2017; 32(4): 722. CrossRef
Systematic review with meta‐analysis: the efficacy and safety of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus
M. H. Hyun, Y.‐S. Lee, J. H. Kim, J. H. Je, Y. J. Yoo, J. E. Yeon, K. S. Byun
Alimentary Pharmacology & Therapeutics.2017; 45(12): 1493. CrossRef
Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
Jung Hee Kim, Dong Hyun Sinn, Geum‐Youn Gwak, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Gastroenterology and Hepatology.2017; 32(5): 1100. CrossRef
Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
Mi Na Kim, Seong Gyu Hwang, Kyu Sung Rim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Seung Up Kim
Liver International.2017; 37(12): 1788. CrossRef
Prognostic effect of transarterial chemoembolization–induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma
Woo‐Hyoung Kang, Shin Hwang, Gi‐Won Song, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Dong‐Hwan Jung, Gil‐Chun Park, Sung‐Gyu Lee
Liver Transplantation.2017; 23(6): 781. CrossRef
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
Dong Hyun Sinn, Jeong-Hoon Lee, Kyunga Kim, Joong Hyun Ahn, Ji Hyeon Lee, Jung Hee Kim, Dong Hyeon Lee, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Gut and Liver.2017; 11(4): 528. CrossRef
Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea
Kyeong Hun Lee, Kyu Seok Shim, In Seok Lim, Soo Ahn Chae, Sin Weon Yun, Na Mi Lee, Young Bae Choi, Dae Yong Yi
BMC Pediatrics.2017;[Epub] CrossRef
Letter: role of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus—authors’ reply
Y.‐S. Lee, M. H. Hyun, J. H. Kim, J. E. Yeon, K. S. Byun
Alimentary Pharmacology & Therapeutics.2017; 46(5): 563. CrossRef
Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B
In Du Jeong, Seok Won Jung, Bo Ryung Park, Byung Uk Lee, Jae Ho Park, Byung Gyu Kim, Sung-Jo Bang, Jung Woo Shin, Neung Hwa Park
Digestive Diseases and Sciences.2017; 62(10): 2908. CrossRef
Clinicopathological features and post-resection outcomes of biliary cystadenoma and cystadenocarcinoma of the liver
Eun-Kyoung Jwa, Shin Hwang
Annals of Hepato-Biliary-Pancreatic Surgery.2017; 21(3): 107. CrossRef
Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
Jihye Park, Kyu Sik Jung, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
Gut and Liver.2017; 11(6): 828. CrossRef
Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Jae Yoon Jeong, Joo Hyun Sohn, Won Sohn, Chan Hyuk Park, Tae Yeob Kim, Dae Won Jun, Yongsoo Kim, Woo Kyoung Jeong
Gut and Liver.2017; 11(6): 852. CrossRef
Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy
Eun-Jung Park, Kyu-sik Choi, Byung-Cheol Song
Journal of Rheumatic Diseases.2017; 24(5): 261. CrossRef
Successful introduction of Model for End-stage Liver Disease scoring in deceased donor liver transplantation in Korea: analysis of first 1 year experience at a high-volume transplantation center
Soo-Min Ha, Shin Hwang, Gi-Won Song, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Ki-Hun Kim, Dae-Yeon Kim, Jungman Namgung, Woo-Hyoung Kang, Seok-Hwan Kim, Eunkyoung Jwa, Jae-Hyeon Kwon, Hui-Dong Cho, Yong-Kyu Jung, Sang-Hyeon
Annals of Hepato-Biliary-Pancreatic Surgery.2017; 21(4): 199. CrossRef
Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching
Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, Choon Hyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
Annals of Surgical Treatment and Research.2017; 93(6): 293. CrossRef
Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study
Yeon Seok Seo, Byoung Kuk Jang, Soon Ho Um, Jae Seok Hwang, Kwang-Hyub Han, Sang Gyune Kim, Kwan Sik Lee, Seung Up Kim, Young Seok Kim, Jung Il Lee
Oncotarget.2017; 8(68): 113213. CrossRef
Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma
Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee
Journal of Gastrointestinal Surgery.2016; 20(11): 1807. CrossRef
Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2016; 61(11): 3354. CrossRef
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
Clinical Gastroenterology and Hepatology.2016; 14(11): 1647. CrossRef
The clinical outcomes of chronic hepatitis C in South Korea
Kyeong Sam Ok, Sook-Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, In Hee Kim, Sung Bum Cho, Si Hyun Bae, Han Chu Lee
Medicine.2016; 95(35): e4594. CrossRef
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
Won Sohn, Tae Wook Kang, Sun-Kyu Choi, Sin-Ho Jung, Min Woo Lee, Hyo Keun Lim, Ju-Yeon Cho, Sang Goon Shim, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Hyunchul Rhim, Yong-Han Paik
Oncotarget.2016; 7(30): 47794. CrossRef

34,287 View
266 Download
152 Web of Science
Crossref

Steatotic liver disease

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease: The Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2013;19(4):325-348.
Published online December 28, 2013; DOI: https://doi.org/10.3350/cmh.2013.19.4.325

Citations

Citations to this article as recorded by

Exercise-Based Interventions for Metabolic Dysfunction–Associated Fatty Liver Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses
Xinjuan Huang, Ruoling Yu, Manjie Guo, Xinyun Tan, Yuanqin Xia, Huihui Zou, Xuelian Liu, Chunxiang Qin
Nutrition Reviews.2026; 84(7): 1418. CrossRef
The association between serum pinenes and non-alcoholic fatty liver disease based on the NHANES 2013–2014
Tuo Xiao, Xue Xing, Lulu Sun, Jin Shang
Ecotoxicology and Environmental Safety.2025; 302: 118712. CrossRef
Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Giorgia Litrico, Marcello Agosta, Gaetano La Greca, Saverio Latteri
Scientific Reports.2024;[Epub] CrossRef
Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults
Junchul Ha, Oak-Kee Hong, Kyungdo Han, Hyuk-Sang Kwon
Diabetes Research and Clinical Practice.2024; 212: 111584. CrossRef
Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population
Young Lee, Eun Ju Cho, Eun Kyung Choe, Min-Sun Kwak, Jong In Yang, Seung-Won Oh, Jeong Yoon Yim, Goh Eun Chung
Scientific Reports.2024;[Epub] CrossRef
Fatty Liver and Risk of Head and Neck Cancer in Type 2 Diabetes Mellitus: A Nationwide Cohort Study
Junhee Park, Kyungdo Han, Seung Woo Lee, Yeong Jeong Jeon, Sang-Man Jin, Wonyoung Jung, Yoon Kyoung So, Sang Duk Hong, Dong Wook Shin
Cancers.2023; 15(4): 1209. CrossRef
Occurrence of Liver Cancer in People without Traditional Risk Factors
Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
Korean Journal of Clinical Geriatrics.2023; 24(1): 41. CrossRef
Protective effect of chlorophyll-removed ethanol extract of Lycium barbarum leaves against non-alcoholic fatty liver disease
Hansol Lee, Eun Young Bae, Kyung Ah Kim, Sun Yung Ly
Journal of Nutrition and Health.2023; 56(2): 123. CrossRef
Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study
Yewan Park, Dong Hyun Sinn, Kyunga Kim, Geum-Youn Gwak
Scientific Reports.2023;[Epub] CrossRef
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeongjun Song
Nutrients.2023; 15(18): 3970. CrossRef
Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease
Da-Hye Son, Jee Hye Han, Jun-Hyuk Lee
Journal of Obesity & Metabolic Syndrome.2023; 32(3): 214. CrossRef
Genome‐wide association of individual vulnerability with alcohol‐associated liver disease: A Korean genome and epidemiology study
Kwang Yoon Kim, Jung Oh Kim, Young‐Sang Kim, Ja‐Eun Choi, Jae‐Min Park, Kunhee Han, Da‐Hyun Park, Yon Chul Park, Bom Taeck Kim, Kyung‐Won Hong
Hepatology.2022; 75(2): 391. CrossRef
Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans
Huiyul Park, Kye-Yeung Park, Minki Kim, Hoon-Ki Park, Hwan-Sik Hwang
Asian Biomedicine.2022; 16(1): 15. CrossRef
Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness
Ji Min Choi, Hyo Eun Park, Yoo Min Han, Jooyoung Lee, Heesun Lee, Su Jin Chung, Seon Hee Lim, Jeong Yoon Yim, Goh Eun Chung
Frontiers in Medicine.2022;[Epub] CrossRef
Association between non‐alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study
Gi‐Ae Kim, Chi Hyuk Oh, Jung Wook Kim, Su Jin Jeong, In‐Hwan Oh, Jin San Lee, Key‐Chung Park, Jae‐Jun Shim
Liver International.2022; 42(5): 1027. CrossRef
Effect of intensive weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCT
Charu Arora, Anita Malhotra, Piyush Ranjan, Vishwajeet Singh, Namrata Singh, Shalimar, S. N. Dwivedi, Naval K. Vikram
European Journal of Clinical Nutrition.2022; 76(9): 1332. CrossRef
Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia
Kwang Woo Kim, Hyoun Woo Kang, Hosun Yoo, Yukyung Jun, Hyun Jung Lee, Jong Pil Im, Ji Won Kim, Joo Sung Kim, Seong-Joon Koh, Yong Jin Jung, Atsushi Hosui
PLOS ONE.2022; 17(12): e0279242. CrossRef
Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
Ji Taek Hong, Min-Jung Lee, Sang Jun Yoon, Seok Pyo Shin, Chang Seok Bang, Gwang Ho Baik, Dong Joon Kim, Gi Soo Youn, Min Jea Shin, Young Lim Ham, Ki Tae Suk, Bong-Soo Kim
Journal of Ginseng Research.2021; 45(2): 316. CrossRef
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Digestive Diseases and Sciences.2021; 66(8): 2816. CrossRef
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation‐wide Cohort Study
Yewan Park, Dong Hyun Sinn, Joo Hyun Oh, Myung Ji Goh, Kyunga Kim, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Geum‐Youn Gwak
Hepatology.2021; 74(6): 2988. CrossRef
Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
Jun-Hyuk Lee, Hye-Sun Lee, Byoung-Kwon Lee, Yu-Jin Kwon, Ji-Won Lee
Biology.2021; 10(2): 122. CrossRef
Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus
Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou, Ilias Migdalis
Journal of Diabetes Research.2021; 2021: 1. CrossRef
Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation
Li Qi, Wanlin Dai, Jing Kong, Yu Tian, Yongsheng Chen
Journal of Physiology and Biochemistry.2021; 77(4): 497. CrossRef
Development and initial validation of the nonalcoholic fatty liver disease self‐management questionnaire
Oh Young Kwon, Yeonsoo Jang, Ji Yea Lee, Seung Up Kim, Sang Hoon Ahn
Research in Nursing & Health.2021; 44(5): 844. CrossRef
Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
Małgorzata Moszak, Monika Szulińska, Marta Walczak-Gałęzewska, Paweł Bogdański
International Journal of Environmental Research and Public Health.2021; 18(4): 1616. CrossRef
Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease
Jun-Hyuk Lee, Hye Sun Lee, Sang Bong Ahn, Yu-Jin Kwon
Clinical Nutrition.2021; 40(10): 5252. CrossRef
Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea
Goh Eun Chung, Eun Ju Cho, Ji Won Yoon, Jeong-Ju Yoo, Young Chang, Yuri Cho, Sang-Hyun Park, Kyungdo Han, Dong Wook Shin, Su Jong Yu
Metabolism.2021; 123: 154866. CrossRef
Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease
Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
European Journal of Gastroenterology & Hepatology.2021; 33(1S): e529. CrossRef
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
Jiyoon Park, Eunice Yewon Lee, Jie Li, Mi Jung Jun, Eileen Yoon, Sang Bong Ahn, Chuanli Liu, Hongli Yang, Fajuan Rui, Biyao Zou, Linda Henry, Dong Hyun Lee, Dae Won Jun, Ramsey C. Cheung, Mindie H. Nguyen
Digestive Diseases.2021; 39(6): 634. CrossRef
SYSTEMATIC REVIEW WITH COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
N.A. TOKTOGULOVA
AVICENNA BULLETIN.2021; 23(1): 107. CrossRef
Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution
Goh Eun Chung, Nam Ju Heo, Donghee Kim, Min‐Sun Kwak, Jeong Yoon Yim, Joo Sung Kim, Aijaz Ahmed
Journal of Gastroenterology and Hepatology.2020; 35(1): 90. CrossRef
Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Soo Jin Cho, Seung Woon Paik, Young Bin Song, Roberto Pastor‐Barriuso, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak
Journal of Gastroenterology and Hepatology.2020; 35(5): 833. CrossRef
Modelling NAFLD disease burden in four Asian regions—2019‐2030
Chris Estes, Henry L. Y. Chan, Rong N. Chien, Wan‐Long Chuang, James Fung, George Boon-Bee Goh, Tsung H. Hu, Jee‐Fu Huang, Byoung K. Jang, Dae W. Jun, Jia H. Kao, Jin‐Woo Lee, Han‐Chieh Lin, Kathryn Razavi‐Shearer, Wai‐Kay Seto, Grace L. ‐H. Wong, Vincent
Alimentary Pharmacology & Therapeutics.2020; 51(8): 801. CrossRef
Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators
Seung Ha Park, Dong Joon Kim, Lindsay D. Plank
European Journal of Clinical Nutrition.2020; 74(10): 1401. CrossRef
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
Stergios A. Polyzos, Eun Seok Kang, Chrysoula Boutari, Eun-Jung Rhee, Christos S. Mantzoros
Metabolism.2020; 111: 154203. CrossRef
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
Eugene Han, Yong-ho Lee, Young Dae Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Kwang-Hyub Han, Hyo Suk Nam, Ji Hoe Heo, Seung Up Kim
American Journal of Gastroenterology.2020; 115(4): 584. CrossRef
Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment
Uk-Il Ju, Do-Won Jeong, Jieun Seo, Jun Bum Park, Jong-Wan Park, Kyung-Suk Suh, Jae Bum Kim, Yang-Sook Chun
Cell Death & Disease.2020;[Epub] CrossRef
Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Boram Park, Seong Joon An, Joo Sung Kim
Journal of Korean Medical Science.2020;[Epub] CrossRef
Dose–response association between physical activity and non-alcoholic fatty liver disease: a case–control study in a Chinese population
YangFan Li, Fei He, Yun He, XinTing Pan, YunLi Wu, ZhiJian Hu, Xu Lin, Xian-E Peng, ShangHua Xu
BMJ Open.2020; 9(3): e026854. CrossRef
Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation
Laura Micheli, Alessandra Pacini, Lorenzo Di Cesare Mannelli, Elena Trallori, Roberta D’Ambrosio, Carlo Bianchini, Pietro Lampertico, Carla Ghelardini
Nutrients.2020; 12(6): 1819. CrossRef
The increased amount of coffee consumption lowers the incidence of fatty liver disease in Korean men
Hye-Kyung Chung, Ji Sun Nam, Mi-Yeon Lee, Yong-Bum Kim, Yu-Sam Won, Won-Jun Song, Young-Hwan Kim, Chul Woo Ahn, Ki-Chul Sung
Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(10): 1653. CrossRef
Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score
Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
International Journal of Epidemiology.2020; 49(5): 1562. CrossRef
History of Nonalcoholic Fatty Liver Disease
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad
International Journal of Molecular Sciences.2020; 21(16): 5888. CrossRef
Dietary patterns are associated with the prevalence of nonalcoholic fatty liver disease in Korean adults
Goh Eun Chung, Jiyoung Youn, Young Sun Kim, Jung Eun Lee, Sun Young Yang, Joo Hyun Lim, Ji Hyun Song, Eun Young Doo, Joo Sung Kim
Nutrition.2019; 62: 32. CrossRef
Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals
Hyemin Jang, Danbee Kang, Yoosoo Chang, Yeshin Kim, Jin San Lee, Ko Woon Kim, Young Kyoung Jang, Hee Jin Kim, Duk L. Na, Hee Young Shin, Mira Kang, Eliseo Guallar, Juhee Cho, Sang Won Seo
Scientific Reports.2019;[Epub] CrossRef
Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
Min Cheol Kim, Jung Gil Park, Byung Ik Jang, Heon Ju Lee, Won Kee Lee
Medicine.2019; 98(6): e14139. CrossRef
Association of low skeletal muscle mass with advanced liver fibrosis in patients with non‐alcoholic fatty liver disease
Min Kyu Kang, Jung Gil Park, Heon Ju Lee, Min Cheol Kim
Journal of Gastroenterology and Hepatology.2019; 34(9): 1633. CrossRef
What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?
Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran
Journal of Digestive Diseases.2019; 20(6): 271. CrossRef
Favorable impact of non‐alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy population
S.‐M. Jeong, H. Kwon, S. Park, S. J. Yu, H.‐Y. Jeong, K.‐W. Nam, H.‐M. Kwon, J.‐H. Park
European Journal of Neurology.2019; 26(12): 1471. CrossRef
Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner
Xin Han, Zhen-Yu Cui, Jian Song, Hui-Qing Piao, Li-Hua Lian, Li-Shuang Hou, Ge Wang, Shuang Zheng, Xiu-Xiu Dong, Ji-Xing Nan, Yan-Ling Wu
Chemico-Biological Interactions.2019; 311: 108794. CrossRef
Association between non-alcoholic fatty liver disease and cancer incidence rate
Gi-Ae Kim, Han Chu Lee, Jaewon Choe, Min-Ju Kim, Min Jung Lee, Hye-Sook Chang, In Young Bae, Hong-Kyu Kim, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim
Journal of Hepatology.2018; 68(1): 140. CrossRef
Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease
Donghee Kim, Goh Eun Chung, Min-Sun Kwak, Yoon Jun Kim, Jung-Hwan Yoon
Digestive and Liver Disease.2018; 50(4): 389. CrossRef
Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction
Goh Eun Chung, Jeong-Hoon Lee, Heesun Lee, Min Kyung Kim, Jeong Yoon Yim, Su-Yeon Choi, Yoon Jun Kim, Jung-Hwan Yoon, Donghee Kim
Atherosclerosis.2018; 272: 137. CrossRef
Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population
Goh Eun Chung, Young Lee, Jeong Yoon Yim, Eun Kyung Choe, Min-Sun Kwak, Jong In Yang, Boram Park, Jong-Eun Lee, Jeong A Kim, Joo Sung Kim
Gut and Liver.2018; 12(3): 316. CrossRef
Management of Patients with Nonalcoholic Fatty Liver Disease with Lifestyle Modification
Byung-Wan Lee
The Journal of Korean Diabetes.2018; 19(2): 82. CrossRef
Glucose-Lowering Agents in the Management of Nonalcoholic Fatty Liver Disease
Hyekyung Yang, Cheol-Young Park
The Journal of Korean Diabetes.2018; 19(2): 88. CrossRef
Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease
Nissar U. Ashraf, Mohammad Altaf
Mutation Research/Reviews in Mutation Research.2018; 778: 1. CrossRef
Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States
Seung Joo Kang, Hwa Jung Kim, Donghee Kim, Aijaz Ahmed, Silvia C. Sookoian
PLOS ONE.2018; 13(8): e0202325. CrossRef
Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim
Digestive and Liver Disease.2017; 49(1): 57. CrossRef
Epigenetics in non-alcoholic fatty liver disease
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi
Molecular Aspects of Medicine.2017; 54: 78. CrossRef
Non‐alcoholic fatty liver diseases and risk of colorectal neoplasia
J. S. Ahn, D. H. Sinn, Y. W. Min, S. N. Hong, H. S. Kim, S.‐H. Jung, S. Gu, P.‐L. Rhee, S. W. Paik, H. J. Son, G.‐Y. Gwak
Alimentary Pharmacology & Therapeutics.2017; 45(2): 345. CrossRef
The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease
Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Joo Sung Kim
Liver International.2017; 37(6): 919. CrossRef
Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Seonhye Gu, Hyunkyoung Kim, Donghyeong Seong, Soo Jin Cho, Byoung-Kee Yi, Hyung-Doo Park, Seung Woon Paik, Young Bin Song, Mariana Lazo, Joao A C Lima, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
Gut.2017; 66(2): 323. CrossRef
Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma
Jee San Lee, Jeong Eun Yoo, Haeryoung Kim, Hyungjin Rhee, Myoung Ju Koh, Ji Hae Nahm, Jin Sub Choi, Kee-Ho Lee, Young Nyun Park, Olorunseun Ogunwobi
PLOS ONE.2017; 12(3): e0171922. CrossRef
A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease
Tae Jun Kim, Dong Hyun Sinn, Yang Won Min, Hee Jung Son, Jae J. Kim, Yoosoo Chang, Sun-Young Baek, Soo Hyun Ahn, Hyuk Lee, Seungho Ryu
Journal of Gastroenterology.2017; 52(11): 1201. CrossRef
Radiologic Evaluation of Non-Alcoholic Fatty Liver Disease in Diabetic Patient
Kwang Joon Kim, Seung Up Kim, Yong Eun Chung, Chang Oh Kim
The Journal of Korean Diabetes.2017; 18(2): 88. CrossRef
Non-alcoholic Fatty Liver Disease: A Clinical Update
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran
Journal of Clinical and Translational Hepatology.2017; XX(XX): XX. CrossRef
Diagnosis of Non-Alcoholic Fatty Liver Disease Based on Clinical and Laboratory Data
Yong-ho Lee
The Journal of Korean Diabetes.2017; 18(2): 102. CrossRef
Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study
Dong Hyun Sinn, Danbee Kang, Hye Ryoun Jang, Seonhye Gu, Soo Jin Cho, Seung Woon Paik, Seungho Ryu, Yoosoo Chang, Mariana Lazo, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
Journal of Hepatology.2017; 67(6): 1274. CrossRef
Effects of Kamichunggantang on Lipoapoptosis and inflammation of NAFLD in db/db mice
Soo young Kwon, Kang-Hoon Kim, Yumi Kim, In-Seung Lee, Ji Young Park, Hyeon-Soo jeong, Jang-Hoon Lee, Hyeung-Jin Jang
Oriental Pharmacy and Experimental Medicine.2017; 17(4): 365. CrossRef
Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence
Jie Ting Tang, Yi Min Mao
Journal of Digestive Diseases.2017; 18(11): 607. CrossRef
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease
Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang-Hyub Han
Digestive Diseases and Sciences.2017; 62(8): 2150. CrossRef
Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men
Hae Jin Yang, Sang Goon Shim, Bong Oh Ma, Ji Yeong Kwak
European Journal of Gastroenterology & Hepatology.2016; 28(3): 338. CrossRef
Discordance between conventional ultrasonography and ElastPQ for assessing hepatic fibrosis in chronic hepatitis B: frequency and independent factors
Mi Sung Kim, Byung Ik Kim, Heon-Ju Kwon, Hae Won Park, Hee-Jin Park, Ki Bae Bang, Hyun Pyo Hong, Myung Ho Rho
Journal of Medical Ultrasonics.2016; 43(2): 201. CrossRef
Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
Dong Hyun Sinn, Soo Jin Cho, Geum-Youn Gwak, Juhee Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyunkyoung Kim, Byoung-Kee Yi, Seung Woon Paik
Medicine.2016; 95(3): e2578. CrossRef
Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease
Meegun Hong, Yoon Hyeong Lee, Seungwoo Kim, Ki Tae Suk, Chang Seok Bang, Jai Hoon Yoon, Gwang Ho Baik, Dong Joon Kim, Myong Jo Kim
Journal of Ginseng Research.2016; 40(3): 203. CrossRef
Can Pharmacologic Therapy Induce Histologic Improvement in Non-alcoholic Steatohepatitis?
Nae-Yun Heo
The Korean Journal of Gastroenterology.2016; 67(5): 286. CrossRef
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Dong Hyun Sinn, Soo Jin Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyunkyoung Kim, Byoung-Kee Yi, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
Gastroenterology.2016; 151(3): 481. CrossRef
Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease
Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee
Gut and Liver.2016; 10(5): 818. CrossRef
Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim
Gastroenterology Research and Practice.2016; 2016: 1. CrossRef
Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
Jin-Zhou Zhu, Kelseanna Hollis-Hansen, Xing-Yong Wan, Su-Juan Fei, Xun-Lei Pang, Fan-Dong Meng, Chao-Hui Yu, You-Ming Li
World Journal of Gastroenterology.2016; 22(36): 8226. CrossRef
Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study
Gi Hyun Kim, Jung Wha Chung, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim
Clinical and Molecular Hepatology.2015; 21(4): 379. CrossRef
The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Seon Hee Lim, Jong In Yang, Young Sun Kim, Sun Young Yang, Min-Sun Kwak, Joo Sung Kim, Sang-Heon Cho
BioMed Research International.2015; 2015: 1. CrossRef
Hepatic fat, not visceral fat, is associated with gallbladder polyps: A study of 2643 healthy subjects
Seon Hee Lim, Donghee Kim, Jin Hwa Kang, Ji Hyun Song, Sun Young Yang, Jeong Yun Yim, Su Jin Chung, Joo Sung Kim, Sang‐Heon Cho
Journal of Gastroenterology and Hepatology.2015; 30(4): 767. CrossRef
Visceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver Disease
Goh Eun Chung, Donghee Kim, Min Sun Kwark, Won Kim, Jeong Yoon Yim, Yoon Jun Kim, Jung-Hwan Yoon
Medicine.2015; 94(9): e573. CrossRef
Nonalcoholic Fatty Liver Disease as a Risk Factor of Arterial Stiffness Measured by the Cardioankle Vascular Index
Goh Eun Chung, Su-Yeon Choi, Donghee Kim, Min-Sun Kwak, Hyo Eun Park, Min-Kyung Kim, Jeong Yoon Yim
Medicine.2015; 94(12): e654. CrossRef
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Su Jong Yu, Won Kim, Donghee Kim, Jung-Hwan Yoon, Kyoungbun Lee, Jung Ho Kim, Eun Ju Cho, Jeong-Hoon Lee, Hwi Young Kim, Yoon Jun Kim, Chung Yong Kim
Medicine.2015; 94(48): e2159. CrossRef
Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Yoon Jun Kim, Jung‐Hwan Yoon
Liver International.2015; 35(3): 944. CrossRef
Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population
Min-Sun Kwak
World Journal of Gastroenterology.2015; 21(20): 6287. CrossRef
Management of Non-alcoholic Fatty Liver Disease
Jaechan Leem, Eun Hee Koh
The Journal of Korean Diabetes.2014; 15(2): 93. CrossRef
Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
Joo Lee, Simonetta Friso, Sang-Woon Choi
Nutrients.2014; 6(8): 3303. CrossRef
The Diagnosis of Nonalcoholic Fatty Liver Disease
Moon Young Kim
Korean Journal of Medicine.2014; 86(4): 405. CrossRef
Clinical Correlation between Serum Cytokeratin-18 and Metabolic Parameters in Patients with Sonographic Non-alcoholic Fatty Liver Disease
Dong Shin Kwak, Dae Won Jun, Yong Kyun Cho, Seung Min Lee, Se Hwan Lee, In Sub Jung, Sung Won Lee, Jae Keun Park, JungHoon Lee, Eun Young Lee, Min Rho, Kang Lok Lee, Jun Kwon Ko, Soon-Eung Park
The Korean Journal of Gastroenterology.2014; 64(4): 206. CrossRef
Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease
Sang Hoon Park
Korean Journal of Medicine.2014; 86(4): 425. CrossRef
Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: The role of interdisciplinary therapy
Priscila L. Sanches, Aline de Piano, Raquel M.S. Campos, June Carnier, Marco T. de Mello, Natália Elias, Francisco A.H. Fonseca, Deborah C.L. Masquio, Patrícia L. da Silva, Flavia C. Corgosinho, Lian Tock, Lila M. Oyama, Sergio Tufik, Ana R. Dâmaso
Journal of Clinical Lipidology.2014; 8(3): 265. CrossRef
Comparison on the Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid in Patients with Abnormal Alanine Aminotransferase: Multicenter, Double-blinded, Randomized, Active-controlled Clinical Trial
Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
The Korean Journal of Gastroenterology.2014; 64(1): 31. CrossRef
Nonalcoholic Fatty Liver Disease: Lifestyle Modification
Ki Deok Yoo, Dae Won Jun
Korean Journal of Medicine.2014; 86(4): 416. CrossRef

20,125 View
167 Download
Crossref

Alcohol-related liver disease

KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease: The Korean Association for the Study of the Liver (KASL); Clin Mol Hepatol 2013;19(3):216-254.
Published online September 30, 2013; DOI: https://doi.org/10.3350/cmh.2013.19.3.216

Citations

Citations to this article as recorded by

Recompensation following first decompensation in patients with alcohol-related cirrhosis
Ji Yoon Kwak, Hankyu Jeon, Hyeon Uk Kwon, Jae Eun Kim, Ji Hee Han, Jung Woo Choi, Ra Ri Cha, Jae Min Lee, Sang Soo Lee
BMC Gastroenterology.2026;[Epub] CrossRef
Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
Jung Hee Kim, Sung-Eun Kim, Do Seon Song, Hee Yeon Kim, Eileen L. Yoon, Ji Won Park, Tae Hyung Kim, Young-Kul Jung, Ki Tae Suk, Hyung Joon Yim, Jung Hyun Kwon, Sung Won Lee, Seong Hee Kang, Moon Young Kim, Soung Won Jeong, Jae-Young Jang, Jeong Ju Yoo, Sa
Annals of Medicine.2025;[Epub] CrossRef
Factors influencing active participation in cardiac rehabilitation among patients with cardiovascular disease: A nationwide cohort study
Chul Kim, Jung Hwa Hong, Jang Woo Lee
PM&R.2025; 17(10): 1140. CrossRef
New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32
Tae Hyung Kim, Hyung Joon Yim, Young Kul Jung, Do Seon Song, Eileen L. Yoon, Hee Yeon Kim, Seong Hee Kang, Young Chang, Jeong-Ju Yoo, Baek Gyu Jun, Sung Won Lee, Jung Gil Park, Ji Won Park, Sung-Eun Kim, Tae Yeob Kim, Soung Won Jeong, Ki Tae Suk, Moon You
Hepatology International.2024; 18(2): 500. CrossRef
Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, Yeon Seok Seo, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
Gut and Liver.2024; 18(2): 305. CrossRef
Validation of MELD 3.0 in patients with alcoholic liver cirrhosis using prospective KACLiF cohort
Jihye Lim, Jung Hee Kim, Sung‐Eun Kim, Seul Ki Han, Tae Hyung Kim, Hyung Joon Yim, Young Kul Jung, Do Seon Song, Eileen L. Yoon, Hee Yeon Kim, Seong Hee Kang, Young Chang, Jeong‐Ju Yoo, Sung Won Lee, Jung Gil Park, Ji Won Park, Soung Won Jeong, Ki Tae Suk
Journal of Gastroenterology and Hepatology.2024; 39(9): 1932. CrossRef
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation
Jihye Lim, Sung-Eun Kim, Ae Jeong Jo, Jung Hee Kim, Seul Ki Han, Tae Hyung Kim, Hyung Joon Yim, Young Kul Jung, Do Seon Song, Eileen L. Yoon, Hee Yeon Kim, Seong Hee Kang, Young Chang, Jeong-Ju Yoo, Sung Won Lee, Jung Gil Park, Ji Won Park, Soung Won Jeon
Hepatology International.2024; 18(5): 1579. CrossRef
The Role of Cardiac Rehabilitation in Promoting Lifestyle Modification Among Cardiovascular Patients: A Nationwide Cohort Study
Chul Kim, Jung Hwa Hong, Jang Woo Lee
Healthcare.2024; 12(24): 2553. CrossRef
Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2023; 58(1): 99. CrossRef
Association of the etiology and peak level of markedly elevated aminotransferases with mortality: a multicenter study
Ji Yoon Kwak, Hyun-gyu Kim, Ji Hee Han, Hankyu Jeon, Ra Ri Cha, Sang Soo Lee
Hepatology Communications.2023;[Epub] CrossRef
Liver Imaging Reporting and Data System version 2018 for diagnosing hepatocellular carcinoma in alcoholic liver cirrhosis and virus-related cirrhosis
Ji Young Choi, Sang Hyun Choi, Jae Ho Byun, So Jung Lee, So Yeon Kim, Hyung Jin Won, Yong Moon Shin
European Journal of Radiology.2023; 168: 111139. CrossRef
The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
Jung Kim, Sung-Eun Kim, Do Song, Hee Kim, Eileen Yoon, Seong Kang, Young-Kul Jung, Jung Kwon, Sung Lee, Seul Han, Young Chang, Soung Jeong, Jeong Yoo, Young-Joo Jin, Gab Cheon, Byung Kim, Yeon Seo, Hyoungsu Kim, Ji Park, Tae Kim, Dong Sinn, Woo Chung, Hwi
Diagnostics.2023; 14(1): 14. CrossRef
Blood Concentrations of Lead, Cadmium, and Mercury Are Associated With Alcohol-Related Liver Disease
Jae Hoon Kim, Ji Eun Na, Junghwan Lee, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Hang Jea Jang, Ha Young Park, Seung Ha Park
Journal of Korean Medical Science.2023;[Epub] CrossRef
Association between Chronic Obsructive Pulmonary Disease and Dietary Inflammatory Index in Korean Men Over 40s-based on the 2016-2019 Korea National Health and Nutrition Examination Survey
Jin-A Kim, Sim-Yeol Lee
Korean Journal of Health Promotion.2023; 23(4): 182. CrossRef
Feasibility and Reproducibility of Multifrequency Magnetic Resonance Elastography in Healthy and Diseased Pancreases
Qike Song, Yu Shi, Feng Gao, Meng Yin, Rui Yang, Yuanyuan Liu, Shiling Zhong, Yang Hong
Journal of Magnetic Resonance Imaging.2022; 56(6): 1769. CrossRef
Association between the dietary inflammatory index and bone markers in postmenopausal women
Daeun Song, Jieun Kim, Minji Kang, Jungwon Park, Haelim Lee, Deog-Yoon Kim, So Young Park, Hyunjung Lim, Masaki Mogi
PLOS ONE.2022; 17(3): e0265630. CrossRef
Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
Ji Hun Lee, Seung Kak Shin, Seong Hee Kang, Tae Hyung Kim, Hyung Joon Yim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Oh Sang Kwon, Soon Ho Um, Kwan Soo Byun
Journal of Clinical Medicine.2022; 11(22): 6613. CrossRef
Correlation between shift work and non-alcoholic fatty liver disease among male workers in the steel manufacturing company of Korea: a cross-sectional study
Kiseok Kim, Yong-Jin Lee, Soon-Chan Kwon, Young-Sun Min, Hyun Kyo Lee, Gwangin Baek, Sang Hyeon Kim, Eun-Chul Jang
Annals of Occupational and Environmental Medicine.2022;[Epub] CrossRef
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Digestive Diseases and Sciences.2021; 66(8): 2816. CrossRef
Current Status of Deceased Donor Liver Transplantation for Alcoholic Liver Disease in Korea in MELD Era
Dong Jin Joo
The Korean Journal of Gastroenterology.2021; 77(1): 4. CrossRef
Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea
Tae Jin Kwon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Dong Hyun Sinn, Seung Woon Paik
Korean Journal of Transplantation.2021; 35(1): 24. CrossRef
Normative Pancreatic Stiffness Levels and Related Influences Established by Magnetic Resonance Elastography in Volunteers
Youli Xu, Xiaoli Cai, Yu Shi, Meng Yin, Gongyu Lan, Xianyi Zhang, Ruoyun Ji, Chang Liu
Journal of Magnetic Resonance Imaging.2020; 52(2): 448. CrossRef
Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea
Won Young Jang, Woo Jin Chung, Byoung Kuk Jang, Jae Seok Hwang, Heon Ju Lee, Moon Joo Hwang, Young Oh Kweon, Won Young Tak, Soo Young Park, Su Hyun Lee, Chang Hyeong Lee, Byung Seok Kim, Si Hye Kim, Jeong Ill Suh, Jun Gi Park
Journal of Korean Medical Science.2020;[Epub] CrossRef
Diagnosis and Severity Assessment of Alcohol-Related Liver Disease
Eunju Kim, Seung Ha Park
The Korean Journal of Gastroenterology.2020; 76(2): 60. CrossRef
Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial
Yuri Cho, Youn Su Park, Hwi Young Kim, Won Kim, Heon Ju Lee, Dong Joon Kim
Trials.2018;[Epub] CrossRef
Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer
Tae Hoon Ha, Byeong Gwan Kim, Donghyong Jeong, Sohee Oh, Won Kim, Yong Jin Jung, Dong Won Ahn, Ji Bong Jeong, Ji Won Kim, Kook Lae Lee, Seong-Joon Koh
Digestive Diseases and Sciences.2017; 62(1): 273. CrossRef
Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation
Suk Kyun Hong, Nam-Joon Yi, Hyo-Sin Kim, Sung Woo Ahn, Kyung Chul Yoon, Hyeyoung Kim, Kwang-Woong Lee, Kyung-Suk Suh
Journal of Korean Medical Science.2017; 32(6): 919. CrossRef
The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study
Yeonjung Ha, Seong Hwang, Kyu Rim
Nutrients.2017; 9(8): 806. CrossRef
Prediction of virologic response to tenofovir mono‐rescue therapy for multidrug resistant chronic hepatitis B
Sangheun Lee, Jun Yong Park, Do Young Kim, Beom Kyung Kim, Seung Up Kim, Kijun Song, Hye Jin Ku, Kwang‐Hyub Han, Sang Hoon Ahn
Journal of Medical Virology.2016; 88(6): 1027. CrossRef
Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease
Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee
Gut and Liver.2016; 10(5): 818. CrossRef
Clinical Characteristics and Prognostic Impact of Bacterial Infection in Hospitalized Patients with Alcoholic Liver Disease
Jin Kyoung Park, Chang Hun Lee, In Hee Kim, Seon Min Kim, Ji Won Jang, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae-Ghon Kim
Journal of Korean Medical Science.2015; 30(5): 598. CrossRef
Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut–liver axis of alcoholic liver disease
Chang Seok Bang, So Hyung Hong, Ki Tae Suk, Jin Bong Kim, Sang Hak Han, Hotaik Sung, Eun Ji Kim, Myoung Jo Kim, Moon Young Kim, Soon Koo Baik, Dong Joon Kim
Journal of Ginseng Research.2014; 38(3): 167. CrossRef
An effective integrated method for comprehensive identification of eighty-five compounds in Zhi-Zi-Da-Huang decoction by HPLC-DAD-ESI-MS (TOF) and HPLC-DAD-ESI-MS/MS (QqQ) without the help of reference standards
Lingling Zou, Xixi Li, Qingshui Shi, Fang Feng
Anal. Methods.2014; 6(12): 4312. CrossRef
Alcoholic liver disease: Treatment
Ki Tae Suk
World Journal of Gastroenterology.2014; 20(36): 12934. CrossRef

32,663 View
178 Download
Crossref

Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions: Jae Young Jang, Moon Young Kim, Soung Won Jeong, Tae Yeob Kim, Seung Up Kim, Sae Hwan Lee, Ki Tae Suk, Soo Young Park, Hyun Young Woo, Sang Gyune Kim, Jeong Heo, Soon Koo Baik, Hong Soo Kim, Won Young Tak; Korean J Hepatol 2013;19(1):1-16.
Published online March 25, 2013; DOI: https://doi.org/10.3350/cmh.2013.19.1.1

Abstract
PDF

The application of ultrasound contrast agents (UCAs) is considered essential when evaluating focal liver lesions (FLLs) using ultrasonography (US). Microbubble UCAs are easy to use and robust; their use poses no risk of nephrotoxicity and requires no ionizing radiation. The unique features of contrast enhanced US (CEUS) are not only noninvasiveness but also real-time assessing of liver perfusion throughout the vascular phases. The later feature has led to dramatic improvement in the diagnostic accuracy of US for detection and characterization of FLLs as well as the guidance to therapeutic procedures and evaluation of response to treatment. This article describes the current consensus and guidelines for the use of UCAs for the FLLs that are commonly encountered in US. After a brief description of the bases of different CEUS techniques, contrast-enhancement patterns of different types of benign and malignant FLLs and other clinical applications are described and discussed on the basis of our experience and the literature data.

Citations

Citations to this article as recorded by

Engineering Ultrasound Contrast Agents for Targeted Therapeutics: A Theranostic Approach to Drug Delivery, Gene Therapy, and Immunomodulation
Ashkan Seza, Kimia Mozahheb Yousefi, Sara Minaeian
Advanced NanoBiomed Research.2026;[Epub] CrossRef
Pedunculated Hepatic Hemangioma Arising from the Left Triangular Ligament: MRI as the Key Modality for Noninvasive Diagnosis—Case Report and Literature Review
Federica Masino, Manuela Montatore, Ruggiero Tupputi, Francesco Pio Tupputi, Gianmichele Muscatella, Sara Pizzileo, Alessio Sciacqua, Giuseppe Guglielmi
Targets.2026; 4(2): 13. CrossRef
Contrast-Enhanced Ultrasound With Ultrasound Localization Microscopy for Differentiating Benign From Malignant Focal Liver Lesions
Hang Li, Xiaoyan Niu, Hui Yang, Sai Wu, Xiaojuan Tian, Zhenghao Bao, Guanghui Li, Cheng Zhao
Ultrasound in Medicine & Biology.2026; 52(8): 1698. CrossRef
A Bibliometric and Visualization Analysis of Global Trends and Research Frontiers on Contrast‐Enhanced Ultrasound in Liver Diseases
Marcela Celiberti Soveral, Victor Arthur Ohannesian, Giovana Baracat Alvarez, Bruno Marçola Ishizuka, Matheus Almeida Cabral, Priscila Mina Falsarella, Pedro Henrique Machado Carani, Victor Arantes Jabour, Guilherme Ciconelli Del Guerra, Miguel José Franc
Journal of Clinical Ultrasound.2026;[Epub] CrossRef
Extending MET-TRIB3 axis research in hepatocellular carcinoma: Immune contexture and patient subgroups: Letter to the editor on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
Lei Wu, Ning Liu, Pengyuan Song, Meili Sun
Clinical and Molecular Hepatology.2026; 32(3): e279. CrossRef
Differentiating between hepatocellular carcinoma and its mimickers using contrast-enhanced ultrasound with perflubutane microbubbles
Yasunori Minami, Katsutoshi Sugimoto, Hidekatus Kuroda, Naohisa Kamiyama, Chikara Ogawa, Masatoshi Kudo
Expert Review of Medical Devices.2025; 22(8): 817. CrossRef
Diagnosis and Management of Benign Liver Tumors
Yeonjung Ha
The Korean Journal of Gastroenterology.2025; 85(3): 314. CrossRef
Operative Procedures for Ultrasound Assessment of Extracranial Artery Disease: A Narrative Review by the Italian Society for Vascular Investigation (SIDV)
Luca Costanzo, Giacomo Failla, Leonardo Aluigi, Tiziana Anna Baroncelli, Chiara Bua, Sergio De Marchi, Elia Diaco, Federico Di Paola, Francesco Lorenzo Di Pino, Ferdinando Mannello, Ombretta Martinelli, Chiara Mascoli, Anastasia Maria Pedi, Ivan Privitera
Journal of Clinical Medicine.2025; 14(19): 7050. CrossRef
Addition of contrast in ultrasound screening for hepatocellular carcinoma
Kathryn McGillen, Nabeal Aljabban, Robert Wu, Benjamin Shin, Ian Schreibman, Franklin Luke, James Birkholz
Research in Diagnostic and Interventional Imaging.2024; 9: 100039. CrossRef
Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation
Wenying Qiao, Zibo Fan, Qi Wang, Ronghua Jin, Caixia Hu
Journal of Hepatocellular Carcinoma.2024; Volume 11: 65. CrossRef
The added value of color parameter imaging for the evaluation of focal liver lesions with “homogenous hyperenhancement and no wash out” on contrast enhanced ultrasound
Zi-Nan Liang, Song Wang, Wei Yang, Hong Wang, Kun Zhao, Xiu-Mei Bai, Zhong-Yi Zhang, Wei Wu, Kun Yan
Frontiers in Oncology.2024;[Epub] CrossRef
Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies
Arkadiusz Kacała, Mateusz Dorochowicz, Iwona Matus, Michał Puła, Adrian Korbecki, Michał Sobański, Jagoda Jacków-Nowicka, Dariusz Patrzałek, Dariusz Janczak, Maciej Guziński
Medicina.2024; 60(3): 449. CrossRef
Principle of contrast-enhanced ultrasonography
Yoshitaka Mine, Etsuo Takada, Katsutoshi Sugimoto, Fuminori Moriyasu
Journal of Medical Ultrasonics.2024; 51(4): 567. CrossRef
Ultrasomics in liver cancer: Developing a radiomics model for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma using contrast-enhanced ultrasound
Li-Ya Su, Ming Xu, Yan-Lin Chen, Man-Xia Lin, Xiao-Yan Xie
World Journal of Radiology.2024; 16(7): 247. CrossRef
The role of CEUS as problem-solving technique when abdominal CT or MRI are inconclusive
Antonino Andrea Blandino, Davide Giangrande, Roberto Cannella, Tommaso Vincenzo Bartolotta
Journal of Medical Imaging and Interventional Radiology.2024;[Epub] CrossRef
Perfusion Patterns of Peripheral Pulmonary Metastasis Using Contrast-Enhanced Ultrasound (CEUS) and Their Correlation with Immunohistochemically Detected Vascularization Pattern
Johannes Kroenig, Christian Görg, Helmut Prosch, Lara Von Schumann, Christina C. Westhoff, Amjad Alhyari, Felix R. M. Koenig, Hajo Findeisen, Ehsan Safai Zadeh
Cancers.2024; 16(19): 3365. CrossRef
Contrast-Enhanced Ultrasound with Optimized Aperture Patterns and Bubble Segmentation Based on Echo Phase
Ting-Yu Lai, Michalakis A. Averkiou
Ultrasound in Medicine & Biology.2023; 49(1): 186. CrossRef
Diagnostic performance of contrast‐enhanced ultrasound in diagnosing hepatic artery occlusion after liver transplantation: A systematic review and meta‐analysis
Busara Songtanin, Kevin Brittan, Sebastian Sanchez, Michelle Le, Cynthia Schmidt, Thammasin Ingviya, Wuttiporn Manatsathit
Clinical Transplantation.2023;[Epub] CrossRef
Assessment of focal liver lesions in non-cirrhotic liver – expert opinion statement by the Swiss Association for the Study of the Liver and the Swiss Society of Gastroenterology
Mikael Sawatzki, Daniela B. Husarik, David Semela
Swiss Medical Weekly.2023; 153(9): 40099. CrossRef
Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring System
Yajuan Sun, Can Yu, Xinxin Wang, Rui Yang, ZhiPeng Ding, Yang Zhou
Journal of Gastrointestinal Surgery.2023; 27(12): 2787. CrossRef
High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions
Xiang Fei, Peng Han, Bo Jiang, Lianhua Zhu, Wenshuo Tian, Maodong Sang, Xirui Zhang, Yaqiong Zhu, Yukun Luo
Journal of Clinical and Translational Hepatology.2022; 10(1): 26. CrossRef
Computer-Aided Color Parameter Imaging of Contrast-Enhanced Ultrasound Evaluates Hepatocellular Carcinoma Hemodynamic Features and Predicts Radiofrequency Ablation Outcome
Hong Wang, Wen Guo, Wei Yang, Gang Liu, Kun Cao, Yu Sun, Zi-Nan Liang, Xiu-Mei Bai, Song Wang, Wei Wu, Kun Yan, S. Nahum Goldberg
Ultrasound in Medicine & Biology.2022; 48(8): 1555. CrossRef
Diagnostic accuracy of hepatic vein arrival time performed with contrast-enhanced ultrasonography for HCV liver cirrhosis
Nahed A. Makhlouf, Ehab F. Moustafa, Sahar M. Hassany
Arab Journal of Gastroenterology.2022; 23(3): 195. CrossRef
Algorithm‐based approach to focal liver lesions in contrast‐enhanced ultrasound
Kheng Song Leow, Christine Ying Kwok, Hsien Min Low, Rahul Lohan, Tze Chwan Lim, Su Chong Albert Low, Cher Heng Tan
Australasian Journal of Ultrasound in Medicine.2022; 25(3): 142. CrossRef
Application of Contrast-Enhanced Ultrasonography with Sonazoid for Focal Liver Lesions
颖高
Advances in Clinical Medicine.2022; 12(10): 9470. CrossRef
Streptococcus pyogenes infection of a mediastinal cyst after endoscopic ultrasound-guided fine-needle aspiration
Shutong Zhou, Hongtao Wei, Huihong Zhai
Heliyon.2022; 8(12): e11900. CrossRef
Investigation of the Phase of Nonlinear Echoes From Microbubbles During Amplitude Modulation
Sara B. Keller, Ting-Yu Lai, Lance De Koninck, Michalakis A. Averkiou
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.2022; 69(3): 1032. CrossRef
Informativeness of methods of radiation diagnostics in the detection of liver hemangiomas
V.N. Najafova
Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini.2021; 2021(2b): 108. CrossRef
Application of new ultrasound techniques for focal liver lesions
Feiqian WANG, Kazushi NUMATA, Hiromi NIHONMATSU, Masahiro OKADA, Shin MAEDA
Choonpa Igaku.2021; 48(6): 317. CrossRef
Cavitation Therapy Monitoring of Commercial Microbubbles With a Clinical Scanner
Sara B. Keller, Paul S. Sheeran, Michalakis A. Averkiou
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.2021; 68(4): 1144. CrossRef
A novel method to determine hepatic segments using Sonazoid, an ultrasound contrast agent
Taehyuk Ham, Joo Hee Jeon, Younghoon Roh, Sungwook Lee, Sangyoon Lee, Heejin Kwon, Jin Han Cho
Ultrasonography.2020; 39(1): 94. CrossRef
Application of new ultrasound techniques for focal liver lesions
Feiqian Wang, Kazushi Numata, Hiromi Nihonmatsu, Masahiro Okada, Shin Maeda
Journal of Medical Ultrasonics.2020; 47(2): 215. CrossRef
Differentiation of atypical hepatic hemangioma from liver metastases: Diagnostic performance of a novel type of color contrast enhanced ultrasound
Xiao-Feng Wu, Xiu-Mei Bai, Wei Yang, Yu Sun, Hong Wang, Wei Wu, Min-Hua Chen, Kun Yan
World Journal of Gastroenterology.2020; 26(9): 960. CrossRef
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid
Jae Young Lee, Yasunori Minami, Byung Ihn Choi, Won Jae Lee, Yi-Hong Chou, Woo Kyoung Jeong, Mi-Suk Park, Nobuki Kudo, Min Woo Lee, Ken Kamata, Hiroko Iijima, So Yeon Kim, Kazushi Numata, Katsutoshi Sugimoto, Hitoshi Maruyama, Yasukiyo Sumino, Chikara Oga
Ultrasonography.2020; 39(3): 191. CrossRef
A pilot trial to evaluate the clinical usefulness of contrast-enhanced ultrasound in predicting renal outcomes in patients with acute kidney injury
Hye Eun Yoon, Da Won Kim, Dongryul Kim, Yaeni Kim, Seok Joon Shin, Yu Ri Shin, Tatsuo Shimosawa
PLOS ONE.2020; 15(6): e0235130. CrossRef
Contrast-Enhanced Ultrasonography for Screening and Diagnosis of Hepatocellular Carcinoma: A Case Series and Review of the Literature
Kathryn L. McGillen, Syeda Zaidi, Amer Ahmed, Shantell Harter, Nelson S. Yee
Medicines.2020; 7(9): 51. CrossRef
Accuracy of contrast-enhanced ultrasound liver imaging reporting and data system: a systematic review and meta-analysis
Jung Hee Son, Sang Hyun Choi, So Yeon Kim, So Jung Lee, Seong Ho Park, Kyung Won Kim, Hyung Jin Won, Yong Moon Shin, Pyo-Nyun Kim
Hepatology International.2020; 14(6): 1104. CrossRef
Intraoperative Imaging Techniques to Visualize Hepatic (Micro)Perfusion: An Overview
Zühre Uz, Lucinda Shen, Dan M.J. Milstein, Krijn P. van Lienden, Rutger-Jan Swijnenburg, Can Ince, Thomas M. van Gulik
European Surgical Research.2020; 61(1): 2. CrossRef
Dynamic Contrast-Enhanced Ultrasound of Gastric Cancer: Correlation with Perfusion CT and Histopathology
Ijin Joo, Se Hyung Kim, Dong Ho Lee, Joon Koo Han
Korean Journal of Radiology.2019; 20(5): 781. CrossRef
Occurrence, diagnosis and management of hepatic fibrosis and cirrhosis: An updated literature review
J Qiao
Archives of Hepatitis Research.2019; 5(1): 022. CrossRef
Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings
Casey N. Ta, Yuko Kono, Mohammad Eghtedari, Young Taik Oh, Michelle L. Robbin, Richard G. Barr, Andrew C. Kummel, Robert F. Mattrey
Radiology.2018; 286(3): 1062. CrossRef
Contrast-Enhanced Ultrasound of the Liver: Optimizing Technique and Clinical Applications
Emily H. T. Pang, Andy Chan, Stephen G. Ho, Alison C. Harris
American Journal of Roentgenology.2018; 210(2): 320. CrossRef
Contrast‐Enhanced Ultrasonography Versus Contrast‐Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta‐analysis
Junlin Zhong, Zhongzhen Su, Yanling Zhang, Hui Zhang, Peijie Lin, Xixiang Tang, Rongqin Zheng
Journal of Ultrasound in Medicine.2018; 37(8): 1881. CrossRef
Contrast-Enhanced Ultrasonography in Sclerotherapy for Ovarian Endometrial Cyst
Xiao-Hui Shao, Xiao-Qiu Dong, De-Jiao Kong, Li-Wei Zhang, Lu-Lu Wang, Si-Ming Wang
Ultrasound in Medicine & Biology.2018; 44(8): 1828. CrossRef
Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography
S.B. Paul, E. Dhamija, S.R. Gamanagatti, V. Sreenivas, D.P. Yadav, S. Jain, Shalimar, S.K. Acharya
Diagnostic and Interventional Imaging.2017; 98(3): 253. CrossRef
Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance
Tae Wook Kang, Min Woo Lee, Kyoung Doo Song, Mimi Kim, Seung Soo Kim, Seong Hyun Kim, Sang Yun Ha
Korean Journal of Radiology.2017; 18(1): 152. CrossRef
Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis
Gaeun Kim, Kwang Yong Shim, Soon Koo Baik
Gut and Liver.2017; 11(1): 93. CrossRef
Diagnosis and management of liver masses in pregnancy
James Milburn, Mairead Black, Irfan Ahmed, Lindsay McLeman, Jack Straiton, Peter Danielian
The Obstetrician & Gynaecologist.2016; 18(1): 43. CrossRef
Ecografía hepática: lesiones focales y enfermedades difusas
A. Segura Grau, I. Valero López, N. Díaz Rodríguez, J.M. Segura Cabral
SEMERGEN - Medicina de Familia.2016; 42(5): 307. CrossRef
Contrast agents in diagnostic imaging: Present and future
Luca Caschera, Angelo Lazzara, Lorenzo Piergallini, Domenico Ricci, Bruno Tuscano, Angelo Vanzulli
Pharmacological Research.2016; 110: 65. CrossRef
Vascular phases in imaging and their role in focal liver lesions assessment
Liliana Chiorean, Cosmin Caraiani, Maija Radziņa, Maciej Jedrzejczyk, Dagmar Schreiber-Dietrich, Christoph F. Dietrich
Clinical Hemorheology and Microcirculation.2016; 62(4): 299. CrossRef
Contrast-Enhanced Ultrasound of Focal Liver Lesions
Nitin Chaubal, Mukund Joshi, Anupam Bam, Rajas Chaubal
Seminars in Roentgenology.2016; 51(4): 334. CrossRef
Optimal injection rate of ultrasound contrast agent for evaluation of focal liver lesions using an automatic power injector: a pilot study
Katsutoshi Sugimoto, Fuminori Moriyasu, Hirohito Takeuchi, Mayumi Kojima, Saori Ogawa, Takatomo Sano, Yoshihiro Furuichi, Yoshiyuki Kobayashi, Ikuo Nakamura
SpringerPlus.2016;[Epub] CrossRef
Contrast Enhanced Ultrasound for the Differentiation of Hepatic Mass
Jae Young Jang
Clinical Ultrasound.2016; 1(2): 71. CrossRef
The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study
Youn Zoo Cho, So Yeon Park, Eun Hee Choi, Soon Koo Baik, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Moon Young Kim
Clinical and Molecular Hepatology.2015; 21(2): 165. CrossRef
Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
Kil Hyo Park, Soon Ha Kwon, Yong Sub Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim
Clinical and Molecular Hepatology.2015; 21(2): 158. CrossRef
Focal masses in a non-cirrhotic liver: The additional benefit of CEUS over baseline imaging
L. Chiorean, V. Cantisani, C. Jenssen, P.S. Sidhu, U. Baum, C.F. Dietrich
European Journal of Radiology.2015; 84(9): 1636. CrossRef
Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies
K. Pschierer, D. Grothues, J. Rennert, N. Platz Batista da Silva, A.G. Schreyer, M. Melter, C. Stroszczysnski, E.M. Jung
Clinical Hemorheology and Microcirculation.2015; 61(2): 333. CrossRef
Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline
Le-Hang Guo, Hui-Xiong Xu
BioMed Research International.2015; 2015: 1. CrossRef
CONSUMER PREFERENCES FOR SCANNING MODALITY TO DIAGNOSE FOCAL LIVER LESIONS
Jennifer Whitty, Alexandra Filby, Adam B Smith, Louise M Carr
International Journal of Technology Assessment in Health Care.2015; 31(1-2): 27. CrossRef
Inertial cavitation threshold of nested microbubbles
N. Wallace, S. Dicker, Peter Lewin, S.P. Wrenn
Ultrasonics.2015; 58: 67. CrossRef
Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US
Ji Hye Min, Hyo Keun Lim, Sanghyeok Lim, Tae Wook Kang, Kyoung Doo Song, Seo-youn Choi, Hyunchul Rhim, Min Woo Lee
Clinical and Molecular Hepatology.2014; 20(1): 61. CrossRef
Influence of nesting shell size on brightness longevity and resistance to ultrasound-induced dissolution during enhanced B-mode contrast imaging
N. Wallace, S. Dicker, P. Lewin, S.P. Wrenn
Ultrasonics.2014; 54(8): 2099. CrossRef
Continuous Dynamic Registration of Microvascularization of Liver Tumors with Contrast-Enhanced Ultrasound
Lukas Philipp Beyer, Benedikt Pregler, Isabel Wiesinger, Christian Stroszczynski, Philipp Wiggermann, Ernst-Michael Jung
Radiology Research and Practice.2014; 2014: 1. CrossRef
Efficacy of contrast grey scale ultrasound in characterization of hepatic focal lesions
C.G. Muralidharan
Medical Journal Armed Forces India.2014; 70(4): 397. CrossRef
Clinically Useful Diagnostic Tool of Contrast Enhanced Ultrasonography for Focal Liver Masses: Comparison to Computed Tomography and Magnetic Resonance Imaging
Sung Woo Ryu, Gene Hyun Bok, Jae Young Jang, Soung Won Jeong, Nam Seok Ham, Ji Hye Kim, Eui Ju Park, Jin Nyoung Kim, Woong Cheul Lee, Kwang Yeun Shim, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim
Gut and Liver.2014; 8(3): 292. CrossRef
Alcohol and hepatocellular carcinoma: A review and a point of view
Gianni Testino, Silvia Leone, Paolo Borro
World Journal of Gastroenterology.2014; 20(43): 15943. CrossRef
Contrast‐enhanced ultrasound for focal liver lesions. Is it necessary an hepatologist expert in ultrasound techniques in the third millennium?
Paolo Borro, Gianni Testino
Liver International.2013; 33(10): 1609. CrossRef

25,252 View
358 Download
Crossref

Viral hepatitis

KASL Clinical Practice Guidelines: Management of chronic hepatitis B: The Korean Association for the Study of the Liver (KASL); Korean J Hepatol 2012;18(2):109-162.
Published online June 26, 2012; DOI: https://doi.org/10.3350/cmh.2012.18.2.109

Citations

Citations to this article as recorded by

Factors associated with hepatitis B mother-to-child transmission in a national prevention program
Moran Ki, Byung-Woo Kim, Dahye Baik, Jong-Hyun Kim
Clinical and Molecular Hepatology.2025; 31(4): 1298. CrossRef
Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
The Journal of Infectious Diseases.2024; 229(1): 108. CrossRef
Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma
Won Tae Cho, Tae Yoo, Jung Min Lee, Jung Woo Lee, Hanbaro Kim, Ji Soo Lee, Sang Hyup Han
Journal of Surgical Research.2024; 295: 231. CrossRef
Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma
Lanqian Su, Huanyu Luo, Yalan Yan, Zhongqiu Yang, Jiaan Lu, Danqi Xu, Linjuan Du, Jie Liu, Guanhu Yang, Hao Chi
Frontiers in Pharmacology.2024;[Epub] CrossRef
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
PLOS ONE.2024; 19(8): e0307712. CrossRef
Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
Ye Ji Jun, Minjong Lee, Ho Soo Chun, Tae Hun Kim
The Korean Journal of Gastroenterology.2024; 84(5): 206. CrossRef
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis
Mi Na Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Se Young Jang, Won Young Tak, Young-Oh Kweon, Soo Young Park, Seung Up Kim
Clinical Gastroenterology and Hepatology.2023; 21(9): 2278. CrossRef
A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid‐Enhanced MRI Features
Shin Hye Hwang, Seung Baek Hong, Kyunghwa Han, Nieun Seo, Jin‐Young Choi, Jei Hee Lee, Sumi Park, Young‐Suk Lim, Do Young Kim, So Yeon Kim, Mi‐Suk Park
Journal of Magnetic Resonance Imaging.2022; 55(6): 1877. CrossRef
Changes in the Deceased-Donor Trend in Korea: Establishment of Regional Trauma Centers and KODA
Jeong-Moo Lee
Journal of Clinical Medicine.2022; 11(5): 1239. CrossRef
Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration
Jung Hee Kim, Sung-Eun Kim, Do-Seon Song, Hee-Yeon Kim, Eileen Yoon, Tae-Hyung Kim, Young-Kul Jung, Ki Tae Suk, Baek-Gyu Jun, Hyung-Joon Yim, Jung-Hyun Kwon, Sung-Won Lee, Seong-Hee Kang, Moon-Young Kim, Soung-Won Jeong, Jae-Young Jang, Jeong-Ju Yoo, Sang
Journal of Clinical Medicine.2022; 11(9): 2463. CrossRef
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir
Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung Up Kim
Journal of Viral Hepatitis.2021; 28(1): 95. CrossRef
Addition of liver stiffness enhances the predictive accuracy of the PAGE‐B model for hepatitis B‐related hepatocellular carcinoma
Hye Yeon Chon, Han Ah Lee, Sang Jun Suh, Jung Il Lee, Byung Seok Kim, In Hee Kim, Chang Hyeong Lee, Byoung Kuk Jang, Hyun Woong Lee, Jae Seok Hwang, Chang Hun Lee, Jin‐Woo Lee, Jung Hwan Yu, Yeon Seok Seo, Hyung Joon Yim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2021; 53(8): 919. CrossRef
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
Hepatology International.2021; 15(6): 1328. CrossRef
Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B
Heechul Nam, Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee, Sun Hong Yoo, Hee Yeon Kim, Do Seon Song, Pil Soo Sung, U Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Nam Ik Han, Jeong Won Jang
American Journal of Gastroenterology.2021; 116(8): 1657. CrossRef
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Korean Medical Science.2021;[Epub] CrossRef
Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores
Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Hoon Sung Choi, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim
European Journal of Gastroenterology & Hepatology.2021; 33(12): 1564. CrossRef
Twelve‐month post‐treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B
Sang Bong Ahn, Jun Choi, Dae Won Jun, Hyunwoo Oh, Eileen L. Yoon, Hyoung Su Kim, Soung Won Jeong, Sung Eun Kim, Jae‐Jun Shim, Yong Kyun Cho, Hyo Young Lee, Sung Won Han, Mindie H. Nguyen
Liver International.2021; 41(7): 1652. CrossRef
Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review
Peter Wigfield, Urbano Sbarigia, Mahmoud Hashim, Talitha Vincken, Bart Heeg
PharmacoEconomics - Open.2020; 4(3): 403. CrossRef
Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Hwa Kim, Ha Yan Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo
Clinical Gastroenterology and Hepatology.2020; 18(3): 693. CrossRef
Predictive factors for risk of hepatocellular carcinoma in immune inactive chronic hepatitis B
Seung In Seo, Hyoung Su Kim, Bo Kyung Yang, Jin Gu Kang, Woon Geon Shin, Jin Heon Lee, Hak Yang Kim, Myoung Kuk Jang
Clinics and Research in Hepatology and Gastroenterology.2020; 44(5): 711. CrossRef
Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinoma
Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim
Journal of Gastroenterology and Hepatology.2020; 35(11): 1960. CrossRef
Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study
Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Hoon Sung Choi, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim
Journal of Gastroenterology and Hepatology.2020; 35(10): 1795. CrossRef
A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
Seung Up Kim, Yong Eun Chon, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, In Kyung Min, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Beom Kyung Kim, Soo Young Park
Journal of Viral Hepatitis.2020; 27(12): 1352. CrossRef
Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Ju Lee, Hye Jung Shin, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Young Park
Cancer Epidemiology, Biomarkers & Prevention.2020; 29(4): 832. CrossRef
Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis?
Hyo‐Sin Kim, Nam‐Joon Yi, Jong Man Kim, Suk Kyun Hong, Choon Hyuck David Kwon, Jae‐Won Joh, Kwang‐Woong Lee, Kyung‐Suk Suh
ANZ Journal of Surgery.2019; 89(3): 216. CrossRef
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
Zhihong Liu, Jian Sun, Jinlin Hou
JAMA Oncology.2019; 5(6): 915. CrossRef
Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
Namyoung Paik, Dong H. Sinn, Ji H. Lee, In S. Oh, Jung H. Kim, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
Liver International.2018; 38(1): 68. CrossRef
Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg‐positive high viral load chronic hepatitis B
J. Y. Nam, Y. Chang, H. Cho, S. H. Kang, Y. Y. Cho, E. J. Cho, J.‐H. Lee, S. J. Yu, J.‐H. Yoon, Y. J. Kim
Journal of Viral Hepatitis.2018; 25(5): 552. CrossRef
Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study
Yeonghee Eun, In Young Kim, Hyemin Jeong, Hyungjin Kim, Jaejoon Lee, Moon Seok Choi, Eunmi Koh, Hoon-Suk Cha
Journal of Korean Medical Science.2018;[Epub] CrossRef
Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study
Hwi Young Kim, Jeong‐Ju Yoo, Sohee Oh, Su Jong Yu, Yoon Jun Kim, Jung‐Hwan Yoon, Won Kim, Yong Jin Jung, Bo Hyun Kim, Chang‐Min Kim, Joong‐Won Park, Jeong‐Hoon Lee
Journal of Medical Virology.2018; 90(10): 1593. CrossRef
Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area
Chang Hwi Yoon, Young-Joo Jin, Jin Woo Lee
European Journal of Gastroenterology & Hepatology.2018; 30(9): 1090. CrossRef
Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
Ji Hyun Kim, Young Don Kim, Minjong Lee, Baek Gyu Jun, Tae Suk Kim, Ki Tae Suk, Seong Hee Kang, Moon Young Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi
Journal of Hepatology.2018; 69(5): 1066. CrossRef
Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study
Baek Gyu Jun, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Seong Hee Kang, Moon Young Kim, Soon Koo Baik, Minjong Lee, Tae-Suk Kim, Dae Hee Choi, Sang-Hyeon Choi, Ki Tae Suk, Dong Joon Kim, Ga
PLOS ONE.2018; 13(7): e0201316. CrossRef
Evaluation of performance characteristics of hepatitis B e antigen serologic assays
Tonya Mixson-Hayden, Michael A. Purdy, Lilia Ganova-Raeva, Daniel McGovern, Joseph C. Forbi, Saleem Kamili
Journal of Clinical Virology.2018; 109: 22. CrossRef
Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels
Gang Huang, Peng-peng Li, Wan Yee Lau, Ze-ya Pan, Ling-hao Zhao, Zhen-guang Wang, Meng-chao Wang, Wei-ping Zhou
Annals of Surgery.2018; 268(6): 943. CrossRef
Expression of MMP-9 in different degrees of chronic hepatitis B and its correlation with inflammation
Yujuan Li, Hongtao Liu, Lixiu Xu
Experimental and Therapeutic Medicine.2018;[Epub] CrossRef
HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea
Chung Hwan Jun, Ban Suk Kim, Chan Young Oak, Du Hyeon Lee, Eunae Cho, Sung Bum Cho, Sung Kyu Choi, Chang Hwan Park, Young Eun Joo, Je-Jung Lee, Hyeoung-Joon Kim
Hepatology International.2017; 11(1): 87. CrossRef
Low‐level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
Jung Hee Kim, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Hepatology.2017; 66(2): 335. CrossRef
Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein predicts the risk of HBV‐related liver cancer development
Seung Up Kim, Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Hyon‐Suk Kim
Liver International.2017; 37(6): 879. CrossRef
Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
Cha Young Kim, Bo Ra Kim, Sang Soo Lee, Dae-Hong Jeon, Chang Min Lee, Wan Soo Kim, Hyun Chin Cho, Jin Joo Kim, Jae Min Lee, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok-Jae Lee
Medicine.2017; 96(2): e5844. CrossRef
Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
Joon Yeul Nam, Jeong-Hoon Lee, Hwi Young Kim, Jieun E. Kim, Dong Hyeon Lee, Young Chang, Hyeki Cho, Jeong-Ju Yoo, Minjong Lee, Young Youn Cho, Yuri Cho, EunJu Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Chi-Ling Chen
PLOS ONE.2017; 12(1): e0166188. CrossRef
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong G
Gut and Liver.2017; 11(1): 129. CrossRef
Management of Antiviral Resistance in Chronic Hepatitis B
Young-Suk Lim
Gut and Liver.2017; 11(2): 189. CrossRef
Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
Jeong-Hoon Lee, Won Young Tak, Yoon Lee, Min-Kyu Heo, Jae-Sung Song, Hak-Yeop Kim, Soo Young Park, Si Hyun Bae, Joon Hyeok Lee, Jeong Heo, Ki-Hwan Kim, Yong-Soo Bae, Yoon Jun Kim
OncoImmunology.2017; : e1328335. CrossRef
Gamma‐glutamyl transpeptidase‐to‐platelet ratio is an independent predictor of hepatitis B virus‐related liver cancer
Yong Eun Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Sojung Han, Mi Young Jeon, Ja Yoon Heo, Kijun Song, Seung Up Kim
Journal of Gastroenterology and Hepatology.2017; 32(6): 1221. CrossRef
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
Dong Hyun Sinn, Jeong-Hoon Lee, Kyunga Kim, Joong Hyun Ahn, Ji Hyeon Lee, Jung Hee Kim, Dong Hyeon Lee, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Gut and Liver.2017; 11(4): 528. CrossRef
3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy
Chang Hun Lee, In Hee Kim, Jin Chang Moon, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim, Jae Do Yang, Hee Chul Yu
World Journal of Gastroenterology.2017; 23(2): 297. CrossRef
Expression of PBMC apoptosis-related factors in patients with chronic hepatitis B and their relationships with clinical prognosis
Li Guo, Yanli Liang
Experimental and Therapeutic Medicine.2017;[Epub] CrossRef
Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma
Tae‐Yong Ha, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Gi‐Young Ko, Dong II Gwon, Chul‐Soo Ahn, Deok‐Bog Moon, Gi‐Won Song, Dong‐Hwan Jung, Han Chu Lee, Young‐Suk Lim, Kang Mo Kim, Ju Hyun Shim, Jeong‐Heon Choi, Sung‐Gyu Lee
World Journal of Surgery.2016; 40(5): 1200. CrossRef
Hepatocellular Carcinoma Screening and Surveillance
Changqing Zhao, Mindie H. Nguyen
Journal of Clinical Gastroenterology.2016; 50(2): 120. CrossRef
Outcome of adefovir add‐on lamivudine rescue therapy of up to 5 years in patients with lamivudine‐resistant chronic hepatitis B
Sung Bae Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han
Journal of Gastroenterology and Hepatology.2016; 31(1): 241. CrossRef
Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy
Yeon Seok Seo, Mi Na Kim, Seung Up Kim, Sang Gyune Kim, Soon Ho Um, Kwang-Hyub Han, Young Seok Kim
Medicine.2016; 95(12): e2985. CrossRef
The Author's Response: Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase
Junggyu Lee, Dong Hyun Sinn, Seung Woon Paik
Journal of Korean Medical Science.2016; 31(5): 825. CrossRef
A 96‐week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy
Sang Hoon Ahn, Jeong Heo, Jun Yong Park, Hyun Young Woo, Heon Ju Lee, Won Young Tak, Soon Ho Um, Ki Tae Yoon, Soo Young Park, Chang Wook Kim, Hyung Hoi Kim, Kwang‐Hyub Han, Mong Cho
Journal of Gastroenterology and Hepatology.2016; 31(4): 865. CrossRef
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial
Young-Suk Lim, Kwan Soo Byun, Byung Chul Yoo, So Young Kwon, Yoon Jun Kim, Jihyun An, Han Chu Lee, Yung Sang Lee
Gut.2016; 65(5): 852. CrossRef
Comprehensive outcomes of on‐ and off‐antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis
Jihyun An, Ju Hyun Shim, Seon‐Ok Kim, Jonggi Choi, Sang‐We Kim, Danbi Lee, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Young‐Hwa Chung, Yung Sang Lee, Dong Jin Suh
Journal of Medical Virology.2016; 88(9): 1576. CrossRef
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
Young-Suk Lim, Byung Chul Yoo, Kwan Soo Byun, So Young Kwon, Yoon Jun Kim, Jihyun An, Han Chu Lee, Yung Sang Lee
Gut.2016; 65(6): 1042. CrossRef
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
Keol Lee, Dong Hyun Sinn, Geum-Youn Gwak, Hyun Chin Cho, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Gut and Liver.2016; 10(5): 796. CrossRef
Consumer's Needs for Development of Smartphone Application for Self Care Performance of Patients with Chronic Hepatitis B
Jae-Hee Jeon, Kyunghee Kim
The Journal of the Korea Contents Association.2016; 16(4): 729. CrossRef
The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kwang Min Kim, Dong Hyun Sinn, Sin‐Ho Jung, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Liver International.2016; 36(10): 1490. CrossRef
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
Clinical Gastroenterology and Hepatology.2016; 14(11): 1647. CrossRef
Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease
Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee
Gut and Liver.2016; 10(5): 818. CrossRef
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Hyeseung Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Gut and Liver.2016; 10(6): 939. CrossRef
Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition
Tae Yeob Kim, Do Seon Song, Hee Yeon Kim, Dong Hyun Sinn, Eileen L. Yoon, Chang Wook Kim, Young Kul Jung, Ki Tae Suk, Sang Soo Lee, Chang Hyeong Lee, Tae Hun Kim, Jeong Han Kim, Won Hyeok Choe, Hyung Joon Yim, Sung Eun Kim, Soon Koo Baik, Byung Seok Lee,
PLOS ONE.2016; 11(1): e0146745. CrossRef
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
Won Sohn, Tae Wook Kang, Sun-Kyu Choi, Sin-Ho Jung, Min Woo Lee, Hyo Keun Lim, Ju-Yeon Cho, Sang Goon Shim, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Hyunchul Rhim, Yong-Han Paik
Oncotarget.2016; 7(30): 47794. CrossRef
Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir
Yu Jung Jo, Kyung-Ah Kim, June Sung Lee, Nam-Hoon Kim, Won Ki Bae, Tae June Song, Jeong Wook Kim
The Korean Journal of Internal Medicine.2015; 30(2): 170. CrossRef
Antiviral therapy for chronic hepatitis B in China
Xin Zheng, Junzhong Wang, Dongliang Yang
Medical Microbiology and Immunology.2015; 204(1): 115. CrossRef
The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients
Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
Journal of Gastrointestinal Surgery.2015; 19(7): 1281. CrossRef
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2015; 16(3): 465. CrossRef
Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
Ji Hoon Kim, June Sung Lee
The Korean Journal of Internal Medicine.2015; 30(1): 23. CrossRef
Reimbursement policies in the Asia-Pacific for chronic hepatitis B
Seng Gee Lim, Deepak N. Amarapurkar, Henry Lik-Yuen Chan, Darrell H. Crawford, Edward J. Gane, Kwang-Hyub Han, Sang Hoon Ahn, Wasim Jafri, Jidong Jia, Jia-Horng Kao, Laurentius A. Lesmana, C. Rinaldi A. Lesmana, Rosmawati Mohamed, Pham Hoang Phiet, Teerha
Hepatology International.2015; 9(1): 43. CrossRef
Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
Hyo Jin Kim, Ju-Yeon Cho, Yu Jin Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee
The Korean Journal of Internal Medicine.2015; 30(1): 32. CrossRef
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Gi-Ae Kim, Han Chu Lee, Min-Ju Kim, Yeonjung Ha, Eui Ju Park, Jihyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim
Journal of Hepatology.2015; 62(5): 1092. CrossRef
Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B
Mi Sung Park, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Hwan Shin, Wonseok Kang, Chansoo Moon, Kwang‐Hyub Han
Liver International.2015; 35(2): 455. CrossRef
Efficacy of Tenofovir-based Rescue Therapy for Patients with Drug-resistant Chronic Hepatitis B
Kanghyug Choi, Han Min Lee, Baek Gyu Jun, Sae Hwan Lee, Hong Soo Kim, Sang Gyune Kim, Young Seok Kim, Boo Sung Kim, Soung Won Jeong, Jae Young Jang, Young Don Kim, Gab Jin Cheon
The Korean Journal of Gastroenterology.2015; 65(1): 35. CrossRef
Hepatocellular carcinoma risk in chronic hepatitis B virus–infected compensated cirrhosis patients with low viral load
Dong Hyun Sinn, Junggyu Lee, Juna Goo, Kyunga Kim, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
Hepatology.2015; 62(3): 694. CrossRef
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
Junggyu Lee, Dong Hyun Sinn, Jung Hee Kim, Geum-Youn Gwak, Hye Seung Kim, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
Journal of Korean Medical Science.2015; 30(11): 1618. CrossRef
Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma
Jeong-Heon Choi, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Young Ko, Dong Il Gwon, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
Korean Journal of Hepato-Biliary-Pancreatic Surgery.2015; 19(2): 59. CrossRef
Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors
Hyo Jin Kim, Dong Hyun Sinn, Nam Jun Kim, Jung Hee Kim, Eun Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Digestive Diseases and Sciences.2015; 60(12): 3794. CrossRef
Liver stiffness‐based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
Seung Hwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Beom Kyung Kim
Liver International.2015; 35(3): 1054. CrossRef
Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance
Hyo Jung Cho, Soon Sun Kim, Sung Jae Shin, Byung Moo Yoo, Sung Won Cho, Jae Youn Cheong
Journal of Medical Virology.2015; 87(9): 1532. CrossRef
Validation of hepatitis B virus–related hepatocellular carcinoma prediction models in the era of antiviral therapy
Kyu Sik Jung, Seung Up Kim, Kijun Song, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Kwang‐Hyub Han
Hepatology.2015; 62(6): 1757. CrossRef
Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
Clinical and Molecular Hepatology.2015; 21(1): 24. CrossRef
Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
Jin Chang Moon, Seong Hun Kim, In Hee Kim, Chang Hun Lee, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae-Ghon Kim
Gut and Liver.2015;[Epub] CrossRef
Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma
Young Woon Kim, Jung Hyun Kwon, Eun Chung, Sung Won Lee, Jong-yul Lee, Jeong Won Jang, Kyu Won Chung, Soon Woo Nam
Gastroenterology Research and Practice.2015; 2015: 1. CrossRef
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
Jem Ma Ahn, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Chun-Jen Liu
PLOS ONE.2015; 10(12): e0144777. CrossRef
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
Sung Hyun Ahn, Doo Hyun Kim, Ah Ram Lee, Beom Kyung Kim, Yong Kwang Park, Eun-Sook Park, Sang Hoon Ahn, Gu-Choul Shin, Soree Park, Hong Seok Kang, Jin-Kyu Rhee, Sung-Il Yang, Youhoon Chong, Kyun-Hwan Kim, Jason Blackard
PLOS ONE.2015; 10(8): e0136728. CrossRef
Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients
Ji Won Park
World Journal of Gastroenterology.2015; 21(13): 3953. CrossRef
Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients with a Partial Virological Response
Hyun Woong Lee, Jae-Cheol Kwon, In Soo Oh, Hye Young Chang, Young Joo Cha, Ik-Seong Choi, Hyung Joon Kim
Antimicrobial Agents and Chemotherapy.2015; 59(9): 5348. CrossRef
Towards the elimination and eradication of hepatitis B
Geoffrey Dusheiko
Journal of Virus Eradication.2015; 1(1): 4. CrossRef
Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogue
Won Jang, Sung In Yu, Dong Hyun Sinn, Sang Hoon Park, Hyun Park, Ji Young Park, Tae Joo Jeon, Tae Hoon Oh, Won Chang Shin, Won-Choong Choi
Clinics and Research in Hepatology and Gastroenterology.2014; 38(2): 195. CrossRef
High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
Jong Man Kim, Hyojun Park, Hye Ryoun Jang, Jae Berm Park, Choon Hyuck David Kwon, Wooseong Huh, Joon Hyeok Lee, Sung Joo Kim, Jae-Won Joh
Annals of Surgical Treatment and Research.2014; 86(5): 256. CrossRef
Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
J.‐H. Cho, J.‐H. Lim, G.‐Y. Park, J.‐S. Kim, Y.‐J. Kang, O. Kwon, J.‐Y. Choi, S.‐H. Park, Y.‐L. Kim, H.‐K. Kim, S. Huh, C.‐D. Kim
Transplant Infectious Disease.2014; 16(2): 295. CrossRef
Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy
Hye Won Lee, Eun Jin Yoo, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han
American Journal of Gastroenterology.2014; 109(8): 1241. CrossRef
Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test
Beom Kyung Kim, Hyon‐Suk Kim, Eun Jin Yoo, Eun Ji Oh, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Seung Up Kim, Young Nyun Park
Hepatology.2014; 60(6): 1911. CrossRef
Long‐term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir
Mi Na Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han
Liver International.2014; 34(8): 1216. CrossRef
Preventing Vertical Transmission of Hepatitis B virus
Won Hyeok Choe, June Sung Lee
Korean Journal of Medicine.2014; 87(5): 557. CrossRef
Oral antiviral agents for treatment of chronic hepatitis B
Soon Young Ko, Won Hyeok Choe
Journal of the Korean Medical Association.2014; 57(1): 60. CrossRef
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
Clinical and Molecular Hepatology.2014; 20(4): 355. CrossRef
Oral antiviral therapy improves the diagnostic accuracy of alpha‐fetoprotein levels in patients with chronic hepatitis B
Jae‐Jun Shim, Jung Wook Kim, Chang Kyun Lee, Jae Young Jang, Byung‐Ho Kim
Journal of Gastroenterology and Hepatology.2014; 29(9): 1699. CrossRef
Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients?
Keunhee Kang, Ji Hoon Kim
The Korean Journal of Gastroenterology.2014; 63(5): 329. CrossRef
Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea
A-Jin Lee, Chang Hyeong Lee, Chang-Ho Jeon
Annals of Laboratory Medicine.2014; 34(3): 230. CrossRef
Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
Young–Suk Lim, Seungbong Han, Nae–Yun Heo, Ju Hyun Shim, Han Chu Lee, Dong Jin Suh
Gastroenterology.2014; 147(1): 152. CrossRef
MicroRNA‐196A‐2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B
Hwi Young Kim, Jung‐Hwan Yoon, Hyo‐Suk Lee, Jae Youn Cheong, Sung Won Cho, Hyoung Doo Shin, Yoon Jun Kim
Journal of Medical Virology.2014; 86(3): 446. CrossRef
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clinical and Molecular Hepatology.2014; 20(3): 274. CrossRef
Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease
Mi Sung Park, Kwang-Hyub Han, Seung Up Kim
Expert Review of Gastroenterology & Hepatology.2014; 8(5): 501. CrossRef
The PERFECT Study (PEnnel Real liFe Efficacy Clinical Trial), a Double-Blind, Randomized, Multicenter Trial Examining the Efficacy of Biphenyl Dimethyl Dicarboxylate Combined with Garlic Oil in Patients with Transaminase Elevated Chronic Liver Disease
Hyung Joon Kim, June Sung Lee, Hyun Woong Lee, Mun Young Kim, Soon Woo Nam, Ju Hyun Sohn, Se Hyun Cho, Seung Gyu Yoon, Jin Mo Yang, Chung Kee Park, Gyu Sung Rim, Young Sok Lee
Korean Journal of Medicine.2014; 86(2): 179. CrossRef
Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital
Jae Hoon Kim, Ju Seung Kim, Jong Joon Lee, Jung Ho Kim, Suk Young Kim, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
The Korean Journal of Internal Medicine.2014; 29(3): 307. CrossRef
Viral evolutionary changes during tenofovir treatment in a chronic hepatitis B patient with sequential nucleos(t)ide therapy
Hyun Woong Lee, Hye Young Chang, Suh Yoon Yang, Hyung Joon Kim
Journal of Clinical Virology.2014; 60(3): 313. CrossRef
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
Clinical and Molecular Hepatology.2014; 20(3): 261. CrossRef
Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
Hyung Rae Sohn, Bo Young Min, Joon Chang Song, Mun Hyuk Seong, Sang Soo Lee, Eun Sun Jang, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim
BMC Infectious Diseases.2014;[Epub] CrossRef
Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
Dong Hyun Sinn, Geum-Youn Gwak, Juhee Cho, Seung Woon Paik, Byung Chul Yoo, Pierre Roques
PLoS ONE.2014; 9(11): e112184. CrossRef
The Impact of the Hepatitis B Virus Polymerase rtA181T Mutation on Replication and Drug Resistance Is Potentially Affected by Overlapping Changes in Surface Gene
Sung Hyun Ahn, Yong Kwang Park, Eun-Sook Park, Jeong Han Kim, Doo Hyun Kim, Keo-Heun Lim, Moon Sun Jang, Won Hyeok Choe, Soon Young Ko, In-Kyung Sung, So Young Kwon, Kyun-Hwan Kim, G. McFadden
Journal of Virology.2014; 88(12): 6805. CrossRef
Oral Antiviral Therapy for Chronic Hepatitis B Virus Infection: Is Continuous Treatment Needed?
Chang Hyeong Lee
Gastroenterology & Hepatology: Open Access.2014;[Epub] CrossRef
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Ju-Yeon Cho, Yong-Han Paik, Won Sohn, Hyun Chin Cho, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Gut.2014; 63(12): 1943. CrossRef
Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
Hyung Joon Yim, Seong Gyu Hwang
Clinical and Molecular Hepatology.2013; 19(3): 195. CrossRef
Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance
Dong Hyun Sinn, Jieun Yi, Moon Seok Choi, Dongil Choi, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Hepatology International.2013; 7(4): 1010. CrossRef
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clinical and Molecular Hepatology.2013; 19(3): 273. CrossRef
Antiviral Effect of Entecavir Switching Therapy in Chronic Hepatitis B Patients with Clevudine-associated Myopathy
Won Young Tak
The Korean Journal of Gastroenterology.2013; 61(1): 1. CrossRef
Occult Hepatitis B Virus Infection: Transmission and Reactivation
Sang Hee Song, Seong Gyu Hwang
The Korean Journal of Gastroenterology.2013; 62(3): 148. CrossRef
Clinical Efficacy of Entecavir and Factors Predicting Long-Term Treatment Response in Nucleoside-Naïve Patients with Chronic Hepatitis B
Beom Hee Kim, Beom Yong Yoon, Dae Wha Park, Eaum Seok Lee, Seok Hyun Kim, Byung Seok Lee, Heon Young Lee
Korean Journal of Medicine.2013; 85(2): 157. CrossRef
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clinical and Molecular Hepatology.2013; 19(4): 409. CrossRef
Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response
Dae Hun Kwon, In Hee Kim, Bum Su Choung, Dae Seon Ahn, Sun Ho Yoo, Sang Bae Park, Seok Lee, Seong Hun Kim, Sang Wook Kim, Yong Jin Im
Gut and Liver.2013; 7(6): 712. CrossRef

21,492 View
111 Download
Crossref

Special Contribution

Special Contribution : Practice guidelines for management of hepatocellular carcinoma 2009: Korean Liver Cancer Study Group and National Cancer Center, Korea; Korean J Hepatol 2009;15(3):391-423.
Published online September 30, 2009; DOI: https://doi.org/10.3350/kjhep.2009.15.3.391

Abstract
PDF

Hepatocellular carcinoma (HCC) is a major cancer in Korea, typically has a poor prognosis, and constitutes the majority of primary hepatic malignancies. It is the number one cause of death among people in their 50s in Korea. The five-year survival rate of liver cancer is poor; at 18.9%. Efforts to increase the survival rate through early diagnosis of HCC and optimal treatments are keenly needed. Western guideline for the management of HCC were developed, but these guidelines are somewhat unsuitable for Korean patients. Thus, the Korean Liver Cancer Study Group (KLCSG) and the National Cancer Center (NCC), Korea jointly produced the Clinical Practice Guidelines for HCC for the first time in Korea in 2003. Owing to medical advances over the following six years, diagnosis and treatment of HCC has changed considerably. As more national and foreign data are accumulated, KLCSG and NCC, Korea recently revised the Clinical Practice Guidelines for HCC. Forty or more specialists in the field of hepatology, general surgery, radiology and radiation oncology participated, and meticulously reviewed national and foreign papers, and collected opinions through advisory committee conferences. These multidisciplinary, evidence-based guidelines summarized diagnosis, surgical resection, liver transplantation, local treatments, transarterial chemoembolization, radiation therapy, chemotherapy, preemptive antiviral treatments, and response evaluation of HCC. These Korean guidelines are expected to be useful for clinical management of and research on HCC. (Korean J Hepatol 2009;15:391-423)

Citations

Citations to this article as recorded by

Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B hepatocellular carcinoma after radical resection
Xu Feng, Yupei Ao, Lili Wang, Kai Chen, Chengjia Tang, Chengcheng Huang
Frontiers in Immunology.2026;[Epub] CrossRef
Neutrophil count predicts the complete response after transarterial chemoembolization related to favorable outcome in hepatocellular carcinoma
Young Mi Hong
European Journal of Gastroenterology & Hepatology.2025; 37(1): 94. CrossRef
Early prediction of proton therapy dose distributions and DVHs for hepatocellular carcinoma using contour-based CNN models from diagnostic CT and MRI
Toshiya Rachi, Taku Tochinai
Radiation Oncology.2025;[Epub] CrossRef
Stereotactic radiosurgery for hepatitis C virus-related hepatocellular carcinoma brain metastasis: A retrospective analysis and systematic review
Muhammad Izhar, Yusuke S. Hori, Ahed H. Kattaa, Fred C. Lam, Neeraj Kalra, Nirmeen Zagzoog, Armine Tayag, Louisa Ustrzynski, Sara C. Emrich, Erqi L. Pollom, Scott G. Soltys, Melanie Hayden Gephart, David J. Park, Steven D. Chang
World Neurosurgery: X.2025; 28: 100541. CrossRef
The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma
Jung Hee Lee, Young Mi Hong
BMC Cancer.2024;[Epub] CrossRef
Prognostic difference between surgery and external radiation in patients with stage I liver cancer based on competitive risk model and conditional survival rate
Rong Chen, Yanli An, Muhao Xu, Calogero Casà
PLOS ONE.2024; 19(3): e0298014. CrossRef
Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
Yuri Cho, Bo Hyun Kim, Young-Suk Lim
Digestive Disease Interventions.2024; 08(03): 169. CrossRef
Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma
Young Mi Hong
Hepatic Oncology.2024;[Epub] CrossRef
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
Xiaoqing Shi, Jiage Ding, Yanyan Zheng, Jiawei Wang, Navid Sobhani, Praveen Neeli, Gang Wang, Junnian Zheng, Dafei Chai
iScience.2023; 26(3): 106143. CrossRef
Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Mirela Georgiana Perne, Adela-Viviana Sitar-Tăut, Teodora Gabriela Alexescu, Lorena Ciumărnean, Mircea-Vasile Milaciu, Sorina-Cezara Coste, Calin-Vasile Vlad, Angela Cozma, Dan-Andrei Sitar-Tăut, Olga Hilda Orăşan, Alexandra Crăciun
Diagnostics.2023; 13(5): 816. CrossRef
Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
Ja Kyung Yoon, Sunyoung Lee, Jeong Ah Hwang, Ji Eun Lee, Seung-seob Kim, Myeong-Jin Kim
Journal of Liver Cancer.2023; 23(1): 157. CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Journal of Liver Cancer.2023; 23(1): 1. CrossRef
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
Clinical and Molecular Hepatology.2023; 29(2): 197. CrossRef
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Min Kyung Park, Yoon Jun Kim
Clinical and Molecular Hepatology.2023; 29(2): 332. CrossRef
Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
Bong Kyung Bae, Jeong Il Yu, Hee Chul Park, Myung Ji Goh, Yong-Han Paik
Radiation Oncology Journal.2023; 41(2): 98. CrossRef
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
Sung Uk Lee, Tae Hyun Kim
Clinical and Molecular Hepatology.2023; 29(4): 958. CrossRef
Has the growing evidence of radiotherapy for hepatocellular carcinoma increased the use of radiotherapy in elderly patients?
Tae Hyun Kim
Radiation Oncology Journal.2023; 41(3): 141. CrossRef
Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B
Myung Ji Goh, Wonseok Kang, Kwang Min Kim, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2022; 57(1): 70. CrossRef
Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts
Sang Il Choi, Yuri Cho, Moran Ki, Bo Hyun Kim, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Eun Kyung Hong, Chang-Min Kim, Joong-Won Park, Hamidreza Karimi-Sari
PLOS ONE.2022; 17(3): e0265668. CrossRef
The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment
Bong Kyung Bae, Hee Chul Park, Gyu Sang Yoo, Moon Seok Choi, Joo Hyun Oh, Jeong Il Yu
Cancers.2022; 14(9): 2081. CrossRef
Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017
Bong Kyung Bae, Hee Chul Park, Jeong Il Yu, Gyu Sang Yoo, Dong Hyun Sinn, Moon Seok Choi, Joo Hyun Oh
Frontiers in Oncology.2022;[Epub] CrossRef
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2022; 23(12): 1126. CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef
Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal
Joo Hye Song, Myung Ji Goh, Yewan Park, Joo Hyun Oh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2021; 56(3): 274. CrossRef
Prognostic factors of gadoxetic acid–enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma
Seung-seob Kim, Sunyoung Lee, Myeong-Jin Kim
European Radiology.2021; 31(5): 3405. CrossRef
Secondarily estimated cure fraction and five-year recurrence-free conditional survival probabilities among patients undergoing surgical resection for hepatocellular carcinoma presenting with minor gross vascular invasion
Byungje Bae, Sung Kyu Song, Eunyoung Choi, Chul-Woon Chung, Yongkeun Park
World Journal of Surgical Oncology.2021;[Epub] CrossRef
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
Tae Hyun Kim, Young Hwan Koh, Bo Hyun Kim, Min Ju Kim, Ju Hee Lee, Boram Park, Joong-Won Park
Journal of Hepatology.2021; 74(3): 603. CrossRef
Diagnostic Performance of KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis
Dong Hwan Kim, Bohyun Kim, Seo Yeon Youn, Hokun Kim, Joon-Il Choi
Diagnostics.2021; 11(10): 1763. CrossRef
Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response
Ji Eun Na, Dong Hyun Sinn, Jeong‐Hoon Lee, Hee Joon Jang, Seon Yeong Baek, Kyung A Kim, Won Seok Kang, Geum‐Youn Gwak, Young‐Han Paik, Yoon Jun Kim, Moon Seok Choi, Jung‐Hwan Yoon, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Viral Hepatitis.2021; 28(10): 1392. CrossRef
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B
Hye Yeon Chon, Yeon Seok Seo, Jung il Lee, Byung Seok Kim, Byoung Kuk Jang, Sang Gyune Kim, Ki Tae Suk, In Hee Kim, Jin-Woo Lee, Young Eun Chon, Moon Young Kim, Soung Won Jeong, Han Ah Lee, Sun Young Yim, Soon Ho Um, Hyun Woong Lee, Kwan Sik Lee, Jeong Eu
European Journal of Gastroenterology & Hepatology.2021; 33(6): 885. CrossRef
Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
Yewan Park, Jeong-Hoon Lee, Dong Hyun Sinn, Jun Yong Park, Minseok Albert Kim, Yoon Jun Kim, Jung-Hwan Yoon, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clinical and Translational Gastroenterology.2021; 12(1): e00290. CrossRef
Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Xin Zhang, Hui Chen, Xiao-Dong Wang, Ren-Jie Yang
World Journal of Gastrointestinal Oncology.2020; 12(6): 663. CrossRef
Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Eun Ju Cho, Seung Up Kim
Gut and Liver.2020; 14(4): 477. CrossRef
A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy
Won Il Jang, Sun Hyun Bae, Mi‐Sook Kim, Chul Ju Han, Su Cheol Park, Sang Bum Kim, Eung‐Ho Cho, Chul Won Choi, Kyung Su Kim, Sangyoun Hwang, Jin Ho Kim, A Ram Chang, Younghee Park, Eun Seog Kim, Woo Chul Kim, Sunmi Jo, Hae Jin Park
Cancer.2020; 126(2): 363. CrossRef
Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma
Hana Park, Jae Hyung Jung, Min Kyung Jung, Eui-Cheol Shin, Simon Weonsang Ro, Jeon Han Park, Do Young Kim, Jun Yong Park, Kwang-Hyub Han
Hepatology International.2020; 14(2): 249. CrossRef
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Eun Sang Oh, Sang Hee Youn, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Dae Yong Kim
Frontiers in Oncology.2020;[Epub] CrossRef
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Sook Young Woo, Hyun Cho, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Hepatology.2020; 71(6): 2023. CrossRef
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Jihye Kim, Dong-Hyun Sinn, Moon Seok Choi, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Enzo Tagliazucchi
PLOS ONE.2019; 14(3): e0213547. CrossRef
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
Yehyun Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jong Eun Yeon, Kwan Soo Byun, Hye Soo Kim, Ji Hoon Kim, Seung Up Kim
BMC Cancer.2019;[Epub] CrossRef
Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?
Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Hyunjung Kim, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Dae Yong Kim, Chang-Min Kim
Cancers.2019; 11(2): 230. CrossRef
Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
Shuling Chen, Huilin Jin, Zihao Dai, Mengchao Wei, Han Xiao, Tianhong Su, Bin Li, Xin Liu, Yu Wang, Jiaping Li, Shunli Shen, Qi Zhou, Baogang Peng, Zhenwei Peng, Sui Peng
Cancer Medicine.2019; 8(4): 1530. CrossRef
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
Mi Young Jeon, Hye Soo Kim, Tae Seop Lim, Dai Hoon Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Seung Up Kim, Gianfranco D. Alpini
PLOS ONE.2019; 14(4): e0214613. CrossRef
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2019; 20(7): 1042. CrossRef
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
KLCA Korean Liver Cancer Association, NCC National Cancer Center
Gut and Liver.2019; 13(3): 227. CrossRef
Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
Bo Hyun Kim, Joong-Won Park, Jin Sook Kim, Sook-Kyung Lee, Eun Kyung Hong
Gut and Liver.2019; 13(3): 342. CrossRef
Paper Alert
Peter Hayes, John Plevris
European Journal of Gastroenterology & Hepatology.2019; 31(10): 1295. CrossRef
Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
Namyoung Paik, Dong H. Sinn, Ji H. Lee, In S. Oh, Jung H. Kim, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
Liver International.2018; 38(1): 68. CrossRef
Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Jung Hee Kim, Dong Hyun Sinn, Jeong-Hoon Lee, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Young Chang, Yoon Jun Kim, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Digestive Diseases and Sciences.2018; 63(4): 1062. CrossRef
Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Song‐Ee Baek, Hye Soo Kim, Seung Up Kim, Mi Suk Park
Liver International.2018; 38(9): 1655. CrossRef
Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
Jie-Yu Kong, Shu-Mei Li, Hai-Yan Fan, Lan Zhang, Hui-Jin Zhao, Sheng-Mian Li
Medicine.2018; 97(33): e11872. CrossRef
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Byeong G. Song, Dong H. Sinn, Sangah Chi, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
European Journal of Gastroenterology & Hepatology.2018; 30(12): 1447. CrossRef
Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
Archana Rastogi
World Journal of Gastroenterology.2018; 24(35): 4000. CrossRef
Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular Carcinoma
Seung Ji Kang, Uh Jin Kim, Seong Eun Kim, Joon Hwan An, Mi Ok Jang, Dae-Seong Myung, Kyung-Hwa Park, Sook-In Jung, Sung Bum Cho, Hee-Chang Jang, Young Eun Joo
Disease Markers.2018; 2018: 1. CrossRef
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kwang Min Kim, Jiyu Kim, Dong Hyun Sinn, Hye Seung Kim, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2018; 53(6): 727. CrossRef
Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma
Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Dae Yong Kim, Sung Ho Moon, Sang Soo Kim, Ju Hee Lee, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Chang-Min Kim
Oncotarget.2018; 9(3): 4034. CrossRef
Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area
Jung Ho Im, Sang Min Yoon, Hee Chul Park, Jong Hoon Kim, Jeong Il Yu, Tae Hyun Kim, Jun Won Kim, Taek‐Keun Nam, Kyubo Kim, Hong Seok Jang, Jin Hee Kim, Mi‐Sook Kim, Won Sup Yoon, Inkyung Jung, Jinsil Seong
Liver International.2017; 37(1): 90. CrossRef
Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis
Dae Yong Kim, Joong-Won Park, Tae Hyun Kim, Bo Hyun Kim, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Chang-Min Kim
Radiotherapy and Oncology.2017; 122(1): 122. CrossRef
Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein predicts the risk of HBV‐related liver cancer development
Seung Up Kim, Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Hyon‐Suk Kim
Liver International.2017; 37(6): 879. CrossRef
Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
Eui Joo Kim, Jong Eun Yeon, Oh Sang Kwon, Heon Nam Lee, Seung Kak Shin, Seong Hee Kang, Kwan Soo Byun, Jeong Han Kim, So Young Kwon, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim
Digestive Diseases and Sciences.2017; 62(3): 808. CrossRef
A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma
Areum Sohn, Hyunsoo Kim, Su Jong Yu, Jung-Hwan Yoon, Youngsoo Kim
Analytical and Bioanalytical Chemistry.2017; 409(11): 2829. CrossRef
Liver Function Assessment Using Albumin–Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
In Soo Oh, Dong Hyun Sinn, Tae Wook Kang, Min Woo Lee, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2017; 62(11): 3235. CrossRef
Strategies to tackle the challenges of external beam radiotherapy for liver tumors
Michael I Lock, Jonathan Klein, Hans T Chung, Joseph M Herman, Edward Y Kim, William Small, Nina A Mayr, Simon S Lo
World Journal of Hepatology.2017; 9(14): 645. CrossRef
Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
Sang Joon Park, Jae Young Jang, Soung Won Jeong, Young Kyu Cho, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Hae In Bang
Medicine.2017; 96(11): e5811. CrossRef
Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma
Yong Keun Park, Sung Kyu Song, Bong-Wan Kim, Seung-Keun Park, Chul-Woon Chung, Hee-Jung Wang
World Journal of Surgical Oncology.2017;[Epub] CrossRef
Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus‐endemic population
Jonggi Choi, Seungbong Han, Namkug Kim, Young‐Suk Lim
Hepatology.2017; 66(5): 1454. CrossRef
Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma
Seung Kak Shin, Yun Soo Kim, Young Sup Shim, Seung Joon Choi, So Hyun Park, Dong Hae Jung, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim
Medicine.2017; 96(33): e7761. CrossRef
A model predicting survival of patients with recurrent or progressive hepatocellular carcinoma: the MORE score
Sang Il Choi, Ami Yu, Bo Hyun Kim, Eun Jeong Ko, Soon Seob Park, Byung‐Ho Nam, Joong‐Won Park
Journal of Gastroenterology and Hepatology.2017; 32(3): 651. CrossRef
Barcelona clinic liver cancer-stage C hepatocellular carcinoma
Chung Hwan Jun, Jae Hyun Yoon, Eunae Cho, Sang Soo Shin, Sung Bum Cho, Hee Joon Kim, Chang Hwan Park, Hyun Soon Kim, Sung Kyu Choi, Jong Sun Rew
Medicine.2017; 96(17): e6745. CrossRef
Prognostic group stratification and nomogram for predicting overall survival in patients who received radiotherapy for abdominal lymph node metastasis from hepatocellular carcinoma: a multi-institutional retrospective study (KROG 15-02)
Youngkyong Kim, Hee Chul Park, Sang Min Yoon, Tae Hyun Kim, Jieun Lee, Jinhyun Choi, Jeong Il Yu, Jin-Hong Park, Jong Hoon Kim, Joong-Won Park, Jinsil Seong
Oncotarget.2017; 8(55): 94450. CrossRef
The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
Sun Young Yim, Yeon Seok Seo, Chang Ho Jung, Tae Hyung Kim, Jae Min Lee, Eun Sun Kim, Bora Keum, Young Kul Jong, Hyunggin An, Ji Hoon Kim, Hyung Joon Yim, Dong Sik Kim, Yoon Tae Jeen, Jong Eun Yeon, Hong Sik Lee, Hoon Jai Chun, Kwan Soo Byun, Soon Ho Um,
Liver International.2016; 36(3): 445. CrossRef
Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial‐embolization prognostic score
Yehyun Park, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong Eun Park, Ji Hye Park, Yong Il Lee, Hae Ryong Yun, Kwang‐Hyub Han
Liver International.2016; 36(1): 100. CrossRef
Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas
Eric C. Ehman, Spencer C. Behr, Sarah E. Umetsu, Nicholas Fidelman, Ben M. Yeh, Linda D. Ferrell, Thomas A. Hope
Abdominal Radiology.2016; 41(5): 963. CrossRef
Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis
Jung‐Woo Lee, Young‐Joo Lee, Kwang‐Min Park, Dae‐Wook Hwang, Jae Hoon Lee, Ki Byung Song
World Journal of Surgery.2016; 40(6): 1429. CrossRef
Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis
Tae Yeob Kim, Jae Gon Lee, Joo Hyun Sohn, Ji Yeoun Kim, Sun Min Kim, Jinoo Kim, Woo Kyoung Jeong
Yonsei Medical Journal.2016; 57(1): 138. CrossRef
The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma
Sung Chan Gong, Mee‐Yon Cho, Sang Woo Lee, Sung Hoon Kim, Moon Young Kim, Soon Koo Baik
Journal of Gastroenterology and Hepatology.2016; 31(1): 206. CrossRef
Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus
Ja Yoon Heo, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Young Nyun Park, Sung Soo Ahn, Kwang-Hyub Han, Hyon-Suk Kim
Medicine.2016; 95(14): e3328. CrossRef
Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology
Francesco Dionisi, Alessia Guarneri, Veronica Dell’Acqua, Mariacristina Leonardi, Rita Niespolo, Gabriella Macchia, Tiziana Comito, Maurizio Amichetti, Pierfrancesco Franco, Savino Cilla, Luciana Caravatta, Filippo Alongi, Giovanna Mantello
La radiologia medica.2016; 121(9): 735. CrossRef
Impact of the activity calculation method used in transarterial radioembolization
Ashish K. Jha, Sneha Mithun, Nilendu C. Purandare, Sneha A. Shah, Archi Agrawal, Suyash S. Kulkarni, Nitin Shetty, Venkatesh Rangarajan
Nuclear Medicine Communications.2016; 37(9): 917. CrossRef
Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2016; 61(11): 3354. CrossRef
Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy
Eric C. Ehman, Sarah E. Umetsu, Michael A. Ohliger, Nicholas Fidelman, Linda D. Ferrell, Ben M. Yeh, Judy Yee, Thomas A. Hope
Abdominal Radiology.2016; 41(11): 2161. CrossRef
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
Keol Lee, Dong Hyun Sinn, Geum-Youn Gwak, Hyun Chin Cho, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Gut and Liver.2016; 10(5): 796. CrossRef
Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria
Jung Hee Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Ki Yeon Kim, Kyunga Kim, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Medicine.2016; 95(35): e4735. CrossRef
The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kwang Min Kim, Dong Hyun Sinn, Sin‐Ho Jung, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Liver International.2016; 36(10): 1490. CrossRef
Usefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosis
Sang Soo Lee, Hyun Ju Min, Ja Yun Choi, Hyun Chin Cho, Jin Joo Kim, Jae Min Lee, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Jin Hyun Kim, Ok-Jae Lee
BMC Gastroenterology.2016;[Epub] CrossRef
Case report of The liver transplant patient's cerebral infarction treated with Korean Medicine
Sang Eun Park
Herbal Formula Science.2016; 24(3): 225. CrossRef
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Hyeseung Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Gut and Liver.2016; 10(6): 939. CrossRef
The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
Jung Hee Kim, Yang Won Min, Geum-Youn Gwak, Yong Han Paik, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik
Medicine.2016; 95(51): e5666. CrossRef
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase
Young-Il Kim, Hyoung Sang Kim, Joong-Won Park, Motoyuki Otsuka
PLOS ONE.2016; 11(6): e0157299. CrossRef
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
Pei-Pei Song
World Journal of Gastroenterology.2016; 22(1): 262. CrossRef
The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma
Hong In Yoon, Inkyung Jung, Kwang-Hyub Han, Jinsil Seong
Oncotarget.2016; 7(38): 62715. CrossRef
The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: Final results of the START trial
Yee Chao, Young‐Hwa Chung, Guohong Han, Jung‐Hwan Yoon, Jijin Yang, Jianhua Wang, Guo‐Liang Shao, Byung Ik Kim, Teng‐Yu Lee
International Journal of Cancer.2015; 136(6): 1458. CrossRef
Prevalence, Risk Factors and Clinical Characteristics in Patients with Genotype 6 Chronic Hepatitis C: A Single Institute Experience
Seung Kak Shin, Soo Yong Park, Young Kul Jung, Eui Joo Kim, Heon Nam Lee, Jong Joon Lee, Oh Sang Kwon, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
The Korean Journal of Gastroenterology.2015; 65(2): 105. CrossRef
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
Jung Gil Park
Clinical and Molecular Hepatology.2015; 21(3): 287. CrossRef
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong‐Won Park, Minshan Chen, Massimo Colombo, Lewis R. Roberts, Myron Schwartz, Pei‐Jer Chen, Masatoshi Kudo, Philip Johnson, Samuel Wagner, Lucinda S. Orsini, Morris Sherman
Liver International.2015; 35(9): 2155. CrossRef
Hepatocellular carcinoma risk in chronic hepatitis B virus–infected compensated cirrhosis patients with low viral load
Dong Hyun Sinn, Junggyu Lee, Juna Goo, Kyunga Kim, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
Hepatology.2015; 62(3): 694. CrossRef
Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy
Ja Young Kim, Young Kyung Lim, Tae Hyun Kim, Kwang Hyun Cho, Sang Hyoun Choi, Hojin Jeong, Dae Woong Kim, Jung Hoon Park, Dong Ho Shin, Se Byeong Lee, Sang Soo Kim, Joo-Young Kim, Dae Yong Kim, Joong-Won Park
Acta Oncologica.2015; 54(10): 1827. CrossRef
Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma
Young Woon Kim, Jung Hyun Kwon, Eun Chung, Sung Won Lee, Jong-yul Lee, Jeong Won Jang, Kyu Won Chung, Soon Woo Nam
Gastroenterology Research and Practice.2015; 2015: 1. CrossRef
Reappraisal of serum alpha‐foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment
Gi‐Ae Kim, Chang Hyeon Seock, Jang Won Park, Jihyun An, Kwang‐Sun Lee, Jee Eun Yang, Young‐Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Han Chu Lee
Liver International.2015; 35(1): 232. CrossRef
Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy
Jong M. Kim, Choon H. D. Kwon, Jae-Won Joh, Dong H. Sinn, Jae B. Park, Joon H. Lee, Sung J. Kim, Seung W. Paik, Cheol K. Park, Byung C. Yoo
Medicine.2015; 94(6): e450. CrossRef
The Korean guideline for hepatocellular carcinoma surveillance
Do Young Kim, Hyun Jung Kim, Seung Eun Jeong, Sang Gyune Kim, Hyung Joon Kim, Dong Hyun Sinn, Yong Joo Lee, Woo Kyoung Jeong, Kui Son Choi, Nae-Yun Heo, Dong Joon Kim, Young Seok Kim, Yong Bum Kim, Yoon Jun Kim, Hyoung-Ryoul Kim, Minseon Park, Chan Wha Le
Journal of the Korean Medical Association.2015; 58(5): 385. CrossRef
Image-guided Treatment in the Hepatobiliary System: Role of Imaging in Treatment Planning and Posttreatment Evaluation
Surabhi Bajpai, Avinash Kambadakone, Alexander R. Guimaraes, Ronald S. Arellano, Debra A. Gervais, Dushyant Sahani
RadioGraphics.2015; 35(5): 1393. CrossRef
Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions
Sae Hwan Lee, Il Han Song, Ran Noh, Ha Yan Kang, Suk Bae Kim, Soon Young Ko, Eoum Seok Lee, Seok Hyun Kim, Byung Seok Lee, An Na Kim, Hee Bok Chae, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Jae Dong Lee, Heon Young Lee
BMC Cancer.2015;[Epub] CrossRef
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2015; 16(3): 465. CrossRef
The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients
Ji Soo Lee, Jong Man Kim, Seunghwan Lee, Jin-Yong Choi, Wontae Cho, Gyu-Seoung Choi, Jae Berm Park, Choon Hyuck David Kwon, Sung Joo Kim, Jae-Won Joh
Korean Journal of Hepato-Biliary-Pancreatic Surgery.2015; 19(4): 154. CrossRef
Liver stiffness‐based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
Seung Hwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Beom Kyung Kim
Liver International.2015; 35(3): 1054. CrossRef
Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma
Doo Yeul Lee, Joong-Won Park, Tae Hyun Kim, Ju Hee Lee, Bo Hyun Kim, Sang Myung Woo, Sang Soo Kim, Woo Jin Lee, Dae Yong Kim, Chang-Min Kim
Strahlentherapie und Onkologie.2015; 191(11): 835. CrossRef
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
Junggyu Lee, Dong Hyun Sinn, Jung Hee Kim, Geum-Youn Gwak, Hye Seung Kim, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
Journal of Korean Medical Science.2015; 30(11): 1618. CrossRef
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Do Seon Song, Myeong Jun Song, Si Hyun Bae, Woo Jin Chung, Jae Young Jang, Young Seok Kim, Sae Hwan Lee, Jun Yong Park, Hyung Joon Yim, Sung Bum Cho, Soo Young Park, Jin Mo Yang
Journal of Gastroenterology.2015; 50(4): 445. CrossRef
Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib
Seungtaek Lim, Jungwoo Han, Gun Min Kim, Kwang‐Hyub Han, Hye Jin Choi
Journal of Gastroenterology and Hepatology.2015; 30(6): 1024. CrossRef
Korean Version of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma (K-MESIAH)
Byung-Ho Nam, Joong-Won Park, Sook-Hyang Jeong, Sang Soo Lee, Ami Yu, Bo Hyun Kim, W. Ray Kim, Sheng-Nan Lu
PLOS ONE.2015; 10(10): e0138374. CrossRef
Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
Dong Hyun Sinn, Ju-Yeon Cho, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Sheng-Nan Lu
PLOS ONE.2015; 10(4): e0124434. CrossRef
Current management of hepatocellular carcinoma: An Eastern perspective
Hyung Joon Yim
World Journal of Gastroenterology.2015; 21(13): 3826. CrossRef
SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma
Yeon-Su Lee, Bo Hyun Kim, Byung Chul Kim, Aesun Shin, Jin Sook Kim, Seung-Hyun Hong, Jung-Ah Hwang, Jung Ahn Lee, Seungyoon Nam, Sung Hoon Lee, Jong Bhak, Joong-Won Park
Oncotarget.2015; 6(18): 16449. CrossRef
Long-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 Years
Hyun Jung Lee, Jong Eun Yeon, Eileen L. Yoon, Sang Jun Suh, Keunhee Kang, Hae Rim Kim, Seong Hee Kang, Yang Jae Yoo, Jihye Je, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Kwan Soo Byun
Intervirology.2015; 58(1): 14. CrossRef
Proton Therapy Results in the Treatment of Hepatocellular Carcinoma According to the Barcelona-Clinic Liver Cancer (BCLC) Staging System
Francesco Dionisi, Maurizio Amichetti
International Journal of Medical Physics, Clinical Engineering and Radiation Oncology.2015; 04(02): 96. CrossRef
Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma
Xiaojing Xu, Peixin Huang, Hui Tian, Yi Chen, Ningling Ge, Wengquing Tang, Biwei Yang, Jinglin Xia
Journal of Gastroenterology and Hepatology.2014; 29(6): 1273. CrossRef
Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first‐line therapy: A Korean multicenter study
Sangheun Lee, Beom Kyung Kim, Seung Up Kim, Soo Young Park, Ja Kyung Kim, Hyun Woong Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Young Oh Kweon, Jung Il Lee, Kwan Sik Lee, Hyung Joon Kim, Kwang‐Hyub Han
Journal of Gastroenterology and Hepatology.2014; 29(7): 1463. CrossRef
Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
Young–Suk Lim, Seungbong Han, Nae–Yun Heo, Ju Hyun Shim, Han Chu Lee, Dong Jin Suh
Gastroenterology.2014; 147(1): 152. CrossRef
The effectiveness of gadolinium MRI to improve target delineation for radiotherapy in hepatocellular carcinoma: A comparative study of rigid image registration techniques
D.S. Yang, W.S. Yoon, J.A. Lee, N.K. Lee, S. Lee, C.Y. Kim, H.J. Yim, S.H. Lee, H.H. Chung, S.H. Cha
Physica Medica.2014; 30(6): 676. CrossRef
Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma
Kyung Hwan Kim, Mi Sun Kim, Jee Suk Chang, Kwang‐Hyub Han, Do Young Kim, Jinsil Seong
Liver International.2014; 34(5): 784. CrossRef
Clinical Features of Non-alcoholic Fatty Liver Disease in Cryptogenic Hepatocellular Carcinoma
Min Young Rim, Oh Sang Kwon, Minsu Ha, Ju Seung Kim, Kwang Il Ko, Dong Kyu Kim, Pil Kyu Jang, Jung Yoon Han, Pyung Hwa Park, Young Kul Jung, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
The Korean Journal of Gastroenterology.2014; 63(5): 292. CrossRef
Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver
Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Jae Berm Park, Joon Hyeok Lee, Sung Joo Kim, Seung Woon Paik, Cheol Keun Park, Byung Chul Yoo
Journal of Surgical Oncology.2014; 110(8): 976. CrossRef
The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
Ju‐Yeon Cho, Yong‐Han Paik, Hee Chul Park, Jeong Il Yu, Won Sohn, Geum‐Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Liver International.2014; 34(5): 795. CrossRef
Long‐term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching
Yang Won Min, Jun Hee Lee, Geum‐Youn Gwak, Yong Han Paik, Joon Hyoek Lee, Poong‐Lyul Rhee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Moon Seok Choi
Journal of Gastroenterology and Hepatology.2014; 29(5): 1043. CrossRef
Long‐term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea
Yoon Hea Park, Beom Kyung Kim, Ja Kyung Kim, Hyeon Chang Kim, Do Young Kim, Jun Yong Park, Kwang‐Hyub Han, Seung Up Kim, Seung Hwan Shin, Kyu Yeon Hahn, Sang Hoon Ahn
Journal of Gastroenterology and Hepatology.2014; 29(5): 1005. CrossRef
Oral antiviral therapy improves the diagnostic accuracy of alpha‐fetoprotein levels in patients with chronic hepatitis B
Jae‐Jun Shim, Jung Wook Kim, Chang Kyun Lee, Jae Young Jang, Byung‐Ho Kim
Journal of Gastroenterology and Hepatology.2014; 29(9): 1699. CrossRef
Effective Biliary Drainage and Proper Treatment Improve Outcomes of Hepatocellular Carcinoma with Obstructive Jaundice
Yang-Gun Suh, Do Young Kim, Kwang-Hyub Han, Jinsil Seong
Gut and Liver.2014; 8(5): 526. CrossRef
A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma
Eun Kyu Park, Hee Joon Kim, Choong Young Kim, Young Hoe Hur, Yang Seok Koh, Jung Chul Kim, Hyun Jong Kim, Jin Woong Kim, Chol Kyoon Cho
Annals of Surgical Treatment and Research.2014; 87(2): 72. CrossRef
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
Thomas Yau, Vikki Y.F. Tang, Tzy-Jyun Yao, Sheung-Tat Fan, Chung-Mau Lo, Ronnie T.P. Poon
Gastroenterology.2014; 146(7): 1691. CrossRef
Long‐term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma
Young‐Il Kim, Joong‐Won Park, Hee‐Won Kwak, Bo Hyun Kim, Ju Hee Lee, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Chang‐Min Kim
Liver International.2014; 34(8): 1278. CrossRef
Comparison of Malnutrition Risk between Patients with Liver Cirrhosis and Viral Hepatitis Carrier: A Single Center Study
Joo Ah Lee, Tae Hee Lee, Ji Yeong Kim, Min Gyu Seok, Min Gyu Kang, Ji Hyun Jeong, Hoon Sup Koo, Kyung Ho Song, Yong Seok Kim, Sun Moon Kim, Kyu Chan Huh, Young Woo Choi, Young Woo Kang
The Korean Journal of Gastroenterology.2014; 64(5): 284. CrossRef
Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma
Sang Won Kim, Dongryul Oh, Hee Chul Park, Do Hoon Lim, Sung Wook Shin, Sung Ki Cho, Geum-Youn Gwak, Moon Seok Choi, Yong Han Paik, Seung Woon Paik
Radiation Oncology Journal.2014; 32(1): 14. CrossRef
Hepatic Arterial Phase on Gadoxetic Acid-Enhanced Liver MR Imaging: A Randomized Comparison of 0.5 mL/s and 1 mL/s Injection Rates
Sung Mo Kim, Suk Hee Heo, Jin Woong Kim, Hyo Soon Lim, Sang Soo Shin, Yong Yeon Jeong, Heoung Keun Kang
Korean Journal of Radiology.2014; 15(5): 605. CrossRef
Added Value of Diffusion-Weighted MRI for Evaluating Viable Tumor of Hepatocellular Carcinomas Treated With Radiotherapy in Patients With Chronic Liver Disease
Hyun Jeong Park, Seong Hyun Kim, Kyung Mi Jang, Sanghyeok Lim, Tae Wook Kang, Hee Chul Park, Dongil Choi
American Journal of Roentgenology.2014; 202(1): 92. CrossRef
Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma
Tae Hyun Kim, Joong-Won Park, Yeon-Joo Kim, Bo Hyun Kim, Sang Myung Woo, Sung Ho Moon, Sang Soo Kim, Woo Jin Lee, Dae Yong Kim, Chang-Min Kim
Strahlentherapie und Onkologie.2014; 190(10): 882. CrossRef
Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic area
Hee‐Won Kwak, Joong‐Won Park, Byung‐Ho Nam, Ami Yu, Sang Myung Woo, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Sang Jae Park, Woo Jin Lee, Eun Kyung Hong, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2014; 29(4): 820. CrossRef
The Use of Proton Therapy in the Treatment of Gastrointestinal Cancers
Francesco Dionisi, Edgar Ben-Josef
The Cancer Journal.2014; 20(6): 371. CrossRef
Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein Are important prognostic factors for salvage liver transplantation
Sanghoon Lee, Choon Hyuck David Kwon, Jong Man Kim, Jae-Won Joh, Seung Woon Paik, Bong-Wan Kim, Hee-Jung Wang, Kwang-Woong Lee, Kyung-Suk Suh, Suk-Koo Lee
Liver Transplantation.2014; 20(9): 1057. CrossRef
Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
Won Sohn, Moon Seok Choi, Ju Yeon Cho, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Gut and Liver.2014; 8(5): 543. CrossRef
Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
Dong Hyun Sinn, Geum-Youn Gwak, Juhee Cho, Seung Woon Paik, Byung Chul Yoo, Pierre Roques
PLoS ONE.2014; 9(11): e112184. CrossRef
Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Sung Uk Lee, Joong-Won Park, Tae Hyun Kim, Yeon-Joo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Sang-Jae Park, Dae Yong Kim, Chang-Min Kim
Strahlentherapie und Onkologie.2014; 190(9): 806. CrossRef
Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
Chihwan Choi, Gi Hong Choi, Tae Hyun Kim, Masatoshi Tanaka, Mao-Bin Meng, Jinsil Seong
Liver Cancer.2014; 3(3-4): 405. CrossRef
Multimodality Treatment Involving Radiotherapy for Advanced Liver-Confined Hepatocellular Carcinoma
Hong In Yoon, Jinsil Seong
Oncology.2014; 87(Suppl. 1): 90. CrossRef
2014 KLCSG-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma: HCC Diagnostic Algorithm
Jeong Min Lee, Joong-Won Park, Byung Ihn Choi
Digestive Diseases.2014; 32(6): 764. CrossRef
Prognostic Values of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 in Hepatocellular Carcinoma after Radiotherapy
Yang-Gun Suh, Eun-Jung Lee, Hyejung Cha, Seung-Hyun Yang, Jinsil Seong
Digestive Diseases.2014; 32(6): 725. CrossRef
Multimodality Treatment with Radiotherapy for Huge Hepatocellular Carcinoma
Hee Ji Han, Mi Sun Kim, Jihye Cha, Jin Sub Choi, Kwang Hyub Han, Jinsil Seong
Oncology.2014; 87(Suppl. 1): 82. CrossRef
Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas
Eun Suk Park, Do Hoon Kwon, Jun Bum Park, Do Hee Lee, Young Hyun Cho, Jeong Hoon Kim, Chang Jin Kim
Journal of Neurosurgery.2014; 121(Suppl_2): 102. CrossRef
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Ju-Yeon Cho, Yong-Han Paik, Won Sohn, Hyun Chin Cho, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Gut.2014; 63(12): 1943. CrossRef
Worse outcome of sorafenib therapy associated with ascites and Child‐Pugh score in advanced hepatocellular carcinoma
Hwi Young Kim, Joong‐Won Park, Jungnam Joo, Hyoseok Kim, Sang Myung Woo, Woo Jin Lee, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2013; 28(11): 1756. CrossRef
Treatment Outcomes of Helical Intensity-Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma
Moonkyoo Kong, Seong Eon Hong, Woo Suk Choi†, Jinhyun Choi, Youngkyong Kim
Gut and Liver.2013; 7(3): 343. CrossRef
Recent developments in radiotherapy for hepatocellular carcinoma
Hee Chul Park
Journal of the Korean Medical Association.2013; 56(11): 983. CrossRef
National Cancer Screening Program for Hepatocellular Carcinoma
Jin-Wook Kim
Korean Journal of Medicine.2013; 84(5): 670. CrossRef
Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
Yang Won Min, Jeong Kim, Seonwoo Kim, Young Kyung Sung, Jin Hee Lee, Geum‐Youn Gwak, Yong Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee
Liver International.2013; 33(2): 197. CrossRef
Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions
Jae Young Jang, Moon Young Kim, Soung Won Jeong, Tae Yeob Kim, Seung Up Kim, Sae Hwan Lee, Ki Tae Suk, Soo Young Park, Hyun Young Woo, Sang Gyune Kim, Jeong Heo, Soon Koo Baik, Hong Soo Kim, Won Young Tak
Clinical and Molecular Hepatology.2013; 19(1): 1. CrossRef
Status of Primary Liver Cancer Found through Routine Health Check-up
Changhyun Lee, Jong In Yang, Hee Jin Byun, Jung Mook Kang, Seoungho Choi, Jeong Yoon Yim
Journal of Korean Medical Science.2013; 28(10): 1449. CrossRef
Is It Time to Adopt External Beam Radiotherapy in the NCCN Guidelines as a Therapeutic Strategy for Intermediate/Advanced Hepatocellular Carcinoma?
Wei Jiang, Zhao-Chong Zeng
Oncology.2013; 84(s1): 69. CrossRef
Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience
Sung Keun Park, Young Kul Jung, Dong Hae Chung, Keon Kuk Kim, Yeon Ho Park, Jung Nam Lee, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
The Korean Journal of Internal Medicine.2013; 28(4): 428. CrossRef
Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
Beom Kyung Kim, Kyung Ah Kim, Jun Yong Park, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han, Seung Up Kim, Myeong-Jin Kim
European Journal of Cancer.2013; 49(4): 826. CrossRef
Recent advances in hepatic resection and liver transplantation for hepatocellular carcinoma
Shin Hwang
Journal of the Korean Medical Association.2013; 56(11): 956. CrossRef
Early on‐treatment change in liver stiffness predicts development of liver‐related events in chronic hepatitis B patients receiving antiviral therapy
Beom K. Kim, Hyun J. Oh, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Kwang H. Han, Yehyun Park, Eun J. Yoo, Young N. Park, Seung U. Kim
Liver International.2013; 33(2): 180. CrossRef
The Korean National Liver Cancer Surveillance Program: Experience of a Single Healthcare Center in 2011
Jae-Jun Shim, Hyun Jin Park, Jung-Wook Kim, Eun Jung Hwang, Chang Kyun Lee, Jae Young Jang, Seong Jin Park, Hyun Rim Choi, Byung-Ho Kim
Korean Journal of Medicine.2013; 84(5): 672. CrossRef
Recent advance of local ablation for hepatocellular carcinoma
Hyunchul Rhim
Journal of the Korean Medical Association.2013; 56(11): 964. CrossRef
Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
Jihye Cha, Jinsil Seong, Ik Jae Lee, Jun Won Kim, Kwang-Hyub Han
Yonsei Medical Journal.2013; 54(5): 1178. CrossRef
Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma
Sun Hyun Bae, Mi-Sook Kim, Chul Koo Cho, Kum Bae Kim, Dong Han Lee, Chul Ju Han, Su Cheol Park, Young Han Kim
Journal of Korean Medical Science.2013; 28(2): 213. CrossRef
Recent advances in the management of hepatocellular carcinoma
Hee Chul Park
Journal of the Korean Medical Association.2013; 56(11): 946. CrossRef
Recent advances in systemic chemotherapy of hepatocellular carcinoma
Bo Hyun Kim, Joong-Won Park
Journal of the Korean Medical Association.2013; 56(11): 993. CrossRef
Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma
Sang Soo Lee, Sook-Hyang Jeong, Young-Sang Byoun, Seong Min Chung, Mun Hyuk Seong, Hyung Rae Sohn, Bo-young Min, Eun Sun Jang, Jin-Wook Kim, Guan Jung Park, Yoon Jin Lee, Kyoung Ho Lee, Soyeon Ahn
BMC Cancer.2013;[Epub] CrossRef
Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
Byong Sun Oh, Jeong Won Jang, Jung Hyun Kwon, Chan Ran You, Kyu Won Chung, Chul Seung Kay, Hyun Suk Jung, Seungok Lee
BMC Cancer.2013;[Epub] CrossRef
Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
Sangheun Lee, Beom Kyung Kim, Seung Up Kim, Yehyun Park, Sooyun Chang, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han, Salomon M Stemmer
PLoS ONE.2013; 8(10): e77240. CrossRef
Two‐week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma
Jin‐hong Park, Sang Min Yoon, Young‐Suk Lim, So Yeon Kim, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Byungchul Cho, Geumju Park, Jong Hoon Kim
Journal of Gastroenterology and Hepatology.2013; 28(10): 1638. CrossRef
Number of Target Lesions for EASL and Modified RECIST to Predict Survivals in Hepatocellular Carcinoma Treated with Chemoembolization
Beom Kyung Kim, Seung Up Kim, Myeong-Jin Kim, Kyung Ah Kim, Do Young Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon
Clinical Cancer Research.2013; 19(6): 1503. CrossRef
Hepatobiliary Malignancies: Lessons from Asia
Tiffany C.L. Wong, Ronnie T.P. Poon
Digestive Diseases.2013; 31(1): 130. CrossRef
Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period
Do Seon Song, Si Hyun Bae
Clinical and Molecular Hepatology.2012; 18(3): 258. CrossRef
Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome
Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim
The Korean Journal of Internal Medicine.2012; 27(1): 47. CrossRef
Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long‐term clinical outcomes of 1717 treatment‐naïve patients with hepatocellular carcinoma
Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Mi Sung Park, Eun Hye Kim, Jinsil Seong, Do Youn Lee, Kwang‐Hyub Han
Liver International.2012; 32(7): 1120. CrossRef
Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Cheol Jin Kim, Dongryul Oh, Byung Chul Yoo, Seung Woon Paik, Kwang Cheol Kho, Joon Hyuk Lee
Journal of Korean Medical Science.2012; 27(7): 736. CrossRef
The Clinical and Laboratory Characteristics of Patients with Chronic Hepatitis B Using Current or Past Antiviral Therapy in Korea: A Multi-Center, Nation-Wide, Cross-Sectional Epidemiologic Study
Moon Seok Choi, Dong Hyun Sinn, Su-A Kim, Yil Seob Lee, Won Choi, Seung Woon Paik
Gut and Liver.2012; 6(2): 241. CrossRef
The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011
Peipei Song, Ruoyan G. Tobe, Yoshinori Inagaki, Norihiro Kokudo, Kiyoshi Hasegawa, Yasuhiko Sugawara, Wei Tang
Liver International.2012; 32(7): 1053. CrossRef
Salvage Treatment With Hypofractionated Radiotherapy in Patients With Recurrent Small Hepatocellular Carcinoma
Sun Hyun Bae, Hee Chul Park, Do Hoon Lim, Jung Ae Lee, Geum Yeon Gwak, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
International Journal of Radiation Oncology*Biology*Physics.2012; 82(4): e603. CrossRef
Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
Joong-Won Park, Young Hwan Koh, Hyun Beom Kim, Hwi Young Kim, Sangbu An, Joon-Il Choi, Sang Myung Woo, Byung-Ho Nam
Journal of Hepatology.2012; 56(6): 1336. CrossRef
Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma
Jeong Won Jang, Byong Sun Oh, Jung Hyun Kwon, Chan Ran You, Kyu Won Chung, Chul Seung Kay, Hyun Suk Jung
Cytokine.2012; 60(3): 686. CrossRef
Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: A case–control study
Oh Sang Kwon, Young Kul Jung, Kyoung Suk Bae, Ju Hyun Kim, Sang Gyune Kim, Young Seok Kim, Jung Il Lee, Jin Woo Lee, Yun Soo Kim
Alcohol.2012; 46(6): 537. CrossRef
KASL Clinical Practice Guidelines: Management of chronic hepatitis B

Clinical and Molecular Hepatology.2012; 18(2): 109. CrossRef
The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma
Ik Jae Lee, Jinsil Seong
Gut and Liver.2012; 6(2): 139. CrossRef
Type and cause of liver disease in Korea: single-center experience, 2005-2010
Sang Soo Lee, Young-Sang Byoun, Sook-Hyang Jeong, Yeo Myung Kim, Ho Gil, Bo-Young Min, Mun Hyuk Seong, Eun Sun Jang, Jin-Wook Kim
Clinical and Molecular Hepatology.2012; 18(3): 309. CrossRef
Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
Hwi Young Kim, Joong‐Won Park, Jungnam Joo, Se Jin Jung, Sangbu An, Sang Myung Woo, Hyun Beom Kim, Young Hwan Koh, Woo Jin Lee, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2012; 27(6): 1051. CrossRef
Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma
Young Il Kim, Hee Chul Park, Do Hoon Lim, Hyo Jung Park, Sang Won Kang, Su Yeon Park, Jin Sung Kim, Youngyih Han, Seung Woon Paik
Radiation Oncology Journal.2012; 30(4): 189. CrossRef
Radiotherapeutic Strategies in the Management of Hepatocellular Carcinoma
Ik Jae Lee, Jinsil Seong
Oncology.2011; 81(s1): 123. CrossRef
Super-selection of a Subgroup of Hepatocellular Carcinoma Patients at Minimal Risk of Recurrence for Liver Transplantation
Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Young-Dong Yu, Pyoung-Jae Park, Young-Il Choi, Kyoung-Won Kim, Young-Suk Lim, Han Chu Lee, Eun-Sil Yu, Sung-Gyu Lee
Journal of Gastrointestinal Surgery.2011; 15(6): 971. CrossRef
Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
Hwi Young Kim, Joong‐Won Park, Byung‐Ho Nam, Hyun Keun Kim, Joon‐Il Choi, Tae Hyun Kim, Hyun Beom Kim, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2011; 26(11): 1612. CrossRef
Relative Etiological Role of Prior Hepatitis B Virus Infection and Nonalcoholic Fatty Liver Disease in the Development of Non-B Non-C Hepatocellular Carcinoma in a Hepatitis B-Endemic Area
Eun Ju Cho, Min Sun Kwack, Eun Sun Jang, Su Jong You, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee
Digestion.2011; 84(s1): 17. CrossRef
Imaging diagnosis and staging of hepatocellular carcinoma
Jeong Min Lee, Franco Trevisani, Valerie Vilgrain, Christoph Wald
Liver Transplantation.2011; 17(S2): S34. CrossRef
Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Won Park, Byung Chul Yoo, Seung Woon Paik, Kwang Cheol Koh, Joon Hyuk Lee
Journal of Korean Medical Science.2011; 26(8): 1014. CrossRef
The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
Hyuk Soo Eun, Min Jung Kim, Hye Jin Kim, Kwang Hun Ko, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Heon Young Lee, Byung Seok Lee
The Korean Journal of Hepatology.2011; 17(3): 189. CrossRef
Multidisciplinary Management of Nonresectable Hepatocellular Carcinoma
Hee Chul Park, Jinsil Seong, Masatoshi Tanaka, Zhao-Chong Zeng, Ho Yeong Lim, Sheng Guan, Si Hyun Bae, Won Young Tak
Oncology.2011; 81(s1): 134. CrossRef
Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia
Kwang-Hyub Han, Masatochi Kudo, Sheng-Long Ye, Jong Young Choi, Roonni Tung-Ping Poon, Jinsil Seong, Joong-Won Park, Takafumi Ichida, Jin Wook Chung, Pierce Chow, Ann-Lii Cheng
Oncology.2011; 81(s1): 158. CrossRef
Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection
J. W. Jang, S. H. Yoo, J. H. Kwon, C. R. You, S. Lee, J. H. Lee, K. W. Chung
Alimentary Pharmacology & Therapeutics.2011; 34(11-12): 1337. CrossRef
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Beom Kyung Kim, Sang Hoon Ahn, Jin Sil Seong, Jun Yong Park, Do Young Kim, Ja Kyung Kim, Do Youn Lee, Kwang Hoon Lee, Kwang-Hyub Han
Liver International.2011; 31(3): 369. CrossRef
Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors
Young Chul Kim, Yun Hwan Kim, Soon Ho Um, Yeon Seok Seo, Eun Kyung Park, Sun Young Oh, You Mie Han, Jae-Gol Choe
Nuclear Medicine and Molecular Imaging.2011; 45(1): 59. CrossRef
Radiation Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Seung Gyu Park, Jin Hee Kim, Sang Jun Byun, Ok Bae Kim, Jae Seok Hwang, Young Kee Oh, Tae Jin Choi
The Journal of the Korean Society for Therapeutic Radiology and Oncology.2011; 29(1): 36. CrossRef
18F‐fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma
Beom Kyung Kim, Won Jun Kang, Ja Kyung Kim, Jinsil Seong, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Do Youn Lee, Kwang Hoon Lee, Jong Doo Lee, Kwang‐Hyub Han
Cancer.2011; 117(20): 4779. CrossRef
Molecularly Targeted Therapies for Hepatocellular Carcinoma: Sorafenib as a Stepping Stone
Hwi Young Kim, Joong-Won Park
Digestive Diseases.2011; 29(3): 303. CrossRef
Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea
Jong Young Choi
Oncology.2011; 81(s1): 141. CrossRef
The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
Hyuk Soo Eun, Min Jung Kim, Hye Jin Kim, Kwang Hun Ko, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Heon Young Lee, Byung Seok Lee
The Korean Journal of Hepatology.2011; 17(3): 189. CrossRef
Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation
Won Kyoung Yun, Moon Seok Choi, Dongil Choi, Hyun-Chul Rhim, Jae Won Joh, Kyung Hee Kim, Tae Hoon Jang, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Hepatology International.2011; 5(2): 722. CrossRef
Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion
Pei-Jer Chen, Junji Furuse, Kwang-Hyub Han, Chiun Hsu, Ho-Yeong Lim, HanLim Moon, Shukui Qin, Sheng-Long Ye, Ee-Min Yeoh, Winnie Yeo
Liver International.2010; 30(10): 1427. CrossRef
Liver Cancer Working Group Report
M. Kudo, K. H. Han, N. Kokudo, A.-L. Cheng, B. I. Choi, J. Furuse, N. Izumi, J.-W. Park, R. T. Poon, M. Sakamoto
Japanese Journal of Clinical Oncology.2010; 40(Supplement): i19. CrossRef
Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study
Oh Sang Kwon, Young Kul Jung, Yun Soo Kim, Sang Gyune Kim, Young Seok Kim, Jung Il Lee, Jin Woo Lee, Young Soo Kim, Byung Chul Chun, Ju Hyun Kim
The Korean Journal of Hepatology.2010; 16(3): 308. CrossRef
Hypofractionated Radiotherapy for Small-sized Hepatocellular Carcinoma as Salvage Therapy: Sustained Local Control and Safety
Sun Hyun Bae, Hee Chul Park, Do Hoon Lim, Jung Ae Lee, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
The Journal of the Korean Society for Therapeutic Radiology and Oncology.2010; 28(2): 85. CrossRef
Liver Transplantation for Advanced Hepatocellular Carcinoma
Kwang-Woong Lee, Kyung-Suk Suh
Korean Journal of Transplantation.2010; 24(1): 4. CrossRef
Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
Ja Young Kang, Moon Seok Choi, Sue Jin Kim, Jae Sook Kil, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
The Korean Journal of Hepatology.2010; 16(4): 383. CrossRef
Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma
Winnie Yeo, Pei-Jer Chen, Junji Furuse, Kwang-Hyub Han, Chiun Hsu, Ho-Yeong Lim, Hanlim Moon, Shukui Qin, Ee-Min Yeoh, Sheng-Long Ye
BMC Cancer.2010;[Epub] CrossRef
Current status of liver diseases in Korea: Hepatocellular carcinoma
Il Han Song, Kyung Sik Kim
The Korean Journal of Hepatology.2009; 15(Suppl 6): S50. CrossRef